
<html lang="en"     class="pb-page"  data-request-id="803c4ce8-9b5a-4e14-a4b4-56a738043e29"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2021.64.issue-9;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.1c00076"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Design and Structure–Activity Relationships of Isothiocyanates as Potent and Selective N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibitors" /></meta><meta name="dc.Creator" content="Michael S.  Malamas" /></meta><meta name="dc.Creator" content="Spiro  Pavlopoulos" /></meta><meta name="dc.Creator" content="Shakiru O.  Alapafuja" /></meta><meta name="dc.Creator" content="Shrouq I.  Farah" /></meta><meta name="dc.Creator" content="Alexander  Zvonok" /></meta><meta name="dc.Creator" content="Khadijah A.  Mohammad" /></meta><meta name="dc.Creator" content="Jay  West" /></meta><meta name="dc.Creator" content="Nicholas Thomas  Perry" /></meta><meta name="dc.Creator" content="Dimitrios N.  Pelekoudas" /></meta><meta name="dc.Creator" content="Girija  Rajarshi" /></meta><meta name="dc.Creator" content="Christina  Shields" /></meta><meta name="dc.Creator" content="Honrao  Chandrashekhar" /></meta><meta name="dc.Creator" content="Jodi  Wood" /></meta><meta name="dc.Creator" content="Alexandros  Makriyannis" /></meta><meta name="dc.Description" content="N-Acylethanolamines are signaling lipid molecules implicated in pathophysiological conditions associated with inflammation and pain. N-Acylethanolamine acid amidase (NAAA) favorably hydrolyzes lipi..." /></meta><meta name="Description" content="N-Acylethanolamines are signaling lipid molecules implicated in pathophysiological conditions associated with inflammation and pain. N-Acylethanolamine acid amidase (NAAA) favorably hydrolyzes lipi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 26, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00076" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00076" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00076" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00076" /></link>
        
    
    

<title>Design and Structure–Activity Relationships of Isothiocyanates as Potent and Selective N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00076" /></meta><meta property="og:title" content="Design and Structure–Activity Relationships of Isothiocyanates as Potent and Selective N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0021.jpeg" /></meta><meta property="og:description" content="N-Acylethanolamines are signaling lipid molecules implicated in pathophysiological conditions associated with inflammation and pain. N-Acylethanolamine acid amidase (NAAA) favorably hydrolyzes lipid palmitoylethanolamide, which plays a key role in the regulation of inflammatory and pain processes. The synthesis and structure-activity relationship studies encompassing the isothiocyanate pharmacophore have produced potent low nanomolar inhibitors for hNAAA, while exhibiting  high selectivity (&gt;100-fold) against other serine hydrolases and cysteine peptidases. We have followed a target-based structure–activity relationship approach, supported by computational methods and known cocrystals of hNAAA. We have identified systemically active inhibitors with good plasma stability (t1/2 &gt; 2 h) and microsomal stability (t1/2 ∼ 15–30 min) as pharmacological tools to investigate the role of NAAA in inflammation, pain, and drug addiction." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00076"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00076">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00076&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00076&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00076&amp;href=/doi/10.1021/acs.jmedchem.1c00076" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 5956-5972</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.1c00065" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.1c00078" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Structure–Activity Relationships of Isothiocyanates as Potent and Selective <i>N</i>-Acylethanolamine-Hydrolyzing Acid Amidase Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Michael S. Malamas</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael S. Malamas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Northeastern University, Boston, Massachusetts 02115, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#fd909c919c909c8ed390949e959c9891bd9a909c9491d39e9290"><span class="__cf_email__" data-cfemail="eb868a878a868a98c5868288838a8e87ab8c868a8287c5888486">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+S.++Malamas">Michael S. Malamas</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4785-7525" title="Orcid link">http://orcid.org/0000-0002-4785-7525</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Spiro Pavlopoulos</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Spiro Pavlopoulos</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Spiro++Pavlopoulos">Spiro Pavlopoulos</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shakiru O. Alapafuja</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shakiru O. Alapafuja</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">MAK Scientific LLC, 151 South Bedford Street, Burlington, Massachusetts 01803, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shakiru+O.++Alapafuja">Shakiru O. Alapafuja</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shrouq I. Farah</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shrouq I. Farah</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shrouq+I.++Farah">Shrouq I. Farah</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alexander Zvonok</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alexander Zvonok</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alexander++Zvonok">Alexander Zvonok</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Khadijah A. Mohammad</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Khadijah A. Mohammad</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Khadijah+A.++Mohammad">Khadijah A. Mohammad</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jay West</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jay West</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jay++West">Jay West</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nicholas Thomas Perry</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nicholas Thomas Perry</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas+Thomas++Perry">Nicholas Thomas Perry</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dimitrios N. Pelekoudas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dimitrios N. Pelekoudas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dimitrios+N.++Pelekoudas">Dimitrios N. Pelekoudas</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Girija Rajarshi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Girija Rajarshi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Girija++Rajarshi">Girija Rajarshi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christina Shields</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christina Shields</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christina++Shields">Christina Shields</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Honrao Chandrashekhar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Honrao Chandrashekhar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Honrao++Chandrashekhar">Honrao Chandrashekhar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jodi Wood</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jodi Wood</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jodi++Wood">Jodi Wood</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Alexandros Makriyannis</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alexandros Makriyannis</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Drug Discovery and Departments of Chemistry and Chemical Biology and Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts 02115, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alexandros++Makriyannis">Alexandros Makriyannis</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00076&amp;href=/doi/10.1021%2Facs.jmedchem.1c00076" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 5956–5972</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 26, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 January 2021</li><li><span class="item_label"><b>Published</b> online</span>26 April 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 May 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00076" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00076</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5956%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMichael%2BS.%2BMalamas%252C%2BSpiro%2BPavlopoulos%252C%2BShakiru%2BO.%2BAlapafuja%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D9%26contentID%3Dacs.jmedchem.1c00076%26title%3DDesign%2Band%2BStructure%25E2%2580%2593Activity%2BRelationships%2Bof%2BIsothiocyanates%2Bas%2BPotent%2Band%2BSelective%2BN-Acylethanolamine-Hydrolyzing%2BAcid%2BAmidase%2BInhibitors%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5972%26publicationDate%3DMay%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00076"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">548</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00076" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Structure–Activity Relationships of Isothiocyanates as Potent and Selective N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;S. Malamas&quot;},{&quot;first_name&quot;:&quot;Spiro&quot;,&quot;last_name&quot;:&quot;Pavlopoulos&quot;},{&quot;first_name&quot;:&quot;Shakiru&quot;,&quot;last_name&quot;:&quot;O. Alapafuja&quot;},{&quot;first_name&quot;:&quot;Shrouq&quot;,&quot;last_name&quot;:&quot;I. Farah&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;Zvonok&quot;},{&quot;first_name&quot;:&quot;Khadijah&quot;,&quot;last_name&quot;:&quot;A. Mohammad&quot;},{&quot;first_name&quot;:&quot;Jay&quot;,&quot;last_name&quot;:&quot;West&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;Thomas Perry&quot;},{&quot;first_name&quot;:&quot;Dimitrios&quot;,&quot;last_name&quot;:&quot;N. Pelekoudas&quot;},{&quot;first_name&quot;:&quot;Girija&quot;,&quot;last_name&quot;:&quot;Rajarshi&quot;},{&quot;first_name&quot;:&quot;Christina&quot;,&quot;last_name&quot;:&quot;Shields&quot;},{&quot;first_name&quot;:&quot;Honrao&quot;,&quot;last_name&quot;:&quot;Chandrashekhar&quot;},{&quot;first_name&quot;:&quot;Jodi&quot;,&quot;last_name&quot;:&quot;Wood&quot;},{&quot;first_name&quot;:&quot;Alexandros&quot;,&quot;last_name&quot;:&quot;Makriyannis&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;26&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;5956-5972&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00076&quot;},&quot;abstract&quot;:&quot;N-Acylethanolamines are signaling lipid molecules implicated in pathophysiological conditions associated with inflammation and pain. N-Acylethanolamine acid amidase (NAAA) favorably hydrolyzes lipid palmitoylethanolamide, which plays a key role in the regulation of inflammatory and pain processes. The synthesis and structure-activity relationship studies encompassing the isothiocyanate pharmacophore have produced potent low nanomolar inhibitors for hNAAA, while exhibiting high selectivity (&gt;100-fold) against other serine hydrolases and cysteine peptidases. We have followed a target-based structure–activity relationship approach, supported by computational methods and known cocrystals of hNAAA. We have identified systemically active inhibitors with good plasma stability (t1/2 &gt; 2 h) and microsomal stability (t1/2 ∼ 15–30 min) as pharmacological tools to investigate the role of NAAA in inflammation, pain, and drug addiction.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00076&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00076" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00076&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00076" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00076&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00076" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00076&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00076&amp;href=/doi/10.1021/acs.jmedchem.1c00076" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00076" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00076" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00076%26sid%3Dliteratum%253Aachs%26pmid%3D33900772%26genre%3Darticle%26aulast%3DMalamas%26date%3D2021%26atitle%3DDesign%2Band%2BStructure%25E2%2580%2593Activity%2BRelationships%2Bof%2BIsothiocyanates%2Bas%2BPotent%2Band%2BSelective%2BN-Acylethanolamine-Hydrolyzing%2BAcid%2BAmidase%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D9%26spage%3D5956%26epage%3D5972%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (4)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292547" title="Adducts">Adducts</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291241" title="Phenyls">Phenyls</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/jmcmar.2021.64.issue-9/20210513/jmcmar.2021.64.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText"><i>N</i>-Acylethanolamines are signaling lipid molecules implicated in pathophysiological conditions associated with inflammation and pain. <i>N</i>-Acylethanolamine acid amidase (NAAA) favorably hydrolyzes lipid palmitoylethanolamide, which plays a key role in the regulation of inflammatory and pain processes. The synthesis and structure-activity relationship studies encompassing the isothiocyanate pharmacophore have produced potent low nanomolar inhibitors for hNAAA, while exhibiting  high selectivity (>100-fold) against other serine hydrolases and cysteine peptidases. We have followed a target-based structure–activity relationship approach, supported by computational methods and known cocrystals of hNAAA. We have identified systemically active inhibitors with good plasma stability (<i>t</i><sub>1/2</sub> > 2 h) and microsomal stability (<i>t</i><sub>1/2</sub> ∼ 15–30 min) as pharmacological tools to investigate the role of NAAA in inflammation, pain, and drug addiction.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30028" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30028" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><i>N</i>-Acylethanolamines (NAEs) are endogenous bioactive lipids that are implicated in many pathophysiological conditions, mostly associated with inflammation<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> and pain.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3−5)</a> Also, recent reports suggest that the modulation of endogenous NAEs plays an important role in neurodegenerative diseases<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and drug addiction.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7−9)</a> The primary NAEs, arachidonoylethanolamine (AEA) and palmitoylethanolamide (PEA), exert their pharmacological action through two distinct molecular pathways. AEA suppresses inflammatory processes and promotes neuroprotective benefits by stimulating cannabinoid receptors CB1 and CB2,<a onclick="showRef(event, 'ref6 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref6 ref10 ref11">(6,10,11)</a> while PEA displays anti-inflammatory and neuroprotective effects by activating nuclear peroxisome proliferator-activated receptor-alpha (PPARα).<a onclick="showRef(event, 'ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15">(12−15)</a> Both NAEs differ in their subcellular localization and substrate preference<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and either independently or synergistically contribute to the pathophysiological conditions. AEA and PEA are synthesized “on-demand” in most mammalian cells<a onclick="showRef(event, 'ref12 ref17'); return false;" href="javascript:void(0);" class="ref ref12 ref17">(12,17)</a> and their pharmacological action is modulated by two distinct hydrolases, fatty acid amide hydrolase (FAAH)<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and <i>N</i>-acylethanolamine acid amidase (NAAA),<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> respectively. There is an abundance of data supporting the role of NAAA inhibition in various diseases, such as inflammation,<a onclick="showRef(event, 'ref21 ref22 ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24 ref25 ref26">(21−26)</a> allergic dermatitis,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> neuropathic pain,<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> multiple sclerosis,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and nicotine addiction.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> To date, only a few systemic NAAA inhibitors are known<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> and there is a need to discover new inhibitors to fully explore the pharmacological benefits of inhibition of NAAA.</div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Known NAAA Inhibitors</h3><div class="NLM_p">The majority of the reported NAAA inhibitors represent β-lactone and β-lactam derivatives<a onclick="showRef(event, 'ref21 ref31 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref21 ref31 ref32 ref33 ref34">(21,31−34)</a> (<b>1</b> to <b>5</b>; <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) that showed nanomolar potency for the target. However, the majority exhibited poor plasma stability (<i>t</i><sub>1/2</sub> < 5 min) and moderate metabolic stability to be considered as development candidates.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> One can consider that the reactive “war-heads” and lipophilic tails of the inhibitors are prone to hydrolytic and cytochrome P450 metabolic processes. It was also shown that β-lactone and β-lactam inhibitors form covalent adducts with the N-terminal catalytic cysteine Cys126 of hNAAA through an <i>S</i>-acylation process as determined by high-resolution MS/MS analysis of the modified peptide.<a onclick="showRef(event, 'ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39">(37−39)</a> NAAA inhibitors <b>6</b> and <b>7</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) carry reactive electrophilic groups, oxazolidinone and cyanamide, that most likely interact covalently with the catalytic Cys126 of NAAA. NAAA inhibitor <b>8</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) represents the first reported reversible inhibitor for NAAA; however, it exhibited >20-fold drop in potency when compared to other irreversible inhibitors (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Known NAAA inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In this paper, we describe a new class of NAAA inhibitors carrying the isothiocyanate (NCS) pharmacophore. NCS compounds occur widely in nature in cruciferous vegetables and are of interest in food science and medicine. Over the past 20 years, many studies have revealed that NCS compounds (natural or synthetic) are chemopreventive agents without any reports of adverse effects in clinical trials.<a onclick="showRef(event, 'ref40 ref41 ref42 ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42 ref43 ref44 ref45">(40−45)</a> Still, there are no known NCS drugs in the market. Furthermore, it has been reported that NCS compounds readily react with alkyl thiols (R-SH) to form conjugate adducts (dithiocarbamates) in aqueous solutions. However, the dithiocarbamate adduct deconjugates over time to regenerate the NCS parent molecule and the corresponding thiol until a state of equilibrium is reached.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The rate of the adduct cleavage depends on the structural features of the thiol group and the overall shape of the ligand.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Both of these characteristics offer an opportunity to design molecules with a long residence time of the formed adduct and deliver a long-lasting pharmacodynamic effect. Notably, fully irreversible adducts have raised serious potential safety concerns in drug development because of the relationship between covalent drug binding and the potential of immunogenic driven allergic reactions and idiosyncratic drug toxicity.<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48,49)</a></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55158" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55158" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Isothiocyanate NAAA Inhibitors</h3><div class="NLM_p">We have recently published a novel series of cyanamide (N-CN) NAAA inhibitors with nanomolar potency for NAAA.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> In this paper, we have exploited structural features of the N-CN inhibitors to design new NCS inhibitors (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). We have retained the biphenyl tail of cyanamide <b>9</b> and replaced the azetidine-nitrile moiety with a cyclobutane ring bearing the NCS pharmacophore (<b>10</b>, dotted lines, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). We have assumed that both ligands <b>9</b> and <b>10</b> are active site inhibitors. Conformational analysis of <b>9</b> and <b>10</b> (cis-isomer) produced a good overlap (cartoon A, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). The corresponding trans-isomer <b>11</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) overlapped poorly with <b>9</b> (not shown). The preparation and biochemical evaluation of the cis-isomer <b>10</b> for hNAAA using a fluorometric assay after a 90 min pre-incubation period revealed that <b>10</b> was a potent NAAA inhibitor (IC<sub>50</sub> = 93 nM) but was 30-fold weaker than <b>9</b>. The decrease in potency of <b>10</b> when compared to that of <b>9</b> was probably due to two factors: (1) the different electrophilic reactivities of the two pharmacophores NCS versus N-CN toward the nucleophilic sulfhydryl group of the catalytic cysteine Cys126 of hNAAA, with the N-CN group being more reactive and forming a tighter interaction (conjugate adduct) with Cys126 and (2) the different conformational adaptations of the NCS ligand <b>10</b> within the NAAA binding pocket when compared to that of <b>9</b>. The NCS group is longer than the N-CN group and also the NCS group projects at an angular orientation because it is attached at the sp<sup>3</sup> carbon of the cyclobutane ring. We have also prepared the analogous trans-isomer <b>11</b>, and it was found to exhibit poor activity for NAAA with an IC<sub>50</sub> value of 4.3 μM. To better assess the inhibitory potency of <b>10</b>, we have determined the <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> value, which is more representative to irreversible inhibition.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Compound <b>10</b> exhibited a high <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> value of 7.23 × 10<sup>6</sup> M<sup>–1</sup> s<sup>–1</sup> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) suggesting the high affinity for NAAA.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of isothiocyanate NAAA inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Alkoxy-Linked Isothiocyanate hNAAA Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0013.gif" alt="" id="GRAPHIC-d7e629-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0014.gif" alt="" id="gr12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub>s performed in triplicate and determined from eight concentrations in the hNAAA inhibition assay. Activity measured after 90 min of pre-incubation of the inhibitor and enzyme prior to the addition of the fluorogenic substrate <i>N</i>-(4-methyl coumarin) palmitamide (PAMCA). IC<sub>50</sub> values were calculated using Prism software (GraphPad).</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Clog <i>P</i> values were calculated using ChemDraw version 16.0.</p></div></div><div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Computer-Assisted Drug Design</h3><div class="NLM_p">We have used computational methods to gain structural insights of the interactions of our ligands with NAAA. The disclosure of two cocrystal structures of hNAAA<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> offered us the opportunity to rationally design NCS-based ligands. We have constructed “pre-covalent” binding poses of the proposed molecules to examine their conformational adaptation within the NAAA binding pocket. For example, induced-fit pre-covalent studies (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) of <b>36</b> with a hNAAA structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DXX">6DXX</a><a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a>) revealed the hydrophobic nature of the binding pocket of NAAA. Several hydrophobic residues Tyr146, Tyr177, Trp181, Phe174, and Met64 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>; ligand interaction diagram of <b>36</b>/hNAAA) point to a highly hydrophobic pocket where the ligand is positioned by making several π-stacking interactions. Next, we performed covalent docking studies of <b>36</b> with NAAA, as shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>. The NCS group of <b>36</b> interacts with the active site catalytic cysteine Cys126 to form a carbonimidodithioate adduct, while the rest of the ligand orients similarly to the pre-covalent binding pose (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). To expand the structure–activity relationships (SARs) of the NCS inhibitors, we have constructed “pre-covalent” NAAA-ligand poses using Glide/Prime<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53,54)</a> (Schrodinger) to determine inhibitor fit into the binding pocket with the correct binding geometry, We have calculated the lowest free-binding energy of the ligand by using the CovDock/Prime<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> method. Additionally, we have compared the conformations and binding energies of the docked ligands in induced-fit and covalent-docked poses to examine the alignment and adaptation of the ligand within the binding pocket before and after its interaction with catalytic cysteine Cys126 of NAAA. We also measured the proximity of the NCS group to Cys126 of the induced-fit ligand orientation to predict the carbonimidodithioate adduct formation. As part of our studies, we have also employed chemoinformatics calculations (i.e., MW, Clog <i>P</i>, tPSA, and LiPE) and applied the Lipinski’s Rule of Five to evaluate drug likeness.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Induced-fit docking of <b>36</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) with a hNAAA structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DXX">6DXX</a>.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> A Connolly surface is used to represent the shape of the binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Interaction diagram of <b>36</b> with hNAAA (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DXX">6DXX</a><a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a>). The ligand orients toward the catalytic region (Cys126) making several hydrophobic contacts with residues Tyr146, Tyr177, Trp181, and Phe174.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Covalent docking of <b>36</b> with a hNAAA crystal structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DXX">6DXX</a><a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a>) forming a carbonimidodithioate adduct.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Synthesis</h3><div class="NLM_p">The reported compounds were prepared according to general synthetic <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<named-content content-type="anchor" rid="sch2" type="simple"></named-content><named-content content-type="anchor" rid="sch3" type="simple"></named-content><a class="ref internalNav" href="#sch4" aria-label="4">4</a>.</div><figure id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>10–55</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) and <b>78–91</b> (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) 4-Br-benzyl bromide, NaH, and THF; (b) Ar-B(OH)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, and H<sub>2</sub>O; (c) TFA and CH<sub>2</sub>Cl<sub>2</sub>; and (d) 1,1′-thiocarbonyldi-2(1<i>H</i>)-pyridone, Et<sub>3</sub>N, and CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>53</b> (<a class="ref internalNav" href="#sch2" aria-label="Table 2">Table 2</a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) 4-BrPhOH, DIAD, and Ph<sub>3</sub>P; (b) Ar-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, and K<sub>2</sub>CO<sub>3</sub>; (c) TFA and CH<sub>2</sub>Cl<sub>2</sub>; and (d) 1,1′-thiocarbonyldi-(1<i>H</i>)-pyridone, Et<sub>3</sub>N.</p></p></figure><figure id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>57–60</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) Na(OAC)<sub>3</sub>BH, AcOH, and THF; (b) R<sub>3</sub>-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, and K<sub>2</sub>CO<sub>3</sub>; (c) TFA and CH<sub>2</sub>Cl<sub>2</sub>; and (d) 1,1′-thiocarbonyldi-(1<i>H</i>)-pyridone and Et<sub>3</sub>N.</p></p></figure><figure id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>61–68</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) and <b>69–71</b>, <b>74–76</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) Aryl carboxylic acid, EDC, DIEA, HOBt, and DMF; (b) Aryl sulfonyl chloride, DIEA, and CH<sub>2</sub>Cl<sub>2</sub>; (c) Ar-B(OH)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, and H<sub>2</sub>O; (d) TFA and CH<sub>2</sub>Cl<sub>2</sub>; and (e) 1,1′-thiocarbonyldi-2(1<i>H</i>)-pyridone, Et<sub>3</sub>N, and CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Synthesis of Alkoxy Analogues (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>)</h4><div class="NLM_p last">Coupling of hydroxy cyclobutane <b>12</b> with 1-bromo-4-(bromomethyl)benzene upon treatment with sodium hydride in tetrahydrofuran afforded <b>13</b> (R<sub>1</sub> = H). The palladium-mediated cross-coupling reaction between aryl bromide <b>13</b> (R<sub>1</sub> = H) and an appropriate aryl boronic acid in the presence of tetrakis (triphenylphosphine) palladium (0), K<sub>2</sub>CO<sub>3</sub>, dioxane, and water produced biaryl <b>14</b> (<b>R</b><sub>1</sub> = H, <b>R</b><sub><b>2</b></sub> = aryl, heteroaryl). Unmasking the BOC group of <b>14</b> (<b>R</b><sub>1</sub> = H, <b>R</b><sub><b>2</b></sub> = aryl, heteroaryl) with trifluoroacetic acid (TFA) in dichloromethane afforded amine <b>15</b> (<b>R</b><sub>1</sub> = H, <b>R</b><sub><b>2</b></sub> = aryl, heteroaryl), which upon treatment with 1,1′-thiocarbonyldi-2(1<i>H</i>)-pyridone and triethylamine in dichloromethane afforded isothiocyanate <b>16</b> (<b>R</b><sub>1</sub> = H, <b>R</b><sub><b>2</b></sub> = aryl, heteroaryl).</div></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Synthesis of Phenoxy Analogues (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>)</h4><div class="NLM_p last">Hydroxy cyclobutane <b>12</b> was coupled with 4-bromo-phenol using the Mitsunobu protocol<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> (DIAD/Ph<sub>3</sub>P) to afford <b>17</b>. Phenoxy <b>17</b> was converted to isothiocyanate <b>19</b> (<b>R</b><sub><b>2</b></sub><b>= aryl</b>) according to <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div></div><div id="sec2_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Synthesis of Amino Analogues (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>)</h4><div class="NLM_p last">The reductive amination of 3-butanone <b>20</b> with amine <b>21</b> using sodium triacetoxy borohydride under acidic conditions (i.e., AcOH) produced <b>22</b>. Intermediate <b>22</b> was converted to isothiocyanates <b>24a and 24b</b>, according to <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The cis- and trans-isomers <b>24a</b> and <b>24b</b> (<i>n</i> = 2) were separated by flash chromatography.</div></div><div id="sec2_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Synthesis of Carboxamide/Sulfonamide Analogues (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>)</h4><div class="NLM_p last">Cyclobutyl-amine <b>25</b> was coupled with an appropriate benzoic acid in the presence <i>N</i>-ethyl-<i>N</i>′-(3-dimethylaminopropyl) carbodiimide (EDC)/HOBt to afford amide <b>26</b>. Also, the coupling of <b>25</b> with an appropriate benzenesulfonyl chloride in the presence of DIEA afforded sulfonamide <b>27</b>. Both, amide <b>26</b> and sulfonamide <b>27</b> were converted to isothiocyanates <b>28</b> and <b>29</b>, respectively, according to <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74222" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74222" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All synthesized compounds were assessed in a fluorescence-based assay for hNAAA inhibition with <i>N</i>-(4-methyl coumarin)palmitamide (PAMCA) as the substrate.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The SAR development of this series of inhibitors was based on IC<sub>50</sub> determinations at 90 min pre-incubation experiments, where we have attained full ligand/enzyme engagement (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>−<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). We have also performed <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> determinations that are independent of pre-incubation times and represent a better measure of potency of covalent inhibitors (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Compounds that inhibited hNAAA with an IC<sub>50</sub> value of <30 nM were further evaluated in selectivity counterscreen assays. First, they were tested for their ability to inhibit human-recombinant FAAH (hFAAH)<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> using the fluorogenic substrate arachidonoyl 7-amino-4-methylcoumarin amide (AAMCA).<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59,60)</a> Following similar fluorometric procedures, compounds that were found to be >100-fold selective against FAAH were tested against the hydrolytic enzymes human monoacylglycerol lipase (hMGL)<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> and human α/β-hydrolase domain containing 6 (hABHD6).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Also, the selected potent NAAA inhibitors were evaluated against the related cysteine peptidase cathepsin K for selectivity because NAAA is a cysteine peptidase that belongs to the N-terminal nucleophile (Ntn) family of enzymes.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Furthermore, the selected compounds were evaluated for their ability to bind to CB1 and CB2 receptors using rat brain<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> or HEK293 cell membranes expressing mouse CB2 (mCB2) or human CB2 (hCB2),<a onclick="showRef(event, 'ref64 ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref64 ref65 ref66">(64−66)</a> respectively, via competition equilibrium binding using [<sup>3</sup>H]CP-55,940<a onclick="showRef(event, 'ref65 ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref65 ref66 ref67">(65−67)</a> to minimize/eliminate any potential cross-reactivity due to potential common pharmacophoric features. Below, we describe our SAR studies of a selection of compounds, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<named-content content-type="anchor" rid="tbl2" type="simple"></named-content><named-content content-type="anchor" rid="tbl3" type="simple"></named-content><a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. <i>N</i>-Linked Isothiocyanate hNAAA Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0015.gif" alt="" id="GRAPHIC-d7e1314-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0016.gif" alt="" id="gr13" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub>s performed in triplicate and determined from eight concentrations in the hNAAA inhibition assay. Activity measured after 90 min of pre-incubation of the inhibitor and enzyme prior to the addition of the fluorogenic substrate PAMCA. IC<sub>50</sub> values were calculated using Prism software (GraphPad).</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Clog <i>P</i> values were calculated using ChemDraw version 16.0.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Carboxamide-/Sulfonamide-Linked Isothiocyanate hNAAA Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0017.gif" alt="" id="GRAPHIC-d7e1342-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">W</th><th class="colsep0 rowsep0" align="center">hNAAA IC<sub>50</sub> (nM) ± SEM<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a>a</th><th class="colsep0 rowsep0" align="center">cathepsin K @ 1 μM<sup>b</sup></th><th class="colsep0 rowsep0" align="center" char=".">Clog <i>P</i><a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="left">4-OMe,3-FPh</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CONH</td><td class="colsep0 rowsep0" align="left">26.6 ± 0.6</td><td class="colsep0 rowsep0" align="left">inactive</td><td class="colsep0 rowsep0" align="char" char=".">3.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b></td><td class="colsep0 rowsep0" align="left">4-OMePh</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CONH</td><td class="colsep0 rowsep0" align="left">7.6 ± 0.9</td><td class="colsep0 rowsep0" align="left">inactive</td><td class="colsep0 rowsep0" align="char" char=".">3.65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="left">MeSO<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CONH</td><td class="colsep0 rowsep0" align="left">41% @ 1 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">2.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="left">4-OMePh</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH</td><td class="colsep0 rowsep0" align="left">6.3 ± 0.4</td><td class="colsep0 rowsep0" align="left">inactive</td><td class="colsep0 rowsep0" align="char" char=".">3.78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="left">4-OMePh</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH</td><td class="colsep0 rowsep0" align="left">2.3 ± 0.35</td><td class="colsep0 rowsep0" align="left">inactive</td><td class="colsep0 rowsep0" align="char" char=".">4.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>66</b></td><td class="colsep0 rowsep0" align="left">4-OMe,3-FPh</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH</td><td class="colsep0 rowsep0" align="left">3.2 ± 0.15</td><td class="colsep0 rowsep0" align="left">inactive</td><td class="colsep0 rowsep0" align="char" char=".">4.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>67</b></td><td class="colsep0 rowsep0" align="left">4-OMePh</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">OCONH</td><td class="colsep0 rowsep0" align="left">7.0 ± 0.3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">4.21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="left">4-OMePhO</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">CONH</td><td class="colsep0 rowsep0" align="left">1416 ± 14</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">4.16</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub>s performed in triplicate and determined from eight concentrations in the hNAAA inhibition assay. Activity measured after 90 min of pre-incubation of the inhibitor and enzyme prior to the addition of the fluorogenic substrate PAMCA. IC<sub>50</sub> values were calculated using Prism software (GraphPad).</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Compounds were tested in triplicate and pre-incubated for 120 min with recombinant human cathepsin K. We used the fluorogenic substrate Z-Phe-Arg-AMC.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Clog <i>P</i> values were calculated using ChemDraw version 16.0.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Polar and Aliphatic Isothiocyanate hNAAA Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0018.gif" alt="" id="GRAPHIC-d7e1568-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0019.gif" alt="" id="gr14" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub>s performed in triplicate and determined from eight concentrations in the hNAAA inhibition assay. Activity measured after 90 min of pre-incubation of the inhibitor and enzyme prior to the addition of the fluorogenic substrate PAMCA. IC<sub>50</sub> values were calculated using Prism software (GraphPad).</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Clog <i>P</i> values were calculated using ChemDraw version 16.0.</p></div></div><div></div></div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Substitutions of Lead Compound <b>10</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>)</h3><div class="NLM_p last">We have introduced substitutions at the distal phenyl group of lead compound <b>10</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) to maximize van der Waals hydrophobic contacts between the ligand and protein to enhance potency for the target, considering the hydrophobic nature of the binding pocket of NAAA. The <i>para</i>-methyl analogue <b>30a</b> was about 3-fold more potent than the unsubstituted analogue <b>10</b>. Both trans-isomers <b>11</b> and <b>30b</b> were about 20–40-fold weaker than the analogous cis-isomers <b>10</b> and <b>30a</b>, respectively. The <i>meta</i>-methoxy analogue <b>31</b> was 4-fold more potent than <b>10</b>, while the <i>meta</i>-trifluoromethyl analogue <b>32</b> was only slightly better than <b>10</b>. Analogue <b>32</b> also carries a second modification with the introduction of the metabolically stable fluorine group at the proximal phenyl moiety of the ligand to limit cytochrome P450 oxidation. The introduction of an electronegative fluorine group at the para-position of the distal phenyl (entry <b>33</b>) caused a 7-fold drop in potency (<b>33</b> vs <b>31</b>). Interchanging the two phenyl substituents of <b>33</b> to generate the 4-OMe, 3-FPh-analogue <b>34</b> resulted in the recovery of potency (<b>34</b> vs <b>33</b>). In contrast, the <i>para</i>-OCF<sub>3</sub> group (<b>35</b>) caused a 4-fold potency loss. We have postulated that the presence of electronegative groups (F, OCF3) at the para-position of the distal phenyl of <b>33</b> and <b>35</b> have triggered unfavorable electrostatic contacts with the residues of the binding pocket causing loss in potency. The more polar analogue, pyridine <b>36</b>, showed similar potency (IC<sub>50</sub> = 20 nM) for NAAA when it was compared to <b>34</b>. We were aiming at increasing the hydrophilic character of <b>36</b> with the introduction the polar pyridyl nucleus to improve water solubility and bioavailability. Compound <b>36</b> has a 1.5 units lower Clog <i>P</i> value than <b>34</b> (3.38 vs 4.89, respectively). Induced-fit molecular modeling studies of <b>36</b> with the hNAAA X-ray crystal structure (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) suggested that hydrophobic substituents at the distal phenyl group of the ligand contributed to increased ligand affinity by making favorable van der Waals hydrophobic interactions with backbone hydrophobic residues (i.e., Met64). Next, we investigated bulkier substituents at the para-position of the distal phenyl (entries <b>37</b> and <b>38</b>). We have observed that when bulkiness increased in the order Me < Et < <i>i</i>-Pr, the ligand potency decreased. The ethyl analogue <b>37</b> was 3-fold weaker than methyl analogue <b>34</b>, while the bulkier isopropyl <b>38</b> was 10-fold weaker. Furthermore, both the longer benzyloxy analogue <b>39</b>, and the bulkier 3,4-disubstituted methoxy analogue <b>40</b> showed reductions in potency. Molecular modeling studies have pointed to the limited available space at the vicinity of the <i>para</i>-phenyl substituent (not shown), which caused steric conflicts between the ligand and protein resulting in the loss of potency. Next, we probed further this region of the molecule by employing fused moieties, as shown in entries <b>41–45</b>. Dioxine <b>41</b>, dioxole <b>42</b>, dihydrobenzofuran <b>43</b>, and benzofuran <b>45</b> exhibited about 4–10-fold increases in potency when compared to dimethoxy analogue <b>40</b>. Dihydrobenzofuran analogue <b>43</b> was the most potent analogue with an IC<sub>50</sub> value of 4.5 nM. Surprisingly, the analogous regioisomeric dihydrobenzofuran <b>45</b> showed a marked loss (>10-fold) in potency (<b>44</b> vs <b>43</b>). 2,2-difluoro-dioxole <b>46</b> showed a marked 20-fold drop in potency (<b>46</b> vs <b>42</b>), further endorsing our earlier findings with <b>33</b> and <b>35</b>, where the electronegative groups at the para-position of the distal phenyl were poorly tolerated causing loss in potency. Next, we investigated if polar groups at the distal aromatic region of the molecule were tolerated to improve water solubility. 5-OMe-pyridyl <b>48</b> showed good potency for NAAA (IC<sub>50</sub> =30.4 nM), while 2-OMe-pyridyl <b>47</b> and pyrazole <b>49</b> analogues (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) were found to be about 10-fold less potent than <b>34</b>. In addition, the replacement of the proximal phenyl group of <b>34</b> with a pyridine nucleus (entries <b>36</b>, <b>50</b>, <b>51</b>; <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) did not affect ligand potency. Also, in an attempt to further improve the water solubility of pyridine <b>36</b> (Clog <i>P</i> 3.38), we have prepared the corresponding polar <i>N</i>-oxide analogue <b>52</b> (Clog <i>P</i> 1.52), which showed almost two units of reduction in the Clog <i>P</i> value without any loss of potency (<b>52</b> vs <b>36</b>). Next, we shortened the linker between the proximal phenyl and cyclobutane ring to eliminate the benzylic position of the molecule, which is prone to CYP450 oxidation. The phenoxy analogue <b>53</b> was about 2-fold weaker than the parent compound <b>34</b>. We have also introduced a methyl group at the benzylic position of the methoxy-linker region of <b>34</b> (entry <b>54</b>; <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) to block any potential cytochrome P450 oxidative metabolism at this site. Methyl analogue <b>54</b> showed similar potency to that of the parent compound <b>34</b>. Finally, we examined substitutions at the cyclobutane ring of the ligand, close to the NCS pharmacophore, to examine the impact on ligand affinity. The gem-dimethyl cyclobutane analogue <b>55</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) was 10-fold weaker than the unsubstituted analogue <b>36</b>, while the bridged bicyclo[1.1.1]pentane analogue <b>56</b> was even weaker, which is indicative that bulkiness at the vicinity of the NCS pharmacophore was poorly tolerated.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Amine-Linked Isothiocyanate Analogues (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>)</h3><div class="NLM_p">We have prepared amine-linked analogues that are more hydrophilic and can facilitate salt formation to increase the water solubility of the molecule.</div><div class="NLM_p last"><i>N</i>-Methylamine <b>57</b> showed a marked drop (20-fold) in potency (<b>57</b> vs <b>10</b>). The bicyclic amines isoquinoline <b>58</b> and tetrahydroisoquinoline <b>59</b> were 4-fold weaker than biphenyl <b>34</b>, while the regioisomeric tetrahydroisoquinoline <b>60</b> was even weaker. Molecular modeling studies pointed to a more preferable alignment of the linear isomer <b>59</b> within the NAAA binding pocket when compared of that of <b>60</b> (not shown).</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Carboxamide- and Sulfonamide-Linked Analogues (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>)</h3><div class="NLM_p last">Next, we have replaced the methoxy linker of <b>34</b> and <b>36</b> with amide and sulfonamide functional groups to: (1) eliminate cytochrome P450 oxidative metabolism at the benzylic position and (2) explore hydrogen-bonding interactions between the amide and sulfonamide moieties and NAAA to enhance ligand affinity. Molecular modeling studies have revealed the presence of Ser123 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) at the vicinity of the linker region that could potentially participate in hydrogen-bonding interaction(s) with amide and sulfonamide functionalities and enhance ligand affinity. Amide <b>61</b> showed similar potency to that of <b>36</b> for NAAA, while eliminating the fluorine group of the distal phenyl (entry <b>62</b>), which resulted in a 3-fold increase of potency (<b>62</b> vs <b>61</b>). The introduction of the hydrophilic MeSO<sub>2</sub> group as a potential bioisostere of the methoxy group (entry <b>63</b>) was found to be detrimental to ligand’s potency (IC<sub>50</sub> > 1 μM). Next, we have prepared sulfonamide-linked analogues <b>64–66</b>, which exhibited comparable nanomolar potency when compared to the amide analogues (<b>62</b> vs <b>64</b>). Furthermore, the carbamate analogue <b>67</b> was found to be highly potent for NAAA with an IC<sub>50</sub> value of 7 nM, while the phenoxy analogue <b>68</b> was weakly active IC<sub>50</sub> = 1.4 μM (<b>68</b> vs <b>62</b>), which is indicative that the shorter biaryl tail was important for good ligand affinity to NAAA.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Modifications of the Proximal Phenyl Group of the Biphenyl Nucleus (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>)</h3><div class="NLM_p">While only limited polar modifications at the distal phenyl moiety of the biphenyl nucleus were tolerated on retaining good affinity for NAAA, we were also interested in exploring polar modifications at the proximal phenyl to improve water solubility and oral bioavailability. The introduction of the isoxazole moiety (<b>69</b>) resulted in a 12-fold decrease of potency (<b>69</b> vs <b>62</b>), while the oxazole analogue <b>70</b> was weakly active (IC<sub>50</sub> ∼ 1 μM). Surprisingly, pyrazine <b>71</b> was also found to be 100-fold weaker than the analogous pyridine analogue <b>62</b>. This was a bit unexpected finding and molecular modeling studies could not explain this dramatic drop in potency of <b>71</b>. One can postulate that unfavorable electrostatic conflicts between the ligand and protein due to the presence of the two nitrogen atoms at the pyrazine nucleus might have contributed to such marked loss in potency. The methoxy-linked isoxazole <b>72</b> showed good activity for NAAA with an IC<sub>50</sub> value of 43.6 nM, while oxadiazole <b>73</b> was 10-fold weaker than <b>72</b>. The loss in potency of <b>73</b> is reminiscent to the loss in potency with pyrazine <b>71</b>, further demonstrating the intolerability of two nitrogen atoms present at the same nucleus (i.e., pyrazine and oxadiazole).</div><div class="NLM_p last">The introduction of a piperidine nucleus (entry <b>74</b>) resulted in about 20-fold of potency (<b>74</b> vs <b>62</b>), while the cyclobutane analogue <b>75</b> was about 2-fold better than the bulkier bicyclo[1.1.1]pentane analogue <b>76</b>. The alkyl-tailed analogues <b>77</b> and <b>78</b> were also weaker than biaryl <b>62</b>, but the longer C5-linker analogue <b>78</b> was 3-fold more potent (IC<sub>50</sub> = 22.5 nM) than the shorter analogue <b>77</b>. These findings are supported by the earlier reported NAAA inhibitors carrying alkyl hydrophobic tails.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Modifications of the Cyclobutane Ring of the Ligand (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>)</h3><div class="NLM_p">Finally, we have altered the size and polarity of the cyclobutane ring of the molecule. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, the cyclopentane analogue <b>79</b> was found to be weakly active for NAAA, dropping 70-fold in potency when compared to the analogous cyclobutane analogue <b>36</b>. One can postulate that <b>79</b> is aligning within the NAAA binding-pocket quite distinctly than <b>36</b> and positioning the NCS group remotely from the catalytic Cys126 to form a carbonimidodithioate adduct. The more linear ligand 1,4-disubstituted cyclohexyl analogue <b>80</b> was about 3-fold more potent than <b>79</b>, while the angular 1,3-disubstituted cyclohexyl ligand <b>81</b> was practically inactive for NAAA. Next, we replaced the cyclobutane ring with a polar azetidine moiety <b>82</b>. This modification has caused an 8-fold loss in potency (<b>82</b> vs <b>35</b>); however, the incorporation of the more flexible C6-phenyl tail (entry <b>83</b>) markedly enhanced ligand potency (IC<sub>50</sub> = 8.3 nM). This observation coincided with the findings of the first-generation NAAA inhibitors<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), where inhibitors carrying flexible phenyl-alkyl tails exhibited high potency for NAAA. Finally, analogue <b>84</b> was prepared to support our metabolic studies with the addition of a methyl group at the cyclobutane ring, which caused >20-fold loss in potency (<b>84</b> vs <b>35</b>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Various Ring-Size Isothiocyanate hNAAA Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0020.gif" alt="" id="gr15" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub>s performed in triplicate and determined from eight concentrations in the hNAAA inhibition assay. Activity measured after 90 min of pre-incubation of the inhibitor and enzyme prior to the addition of the fluorogenic substrate PAMCA. IC<sub>50</sub> values were calculated using Prism software (GraphPad).</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Clog <i>P</i> values were calculated using ChemDraw version 16.0.</p></div></div><div></div></div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Selectivity Profile of Isothiocyanate NAAA Inhibitors</h3><div class="NLM_p">All the prepared NAAA inhibitors with IC<sub>50</sub> values of <30 nM were evaluated against serine hydrolases hFAAH, hMGL, and hABHD6 at a 1 μM concentration and were found to be inactive. Also, they lacked affinity against the cannabinoid CB1 and CB2 receptors at 1 μM concentration. Notwithstanding NAAA’s functional similarity with FAAH, both known to degrade NAEs,<a onclick="showRef(event, 'ref20 ref68'); return false;" href="javascript:void(0);" class="ref ref20 ref68">(20,68)</a> NAAA shares no homology with FAAH or other enzymes of the same “amidase signature” family.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> NAAA is a cysteine protease that belongs to the Ntn family of lysosomal enzymes<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and closely relates to 11-membered family of cathepsins.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> We have evaluated several NAAA inhibitors against cathepsin K (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). All the tested NAAA inhibitors with a methoxy linker between the proximal phenyl group and the cyclobutane ring of the ligand inhibited cathepsin K with IC<sub>50</sub> values of about 50–100 nM (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). In contrast, when we replaced the methoxy linker with either carboxamide or sulfonamide linkers, the new ligands were found to be inactive against cathepsin K at 1 μM concentration (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). We have postulated that either the constrained nature of the carboxamide and sulfonamide linkers or their electrophilic nature could have altered the recognition of the ligand against cathepsin K, resulting in lower binding affinity.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Evaluation of Isothiocyanate hNAAA Inhibitors against Cathepsin K</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">cathepsin K IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">56.50 @ 100 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">58.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">120.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">83.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="1025253e2850">[email protected]</a> 100 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">43.7 @100 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">56.75 @ 100 nM</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub>s performed in triplicate. Compounds were pre-incubated for 120 min with recombinant human cathepsin K. We used the fluorogenic substrate Z-Phe-Arg-AMC. IC<sub>50</sub> values were calculated using Prism software (GraphPad).</p></div></div></div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Stability of Isothiocyanate NAAA Inhibitors (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>)</h3><div class="NLM_p">Several inhibitors were evaluated in plasma stability assays (human, rat, and mouse) and demonstrated good plasma stability <i>t</i><sub>1/2</sub> > 2 h (not shown). Furthermore, we have evaluated several NCS NAAA inhibitors in human, rat, and mouse liver microsomal preparations for metabolic stability (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). Biaryl analogues <b>10</b>, <b>32</b>, and <b>36</b> showed good metabolic stability, <i>t</i><sub>1/2</sub> ∼15–28 min, while the remaining were only weakly stable <i>t</i><sub>1/2</sub> ∼ 3–10 min. The introduction of various substitutions consisting of metabolic stable groups (i.e., F and CF<sub>3</sub>) to minimize cytochrome P450 oxidative metabolism and modifications of the methoxy linker of the parent compound with carboxamide and sulfonamide moieties produced only modest benefits.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Microsomal Stability of Isothiocyanate hNAAA Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="4" align="center"><i>t</i>1/2 min</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char=".">mouse</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">16.1</td><td class="colsep0 rowsep0" align="char" char=".">19.6</td><td class="colsep0 rowsep0" align="char" char=".">14.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">17.9</td><td class="colsep0 rowsep0" align="char" char=".">13.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">10.9</td><td class="colsep0 rowsep0" align="char" char=".">9.1</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="char" char=".">16.7</td><td class="colsep0 rowsep0" align="char" char=".">19.2</td><td class="colsep0 rowsep0" align="char" char=".">28.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="char" char=".">15.3</td><td class="colsep0 rowsep0" align="char" char=".">14.5</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">7.4</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="char" char=".">11.8</td><td class="colsep0 rowsep0" align="char" char=".">10.2</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="char" char=".">14.7</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">8.6</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>66</b></td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>67</b></td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">6.2</td></tr></tbody></table></div></div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Metabolite Identification Studies</h3><div class="NLM_p">Next, we conducted metabolite identification studies to gain insights of the potential metabolic liabilities of the cyclobutane and NCS groups of the molecule. We have investigated analogue <b>47</b> (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>) and identified two metabolic “soft spots” (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). MS/MS fragmentation pattern analysis was consistent with two major metabolites <b>A</b> and <b>B</b>, resulting from the fragmentation of the NCS group to corresponding amine <b>A</b> (fragment 303) and cleavage of the bond attached at the cyclobutane ring to afford benzylic alcohol <b>B</b> (fragment 234). Both metabolites were confirmed by comparison to authentic synthetic compounds. The formation of <b>B</b> occurred by the oxidation of the cyclobutane ring at position-1 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) that produced an unstable hemiketal intermediate, which further degraded to metabolite <b>B</b>. We have attempted to block this position with the addition of a methyl group at position-1 of the cyclobutane ring (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Unfortunately, the synthesized methyl analogue (<b>84</b>) was only weakly active (IC<sub>50</sub> = 480 nM) for NAAA. Also, as we discussed above, various modifications of the benzylic linker have not translated to more stable molecules (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>).</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Identification of metabolites of NAAA inhibitor <b>47</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Furthermore, we have studied the fragmentation of the NCS group to produce metabolite <b>A</b>. The NCS group conjugates with sulfhydryl groups to form dithiocarbamate adducts. We have conducted metabolic studies with <b>47</b> using cysteine as the trapping nucleophile with and without NADPH activation. <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> outlines the potential pathway for the formation of metabolite <b>A</b>. Without NADPH activation, we have observed only dithiocarbamate adduct <b>C</b>, while with NADPH activation, we have observed thiocarbamate adduct <b>D</b>. The formation of this adduct could be derived from the isocyanate intermediate <b>E</b> (P450-driven oxidative desulfurization). Moreover, isocyanate <b>E</b> is highly unstable in aqueous media and can easily degrade to metabolite <b>A</b>. Likely, these two metabolic fragmentations are the primary contributors to the metabolic instability of this series of NAAA inhibitors.</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Microsomal metabolic studies of <b>47</b> with cysteine as the trapping nucleophile.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Cassette Dosing Pharmacokinetics of NAAA Inhibitors (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>)</h3><div class="NLM_p">We have assessed the pharmacokinetic properties of several NAAA inhibitors. First, we conducted pharmacokinetic cassette experiments to assess the drug concentrations in the plasma and brain in male CD-1 mice (Charles River), applying an intravenous dose of 2 mg/kg and an oral dose of 8 mg/kg at 15, 30, and 60 min timepoints (<i>n</i> = 3 animals per time point). The findings shown in <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a> suggested that the majority of the NCS NAAA inhibitors exhibited low plasma levels but higher drug levels in the brain.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Cassette Dosing Pharmacokinetics of the Selected Isothiocyanate NAAA Inhibitors<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">15 min IV brain (μg/g)</th><th class="colsep0 rowsep0" align="center" char="±">15 min IV plasma (μg/mL)</th><th class="colsep0 rowsep0" align="center" char="±">30 min oral plasma (μg/mL)</th><th class="colsep0 rowsep0" align="center" char="±">60 min oral plasma (μg/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char="±">0.81 ± 0.17</td><td class="colsep0 rowsep0" align="char" char="±">1.01 ± 0.27</td><td class="colsep0 rowsep0" align="char" char="±">0.019 ± 0.07</td><td class="colsep0 rowsep0" align="char" char="±">0.331 ± 0.21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char="±">0.008 ± 0.005</td><td class="colsep0 rowsep0" align="char" char="±">0.178 ± 0.044</td><td class="colsep0 rowsep0" align="char" char="±">0.012 ± 0.002</td><td class="colsep0 rowsep0" align="char" char="±">0.007 ± 0.003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="char" char="±">0.873 ± 0.284</td><td class="colsep0 rowsep0" align="char" char="±">0.189 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">0.016 ± 0.002</td><td class="colsep0 rowsep0" align="char" char="±">0.054 ± 0.062</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="char" char="±">0.012 ± 0.002</td><td class="colsep0 rowsep0" align="char" char="±">0.168 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">0.012 ± 0.002</td><td class="colsep0 rowsep0" align="char" char="±">0.007 ± 0.003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="char" char="±">0.014 ± 0.009</td><td class="colsep0 rowsep0" align="char" char="±">0.244 ± 0.082</td><td class="colsep0 rowsep0" align="char" char="±">0.031 ± 0.004</td><td class="colsep0 rowsep0" align="char" char="±">0.013 ± 0.006</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="char" char="±">0.69 ± 0.181</td><td class="colsep0 rowsep0" align="char" char="±">0.264 ± 0.057</td><td class="colsep0 rowsep0" align="char" char="±">0.011 ± 0.005</td><td class="colsep0 rowsep0" align="char" char="±">0.008 ± 0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b></td><td class="colsep0 rowsep0" align="char" char="±">0.809 ± 0.225</td><td class="colsep0 rowsep0" align="char" char="±">0.264 ± 0.057</td><td class="colsep0 rowsep0" align="char" char="±">0.012 ± 0.005</td><td class="colsep0 rowsep0" align="char" char="±">0.008 ± 0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="char" char="±">1.15 ± 0.32</td><td class="colsep0 rowsep0" align="char" char="±">0.126 ± 0.013</td><td class="colsep0 rowsep0" align="char" char="±">0.003 ± 0.002</td><td class="colsep0 rowsep0" align="char" char="±">0.002 ± 0.0003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="char" char="±">1.09 ± 0.62</td><td class="colsep0 rowsep0" align="char" char="±">0.164 ± 0.057</td><td class="colsep0 rowsep0" align="char" char="±">0.02 ± 0.002</td><td class="colsep0 rowsep0" align="char" char="±">0.02 ± 0.001</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last">Male CD-1 mice (Charles River) following a single intravenous dose of NAAA inhibitor 2 mg/kg and an oral dose of 8 mg/kg at 15, 30 and 60 min time points (n = 3 animals per time point).</p></div></div></div><div id="sec3_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Pharmacokinetic Study of <b>36</b></h4><div class="NLM_p">Male CD-1 mice (25–30 g) from Charles River were used to determine the oral bioavailability and brain exposure of <b>36</b> after intravenous (iv) and oral (po) administration. Animals were fasted overnight prior to dosing and until 4 h post-dose. Mice were given 2 mg/kg of compound <b>36</b> intravenously and 8 mg/kg orally in 3% DMSO, 1:1:18 Emulphor/ethanol/saline vehicle.</div><div class="NLM_p">In <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>, we summarize the findings of the studies. Compound <b>36</b> showed moderate bioavailability 13% and high brain penetrability (AUC<sub>brain</sub>/AUC<sub>plasma</sub> 3.8; iv dosing).</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Pharmacokinetic Study of Compound <b>36</b><a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose</th><th class="colsep0 rowsep0" align="center">2 mg/kg IV</th><th class="colsep0 rowsep0" align="center">8 mg/kg PO</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Plasma</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC (min·μg/mL/kg)</td><td class="colsep0 rowsep0" align="left">4.71 ± 0.56</td><td class="colsep0 rowsep0" align="left">2.48 ± 0.46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">clearance (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">412</td><td class="colsep0 rowsep0" align="left">2763</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">volume of distribution (L/kg)</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">126</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mean residence time (min)</td><td class="colsep0 rowsep0" align="left">20.3</td><td class="colsep0 rowsep0" align="left">64.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">half-life (min)</td><td class="colsep0 rowsep0" align="left">45.5</td><td class="colsep0 rowsep0" align="left">31.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bioavailability</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">13%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Brain</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC (min·μg/mL)</td><td class="colsep0 rowsep0" align="left">17.9</td><td class="colsep0 rowsep0" align="left">0.618</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tissue/plasma ratio</td><td class="colsep0 rowsep0" align="left">3.8</td><td class="colsep0 rowsep0" align="left">0.25</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup><sup>a</sup></sup><p class="last">Male CD-1 mice were given <b>36</b> at the dose of 2 mg/kg iv and 8 mg/kg po in vehicle 3% DMSO, 1:1:18 Emulphor/ethanol/saline; <i>n</i> = 3 animals per time point.</p></div></div></div></div><div id="sec3_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Safety Profile of NAAA Inhibitor <b>36</b></h4><div class="NLM_p">NCS compounds natural or synthetic have been reported as chemopreventive agents and lacked any adverse effects in clinical trials.<a onclick="showRef(event, 'ref40 ref41 ref42 ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42 ref43 ref44 ref45">(40−45)</a> We have studied NAAA inhibitor <b>36</b> in CEREP “off-target” panels consisting of receptors (i.e., 5HT1A, 5HT2A, 5HT2C, DA D1, DA D2, DA D3, DA D4.4, delta-opioid, κ-opioid, and μ-opioid) and transporters (i.e., DAT, SERT, and NET). Additionally, we have evaluated <b>36</b> in various cytochrome P450 isoforms CYP1A2, CYP2A6, CYP3A4, CYP2C9,  CYP2C19, and CYP2D6 for inhibition; <i>in vitro</i> safety pharmacology against hERG for potential QT prolongation; and Ames test strains of TA98, TA100, TA1535, and TA1537 with and without metabolic activation by rat liver microsome fraction S9 for mutagenicity. Compound <b>36</b> remarkably showed nominal “off-target” effects in 70 assays of receptors, ion channels, and enzymes at 10 μM concentrations (<a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>). Only CYP-isozymes, 1A2, 2C19, and 3A4, have raised some concerns, nevertheless at micromolar concentrations. Also, <b>36</b> was found to be negative in the Ames test and weakly active against hERG.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Compound <b>36</b> “Off-Target” Profile</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>CYP inhibition</b>: CYP2D6, CYP2A6, CYP2C9—<b>no effect</b> at 10 μM IC<sub>50</sub> μM: CYP1A2 = 1.8, CYP2C19 = 3.3, CYP3A4 = 2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>CEREP:</b> panel of receptors, ion channels, and enzymes 70 assays—<b>no effect</b> at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>transporters</b>: DAT, SERT, and NET—<b>no effect</b> at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AMES:</b> TA98, TA100, TA1535, and TA1537 with and without metabolic activation by rat liver microsomes fraction S9 (5–100 μM range, in duplicate)—<b>negative AMES</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>hERG:</b> IC<sub>50</sub> = 19 μM</td></tr></tbody></table></div></div><div class="NLM_p last">We have selected NAAA inhibitor <b>36</b> as a promising pharmacological tool compound to study addictive disorders (nicotine addiction, and opioids), gastrointestinal inflammatory diseases (ulcerative colitis), and autoimmune encephalomyelitis, a type of inflammation of the brain and spinal cord. We have recently published the role of NAAA inhibitor <b>36</b> in nicotine addiction.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Our findings supported NAAA inhibitor <b>36</b> as a new pharmacological tool to modulate PEA/PPAR-α signaling in the brain by reducing nicotine’s rewarding properties as a  promising smoking cessation therapy.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02225" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02225" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have identified a new series of potent and selective isothiocyanate NAAA inhibitors with nanomolar potency. NAAA is the primary hydrolytic enzyme of lipid PEA, which is an agonist of the nuclear peroxisome proliferator-activated receptor-α (PPAR-α). The PEA/PPAR-α signaling pathway has been implicated in many diseases, such inflammation,<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70,71)</a> pain,<a onclick="showRef(event, 'ref2 ref72'); return false;" href="javascript:void(0);" class="ref ref2 ref72">(2,72)</a> and neuroprotection.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> The new NAAA inhibitors showed low nanomolar inhibitory activity against human NAAA and were selective (>100-fold) against serine hydrolases and cysteine peptidase. Also, they lacked affinity for the cannabinoid receptors CB1 and CB2. We have followed a target-based SAR approach, supported by computational methods and known cocrystals of hNAAA. We have constructed “pre-covalent” NAAA-ligand complexes to identify good ligand binding geometries within the binding pocket of NAAA and then calculated covalent docking poses of the formed adducts (with catalytic cysteine Cys126) to select compounds for synthesis. Several inhibitors demonstrated good plasma stability (<i>t</i><sub>1/2</sub> > 2 h; human and rodents) and good microsomal stability (<i>t</i><sub>1/2</sub> ∼ 15–28 min; human and rodents). We have identified a robust systemically available tool compound <b>36</b> with excellent brain penetrability, and we have successfully completed studies as a potential candidate for nicotine addiction/smoking cessation.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Furthermore, several of the disclosed isothiocyanate NAAA inhibitors represent promising pharmacological tools to investigate the role of NAAA in inflammation and pain.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53564" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53564" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Chemistry</h3><div class="NLM_p last">All solvents and reagents were obtained from commercial sources and were used as received. All nonaqueous reactions were carried out in oven-dried glassware under an atmosphere of dried argon or nitrogen. All reactions were monitored by thin-layer chromatography (TLC plates F254, Merck) or LC–MS analysis. All products, unless otherwise noted, were purified by flash chromatography using Biotage purification system and pre-packed silica cartridges. Proton nuclear magnetic resonance spectra were obtained on a VARIAN 400 spectrometer at 500 MHz. Spectra are given in ppm (δ) and coupling constants, <i>J</i> values, are reported in hertz. Splitting patterns are designated as follows: s, singlet; brs, broad singlet; d, doublet; t, triplet; q, quartet; and m, multiplet. Tetramethylsilane was used as an internal reference standard. Mass spectra were obtained on a Waters Micromass ZQ spectrometer. <sup>1</sup>H NMR, HPLC, and mass spectrometry were used to determine the purity of the compounds. The purity of all final products was >96% as determined by LC–MS using the following protocol. Mobile phase A = water, B = acetonitrile solvent gradient 95/5 to 5/95 A/B in 11 min; flow rate: 1.5 mL/min; Waters XTerra MS C8 column (4.6 × 50 mm) with UV detection at 190–400 nm wavelength.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Method A (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>)</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 4-(((1<i>s</i>,3<i>s</i>)-3-Isothiocyanatocyclobutoxy)methyl)-4′-methyl-1,1′-biphenyl (<b>30a</b>) and 4-(((1<i>R</i>,3<i>R</i>)-3-isothiocyanatocyclobutoxy)methyl)-4′-methyl-1,1′-biphenyl (<b>30b</b>)</h4><div id="sec5_2_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> Step a</h5><div class="NLM_p last">Sodium hydride (60% dispersion in mineral oil; 58.8 mg, 1.47 mmol) was added into a cold (0 °C) mixture of <i>tert</i>-butyl (3-hydroxycyclobutyl)carbamate (260 mg, 1.39 mmol) and anhydrous tetrahydrofuran (THF) (5 mL). After stirring for 1 h, 1-bromo-4-(bromomethyl)benzene (422 mg, 1.69 mmol) was added and the mixture was allowed to come to room temperature and stirred for 8 h. Then, the mixture was poured into saturated aqueous ammonium chloride and extracted twice with ethyl acetate. The organic extracts were dried over anhydrous MgSO<sub>4</sub>. The solvents were removed under vacuum, and the residue was purified on silica gel (Biotage; eluting solvents: hexanes/EtOAc in a 4/1 ratio) to afford <i>tert</i>-butyl (3-((4-bromobenzyl)oxy)cyclobutyl)carbamate as oil (382 mg, 63.5% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ ppm 7.47 (d, <i>J</i> = 8.5 Hz, 2H), 7.2 (d, <i>J</i> = 8.5 Hz, 2H), 4.61 (m, 1H), 4.35 (s, 2H), [4.16(m), 3.76–3.7 (m), 2H], [2.71–2.7 (m), 2.41(m), 2H], [2.14 (m), 1.82–1.76 (m), 2H], 1.43 (s, 9H); MS (ES) <i>m</i>/<i>z</i>: 356.12 [M + 1]<sup>+</sup>.</div></div><div id="sec5_2_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> Step b</h5><div class="NLM_p last">Into a microwave vessel were added <i>tert</i>-butyl (3-((4-bromobenzyl)oxy)cyclobutyl)carbamate (150 mg, 0.42 mmol), <i>p</i>-tolyl-boronic acid (114.2 mg, 0.84 mmol), K<sub>2</sub>CO<sub>3</sub> (174 mg, 1.26 mmol), dioxane (8 mL), and water (2 mL). The argon gas was passed through the mixture for 10 min, then tetrakis(triphenylphosphine)palladium(0) (4.8 mg 0.0042 mmol) was added, and the argon flow was continued for 5 additional minutes. Then, the vessel was sealed and microwaved at 110 °C for 2 h. The mixture was cooled to room temperature, diluted with EtOAc (30 mL), and washed with water and brine. The organic extracts were dried over anhydrous MgSO<sub>4</sub>. The solvents were removed under vacuum, and the residue was purified on silica gel (Biotage; eluting solvent hexanes: EtOAc 4/1 ratio) to afford <i>tert</i>-butyl (3-((4′-methyl-[1,1′-biphenyl]-4-yl)methoxy)cyclobutyl)carbamate as oil (123.8 mg, 80% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ ppm 7.56 (dd, <i>J</i> = 8.0 Hz, 2H), 7.49 (d, <i>J</i> = 8.5 Hz, 2H), 7.38 (d, <i>J</i> = 8.0 Hz, 2H), 7.25 (d, <i>J</i> = 8.5 Hz, 2H), 4.61 (m, 1H), 4.43 (s, 2H), [4.27–4.21 (m), 3.79–3.57 (m) 2H], [2.72 (m), 2.42 (m), 2H], [2.18 (m), 1.85–1.79 (m), 2H], 1.43 (s, 9H); MS (ES) <i>m</i>/<i>z</i>: 368.22 [M + 1]<sup>+</sup>.</div></div><div id="sec5_2_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> Step c</h5><div class="NLM_p last">TFA (0.25 mL, 3.26 mmol) was added into a mixture of <i>tert</i>-butyl (3-((4′-methyl-[1,1′-biphenyl]-4-yl)methoxy)cyclobutyl)carbamate (120 mg, 0.32 mmol) and CH<sub>2</sub>Cl<sub>2</sub> (5 mL). The mixture was stirred at room temperature for 5 h, and then, the volatiles were removed under vacuum. The residue was successively taken three times in CHCl<sub>3</sub> (10 mL) and the volatiles were removed under vacuum to ensure the removal of the excess TFA. The crude 3-((4′-methyl-[1,1′-biphenyl]-4-yl)methoxy)cyclobutan-1-amine. TFA salt A salt (122 mg) was carried to the next step without any further purification.</div></div><div id="sec5_2_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> Step d</h5><div class="NLM_p last">Trimethylamine (0.33 mL, 2.35 mmol) was added into a mixture of 3-((4′-methyl-[1,1′-biphenyl]-4-yl)methoxy)cyclobutan-1-amine. TFA salt (122 mg, 0.32 mmol) and CH<sub>2</sub>Cl<sub>2</sub> (5 mL). After stirring for 10 min, 1,1′-thiocarbonyldi-2(1<i>H</i>)-pyridone (222.7 mg, 0.96 mmol) was added, and the mixture was stirred at temperature for 2 h. The mixture was diluted in EtOAc (30 mL) and washed with water and brine. The organic extracts were dried over anhydrous MgSO<sub>4</sub>. The solvents were removed under vacuum, and the residue was purified on silica gel (Biotage; eluting solvents: hexanes/EtOAc in a 15/1 ratio) to afford <b>30b</b> 4-(((1<i>R</i>,3<i>R</i>)-3-isothiocyanatocyclobutoxy)methyl)-4′-methyl-1,1′-biphenyl as oil (12.6 mg), <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ ppm 7.57 (d, <i>J</i> = 8.0 Hz, 2H), 7.49 (d, <i>J</i> = 7.5 Hz, 2H), 7.37 (d, <i>J</i> = 8.0 Hz, 2H), 7.25 (d, <i>J</i> = 7.5 Hz, 2H), 4.44 (s, 2H), 4.37–4.34 (m, 1H), 4.31–4.27 (m, 1H), 2.51–2.48 (m, 4H), 2.39 (s, 3H); MS (ES) <i>m</i>/<i>z</i>: 310.1112 [M + 1]<sup>+</sup>; and <b>30a</b> 4-(((1<i>s</i>,3<i>s</i>)-3-isothiocyanatocyclobutoxy)methyl)-4′-methyl-1,1′-biphenyl (79.8 mg), <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ ppm 7.57 (d, <i>J</i> = 7.5 Hz, 2H), 7.49 (d, <i>J</i> = 8.5 Hz, 2H), 7.37 (d, <i>J</i> = 7.5 Hz, 2H), 7.25 (d, <i>J</i> = 8.5 Hz, 2H), 4.45 (s, 2H), 3.81–3.78 (m, 1H), 3.71–3.68 (m, 1H), 2.82–2.76 (m, 2H), 2.39 (s, 3H), 2.33–2.27 (m, 2H); MS (ES) <i>m</i>/<i>z</i>: 310.1081 [M + 1]<sup>+</sup>; purity: 100%, retention time: 5.5 min.</div></div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Method B (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>)</h3><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 3-Fluoro-4’-((1<i>s</i>,3<i>s</i>)-3-isothiocyanatocyclobutoxy)-4-methoxy-1,1′-biphenyl (<b>53</b>)</h4><div id="sec5_3_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> Strep a</h5><div class="NLM_p last">Diisopropyl azodicarboxylate (0.76 mL, 3.88 mmol) was added into a mixture of <i>tert</i>-butyl ((1<i>s</i>,3<i>s</i>)-3-hydroxycyclobutyl)carbamate (485 mg, 2.59 mmol), 4-bromophenol (538 mg, 3.11 mmol), and anhydrous THF (25 mL). The mixture was stirred at 50 °C for 8 h and then poured into water and extracted with EtOAc. The organic extracts were washed with brine and dried over anhydrous MgSO<sub>4</sub>. The solvents were removed under vacuum and the residue was purified on silica gel (Biotage; eluting solvents: hexanes/EtOAc in a 4/1 ratio) to afford <i>tert</i>-butyl ((1<i>s</i>,3<i>s</i>)-3-(4-bromophenoxy)cyclobutyl)carbamate as oil (487 mg, 55% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ ppm 7.33 (<i>d</i>, <i>J</i> = 8.0 Hz, 1H), 7.31 (<i>d</i>, <i>J</i> = 8.0 Hz, 1H), 6.74 (<i>d</i>, <i>J</i> = 8.0 Hz, 1H), 6.64 (<i>d</i>, <i>J</i> = 8.0 Hz, 1H), 4.79 (br s, 1H), 4.74–4.71 (m, 2H), 4.31–4.29 (m, 1H), 2.56–2.51 (m, 2H), 2.37–2.36 (m, 2), 1.45 (s, 9H); MS (ES) <i>m</i>/<i>z</i>: 342.08 [M + 1]<sup>+</sup>.</div></div><div id="sec5_3_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> Step b</h5><div class="NLM_p last"><i>tert</i>-Butyl ((1<i>s</i>,3<i>s</i>)-3-(4-bromophenoxy)cyclobutyl)carbamate was converted to <b>53</b> according to method A (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ ppm 7.54 (d, <i>J</i> = 8.5 Hz, 1H), 7.28–7.23 (m, 2H), 7.0 (t, <i>J</i> = 8.5 Hz, 1H), 6.84 (d, <i>J</i> = 8.5 Hz, 1H), 4.45–4.40 (m, 1H), 3.94–3.86 (m, 1H), 3.05–3.03 (m, 2H), 2.53–2.47 (m, 2H); MS (ES) <i>m</i>/<i>z</i>: 330.1102 [M + 1]<sup>+</sup>; purity: 98%, retention time: 5.35 min.</div></div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Method C (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>)</h3><div id="sec5_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (1<i>s</i>,3<i>s</i>)-<i>N</i>-([1,1′-Biphenyl]-4-ylmethyl)-3-isothiocyanato-<i>N</i>-methylcyclobutan-1-amine (<b>57</b>)</h4><div id="sec5_4_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> Step a</h5><div class="NLM_p last">To a mixture of 1-([1,1′-biphenyl]-4-yl)-<i>N</i>-methylmethanamine hydrochloride (254 mg, 1.09 mmol), <i>tert</i>-butyl (3-oxocyclobutyl)carbamate (183 mg, 0.99 mmol), acetic acid (0.17 mL), and anhydrous THF (3 mL) was added sodiumtriacetoxy borohydride (292 mg, 1.39 mmol). The mixture was stirred for 5 h and then was quenched with saturated aqueous sodium bicarbonate. The mixture was extracted with ethyl acetate, washed with brine, and dried over anhydrous MgSO<sub>4</sub>. The solvents were removed under vacuum, and the residue was purified on silica gel (Biotage; eluting solvents: hexanes/EtOAc in a 2/1 ratio) to afford <i>tert</i>-butyl (3-(([1,1′-biphenyl]-4-ylmethyl) (methyl)amino)cyclobutyl)carbamate as oil (351 mg, 96.9% yield): <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ ppm 7.6 (d, <i>J</i> = 5.5 Hz, 2H), 7.5 (d, <i>J</i> = 8.0 Hz, 2H), 7.4 (t, <i>J</i> = 7.5 Hz, 2H), 7.35 (m, 3H), [4.82 (m), 4.62 (m), 1H], [4.13 (m), 3.86 (m), 1H], 3.4 (s, 2H), [3.08–3.05 (m), 2.57–2.54 (m), 2H], [2.05 (s), 2.04 (m), 3H], [2.39 (m), 1.73–1.71 (m), 2H], [1.45 (s), 1.44 (s), 9H]; MS (ES) <i>m</i>/<i>z</i>: 367.19 [M + 1]<sup>+</sup>.</div></div><div id="sec5_4_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> Step b</h5><div class="NLM_p last"><i>tert</i>-Butyl (3-(([1,1′-biphenyl]-4-ylmethyl) (methyl)amino)cyclobutyl)carbamate was converted to <b>57</b> according to method A: <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ ppm 7.6–7.58 (m, 2H), 7.56 (d, <i>J</i> = 8.0, 2H), 7.45 (t, <i>J</i> = 7.5 Hz, 2H), 7.36–7.32 (m, 3H), 4.2 (m, 1H), 3.41 (s, 2H), 3.27 (m, 1H), 2.41–2.38 (m, 4H), 2.06 (s, 3H); MS (ES) <i>m</i>/<i>z</i>: 309.1221 [M + 1]<sup>+</sup>; purity: 99%, retention time: 6.95 min.</div></div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 5-(3-Fluoro-4-methoxyphenyl)-2-((1<i>s</i>,3<i>s</i>)-3-isothiocyanatocyclobutyl)isoindoline (<b>58</b>)</h4><div class="NLM_p last">This compound was prepared from 5-bromoisoindoline according to methods A and C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ ppm 7.38 (m, 2H), 7.32–7.24 (m, 3H), 7.04 (t, <i>J</i> = 9.0 Hz, 1H), 3.85 (s, 3H), 3.77 (m, 1H), 3.3–3.2 (m, 1H), 2.9–2.8 (m, 2H), 2.6–2.5 (m, 1H), 2.35–2.45 (m, 1H), 2.25–2.1 (m, 2H); MS (ES) <i>m</i>/<i>z</i>: 354.1183 [M + 1]<sup>+</sup>; purity: 98%, retention time: 6.05 min.</div></div><div id="sec5_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 6-(3-Fluoro-4-methoxyphenyl)-2-((1<i>s</i>,3<i>s</i>)-3-isothiocyanatocyclobutyl)-1,2,3,4-tetrahydro-isoquinoline (<b>59</b>)</h4><div class="NLM_p last">This compound was prepared from 6-bromo-1,2,3,4-tetrahydroisoquinoline according to methods A and C (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ ppm 7.31 (m, 1H), 7.27–7.26 (m, 3H), 7.09 (d, <i>J</i> = 7.5 Hz, 1H), 7.02 (t, <i>J</i> = 9.0 Hz, 1H), 3.92 (s, 3H), 3.89–3.85 (m, 1H), 3.54 (m, 2H), 2.96 (t, <i>J</i> = 5.5 Hz, 2H), 2.74–2.7 (m, 3H), 2.65 (t, <i>J</i> = 5.5 Hz, 2H), 2.28–2.27 (m, 2H); MS (ES) <i>m</i>/<i>z</i>: 368.1276 [M + 1]<sup>+</sup>; purity: 97%, retention time: 6.15 min.</div></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Method D (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>)</h3><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 5-(3-Fluoro-4-methoxyphenyl)-<i>N</i>-((1<i>s</i>,3<i>s</i>)-3-isothiocyanatocyclobutyl)picolinamide (<b>61</b>)</h4><div id="sec5_5_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> Step a</h5><div class="NLM_p last">To a suspension of 5-bromopicolinic acid (404 mg, 2.0 mmol), <i>tert</i>-butyl (<i>cis</i>-3-aminocyclobutyl) carbamate (372 mg, 2.0 mmol) and <i>N</i>-ethyl-<i>N</i>-diisopropyl amine (750 mg, 6.0 mmol) in anhydrous dichloromethane (20 mL) at room temperature were added dimethylformamide (DMF) (0.5 mL), EDC (480 mg, 2.5 mmol), and HOBt (338 mg, 2.5 mmol). The resulting mixture was stirred at room temperature for 12 h, diluted with methylene chloride (20 mL), and saturated aqueous NaHCO<sub>3</sub> (10 mL). The aqueous layer was further extracted twice with methylene chloride (10 mL). The combined organics were dried over anhydrous MgSO<sub>4</sub>. The solvents were removed under vacuum, and the residue was purified on silica gel (Biotage; eluting solvents: hexanes/EtOAc in a 1/1 ratio) to afford <i>tert</i>-butyl ((1<i>s</i>,3<i>s</i>)-3-(5-bromopicolinamido) cyclobutyl)carbamate (562 mg, 76% yield); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.58 (d, <i>J</i> = 2.0 Hz, 1H); 8.05 (dd, <i>J</i> = 8.0 Hz <i>J</i> = 2.0 Hz, 1H); 7.96 (d, <i>J</i> = 8.0 Hz, 1H); 7.95 (br s, 1H); 4.71 (br s, 1H), 4.27–4.17 (m, 1H); 3.89–3.80 (m, 1H); 2.88–2.84 (m, 2H); 1.87–1.80 (m, 2H); 1.43 (s, 9H); MS (ES) <i>m</i>/<i>z</i>: 370.12 [M + 1]<sup>+</sup>.</div></div><div id="sec5_5_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> Step b</h5><div class="NLM_p last"><i>tert</i>-Butyl ((1s,3s)-3-(5-bromopicolinamido) cyclobutyl)carbamate was converted to <b>61</b> and <b>57</b> according to method A: <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.72 (d, <i>J</i> = 2 Hz, 1H), 8.21 (t, <i>J</i> = 8, 10 Hz, 2H), 7.98 (dd, <i>J</i> = 2.5, 8.5 Hz, 1H), 7.38 (m, 2H), 7.11 (t, <i>J</i> = 8, 9.5 Hz, 1H), 4.42–4.36 (m, 1H), 3.96 (s, 3H), 3.94–3.91 (m, 2H), 2.39–2.33 (m, 2H); MS (ESI) <i>m</i>/<i>z</i>: 358.4412 [M + 1]<sup>+</sup>.</div></div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 5-(3-Fluoro-4-methoxyphenyl)-<i>N</i>-((1s,3s)-3-isothiocyanatocyclobutyl)pyridine-2-sulfonamide (<b>66</b>)</h4><div id="sec5_5_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> Step a</h5><div class="NLM_p last">To a stirring solution of 4-bromobenzene-sulfonyl chloride (172 mg, 0.67 mmol) in dichloromethane (5 mL) at room temperature were added <i>tert</i>-butyl (<i>cis</i>-3-aminocyclobutyl) carbamate (150 mg, 0.81 mmol) and diisopropylethylamine (0.23 mL, 1.34 mmol). The reaction mixture was stirred for 18 h, then diluted with EtOAc, and washed with water and saturated solution of ammonium chloride. The organic layer was dried over anhydrous MgSO<sub>4</sub>. The solvents were removed under vacuum to afford <i>tert</i>-butyl((1s,3s)-3-((4-bromophenyl) sulfonamide) cyclobutyl)carbamate (233 mg, 86% yield) as a white solid; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.02–8.05 (m, 1H), 7.82 (d, <i>J</i> = 9 Hz, 2H), 7.71 (d, <i>J</i> = 9 Hz, 2H), 7.08–7.06 (m, 1H), 3.49–3.44 (m, 1H), 3.28–3.21 (m, 1H), 2.25–2.18 (m, 2H), 1.68–1.61 (m, 2H), 1.33 (s, 9H); MS (ESI) <i>m</i>/<i>z</i>: 405.14 [M + 1]<sup>+</sup>.</div></div><div id="sec5_5_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> Step b</h5><div class="NLM_p last"><i>tert</i>-Butyl((1<i>s</i>,3<i>s</i>)-3-((4-bromophenyl) sulfonamide) cyclobutyl)carbamate was converted to <b>66</b> according to Method A: <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.10 (d, <i>J</i> = 10 Hz, 1H), 7.86 (dd, <i>J</i> = 25, 9 Hz, 4H), 7.72 (d, <i>J</i> = 9.5 Hz, 2H), 7.08 (d, <i>J</i> = 9 Hz, 2H), 3.94–3.86 (m, 1H), 3.82 (s, 3H), 3.51–3.42 (m, 1H), 2.56–2.49 (m, 2H), 2.04–1.97 (m, 2H); MS (ESI) <i>m</i>/<i>z</i>: 375.4911 [M + 1]<sup>+</sup>.</div></div></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64">Biochemical Pharmacology</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68313" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68313" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> NAAA Inhibitor Fluorescence Assay</h3><div class="NLM_p last">Compounds were assessed in a fluorescence-based assay for NAAA inhibition with PAMCA as the substrate.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> For three-point concentration inhibition assays with hNAAA, the following procedure was used. Purified activated hNAAA<a onclick="showRef(event, 'ref57 ref74'); return false;" href="javascript:void(0);" class="ref ref57 ref74">(57,74)</a> (final concentration of 0.25 μg/mL) was incubated in assay buffer (100 mM citrate-phosphate buffer, pH 4.5, 3 mM DTT, 0.1% Triton X-100, 0.05% bovine serum albumin (BSA), and 150 mM NaCl) made up to a total volume of 180 μL, followed by the addition of the compound dissolved in 10 μL of DMSO (along with DMSO neat for the control sample) with the final concentrations for each compound of 100, 10, and 1 μM, in triplicate on a 96 well plate. These samples were allowed to incubate for 90 min at room temperature, and then, 10 μL of a PAMCA stock solution in DMSO (final PAMCA concentration [5 μM]) was added. After 5 min of agitation on a shaking plate, the reaction was allowed to proceed at 37 °C for 90 min, with fluorescence readings taken every 10 min at a wavelength of 460 nm (using an excitation wavelength of 360 nm) on a Synergy HT Plate Reader using Gen5 software from Bio-Tek. The enzyme activity was calculated by converting the relative fluorescence units to AMC formed, using a standard curve of AMC. For compounds that inhibited hNAAA in range IC<sub>50</sub> < 1 μM, full inhibition curves using eight different concentrations of inhibitor (8-point assay) were generated. The assay procedure used was the same as the three-point assay. Inhibition constants were calculated using pro Fit software (Quantum Soft, Switzerland) and a Levenberg–Marquardt.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Determination of NAAA Potencies (<i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> Values)</h3><div class="NLM_p last">The potency of NAAA inhibitors was determined by the second-order rate constants <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> values using an enzyme-coupled NAAA assay in 96-well microplates as described previously.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> The overall potency, <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> values, was calculated from the slope, <i>k</i><sub>inact</sub>/[<i>K</i><sub>i</sub>(1 + [S]/<i>K</i><sub>m</sub>)], which was obtained from the <i>k</i><sub>obs</sub> equation as described.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> NAAA inactivation rates in the absence of inhibitors were subtracted from all <i>k</i><sub>obs</sub> values obtained in the presence of inhibitors.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> MGL and FAAH Inhibitor Fluorescence Assay</h3><div class="NLM_p last">Human-recombinant FAAH (hFAAH) and MGL (hMGL) were expressed in <i>Escherichia coli</i> and purified as described.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> A high-throughput fluorometric screening assay for FAAH inhibition using a fluorescent substrate, AAMCA, was performed as reported.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> MGL assays used the fluorescent substrate arachidonoyl, 7-hydroxy-6-methoxy-4-methylcoumarin ester (AHMMCE).<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> IC<sub>50</sub> values were calculated using Prism software (GraphPad).</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> ABHD6 Inhibitor Fluorescence Assay</h3><div class="NLM_p last">Compounds were assessed in a high throughput fluorescence-based assay for their ability to inhibit the full-length hABHD6 enzyme. We used the fluorogenic substrate arachidonoyl, 7-hydroxy-6-methoxy-4-methylcoumarin ester (AHMMCE)<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> that is hydrolyzed to the fluorescent product HMMCE in the presence of active ABHD6 enzyme.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Cathepsin K Assay</h3><div class="NLM_p last">Compounds were pre-incubated for 120 min at 37 °C recombinant human Cathepsin K enzyme (Enzo; BML-SE553-0010). We used the fluorogenic substrate Z-Phe-Arg-AMC (Enzo; BML-P139) for the reaction, and the enzyme activity was measured from the increase of OD at 405 nm.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> rCB1, hCB2, and mCB2 Binding Assay</h3><div class="NLM_p last">The selected compounds were tested for their ability to bind to CB1 and CB2 receptors using the rat brain<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> or HEK293 cell membranes expressing mouse CB2 (mCB2) or human CB2 (hCB2),<a onclick="showRef(event, 'ref64 ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref64 ref65 ref66">(64−66)</a> respectively, via competition-equilibrium binding using [<sup>3</sup>H]CP-55,940.<a onclick="showRef(event, 'ref65 ref66 ref67 ref78'); return false;" href="javascript:void(0);" class="ref ref65 ref66 ref67 ref78">(65−67,78)</a></div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Stability in Plasma and Buffer</h3><div class="NLM_p last">Compound solutions (200 μM) were made in mouse, rat, or human plasma, buffer containing 0.1% BSA, or artificial gastric juice. After quenching with acetonitrile, the samples were analyzed by HPLC to predict plasma half-lives.<a onclick="showRef(event, 'ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref79 ref80">(79,80)</a></div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Stability toward Rat Liver Microsomal Preparations</h3><div class="NLM_p last">Compound solutions (1 μM) were pre-incubated with the rat liver microsomal protein (Celsis) at 37 °C before the reaction was initiated with NADPH or buffer (control).<a onclick="showRef(event, 'ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref81 ref82">(81,82)</a> Following protein precipitation, the samples were analyzed using a LC–MS/MS system in the SRM mode.</div></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Pharmacokinetic Study of Compound <b>36</b></h3><div class="NLM_p">Male CD-1 mice (25–30 g) from Charles River were used to determine the oral bioavailability and brain exposure of <b>36</b> after intravenous (iv) and oral (po) administration. Animals were fasted overnight prior to dosing and until 4-h post-dose. Mice were given 2 mg/kg of compound <b>36</b> intravenously and 8 mg/kg orally in 3% DMSO, 1:1:18 Emulphor/ethanol/saline vehicle.</div><div id="sec6_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Blood Sampling Time Points</h4><div class="NLM_p last">After iv injection, plasma samples were taken at the following time points: pre-dose 0 min, at 2, 5, 15, and 30 min and 1, 2, 4, 6, and 8 h. After po administration, plasma samples were taken at pre-dose 0 min, then at 15 and 30 min and 1, 2, 4, 6, and 8 h.</div></div><div id="sec6_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Brain Sampling Time Points</h4><div class="NLM_p last">After iv injection, blood sampling was done at time points 0, 0.25, 0.5, 1, 2, and 6 h. The plasma samples were flash-frozen with liquid nitrogen to prevent the post-mortem degradation of the compounds. We homogenized the brain in 10 mL of water and freezed it as soon as possible. We have used three animals per time point. The animals were sacrificed by decapitation followed by blood collection (500 μL) and tissue dissection; samples are flash-frozen with liquid nitrogen to prevent the post-mortem degradation of the compounds. The animals were sacrificed by cervical dislocation followed by decapitation, at which point, the trunk blood will be collected and tissues harvested; this method is consistent with the June 2007 AVMA Guidelines on Euthanasia and our IACUC-approved animal protocol (#16-0402R). Northeastern University’s animal assurance number is #A-3155.</div></div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76">Computational Studies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85778" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85778" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Modeling Methods</h3><div class="NLM_p last">The computational studies were conducted in Schrodinger Suite (version 2018-3). The ligands were prepared in the OPLSe3 force field using the Ligprep module.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Induced-fit docking<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> and covalent docking<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> used Glide and was conducted in the XP (extra precision) mode in the OPLS3e force field.<a onclick="showRef(event, 'ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref85 ref86">(85,86)</a> MM-GBSA rescoring was conducted using the Prime module.</div></div><div id="sec7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> Computational (<i>In Silico</i>) Analysis of Physicochemical Properties of Ligands</h3><div class="NLM_p last"><i>In silico</i> ligand screening with commercial computational software (Schrodinger Suite 2018-3) was used to assess early ADME/pharmacokinetic properties of the proposed compounds in areas of Lipinski rules, ligand efficiency, topological polar surface area (tPSA), and lipophilicity (Clog <i>P</i>).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79"><a href="/doi/suppl/10.1021/acs.jmedchem.1c00076" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31685" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31685" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.1c00076?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00076</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Full experimental details of the preparation of the disclosed compounds, methods for testing the compounds, and methods used in the molecular modeling studies (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00076/suppl_file/jm1c00076_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00076/suppl_file/jm1c00076_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Induced Fit Docking of inhibitor 36 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) with a hNAAA structure 6DXX  (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00076/suppl_file/jm1c00076_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Covalent Docking of inhibitor 36 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) with a hNAAA structure 6DXX (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00076/suppl_file/jm1c00076_si_004.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00076/suppl_file/jm1c00076_si_001.pdf">jm1c00076_si_001.pdf (5.07 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00076/suppl_file/jm1c00076_si_002.csv">jm1c00076_si_002.csv (3.93 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00076/suppl_file/jm1c00076_si_003.pdb">jm1c00076_si_003.pdb (413.89 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00076/suppl_file/jm1c00076_si_004.pdb">jm1c00076_si_004.pdb (421.01 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.1c00076" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70134" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70134" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael S. Malamas</span> - <span class="hlFld-Affiliation affiliation">Northeastern
University, Boston, Massachusetts 02115, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4785-7525" title="Orcid link">http://orcid.org/0000-0002-4785-7525</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4e232f222f232f3d6023272d262f2b220e29232f2722602d2123"><span class="__cf_email__" data-cfemail="eb868a878a868a98c5868288838a8e87ab8c868a8287c5888486">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Spiro Pavlopoulos</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shakiru O. Alapafuja</span> - <span class="hlFld-Affiliation affiliation">MAK
Scientific LLC, 151 South
Bedford Street, Burlington, Massachusetts 01803, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shrouq I. Farah</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander Zvonok</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Khadijah A. Mohammad</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jay West</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas Thomas Perry</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dimitrios N. Pelekoudas</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Girija Rajarshi</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christina Shields</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Honrao Chandrashekhar</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jodi Wood</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexandros Makriyannis</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery and Departments of Chemistry and Chemical Biology
and Pharmaceutical Sciences, Northeastern
University, Boston, Massachusetts 02115, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31381" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31381" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health under Award Numbers R43DK104636 and R44DK104636.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">NAEs</td><td class="NLM_def"><p class="first last"><i>N</i>-acylethanolamines</p></td></tr><tr><td class="NLM_term">NAAA</td><td class="NLM_def"><p class="first last"><i>N</i>-acylethanolamine acid amidase</p></td></tr><tr><td class="NLM_term">PEA</td><td class="NLM_def"><p class="first last">palmitoylethanolamide</p></td></tr><tr><td class="NLM_term">PPARα</td><td class="NLM_def"><p class="first last">nuclear peroxisome proliferator-activated receptor-α</p></td></tr><tr><td class="NLM_term">MGL</td><td class="NLM_def"><p class="first last">monoacylglycerol lipase</p></td></tr><tr><td class="NLM_term">FAAH</td><td class="NLM_def"><p class="first last">fatty acid amide hydrolase</p></td></tr><tr><td class="NLM_term">CB1</td><td class="NLM_def"><p class="first last">CB1 cannabinoid receptor</p></td></tr><tr><td class="NLM_term">CB2</td><td class="NLM_def"><p class="first last">CB2 cannabinoid receptor</p></td></tr><tr><td class="NLM_term">NCS</td><td class="NLM_def"><p class="first last">isothiocyanate</p></td></tr><tr><td class="NLM_term">N-CN</td><td class="NLM_def"><p class="first last">cyanamide</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">BOC</td><td class="NLM_def"><p class="first last"><i>tert</i>-butoxycarbonyl</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">tPSA</td><td class="NLM_def"><p class="first last">total polar surface area</p></td></tr><tr><td class="NLM_term">LiPE</td><td class="NLM_def"><p class="first last">lipophilic efficiency</p></td></tr><tr><td class="NLM_term">DIAD</td><td class="NLM_def"><p class="first last">diisopropyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">Ph<sub>3</sub>P</td><td class="NLM_def"><p class="first last">triphenyl phosphine</p></td></tr><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last"><i>N</i>-ethyl-<i>N</i>′-(3-dimethylaminopropyl) carbodiimide</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">orally</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60044" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60044" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 86 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capoccia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turco, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palumbo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steardo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuomo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarnelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steardo, L.</span></span> <span> </span><span class="NLM_article-title">Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-alpha activation</span>. <i>Gut</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">1300</span>– <span class="NLM_lpage">1312</span>, <span class="refDoi"> DOI: 10.1136/gutjnl-2013-305005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1136%2Fgutjnl-2013-305005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=24082036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFGhurrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2014&pages=1300-1312&author=G.+Espositoauthor=E.+Capocciaauthor=F.+Turcoauthor=I.+Palumboauthor=J.+Luauthor=A.+Steardoauthor=R.+Cuomoauthor=G.+Sarnelliauthor=L.+Steardo&title=Palmitoylethanolamide+improves+colon+inflammation+through+an+enteric+glia%2Ftoll+like+receptor+4-dependent+PPAR-alpha+activation&doi=10.1136%2Fgutjnl-2013-305005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Palmitoylethanolamide improves colon inflammation through an enteric glial toll like receptor 4-dependent PPAR-α activation</span></div><div class="casAuthors">Esposito, Giuseppe; Capoccia, Elena; Turco, Fabio; Palumbo, Ilaria; Lu, Jie; Steardo, Antonio; Cuomo, Rosario; Sarnelli, Giovanni; Steardo, Luca</div><div class="citationInfo"><span class="NLM_cas:title">Gut</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1300-1312</span>CODEN:
                <span class="NLM_cas:coden">GUTTAK</span>;
        ISSN:<span class="NLM_cas:issn">0017-5749</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Objective Enteric glia activation has been reported to amplify intestinal inflammation via the enteroglial-specific S100B protein.  This neurotrophin promotes macrophage recruitment in the mucosa, amplify colonic inflammation and interacts with toll-like receptors (TLR).  Mols. inhibiting S100B-driven enteric activation might mitigate the course of ulcerative colitis (UC).  This study aims to investigate the effects of palmitoylethanolamide (PEA), a drug able to counteract astroglial activation in the central nervous system, on intestinal inflammation, in humans and mice.  Design Mouse models of dextran sodium sulfate (DSS)-induced colitis, colonic biopsies deriving from UC patients and primary cultures of mouse and human enteric glial cells (EGC), have been used to assess the effects of PEA, alone or in the presence of specific PPARα or PPARγ antagonists, on: macroscopic signs of UC (DAI score, colon length, spleen wt., macrophages/neutrophils infiltration); the expression and release of proinflammatory markers typical of UC; LR pathway in EGCs.  Results PEA treatment improves all macroscopic signs of UC and decreases the expression and release of all the proinflammatory markers tested.  PEA antiinflammatory effects are mediated by the selective targeting of the S100B/TLR4 axis on ECG, causing a downstream inhibition of nuclear factor kappa B (NF-kB)-dependent inflammation.  Antagonists at PPARα, but not PPARγ, abolished PEA effects, in mice and in humans.  Conclusions Because of its lack of toxicity, its ability in reducing inflammation and its selective PPARα action, PEA might be an innovative mol. to broaden pharmacol. strategies against UC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAh5Kh3wU4bLVg90H21EOLACvtfcHk0lg2HP0M2SWlCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFGhurrN&md5=3f6e45aee26a81578e9a88beece89ba5</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1136%2Fgutjnl-2013-305005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fgutjnl-2013-305005%26sid%3Dliteratum%253Aachs%26aulast%3DEsposito%26aufirst%3DG.%26aulast%3DCapoccia%26aufirst%3DE.%26aulast%3DTurco%26aufirst%3DF.%26aulast%3DPalumbo%26aufirst%3DI.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DSteardo%26aufirst%3DA.%26aulast%3DCuomo%26aufirst%3DR.%26aulast%3DSarnelli%26aufirst%3DG.%26aulast%3DSteardo%26aufirst%3DL.%26atitle%3DPalmitoylethanolamide%2520improves%2520colon%2520inflammation%2520through%2520an%2520enteric%2520glia%252Ftoll%2520like%2520receptor%25204-dependent%2520PPAR-alpha%2520activation%26jtitle%3DGut%26date%3D2014%26volume%3D63%26spage%3D1300%26epage%3D1312%26doi%3D10.1136%2Fgutjnl-2013-305005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Costa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giagnoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colleoni, M.</span></span> <span> </span><span class="NLM_article-title">Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">420</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0704900</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1038%2Fsj.bjp.0704900" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=12359622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD38XotFeltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2002&pages=413-420&author=B.+Costaauthor=S.+Contiauthor=G.+Giagnoniauthor=M.+Colleoni&title=Therapeutic+effect+of+the+endogenous+fatty+acid+amide%2C+palmitoylethanolamide%2C+in+rat+acute+inflammation%3A+inhibition+of+nitric+oxide+and+cyclo-oxygenase+systems&doi=10.1038%2Fsj.bjp.0704900"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems</span></div><div class="casAuthors">Costa, Barbara; Conti, Silvia; Giagnoni, Gabriella; Colleoni, Mariapia</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">413-420</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The anti-inflammatory activity of the endogenous fatty acid amide palmitoylethanolamide and its relationship to cyclo-oxygenase (COX) activity, nitric oxide (NO) and oxygen free radical prodn. were investigated in the rat model of carrageenan-induced acute paw inflammation and compared with the nonsteroidal anti-inflammatory drug (NSAID) indomethacin.  Palmitoylethanolamide (1, 3, 5, 10 mg kg-1; p.o.) and indomethacin (5 mg kg-1; p.o.) were administered daily after the onset of inflammation for three days and the paw edema was measured daily; 24 h after the last dose (fourth day) the rats were killed and the COX activity and the content of nitrite/nitrate (NO2-/NO3-), malondialdehyde (MDA), endothelial and inducible nitric oxide synthase (eNOS and iNOS) were evaluated in the paw tissues.  Palmitoylethanolamide had a curative effect on inflammation, inhibiting the carrageenan-induced edema in a dose- and time-dependent manner.  This effect was not reversed by the selective CB2 receptor antagonist (N-[(1S)-endo-1,3,3-trimethylbicyclo[2.2.1]heptan-2yl]-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)pyrazole-3 carboxamide) (SR144528), 3 mg kg-1 p.o.  On the fourth day after carrageenan injection, COX activity and the level of NO2-/NO3-, eNOS and MDA were increased in the inflamed paw, but iNOS was not present.  Palmitoylethanolamide (10 mg kg-1) and indomethacin markedly reduced these increases.  Our findings show, for the first time, that palmitoylethanolamide has a curative effect in a model of acute inflammation.  The inhibition of COX activity and of NO and free radical prodn. at the site of inflammation might account for this activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRSouzarUmDLVg90H21EOLACvtfcHk0lg2HP0M2SWlCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotFeltrg%253D&md5=0a989953faac096ccd8291b5a02732ef</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704900%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DB.%26aulast%3DConti%26aufirst%3DS.%26aulast%3DGiagnoni%26aufirst%3DG.%26aulast%3DColleoni%26aufirst%3DM.%26atitle%3DTherapeutic%2520effect%2520of%2520the%2520endogenous%2520fatty%2520acid%2520amide%252C%2520palmitoylethanolamide%252C%2520in%2520rat%2520acute%2520inflammation%253A%2520inhibition%2520of%2520nitric%2520oxide%2520and%2520cyclo-oxygenase%2520systems%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D137%26spage%3D413%26epage%3D420%26doi%3D10.1038%2Fsj.bjp.0704900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calignano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rana, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuffrida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Control of pain initiation by endogenous cannabinoids</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>394</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1038/28393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1038%2F28393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=9685157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaK1cXkvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=1998&pages=277-281&author=A.+Calignanoauthor=G.+L.+Ranaauthor=A.+Giuffridaauthor=D.+Piomelli&title=Control+of+pain+initiation+by+endogenous+cannabinoids&doi=10.1038%2F28393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Control of pain initiation by endogenous cannabinoids</span></div><div class="casAuthors">Calignano, Antonio; La Rana, Giovanna; Giuffrida, Andrea; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">394</span>
        (<span class="NLM_cas:issue">6690</span>),
    <span class="NLM_cas:pages">277-281</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The potent analgesic effects of cannabis-like drugs and the presence of CB1-type cannabinoid receptors in pain-processing areas of the brain and spinal cord indicate that endogenous cannabinoids such as anandamide may contribute to the control of pain transmission within the central nervous system (CNS).  Here the authors show that anandamide attenuates the pain behavior produced by chem. damage to cutaneous tissue by interacting with CB1-like cannabinoid receptors located outside the CNS.  Palmitylethanolamide (PEA), which is released together with anandamide from a common phospholipid precursor, exerts a similar effect by activating peripheral CB2-like receptors.  When administered together, the two compds. at synergistically reducing pain responses 100-fold more potently than does each compd. alone.  Gas-chromatog./mass-spectrometry measurements indicate that the levels of anandamide and PEA in the skin are enough to cause a tonic activation of local cannabinoid receptors.  In agreement with this possibility, the CB1 antagonist SR141716A and the CB2 antagonist SR144528 prolong and enhance the pain behavior produced by tissue damage.  These results indicate that peripheral CB1-like and CB2-like receptors participate in the intrinsic control of pain initiation and that locally generated anandamide and PEA may mediate this effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpKwHMI3BI9LVg90H21EOLACvtfcHk0liPJIr7MT4VYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvVKjt7w%253D&md5=811026d275d0cba5c01567bdebe16ec8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F28393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F28393%26sid%3Dliteratum%253Aachs%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DRana%26aufirst%3DG.%2BL.%26aulast%3DGiuffrida%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DControl%2520of%2520pain%2520initiation%2520by%2520endogenous%2520cannabinoids%26jtitle%3DNature%26date%3D1998%26volume%3D394%26spage%3D277%26epage%3D281%26doi%3D10.1038%2F28393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaggar, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasnie, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellaturay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, A. S. C.</span></span> <span> </span><span class="NLM_article-title">The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1016/s0304-3959(98)00041-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fs0304-3959%2898%2900041-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=9696473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaK1cXjtVKqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1998&pages=189-199&author=S.+I.+Jaggarauthor=F.+S.+Hasnieauthor=S.+Sellaturayauthor=A.+S.+C.+Rice&title=The+anti-hyperalgesic+actions+of+the+cannabinoid+anandamide+and+the+putative+CB2+receptor+agonist+palmitoylethanolamide+in+visceral+and+somatic+inflammatory+pain&doi=10.1016%2Fs0304-3959%2898%2900041-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain</span></div><div class="casAuthors">Jaggar, Sian I.; Hasnie, Fauzia S.; Sellaturay, Senthy; Rice, Andrew S. C.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">189-199</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">This study assessed the effects of two N-acylethanolamides in established rat models of visceral and somatic inflammatory pain.  (1) The therapeutic effects of the cannabinoid anandamide and the putative CB2 agonist palmitoylethanolamide were tested in a model of persistent visceral pain (turpentine inflammation of the urinary bladder).  Both anandamide (at a dose of 25 mg/kg) and palmitoylethanolamide (at doses of 10-30 mg/kg) were able to attenuate the viscero-visceral hyper-reflexia (VVH) induced by inflammation of the urinary bladder.  (2) The effects of the same compds. on the behavioral response to s.c. formalin injection were assessed.  The characteristic biphasic response was obsd. in control animals.  Anandamide (dose range 5-25 mg/kg) and palmitoylethanolamide (dose range 5-10 mg/kg) both reduced the second phase of the response.  The results confirm the analgesic potential of endogenous ligands at cannabinoid receptor sites.  The anti-nociceptive effect of the putative CB2 receptor agonist, palmitoylethanolamide, is particularly interesting since it is believed to be a peripherally mediated effect.  This observation might be exploited to sep. central psychotropic effects from peripheral analgesic actions of the cannabinoids, under inflammatory conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHpLobKz0KYLVg90H21EOLACvtfcHk0liPJIr7MT4VYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtVKqsL0%253D&md5=8f9d3751ab85b7455bdf5c7515676971</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fs0304-3959%2898%2900041-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0304-3959%252898%252900041-4%26sid%3Dliteratum%253Aachs%26aulast%3DJaggar%26aufirst%3DS.%2BI.%26aulast%3DHasnie%26aufirst%3DF.%2BS.%26aulast%3DSellaturay%26aufirst%3DS.%26aulast%3DRice%26aufirst%3DA.%2BS.%2BC.%26atitle%3DThe%2520anti-hyperalgesic%2520actions%2520of%2520the%2520cannabinoid%2520anandamide%2520and%2520the%2520putative%2520CB2%2520receptor%2520agonist%2520palmitoylethanolamide%2520in%2520visceral%2520and%2520somatic%2520inflammatory%2520pain%26jtitle%3DPain%26date%3D1998%26volume%3D76%26spage%3D189%26epage%3D199%26doi%3D10.1016%2Fs0304-3959%2898%2900041-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barrie, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manolios, N.</span></span> <span> </span><span class="NLM_article-title">The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease</span>. <i>Eur. J. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">210</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.5152/eurjrheum.2017.17025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.5152%2Feurjrheum.2017.17025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=29164003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A280%3ADC%252BC1M3jvVeisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2017&pages=210-218&author=N.+Barrieauthor=N.+Manolios&title=The+endocannabinoid+system+in+pain+and+inflammation%3A+Its+relevance+to+rheumatic+disease&doi=10.5152%2Feurjrheum.2017.17025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease</span></div><div class="casAuthors">Barrie Nicola; Manolios Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">European journal of rheumatology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">210-218</span>
        ISSN:<span class="NLM_cas:issn">2147-9720</span>.
    </div><div class="casAbstract">Pain is the most common manifestation of both acute and chronic inflammation that often challenges patients with rheumatic disease.  Simply, we attribute this to local joint changes of pH in joints, the formation of radicals, enhanced joint pressure, or cytokine release acting on local nerves to produce pain.  However, there is a more complex interplay of interactions between cytokines, mediators of inflammation, and ion channels that influence the final immune response and our perception of pain.  Endocannabinoids, a group of less well-known endogenous bioactive lipids, have such manifold immunomodulatory effects able to influence both inflammation and pain.  In this review, we overview the endocannabinoid system, its role in pain, inflammation, and immune regulation, and highlight the emerging challenges and therapeutic hopes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRx9429BdJqzmmbXvSEQle5fW6udTcc2eZVBw5W6afyFrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3jvVeisQ%253D%253D&md5=19f76725788e79428e07179e45aa46d8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.5152%2Feurjrheum.2017.17025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5152%252Feurjrheum.2017.17025%26sid%3Dliteratum%253Aachs%26aulast%3DBarrie%26aufirst%3DN.%26aulast%3DManolios%26aufirst%3DN.%26atitle%3DThe%2520endocannabinoid%2520system%2520in%2520pain%2520and%2520inflammation%253A%2520Its%2520relevance%2520to%2520rheumatic%2520disease%26jtitle%3DEur.%2520J.%2520Rheumatol.%26date%3D2017%26volume%3D4%26spage%3D210%26epage%3D218%26doi%3D10.5152%2Feurjrheum.2017.17025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Micale, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drago, F.</span></span> <span> </span><span class="NLM_article-title">Endocannabinoids and neurodegenerative diseases</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">382</span>– <span class="NLM_lpage">392</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2007.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.phrs.2007.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=17950616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KgsbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2007&pages=382-392&author=V.+Micaleauthor=C.+Mazzolaauthor=F.+Drago&title=Endocannabinoids+and+neurodegenerative+diseases&doi=10.1016%2Fj.phrs.2007.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoids and neurodegenerative diseases</span></div><div class="casAuthors">Micale, Vincenzo; Mazzola, Carmen; Drago, Filippo</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">382-392</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The cannabinoid CB1 and CB2 receptors, the endogenous endocannabinoid (EC) ligands anandamide (AEA) and 2-arachidonylethanolamide, and the degradative enzymes fatty acid amide hydrolase (FAAH) and monoglyceride lipase (ML) are key elements of the EC system implicated in different physiol. functions including cognition, motor activity and immune responses.  Thus, both the possible neuroprotective role of ECs and their modulating action on neurotransmitter systems affected in several neurodegenerative diseases such as Alzheimer's disease (AD), Huntington's disease (HD) and multiple sclerosis (MS) are currently under investigation.  Accumulating data show an unbalance in the EC system (i.e. decrease of neuronal cannabinoid CB1 receptors, increase of glial cannabinoid CB2 receptors and over-expression of FAAH in astrocytes) in exptl. models of AD as well as in post-mortem brain tissue of AD patients, suggesting its possible role in inflammatory processes and in neuroprotection.  However, the mechanisms of the EC modulation of immune response are not fully understood.  By contrast, in HD a reduced EC signaling, given both by the loss of cannabinoid CB1 receptors and decrease of ECs in brain structures involved in movement control as basal ganglia, has been well documented in preclin. and clin. studies.  Thus, in the present review we discuss recent data concerning the role of the EC system in the pathophysiol. of AD and HD, two neurodegenerative diseases characterized by cognitive deficit and motor impairment, resp.  We focus on the effects of compds. modulating the EC system (agonists/antagonists of cannabinoid CB1 and CB2 receptors, or inhibitors of ECs metab. processes) on the symptoms and/or progression of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYW5Alqe2qoLVg90H21EOLACvtfcHk0lgNMKR-HzamZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KgsbzN&md5=b7bb6d6e1edf2c0b4165da9408db9aa4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2007.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2007.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DMicale%26aufirst%3DV.%26aulast%3DMazzola%26aufirst%3DC.%26aulast%3DDrago%26aufirst%3DF.%26atitle%3DEndocannabinoids%2520and%2520neurodegenerative%2520diseases%26jtitle%3DPharmacol.%2520Res.%26date%3D2007%26volume%3D56%26spage%3D382%26epage%3D392%26doi%3D10.1016%2Fj.phrs.2007.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sagheddu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congiu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadda, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pistis, M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2018.11.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.neuropharm.2018.11.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=30439418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1CrsLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2019&pages=327-336&author=C.+Saghedduauthor=M.+Schermaauthor=M.+Congiuauthor=P.+Faddaauthor=G.+Cartaauthor=S.+Banniauthor=J.+T.+Woodauthor=A.+Makriyannisauthor=M.+S.+Malamasauthor=M.+Pistis&title=Inhibition+of+N-acylethanolamine+acid+amidase+reduces+nicotine-induced+dopamine+activation+and+reward&doi=10.1016%2Fj.neuropharm.2018.11.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward</span></div><div class="casAuthors">Sagheddu, Claudia; Scherma, Maria; Congiu, Mauro; Fadda, Paola; Carta, Gianfranca; Banni, Sebastiano; Wood, JodiAnne T.; Makriyannis, Alexandros; Malamas, Michael S.; Pistis, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">327-336</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tobacco smoke is the leading preventable cause of death in the world and treatments aimed to increase success rate in smoking cessation by reducing nicotine dependence are sought.  Activation of peroxisome proliferator-activated receptor-alpha (PPARα) by synthetic or endogenous agonists was shown to suppress nicotine-induced activation of mesolimbic dopamine system, one of the major neurobiol. substrates of nicotine dependence, and nicotine-seeking behavior in rats and monkeys.  An alternative indirect way to activate PPARα is inhibition of N-acylethanolamine acid amidase (NAAA), one of the major hydrolyzing enzyme for its endogenous agonists palmitoylethanolamide (PEA) and oleoylethanolamide (OEA).  We synthesized a novel specific brain permeable NAAA inhibitor, AM11095.  We administered AM11095 to rats and carried out brain lipid anal., a functional observational battery (FOB) to assess toxicity, in vivo electrophysiol. recording from dopamine cells in the ventral tegmental area, brain microdialysis in the nucleus accumbens shell and behavioral expts. to assess its effect on nicotine -induced conditioned place preference (CPP).  AM11095 (5 and 25 mg/kg, i.p.) was devoid of neurotoxic and behavioral effects and did not affect motor behavior and coordination.  This NAAA inhibitor (5 mg/kg i.p.) increased OEA and PEA levels in the hippocampus and cortex, prevented nicotine-induced activation of mesolimbic dopamine neurons in the ventral tegmental area, nicotine-induced elevation of dopamine levels in the nucleus accumbens shell and decreased the expression of nicotine CPP.  Our results indicate that NAAA inhibitors represent a new class of pharmacol. tools to modulate brain PEA/PPARa signalling and show potential in the treatment of nicotine dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWtP3kL6bfBbVg90H21EOLACvtfcHk0lgNMKR-HzamZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1CrsLzM&md5=4a4f4bfe9da9993097774135f12308a4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2018.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2018.11.013%26sid%3Dliteratum%253Aachs%26aulast%3DSagheddu%26aufirst%3DC.%26aulast%3DScherma%26aufirst%3DM.%26aulast%3DCongiu%26aufirst%3DM.%26aulast%3DFadda%26aufirst%3DP.%26aulast%3DCarta%26aufirst%3DG.%26aulast%3DBanni%26aufirst%3DS.%26aulast%3DWood%26aufirst%3DJ.%2BT.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DPistis%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520N-acylethanolamine%2520acid%2520amidase%2520reduces%2520nicotine-induced%2520dopamine%2520activation%2520and%2520reward%26jtitle%3DNeuropharmacology%26date%3D2019%26volume%3D144%26spage%3D327%26epage%3D336%26doi%3D10.1016%2Fj.neuropharm.2018.11.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panlilio, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Justinova, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, S. R.</span></span> <span> </span><span class="NLM_article-title">Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2013.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.pharmthera.2013.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=23333350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitlamsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2013&pages=84-102&author=L.+V.+Panlilioauthor=Z.+Justinovaauthor=S.+R.+Goldberg&title=Inhibition+of+FAAH+and+activation+of+PPAR%3A+new+approaches+to+the+treatment+of+cognitive+dysfunction+and+drug+addiction&doi=10.1016%2Fj.pharmthera.2013.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction</span></div><div class="casAuthors">Panlilio, Leigh V.; Justinova, Zuzana; Goldberg, Steven R.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84-102</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Enhancing the effects of endogenously-released cannabinoid ligands in the brain might provide therapeutic effects more safely and effectively than administering drugs that act directly at the cannabinoid receptor.  Inhibitors of fatty acid amide hydrolase (FAAH) prevent the breakdown of endogenous ligands for cannabinoid receptors and peroxisome proliferator-activated receptors (PPAR), prolonging and enhancing the effects of these ligands when they are naturally released.  This review considers recent research on the effects of FAAH inhibitors and PPAR activators in animal models of addiction and cognition (specifically learning and memory).  These studies show that FAAH inhibitors can produce potentially therapeutic effects, some through cannabinoid receptors and some through PPAR.  These effects include enhancing certain forms of learning, counteracting the rewarding effects of nicotine and alc., relieving symptoms of withdrawal from cannabis and other drugs, and protecting against relapse-like reinstatement of drug self-administration.  Since FAAH inhibition might have a wide range of therapeutic actions but might also share some of the adverse effects of cannabis, it is noteworthy that at least one FAAH-inhibiting drug (URB597) has been found to have potentially beneficial effects but no indication of liability for abuse or dependence.  Although these areas of research are new, the preliminary evidence indicates that they might lead to improved therapeutic interventions and a better understanding of the brain mechanisms underlying addiction and memory.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVfd0ns0RUZrVg90H21EOLACvtfcHk0lgNMKR-HzamZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitlamsrc%253D&md5=a13bc121f2523849c97c8029d279e8a7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2013.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2013.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DPanlilio%26aufirst%3DL.%2BV.%26aulast%3DJustinova%26aufirst%3DZ.%26aulast%3DGoldberg%26aufirst%3DS.%2BR.%26atitle%3DInhibition%2520of%2520FAAH%2520and%2520activation%2520of%2520PPAR%253A%2520new%2520approaches%2520to%2520the%2520treatment%2520of%2520cognitive%2520dysfunction%2520and%2520drug%2520addiction%26jtitle%3DPharmacol.%2520Ther.%26date%3D2013%26volume%3D138%26spage%3D84%26epage%3D102%26doi%3D10.1016%2Fj.pharmthera.2013.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Melis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pistis, M.</span></span> <span> </span><span class="NLM_article-title">Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: therapeutic perspectives</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2014.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.phrs.2014.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=24704146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvVWqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=42-49&author=M.+Melisauthor=M.+Pistis&title=Targeting+the+interaction+between+fatty+acid+ethanolamides+and+nicotinic+receptors%3A+therapeutic+perspectives&doi=10.1016%2Fj.phrs.2014.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: Therapeutic perspectives</span></div><div class="casAuthors">Melis, Miriam; Pistis, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">42-49</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Nicotine is one of the drugs of abuse that frequently causes addiction and relapse during abstinence.  Nicotine's strong addicting properties reside in its ability to enhance dopamine transmission, and to induce specific changes in synaptic plasticity.  Currently, approved therapies for smoking cessation increase the chances of remaining abstinent, but lack high levels of efficacy and are assocd. with significant adverse side effects.  As a result, there is an urgent need for more effective antismoking medications.  Studies have revealed that drugs targeting the peroxisome proliferator-activated-receptor-α (PPARα) show promise for the treatment of nicotine addiction.  These drugs include synthetic PPARα ligands, such as the clin. available hypolipidemic fibrates, and drugs that increase levels of endogenous endocannabinoid-like fatty acid ethanolamides (FAEs) that act as PPARα agonists.  In this review, we will discuss the specific interaction between PPARα and nicotine, and the mol. mechanisms whereby these intracellular receptors regulate nicotinic acetylcholine receptor functions in neurons.  Modulation of neurophysiol., neurochem. and behavioral effects of nicotine by PPARα will be also reviewed.  Indeed, a picture is emerging where FAEs are endogenous regulators of acetylcholine transmission.  Notably, the implications of this specific cross talk extend beyond nicotine addiction, and might bear relevance for psychiatric disorders and epilepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxOH2ZeV_YubVg90H21EOLACvtfcHk0lhYksyy2C6Drw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvVWqs7o%253D&md5=17d3aa519dac43786749155ed9126e60</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2014.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2014.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DMelis%26aufirst%3DM.%26aulast%3DPistis%26aufirst%3DM.%26atitle%3DTargeting%2520the%2520interaction%2520between%2520fatty%2520acid%2520ethanolamides%2520and%2520nicotinic%2520receptors%253A%2520therapeutic%2520perspectives%26jtitle%3DPharmacol.%2520Res.%26date%3D2014%26volume%3D86%26spage%3D42%26epage%3D49%26doi%3D10.1016%2Fj.phrs.2014.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Stelt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veldhuis, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bär, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolay, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veldink, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vliegenthart, J. F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, H. S.</span></span> <span> </span><span class="NLM_article-title">Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases</span>. <i>Neurotox. Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">183</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1007/bf03033139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1007%2Fbf03033139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=12835123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A280%3ADC%252BD3szgslynug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=183-199&author=M.+van%0Ader+Steltauthor=H.+H.+Hansenauthor=W.+B.+Veldhuisauthor=P.+R.+B%C3%A4rauthor=K.+Nicolayauthor=G.+A.+Veldinkauthor=J.+F.+G.+Vliegenthartauthor=H.+S.+Hansen&title=Biosynthesis+of+endocannabinoids+and+their+modes+of+action+in+neurodegenerative+diseases&doi=10.1007%2Fbf03033139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases</span></div><div class="casAuthors">van der Stelt Mario; Hansen Henrik H; Veldhuis Wouter B; Bar Peter R; Nicolay Klaas; Veldink Gerrit A; Vliegenthart Johannes F G; Hansen Harald S</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicity research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">183-200</span>
        ISSN:<span class="NLM_cas:issn">1029-8428</span>.
    </div><div class="casAbstract">Endocannabinoids are thought to function as retrograde messengers, which modulate neurotransmitter release by activating presynaptic cannabinoid receptors.  Anandamide and 2-arachidonoylglycerol (2-AG) are the two best studied endogenous lipids which can act as endocannabinoids.  Together with the proteins responsible for their biosynthesis, inactivation and the cannabinoid receptors, these lipids constitute the endocannabinoid system.  This system is proposed to be involved in various neurodegenerative diseases such as Parkinson's and Huntington's diseases as well as Multiple Sclerosis.  It has been demonstrated that the endocannabinoid system can protect neurons against glutamate excitotoxicity and acute neuronal damage in both in vitro and in vivo models.  In this paper we review the data concerning the involvement of the endocannabinoid system in neurodegenerative diseases in which neuronal cell death may be elicited by excitotoxicity.  We focus on the biosynthesis of endocannabinoids and on their modes of action in animal models of these neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRWXnazzQtAeP6xYuD7tu2XfW6udTcc2eblnD38hN6G0bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3szgslynug%253D%253D&md5=f77f20491cd213d737628817921dd91f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fbf03033139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fbf03033139%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BStelt%26aufirst%3DM.%26aulast%3DHansen%26aufirst%3DH.%2BH.%26aulast%3DVeldhuis%26aufirst%3DW.%2BB.%26aulast%3DB%25C3%25A4r%26aufirst%3DP.%2BR.%26aulast%3DNicolay%26aufirst%3DK.%26aulast%3DVeldink%26aufirst%3DG.%2BA.%26aulast%3DVliegenthart%26aufirst%3DJ.%2BF.%2BG.%26aulast%3DHansen%26aufirst%3DH.%2BS.%26atitle%3DBiosynthesis%2520of%2520endocannabinoids%2520and%2520their%2520modes%2520of%2520action%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNeurotox.%2520Res.%26date%3D2003%26volume%3D5%26spage%3D183%26epage%3D199%26doi%3D10.1007%2Fbf03033139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turcotte, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chouinard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefebvre, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flamand, N.</span></span> <span> </span><span class="NLM_article-title">Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites</span>. <i>J. Leukoc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">1049</span>– <span class="NLM_lpage">1070</span>, <span class="refDoi"> DOI: 10.1189/jlb.3ru0115-021r</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1189%2Fjlb.3ru0115-021r" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=25877930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVGgtbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2015&pages=1049-1070&author=C.+Turcotteauthor=F.+Chouinardauthor=J.+S.+Lefebvreauthor=N.+Flamand&title=Regulation+of+inflammation+by+cannabinoids%2C+the+endocannabinoids+2-arachidonoyl-glycerol+and+arachidonoyl-ethanolamide%2C+and+their+metabolites&doi=10.1189%2Fjlb.3ru0115-021r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites</span></div><div class="casAuthors">Turcotte, Caroline; Chouinard, Francois; Lefebvre, Julie S.; Flamand, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1049-1070</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Society for Leukocyte Biology</span>)
        </div><div class="casAbstract">2-Arachidonoyl-glycerol (2-AG) and arachidonyl-ethanolamide (AEA) are endocannabinoids that have been implicated in many physiol. disorders, including obesity, metabolic syndromes, hepatic diseases, pain, neurol. disorders, and inflammation.  Their immunomodulatory effects are numerous and are not always mediated by cannabinoid receptors, reflecting the presence of an arachidonic acid (AA) mol. in their structure, the latter being the precursor of numerous bioactive lipids that are pro- or anti-inflammatory.  2-AG and AEA can thus serve as a source of AA but can also be metabolized by most eicosanoid biosynthetic enzymes, yielding addnl. lipids.  In this regard, enhancing endocannabinoid levels by using endocannabinoid hydrolysis inhibitors is likely to augment the levels of these lipids that could regulate inflammatory cell functions.  This review summarizes the metabolic pathways involved in the biosynthesis and metab. of AEA and 2-AG, as well as the biol. effects of the 2-AG and AEA lipidomes in the regulation of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsACPa4v3wHrVg90H21EOLACvtfcHk0lhYksyy2C6Drw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVGgtbvF&md5=cd0e1dcd26a044d3ce3cabb956ed3358</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1189%2Fjlb.3ru0115-021r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.3ru0115-021r%26sid%3Dliteratum%253Aachs%26aulast%3DTurcotte%26aufirst%3DC.%26aulast%3DChouinard%26aufirst%3DF.%26aulast%3DLefebvre%26aufirst%3DJ.%2BS.%26aulast%3DFlamand%26aufirst%3DN.%26atitle%3DRegulation%2520of%2520inflammation%2520by%2520cannabinoids%252C%2520the%2520endocannabinoids%25202-arachidonoyl-glycerol%2520and%2520arachidonoyl-ethanolamide%252C%2520and%2520their%2520metabolites%26jtitle%3DJ.%2520Leukoc.%2520Biol.%26date%3D2015%26volume%3D97%26spage%3D1049%26epage%3D1070%26doi%3D10.1189%2Fjlb.3ru0115-021r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LoVerme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Rana, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calignano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">The search for the palmitoylethanolamide receptor</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">1685</span>– <span class="NLM_lpage">1698</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2005.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.lfs.2005.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=15963531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvVGit7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2005&pages=1685-1698&author=J.+LoVermeauthor=G.+La+Ranaauthor=R.+Russoauthor=A.+Calignanoauthor=D.+Piomelli&title=The+search+for+the+palmitoylethanolamide+receptor&doi=10.1016%2Fj.lfs.2005.05.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The search for the palmitoylethanolamide receptor</span></div><div class="casAuthors">LoVerme, Jesse; La Rana, Giovanna; Russo, Roberto; Calignano, Antonio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1685-1698</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Palmitoylethanolamide (PEA), the naturally occurring amide of ethanolamine and palmitic acid, is an endogenous lipid that modulates pain and inflammation.  Although the anti-inflammatory effects of PEA were first characterized nearly 50 years ago, the identity of the receptor mediating these actions has long remained elusive.  We recently identified the ligand-activated transcription factor, peroxisome proliferator-activated receptor-alpha (PPAR-α), as the receptor mediating the anti-inflammatory actions of this lipid amide.  Here we outline the history of PEA, starting with its initial discovery in the 1950s, and discuss the pharmacol. properties of this compd., particularly in regards to its ability to activate PPAR-α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvNrDB4VpEv7Vg90H21EOLACvtfcHk0lhYksyy2C6Drw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvVGit7c%253D&md5=5aff137dd05089d62a32cefe637b83b9</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2005.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2005.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DLoVerme%26aufirst%3DJ.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DThe%2520search%2520for%2520the%2520palmitoylethanolamide%2520receptor%26jtitle%3DLife%2520Sci.%26date%3D2005%26volume%3D77%26spage%3D1685%26epage%3D1698%26doi%3D10.1016%2Fj.lfs.2005.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scuderi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stecca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronzuoli, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartoli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steardo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pompili, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fumagalli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campolongo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steardo, L.</span></span> <span> </span><span class="NLM_article-title">Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer’s disease</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e1419</span> <span class="refDoi"> DOI: 10.1038/cddis.2014.376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1038%2Fcddis.2014.376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=25210802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFyit73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&author=C.+Scuderiauthor=C.+Steccaauthor=M.+Valenzaauthor=P.+Ratanoauthor=M.+R.+Bronzuoliauthor=S.+Bartoliauthor=L.+Steardoauthor=E.+Pompiliauthor=L.+Fumagalliauthor=P.+Campolongoauthor=L.+Steardo&title=Palmitoylethanolamide+controls+reactive+gliosis+and+exerts+neuroprotective+functions+in+a+rat+model+of+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fcddis.2014.376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer's disease</span></div><div class="casAuthors">Scuderi, C.; Stecca, C.; Valenza, M.; Ratano, P.; Bronzuoli, M. R.; Bartoli, S.; Steardo, L.; Pompili, E.; Fumagalli, L.; Campolongo, P.; Steardo, L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e1419</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Given the complex heterogeneity of pathol. changes occurring in Alzheimer's disease (AD), any therapeutic effort absolutely requires a multi-targeted approach, because attempts addressing only a single event may result ineffective.  Palmitoylethanolamide (PEA), a naturally occurring lipid amide between palmitic acid and ethanolamine, seems to be a compd. able to fulfill the criteria of a multi-factorial therapeutic approach.  Here, we describe the anti-inflammatory and neuroprotective activities of systemic administration of PEA in adult male rats given intrahippocampal injection of beta amyloid 1-42 (Aβ 1-42).  Moreover, to investigate the mol. mechanisms responsible for the effects induced by PEA, we co-administered PEA with the GW6471, an antagonist of peroxisome proliferator-activated receptor-α (PPAR-α).  We found that Aβ 1-42 infusion results in severe changes of biochem. markers related to reactive gliosis, amyloidogenesis, and tau protein hyperphosphorylation.  Interestingly, PEA was able to restore the Aβ 1-42-induced alterations through PPAR-α involvement.  In addn., results from the Morris water maze task highlighted a mild cognitive deficit during the reversal learning phase of the behavioral study.  Similarly to the biochem. data, also amnestic deficits were reduced by PEA treatment.  These data disclose novel findings about the therapeutic potential of PEA, and suggest novel strategies that hopefully could have the potential not just to alleviate the symptoms but also to modify disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt3FJJBwoW47Vg90H21EOLACvtfcHk0lg2ytfwR4Xx5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFyit73J&md5=dd825f970b31d33f9b11fcce433940e7</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.376%26sid%3Dliteratum%253Aachs%26aulast%3DScuderi%26aufirst%3DC.%26aulast%3DStecca%26aufirst%3DC.%26aulast%3DValenza%26aufirst%3DM.%26aulast%3DRatano%26aufirst%3DP.%26aulast%3DBronzuoli%26aufirst%3DM.%2BR.%26aulast%3DBartoli%26aufirst%3DS.%26aulast%3DSteardo%26aufirst%3DL.%26aulast%3DPompili%26aufirst%3DE.%26aulast%3DFumagalli%26aufirst%3DL.%26aulast%3DCampolongo%26aufirst%3DP.%26aulast%3DSteardo%26aufirst%3DL.%26atitle%3DPalmitoylethanolamide%2520controls%2520reactive%2520gliosis%2520and%2520exerts%2520neuroprotective%2520functions%2520in%2520a%2520rat%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26doi%3D10.1038%2Fcddis.2014.376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beggiato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasini, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraro, L.</span></span> <span> </span><span class="NLM_article-title">Chronic Oral Palmitoylethanolamide Administration Rescues Cognitive Deficit and Reduces Neuroinflammation, Oxidative Stress, and Glutamate Levels in A Transgenic Murine Model of Alzheimer’s Disease</span>. <i>J. Clin. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">428</span>, <span class="refDoi"> DOI: 10.3390/jcm9020428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.3390%2Fjcm9020428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BB3cXms1WntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2020&pages=428&author=S.+Beggiatoauthor=M.+C.+Tomasiniauthor=T.+Cassanoauthor=L.+Ferraro&title=Chronic+Oral+Palmitoylethanolamide+Administration+Rescues+Cognitive+Deficit+and+Reduces+Neuroinflammation%2C+Oxidative+Stress%2C+and+Glutamate+Levels+in+A+Transgenic+Murine+Model+of+Alzheimer%E2%80%99s+Disease&doi=10.3390%2Fjcm9020428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic Oral Palmitoylethanolamide Administration Rescues Cognitive Deficit and Reduces Neuroinflammation, Oxidative Stress, and Glutamate Levels in A Transgenic Murine Model of Alzheimer's Disease</span></div><div class="casAuthors">Beggiato, Sarah; Tomasini, Maria Cristina; Cassano, Tommaso; Ferraro, Luca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">428</span>CODEN:
                <span class="NLM_cas:coden">JCMOHK</span>;
        ISSN:<span class="NLM_cas:issn">2077-0383</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">N-palmitoylethanolamide (PEA) is a lipid mediator belonging to the class of the N-acylethanolamine.  Products contg. PEA, also in ultramicronized formulation (um-PEA), are already licensed for use in humans for its analgesic and anti-inflammatory properties, and demonstrated high safety and tolerability.  Preclin. studies indicate that PEA, esp. in the ultramicronized form, could be a potential therapeutic agent for Alzheimer's disease (AD).  In this study, we evaluated the neuroprotective and antioxidant effects of chronic (three months) um-PEA administration in an animal model of AD (3xTg-AD mice).  For translation purposes, the compd. has been orally administered.  Cognitive performance as well as biochem. markers [(interleukin-16 (IL-16) and tumor necrosis factor-α (TNF-α)] levels, reactive oxygen species (ROS) prodn., synaptophysin and glutamate levels) have been evaluated at the end of um-PEA treatment.  The results indicate that orally administered um-PEA was adsorbed and distributed in the mice brain.  The chronic treatment with um-PEA (100 mg/kg/day for three months) rescued cognitive deficit, restrained neuroinflammation and oxidative stress, and reduced the increase in hippocampal glutamate levels obsd. in 3 x Tg-AD mice.  Overall, these data reinforce the concept that um-PEA exerts beneficial effects in 3xTg-AD mice.  The fact that PEA is already licensed for the use in humans strongly supports its rapid translation in clin. practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1OTGNJNc_0rVg90H21EOLACvtfcHk0lg2ytfwR4Xx5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXms1WntrY%253D&md5=3bf8e10fa27c085d5df5517acfc63c7e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.3390%2Fjcm9020428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcm9020428%26sid%3Dliteratum%253Aachs%26aulast%3DBeggiato%26aufirst%3DS.%26aulast%3DTomasini%26aufirst%3DM.%2BC.%26aulast%3DCassano%26aufirst%3DT.%26aulast%3DFerraro%26aufirst%3DL.%26atitle%3DChronic%2520Oral%2520Palmitoylethanolamide%2520Administration%2520Rescues%2520Cognitive%2520Deficit%2520and%2520Reduces%2520Neuroinflammation%252C%2520Oxidative%2520Stress%252C%2520and%2520Glutamate%2520Levels%2520in%2520A%2520Transgenic%2520Murine%2520Model%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Clin.%2520Med.%26date%3D2020%26volume%3D9%26spage%3D428%26doi%3D10.3390%2Fjcm9020428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beggiato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasini, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraro, L.</span></span> <span> </span><span class="NLM_article-title">Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s Disease</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">821</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.3389%2Ffphar.2019.00821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=31396087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksVaks7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=821&author=S.+Beggiatoauthor=M.+C.+Tomasiniauthor=L.+Ferraro&title=Palmitoylethanolamide+%28PEA%29+as+a+Potential+Therapeutic+Agent+in+Alzheimer%E2%80%99s+Disease&doi=10.3389%2Ffphar.2019.00821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Palmitoylethanolamide (PEA) as a potential therapeutic agent in Alzheimer's disease</span></div><div class="casAuthors">Beggiato, Sarah; Tomasini, Maria Cristina; Ferraro, Luca</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">821</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">N-Palmitoylethanolamide (PEA) is a non-endocannabinoid lipid mediator belonging to the class of the N-acylethanolamine phospolipids and was firstly isolated from soy lecithin, egg yolk, and peanut meal.  Either preclin. or clin. studies indicate that PEA is potentially useful in a wide range of therapeutic areas, including eczema, pain, and neurodegeneration.  PEA-contg. products are already licensed for use in humans as a nutraceutical, a food supplement, or a food for medical purposes, depending on the country.  PEA is esp. used in humans for its analgesic and anti-inflammatory properties and has demonstrated high safety and tolerability.  Several preclin. in vitro and in vivo studies have proven that PEA can induce its biol. effects by acting on several mol. targets in both central and peripheral nervous systems.  These multiple mechanisms of action clearly differentiate PEA from classic anti-inflammatory drugs and are attributed to the compd. that has quite unique anti(neuro)inflammatory properties.  According to this view, preclin. studies indicate that PEA, esp. in micronized or ultramicronized forms (i.e., formulations that maximize PEA bioavailability and efficacy), could be a potential therapeutic agent for the effective treatment of different pathologies characterized by neurodegeneration, (neuro) inflammation, and pain.  In particular, the potential neuroprotective effects of PEA have been demonstrated in several exptl. models of Alzheimer's disease.  Interestingly, a singlephoton emission computed tomog. (SPECT) case study reported that a mild cognitive impairment (MCI) patient, treated for 9 mo with ultramicronized-PEA/luteolin, presented an improvement of cognitive performances.  In the present review, we summarized the current preclin. and clin. evidence of PEA as a possible therapeutic agent in Alzheimer's disease.  The possible PEA neuroprotective mechanism(s) of action is also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVzMaU8QASwbVg90H21EOLACvtfcHk0lg2ytfwR4Xx5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksVaks7Y%253D&md5=03a7763672770bf5836eeb028502d035</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00821%26sid%3Dliteratum%253Aachs%26aulast%3DBeggiato%26aufirst%3DS.%26aulast%3DTomasini%26aufirst%3DM.%2BC.%26aulast%3DFerraro%26aufirst%3DL.%26atitle%3DPalmitoylethanolamide%2520%2528PEA%2529%2520as%2520a%2520Potential%2520Therapeutic%2520Agent%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D821%26doi%3D10.3389%2Ffphar.2019.00821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uyama, T.</span></span> <span> </span><span class="NLM_article-title">Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">1874</span>– <span class="NLM_lpage">1894</span>, <span class="refDoi"> DOI: 10.1111/febs.12152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1111%2Ffebs.12152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=23425575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsFWgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=1874-1894&author=N.+Uedaauthor=K.+Tsuboiauthor=T.+Uyama&title=Metabolism+of+endocannabinoids+and+related+N-acylethanolamines%3A+canonical+and+alternative+pathways&doi=10.1111%2Ffebs.12152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of endocannabinoids and related N-acylethanolamines: Canonical and alternative pathways</span></div><div class="casAuthors">Ueda, Natsuo; Tsuboi, Kazuhito; Uyama, Toru</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1874-1894</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Endocannabinoids are endogenous ligands of the cannabinoid receptors CB1 and CB2.  Two arachidonic acid derivs., arachidonoylethanolamide (anandamide) and 2-arachidonoyl glycerol, are considered to be physiol. important endocannabinoids.  In the known metabolic pathway in mammals, anandamide and other bioactive N-acylethanolamines, such as palmitoylethanolamide and oleoylethanolamide, are biosynthesized from glycerophospholipids by a combination of Ca2+-dependent N-acyltransferase and N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D, and are degraded by fatty acid amide hydrolase.  However, recent studies have shown the involvement of other enzymes and pathways, which include the members of the tumor suppressor HRASLS family (the phospholipase A/acyltransferase family) functioning as Ca2+-independent N-acyltransferases, N-acyl-phosphatidylethanolamine-hydrolyzing phospholipaseD-independent multistep pathways via N-acylated lysophospholipid, and N-acylethanolamine-hydrolyzing acid amidase, a lysosomal enzyme that preferentially hydrolyzes palmitoylethanolamide.  Although their physiol. significance is poorly understood, these new enzymes/pathways may serve as novel targets for the development of therapeutic drugs.  For example, selective N-acylethanolamine-hydrolyzing acid amidase inhibitors are expected to be new anti-inflammatory and analgesic drugs.  In this minireview, we focus on advances in the understanding of these enzymes/pathways.  In addn., recent findings on 2-arachidonoyl glycerol metab. are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXGslrDcd7BrVg90H21EOLACvtfcHk0liyjg7YzVOkMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsFWgur4%253D&md5=8ad15d152019255551ab6e5bac9817d1</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12152%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DN.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DUyama%26aufirst%3DT.%26atitle%3DMetabolism%2520of%2520endocannabinoids%2520and%2520related%2520N-acylethanolamines%253A%2520canonical%2520and%2520alternative%2520pathways%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D1874%26epage%3D1894%26doi%3D10.1111%2Ffebs.12152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span> <span> </span><span class="NLM_article-title">Molecular characterization of a phospholipase D generating anandamide and its congeners</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">5298</span>– <span class="NLM_lpage">5305</span>, <span class="refDoi"> DOI: 10.1074/jbc.m306642200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1074%2Fjbc.m306642200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=14634025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFeqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=5298-5305&author=Y.+Okamotoauthor=J.+Morishitaauthor=K.+Tsuboiauthor=T.+Tonaiauthor=N.+Ueda&title=Molecular+characterization+of+a+phospholipase+D+generating+anandamide+and+its+congeners&doi=10.1074%2Fjbc.m306642200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners</span></div><div class="casAuthors">Okamoto, Yasuo; Morishita, Jun; Tsuboi, Kazuhito; Tonai, Takeharu; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">5298-5305</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Anandamide (N-arachidonoylethanolamine) is known to be an endogenous ligand of cannabinoid and vanilloid receptors.  Its congeners (collectively referred to as N-acylethanolamines) also show a variety of biol. activities.  These compds. are principally formed from their corresponding N-acylphosphatidylethanolamines by a phosphodiesterase of the phospholipase D-type in animal tissues.  The authors purified the enzyme from rat heart, and by the use of the sequences of its internal peptides cloned its cDNAs from mouse, rat, and human.  The deduced amino acid sequences were composed of 393-396 residues, and showed that the enzyme has no homol. with the known phospholipase D enzymes but is classified as a member of the zinc metallohydrolase family of the β-lactamase fold.  As was overexpressed in COS-7 cells, the recombinant enzyme generated anandamide and other N-acylethanolamines from their corresponding N-acylphosphatidylethanolamines at comparable rates.  In contrast, the enzyme was inactive with phosphatidylcholine and phosphatidylethanolamine.  Assays of the enzyme activity and the mRNA and protein levels revealed its wide distribution in murine organs with higher contents in the brain, kidney, and testis.  These results confirm that a specific phospholipase D is responsible for the generation of N-acylethanolamines including anandamide, strongly suggesting the physiol. importance of lipid mols. of this class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK_-VVe-jk7rVg90H21EOLACvtfcHk0liyjg7YzVOkMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFeqtrY%253D&md5=f1c00a4d0e21163c03b5a70d2f46c721</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m306642200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m306642200%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DMorishita%26aufirst%3DJ.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DTonai%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DMolecular%2520characterization%2520of%2520a%2520phospholipase%2520D%2520generating%2520anandamide%2520and%2520its%2520congeners%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D5298%26epage%3D5305%26doi%3D10.1074%2Fjbc.m306642200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giang, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayfield, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilula, N. B.</span></span> <span> </span><span class="NLM_article-title">Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>384</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1038/384083a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1038%2F384083a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=8900284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaK28XmvVegt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=1996&pages=83-87&author=B.+F.+Cravattauthor=D.+K.+Giangauthor=S.+P.+Mayfieldauthor=D.+L.+Bogerauthor=R.+A.+Lernerauthor=N.+B.+Gilula&title=Molecular+characterization+of+an+enzyme+that+degrades+neuromodulatory+fatty-acid+amides&doi=10.1038%2F384083a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides</span></div><div class="casAuthors">Cravatt, Benjamin F.; Giang, Dan K.; Mayfield, Stephen P.; Boger, Dale L.; Lerner, Richard A.; Gilula, Norton B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">6604</span>),
    <span class="NLM_cas:pages">83-87</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Endogenous neuromodulatory mols.. are commonly couples to specific metabolic enzymes to ensure rapid signal inactivation.  Thus, acetylcholine is hydrolyzed by acetylcholine esterase and tryptamine neurotransmitters like serotonin are degraded by monoamine oxidases.  Previously, we reported the structure and sleep-deproved cats.  Cis-9-Octadecenamide, or oleamide, has since been shown to affect serotonergic systems and block gap-junction communication in glial cells (our unpublished results).  We also identified a membrane-bound enzyme activity that hydrolyses oleamide to its inactive acid, oleic acid.  We now report the mechanism-based isolation, cloning and expression of this enzyme activity, originally named oleamide hydrolase, from rat liver plasma membranes.  We also show that oleamide hydrolase converts anandamide, a fatty-acid amide identified as the endogenous ligand for the cannabinoid receptor, to arachidonic acid, indicating that oleamide hydrolase may serve as the general inactivating enzyme for a growing family of bioactive signalling mols., the fatty-acid amides.  Therefore we will hereafter refer to oelamide hydrolase as fatty-acid amide hydrolase, in recognition of the plurality of fatty-acid amide hydrolase, in recognition of the plurality of fatty-acid amides that the enzyme can accept as substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEhJfsk7jdmLVg90H21EOLACvtfcHk0liyjg7YzVOkMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmvVegt7s%253D&md5=155095116ad61669c06c4b6dcc25e28a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2F384083a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F384083a0%26sid%3Dliteratum%253Aachs%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DGiang%26aufirst%3DD.%2BK.%26aulast%3DMayfield%26aufirst%3DS.%2BP.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DLerner%26aufirst%3DR.%2BA.%26aulast%3DGilula%26aufirst%3DN.%2BB.%26atitle%3DMolecular%2520characterization%2520of%2520an%2520enzyme%2520that%2520degrades%2520neuromodulatory%2520fatty-acid%2520amides%26jtitle%3DNature%26date%3D1996%26volume%3D384%26spage%3D83%26epage%3D87%26doi%3D10.1038%2F384083a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, S.</span></span> <span> </span><span class="NLM_article-title">Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">35552</span>– <span class="NLM_lpage">35557</span>, <span class="refDoi"> DOI: 10.1074/jbc.m106261200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1074%2Fjbc.m106261200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=11463796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntFahs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=35552-35557&author=N.+Uedaauthor=K.+Yamanakaauthor=S.+Yamamoto&title=Purification+and+characterization+of+an+acid+amidase+selective+for+N-palmitoylethanolamine%2C+a+putative+endogenous+anti-inflammatory+substance&doi=10.1074%2Fjbc.m106261200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance</span></div><div class="casAuthors">Ueda, Natsuo; Yamanaka, Kenji; Yamamoto, Shozo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">35552-35557</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">N-Arachidonoylethanolamine (anandamide) is cannabimimetic, and N-palmitoylethanolamine is anti-inflammatory and immunosuppressive.  We found an amidase that is more active with the latter than the former in contrast to the previously known anandamide amidohydrolase for which N-palmitoylethanolamine is a poor substrate.  Proteins solubilized by freezing and thawing from the 12,000 × g pellet of various rat organs hydrolyzed [14C]N-palmitoylethanolamine to palmitic acid and ethanolamine.  The specific enzyme activity was higher in the order of lung > spleen > small intestine > thymus > cecum, and high activity was found in peritoneal and alveolar macrophages.  The enzyme with a mol. mass of 31 kDa was purified from rat lung to a specific activity of 1.8 μmol/min/mg protein.  Relative reactivities of the enzyme with various N-acylethanolamines (100 μM) were as follows: N-palmitoylethanolamine, 100%; N-myristoylethanolamine, 48%; N-stearoylethanolamine, 21%; N-oleoylethanolamine, 20%; N-linoleoylethanolamine, 13%; anandamide, 8%.  The enzyme was the most active at pH 5 and was activated 7-fold by Triton X-100.  The enzyme was almost insensitive to Me arachidonyl fluorophosphonate, which inhibited anandamide amidohydrolase potently.  Thus, the new enzyme referred to as N-palmitoylethanolamine hydrolase was clearly distinguishable from anandamide amidohydrolase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5UIYxO9poNrVg90H21EOLACvtfcHk0lgPTcn07YzQRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntFahs7g%253D&md5=b7bb8c14c642547023582e27c4c1d79e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m106261200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m106261200%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DN.%26aulast%3DYamanaka%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DS.%26atitle%3DPurification%2520and%2520characterization%2520of%2520an%2520acid%2520amidase%2520selective%2520for%2520N-palmitoylethanolamine%252C%2520a%2520putative%2520endogenous%2520anti-inflammatory%2520substance%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D35552%26epage%3D35557%26doi%3D10.1074%2Fjbc.m106261200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takezaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span> <span> </span><span class="NLM_article-title">The N-acylethanolamine-hydrolyzing acid amidase (NAAA)</span>. <i>Chem. Biodivers.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1914</span>– <span class="NLM_lpage">1925</span>, <span class="refDoi"> DOI: 10.1002/cbdv.200790159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1002%2Fcbdv.200790159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=17712833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A280%3ADC%252BD2svpvF2qtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=1914-1925&author=K.+Tsuboiauthor=N.+Takezakiauthor=N.+Ueda&title=The+N-acylethanolamine-hydrolyzing+acid+amidase+%28NAAA%29&doi=10.1002%2Fcbdv.200790159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The N-acylethanolamine-hydrolyzing acid amidase (NAAA)</span></div><div class="casAuthors">Tsuboi Kazuhito; Takezaki Naoko; Ueda Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & biodiversity</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1914-25</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Bioactive N-acylethanolamines, including the endocannabinoid anandamide and anti-inflammatory N-palmitoylethanolamine, are hydrolyzed to fatty acids and ethanolamine in animal tissues by the catalysis of fatty acid amide hydrolase (FAAH).  We recently cloned cDNA of N-acylethanolamine-hydrolyzing acid amidase (NAAA), another enzyme catalyzing the same reaction, from human, rat, and mouse.  NAAA reveals no sequence homology with FAAH and belongs to the choloylglycine hydrolase family.  The most striking catalytic property of NAAA is pH optimum at 4.5-5, which is consistent with its immunocytochemical localization in lysosomes.  In rat, NAAA is highly expressed in lung, spleen, thymus, and intestine.  Notably, the expression level of NAAA is exceptionally high in rat alveolar macrophages.  The primary structure of NAAA exhibits 33-35% amino acid identity to that of acid ceramidase, a lysosomal enzyme hydrolyzing ceramide to fatty acid and sphingosine.  NAAA actually showed a low, but detectable ceramide-hydrolyzing activity, while acid ceramidase hydrolyzed N-lauroylethanolamine.  Thus, NAAA is a novel lysosomal hydrolase, which is structurally and functionally similar to acid ceramidase.  These results suggest a unique role of NAAA in the degradation of N-acylethanolamines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTphOU5U8yJf2xpATR2EQURfW6udTcc2eYv_gSBH-t0I7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svpvF2qtw%253D%253D&md5=440267d95b6b0755fa6c3476e54272de</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.200790159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.200790159%26sid%3Dliteratum%253Aachs%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DTakezaki%26aufirst%3DN.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DThe%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520%2528NAAA%2529%26jtitle%3DChem.%2520Biodivers.%26date%3D2007%26volume%3D4%26spage%3D1914%26epage%3D1925%26doi%3D10.1002%2Fcbdv.200790159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span> <span> </span><span class="NLM_article-title">Inflammation-restricted anti-inflammatory activities of a N-acylethanolamine acid amidase (NAAA) inhibitor F215</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2018.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.phrs.2018.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=29572189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntFOqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2018&pages=7-14&author=Y.+Liauthor=P.+Zhouauthor=H.+Chenauthor=Q.+Chenauthor=X.+Kuangauthor=C.+Luauthor=J.+Renauthor=Y.+Qiu&title=Inflammation-restricted+anti-inflammatory+activities+of+a+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitor+F215&doi=10.1016%2Fj.phrs.2018.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation-restricted anti-inflammatory activities of a N-acylethanolamine acid amidase (NAAA) inhibitor F215</span></div><div class="casAuthors">Li, Yuhang; Zhou, Pan; Chen, Huixia; Chen, Qi; Kuang, Xiaofei; Lu, Canzhong; Ren, Jie; Qiu, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7-14</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">N-Acylethanolamine acid amidase (NAAA) is a cysteine enzyme that catalyzes the hydrolysis of palmitoylethanolamide (PEA).  Pharmacol. blockage of NAAA elevates PEA levels and exerts powerful anti-inflammatory activities.  We have recently identified a highly potent NAAA inhibitor F215.  Here, we demonstrated that F215 was an unusual inflammation-restricted NAAA inhibitor.  In lipopolysaccharides (LPS) induced acute lung injury (ALI) model, F215 markedly accelerated inflammation resoln., promoted clearance of neutrophils infiltration and alveolar repair in the lungs.  F215 efficiently inhibited NAAA and protected endogenous PEA from degrdn. in ALI model, but it cannot readily suppress the NAAA activity in naive mice.  The inflammation-restricted effect of F215 was further confirmed in the alveolar macrophage, F215 only increased PEA levels and exerted anti-inflammatory effects in activated macrophages, but not in unstimulated macrophages.  Moreover, we also showed that the pharmacol. effects of F215 were restricted to the local inflamed skin elicited by 12-o-tetradecanoylphorbol-13-acetate (TPA), but not the normal tissues.  We believe that F215 could be a useful probe to investigate the function of NAAA, as well as a potent anti-inflammatory agent, and its inflammation-restricted feature might offer a new approach to prevent potential side effects of systemic enzyme inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8L-Zp8dasMrVg90H21EOLACvtfcHk0ljj6ihiuv0wxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntFOqsbg%253D&md5=e23ae7e46426bf1394ac68b6a6881674</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2018.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2018.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DKuang%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DY.%26atitle%3DInflammation-restricted%2520anti-inflammatory%2520activities%2520of%2520a%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitor%2520F215%26jtitle%3DPharmacol.%2520Res.%26date%3D2018%26volume%3D132%26spage%3D7%26epage%3D14%26doi%3D10.1016%2Fj.phrs.2018.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petrosino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campolo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Impellizzeri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paterniti, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gugliandolo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Amico, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siracusa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span> <span> </span><span class="NLM_article-title">2-Pentadecyl-2-Oxazoline, the Oxazoline of Pea, Modulates Carrageenan-Induced Acute Inflammation</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">308</span>, <span class="refDoi"> DOI: 10.3389/fphar.2017.00308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.3389%2Ffphar.2017.00308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=28611664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFenu7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=308&author=S.+Petrosinoauthor=M.+Campoloauthor=D.+Impellizzeriauthor=I.+Paternitiauthor=M.+Allaraauthor=E.+Gugliandoloauthor=R.+D%E2%80%99Amicoauthor=R.+Siracusaauthor=M.+Cordaroauthor=E.+Espositoauthor=V.+Di+Marzoauthor=S.+Cuzzocrea&title=2-Pentadecyl-2-Oxazoline%2C+the+Oxazoline+of+Pea%2C+Modulates+Carrageenan-Induced+Acute+Inflammation&doi=10.3389%2Ffphar.2017.00308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">2-Pentadecyl-2-oxazoline, the oxazoline of pea, modulates carrageenan-induced acute inflammation</span></div><div class="casAuthors">Petrosino, Stefania; Campolo, Michela; Impellizzeri, Daniela; Paterniti, Irene; Allara, Marco; Gugliandolo, Enrico; D'amico, Ramona; Siracusa, Rosalba; Cordaro, Marika; Esposito, Emanuela; Di Marzo, Vincenzo; Cuzzocrea, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">308/1-308/16</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">N-acylethanolamines (NAEs) involve a family of lipid mols. existent in animal and plant, with N-palmitoylethanolamide (PEA) that arouses great attention owing to its anti- inflammatory, analgesic and neuroprotective activities.  Because PEA is produced on demand and exerts pleiotropic effects, the modulation of specific amidases for NAEs (and in particular NAE-hydrolyzing acid amidase NAAA, which is more selective for PEA) could be a condition to preserve its levels.  Here we investigate the effect of 2-Pentadecyl-2-oxazoline (PEA-OXA) the oxazoline of PEA, on human recombinant NAAA in vitro and in an established model of Carrageenan (CAR)-induced rat paw inflammation.  PEA-OXA dose-dependently significantly inhibited recombinant NAAA and, orally administered to rats (10 mg/kg), limiting histol. damage, thermal hyperalgesia and the increase of infiltrating inflammatory cells after CAR injection in the rat right hindpaw, compared to ultramicronized PEA given orally at the same dose (10 mg/kg).  These effects were accompanied by elevation of paw PEA levels.  Moreover, PEA-OXA markedly reduced neutrophil infiltration and pro-inflammatory cytokine release and prevented CAR-induced IκB-α degrdn., nuclear translocation of NF-κB p65, the increase of inducible nitric oxide synthase, cyclooxygenase-2, intercellular adhesion mol.-1, and mast cell activation.  Expts. in PPAR-α knockout mice showed that the anti-inflammatory effects of PEA-OXA were not dependent on the presence of PPAR-α receptors.  In conclusion, NAAA modulators as PEA-OXA could help to maximize the tissue availability of PEA by increasing its levels and anti-inflammatory effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn273XvrvHbbVg90H21EOLACvtfcHk0ljj6ihiuv0wxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFenu7vF&md5=23898efd143bd1506d64425dbe349a52</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2017.00308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2017.00308%26sid%3Dliteratum%253Aachs%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DCampolo%26aufirst%3DM.%26aulast%3DImpellizzeri%26aufirst%3DD.%26aulast%3DPaterniti%26aufirst%3DI.%26aulast%3DAllara%26aufirst%3DM.%26aulast%3DGugliandolo%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DR.%26aulast%3DSiracusa%26aufirst%3DR.%26aulast%3DCordaro%26aufirst%3DM.%26aulast%3DEsposito%26aufirst%3DE.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DCuzzocrea%26aufirst%3DS.%26atitle%3D2-Pentadecyl-2-Oxazoline%252C%2520the%2520Oxazoline%2520of%2520Pea%252C%2520Modulates%2520Carrageenan-Induced%2520Acute%2520Inflammation%26jtitle%3DFront.%2520Pharmacol.%26date%3D2017%26volume%3D8%26spage%3D308%26doi%3D10.3389%2Ffphar.2017.00308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengatto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiurchiù, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capurro, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuzzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-Sanz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccarrone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1838</span>– <span class="NLM_lpage">1846</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00114</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00114" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsV2lsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1838-1846&author=A.+Ribeiroauthor=S.+Pontisauthor=L.+Mengattoauthor=A.+Armirottiauthor=V.+Chiurchi%C3%B9author=V.+Capurroauthor=A.+Fiasellaauthor=A.+Nuzziauthor=E.+Romeoauthor=G.+Moreno-Sanzauthor=M.+Maccarroneauthor=A.+Reggianiauthor=G.+Tarziaauthor=M.+Morauthor=F.+Bertozziauthor=T.+Bandieraauthor=D.+Piomelli&title=A+Potent+Systemically+Active+N-Acylethanolamine+Acid+Amidase+Inhibitor+that+Suppresses+Inflammation+and+Human+Macrophage+Activation&doi=10.1021%2Facschembio.5b00114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation</span></div><div class="casAuthors">Ribeiro, Alison; Pontis, Silvia; Mengatto, Luisa; Armirotti, Andrea; Chiurchiu, Valerio; Capurro, Valeria; Fiasella, Annalisa; Nuzzi, Andrea; Romeo, Elisa; Moreno-Sanz, Guillermo; Maccarrone, Mauro; Reggiani, Angelo; Tarzia, Giorgio; Mor, Marco; Bertozzi, Fabio; Bandiera, Tiziano; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1838-1846</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid ethanolamides such as palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) are lipid-derived mediators that potently inhibit pain and inflammation by ligating type-α peroxisome proliferator-activated receptors (PPAR-α).  These bioactive substances are preferentially degraded by the cysteine hydrolase, N-acylethanolamine acid amidase (NAAA), which is highly expressed in macrophages.  Here, we describe a new class of β-lactam derivs. that are potent, selective, and systemically active inhibitors of intracellular NAAA activity.  The prototype of this class deactivates NAAA by covalently binding the enzyme's catalytic cysteine and exerts profound anti-inflammatory effects in both mouse models and human macrophages.  This agent may be used to probe the functions of NAAA in health and disease and as a starting point to discover better anti-inflammatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD6Y2cNKursLVg90H21EOLACvtfcHk0ljj6ihiuv0wxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsV2lsrw%253D&md5=a240d871adfc85b99c7e148600573217</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00114%26sid%3Dliteratum%253Aachs%26aulast%3DRibeiro%26aufirst%3DA.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DChiurchi%25C3%25B9%26aufirst%3DV.%26aulast%3DCapurro%26aufirst%3DV.%26aulast%3DFiasella%26aufirst%3DA.%26aulast%3DNuzzi%26aufirst%3DA.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DMaccarrone%26aufirst%3DM.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DA%2520Potent%2520Systemically%2520Active%2520N-Acylethanolamine%2520Acid%2520Amidase%2520Inhibitor%2520that%2520Suppresses%2520Inflammation%2520and%2520Human%2520Macrophage%2520Activation%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D1838%26epage%3D1846%26doi%3D10.1021%2Facschembio.5b00114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonezzi, F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuzzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">An Important Role for N-Acylethanolamine Acid Amidase in the Complete Freund’s Adjuvant Rat Model of Arthritis</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>356</i></span>,  <span class="NLM_fpage">656</span>– <span class="NLM_lpage">663</span>, <span class="refDoi"> DOI: 10.1124/jpet.115.230516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1124%2Fjpet.115.230516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=26769918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvVeks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2016&pages=656-663&author=F.+T.+Bonezziauthor=O.+Sassoauthor=S.+Pontisauthor=N.+Realiniauthor=E.+Romeoauthor=S.+Ponzanoauthor=A.+Nuzziauthor=A.+Fiasellaauthor=F.+Bertozziauthor=D.+Piomelli&title=An+Important+Role+for+N-Acylethanolamine+Acid+Amidase+in+the+Complete+Freund%E2%80%99s+Adjuvant+Rat+Model+of+Arthritis&doi=10.1124%2Fjpet.115.230516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">An important role for N-acylethanolamine acid amidase in the complete Freund's adjuvant rat model of arthritis</span></div><div class="casAuthors">Bonezzi, F. T.; Sasso, O.; Pontis, S.; Realini, N.; Romeo, E.; Ponzano, S.; Nuzzi, A.; Fiasella, A.; Bertozzi, F.; Piomelli, D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">656-663</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The endogenous lipid amides, palmitoylethanolamide (PEA) and oleoylethanolamide (OEA), exert marked antinociceptive and anti-inflammatory effects in animal models by engaging nuclear peroxisome proliferator-activated receptor-α.  PEA and OEA are produced by macrophages and other host-defense cells and are deactivated by the cysteine amidase, N-acylethanolamine acid amidase (NAAA), which is highly expressed in macrophages and B-lymphocytes.  In the present study, we examd. whether (a) NAAA might be involved in the inflammatory reaction triggered by injection of complete Freund's adjuvant (CFA) into the rat paw and (b) administration of 4-cyclohexylbutyl-N-[(S)-2-oxoazetidin-3-yl]-carbamate (ARN726), a novel systemically active NAAA inhibitor, attenuates such reaction.  Injection of CFA into the paw produced local edema and heat hyperalgesia, which were accompanied by decreased PEA and OEA content (assessed by liq. chromatog./mass spectrometry) and increased NAAA levels (assessed by Western blot and ex vivo enzyme activity measurements) in paw tissue.  Administration of undec-10-ynyl-N-[(3S)-2-oxoazetidin-3-yl] carbamate (ARN14686), a NAAA-preferring activity-based probe, revealed that NAAA was catalytically active in CFA-treated paws.  Administration of ARN726 reduced NAAA activity and restored PEA and OEA levels in inflamed tissues, and significantly decreased CFA-induced inflammatory symptoms, including pus prodn. and myeloperoxidase activity.  The results confirm the usefulness of ARN726 as a probe to investigate the functions of NAAA in health and disease and suggest that this enzyme may provide a new mol. target for the treatment of arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG6IIltfdLQbVg90H21EOLACvtfcHk0ljchwvwl5Kw3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvVeks7s%253D&md5=5ce843469c81ad112b95c9a59a8bfbe5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.230516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.230516%26sid%3Dliteratum%253Aachs%26aulast%3DBonezzi%26aufirst%3DF.%2BT.%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DNuzzi%26aufirst%3DA.%26aulast%3DFiasella%26aufirst%3DA.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAn%2520Important%2520Role%2520for%2520N-Acylethanolamine%2520Acid%2520Amidase%2520in%2520the%2520Complete%2520Freund%25E2%2580%2599s%2520Adjuvant%2520Rat%2520Model%2520of%2520Arthritis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D356%26spage%3D656%26epage%3D663%26doi%3D10.1124%2Fjpet.115.230516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solorzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonietti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duranti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tontini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacondio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of N-(2-oxo-3-oxetanyl)amides as N-acylethanolamine-hydrolyzing acid amidase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5770</span>– <span class="NLM_lpage">5781</span>, <span class="refDoi"> DOI: 10.1021/jm100582w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100582w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVGhsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5770-5781&author=C.+Solorzanoauthor=F.+Antoniettiauthor=A.+Durantiauthor=A.+Tontiniauthor=S.+Rivaraauthor=A.+Lodolaauthor=F.+Vacondioauthor=G.+Tarziaauthor=D.+Piomelliauthor=M.+Mor&title=Synthesis+and+structure-activity+relationships+of+N-%282-oxo-3-oxetanyl%29amides+as+N-acylethanolamine-hydrolyzing+acid+amidase+inhibitors&doi=10.1021%2Fjm100582w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationships of N-(2-Oxo-3-oxetanyl)amides as N-Acylethanolamine-hydrolyzing Acid Amidase Inhibitors</span></div><div class="casAuthors">Solorzano, Carlos; Antonietti, Francesca; Duranti, Andrea; Tontini, Andrea; Rivara, Silvia; Lodola, Alessio; Vacondio, Federica; Tarzia, Giorgio; Piomelli, Daniele; Mor, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5770-5781</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The fatty acid ethanolamides (FAEs) are a family of bioactive lipid mediators that include the endogenous agonist of peroxisome proliferator-activated receptor-α, palmitoylethanolamide (PEA).  FAEs are hydrolyzed intracellularly by either fatty acid amide hydrolase or N-acylethanolamine-hydrolyzing acid amidase (NAAA).  Selective inhibition of NAAA by I [R = PhCH2CH2 (II)] was found to prevent PEA degrdn. in mouse leukocytes and attenuated responses to proinflammatory stimuli.  Starting from the structure of II, a series of β-lactones was prepd. and tested on recombinant rat NAAA to explore structure-activity relationships (SARs) for this class of inhibitors and improve their in vitro potency.  Following the hypothesis that these compds. inhibited NAAA by acylation of the catalytic cysteine, several requirements for recognition at the active site were identified and new potent inhibitors obtained.  In particular, I [R = 4-PhC6H4 (III)] was more potent than II at inhibiting recombinant rat NAAA activity (II, IC50 = 420 nM; III, IC50 = 115 nM) in vitro and at reducing carrageenan-induced leukocyte infiltration in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgnb77O8b6N7Vg90H21EOLACvtfcHk0ljchwvwl5Kw3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVGhsLw%253D&md5=205063c7b40e432bd79a2254ec7d448c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm100582w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100582w%26sid%3Dliteratum%253Aachs%26aulast%3DSolorzano%26aufirst%3DC.%26aulast%3DAntonietti%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DMor%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520N-%25282-oxo-3-oxetanyl%2529amides%2520as%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5770%26epage%3D5781%26doi%3D10.1021%2Fjm100582w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alhouayek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottemanne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cani, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muccioli, G. G.</span></span> <span> </span><span class="NLM_article-title">N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">650</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1096/fj.14-255208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1096%2Ffj.14-255208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=25384424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislGis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=650-661&author=M.+Alhouayekauthor=P.+Bottemanneauthor=K.+V.+Subramanianauthor=D.+M.+Lambertauthor=A.+Makriyannisauthor=P.+D.+Caniauthor=G.+G.+Muccioli&title=N-Acylethanolamine-hydrolyzing+acid+amidase+inhibition+increases+colon+N-palmitoylethanolamine+levels+and+counteracts+murine+colitis&doi=10.1096%2Ffj.14-255208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">N-acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis</span></div><div class="casAuthors">Alhouayek, Mireille; Bottemanne, Pauline; Subramanian, Kumar V.; Lambert, Didier M.; Makriyannis, Alexandros; Cani, Patrice D.; Muccioli, Giulio G.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">650-661, 10.1096/fj.14-255208</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">N-Palmitoylethanolamine or palmitoylethanolamide (PEA) is an anti-inflammatory compd. that was recently shown to exert peroxisome proliferator-activated receptor-α-dependent beneficial effects on colon inflammation.  The actions of PEA are terminated following hydrolysis by 2 enzymes: fatty acid amide hydrolase (FAAH), and the less-studied N-acylethanolamine-hydrolyzing acid amidase (NAAA).  This study aims to investigate the effects of inhibiting the enzymes responsible for PEA hydrolysis in colon inflammation in order to propose a potential therapeutic target for inflammatory bowel diseases (IBDs).  Two murine models of IBD were used to assess the effects of NAAA inhibition, FAAH inhibition, and PEA on macroscopic signs of colon inflammation, macrophage/neutrophil infiltration, and the expression of proinflammatory mediators in the colon, as well as on the colitis-related systemic inflammation.  NAAA inhibition increases PEA levels in the colon and reduces colon inflammation and systemic inflammation, similarly to PEA.  FAAH inhibition, however, does not increase PEA levels in the colon and does not affect the macroscopic signs of colon inflammation or immune cell infiltration.  This is the first report of an anti-inflammatory effect of a systemically administered NAAA inhibitor.  Because NAAA is the enzyme responsible for the control of PEA levels in the colon, we put forth this enzyme as a potential therapeutic target in chronic inflammation in general and IBD in particular.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1s3Cs4nu0sbVg90H21EOLACvtfcHk0ljchwvwl5Kw3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislGis7Y%253D&md5=608b15a459887f1cde27f68e241d85b2</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1096%2Ffj.14-255208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.14-255208%26sid%3Dliteratum%253Aachs%26aulast%3DAlhouayek%26aufirst%3DM.%26aulast%3DBottemanne%26aufirst%3DP.%26aulast%3DSubramanian%26aufirst%3DK.%2BV.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DCani%26aufirst%3DP.%2BD.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26atitle%3DN-Acylethanolamine-hydrolyzing%2520acid%2520amidase%2520inhibition%2520increases%2520colon%2520N-palmitoylethanolamine%2520levels%2520and%2520counteracts%2520murine%2520colitis%26jtitle%3DFASEB%2520J.%26date%3D2015%26volume%3D29%26spage%3D650%26epage%3D661%26doi%3D10.1096%2Ffj.14-255208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Mei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">The N-Acylethanolamine Acid Amidase Inhibitor ARN077 Suppresses Inflammation and Pruritus in a Mouse Model of Allergic Dermatitis</span>. <i>J. Invest. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">562</span>– <span class="NLM_lpage">569</span>, <span class="refDoi"> DOI: 10.1016/j.jid.2017.07.853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.jid.2017.07.853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=29054595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitl2qtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2018&pages=562-569&author=O.+Sassoauthor=M.+Summaauthor=A.+Armirottiauthor=S.+Pontisauthor=C.+De+Meiauthor=D.+Piomelli&title=The+N-Acylethanolamine+Acid+Amidase+Inhibitor+ARN077+Suppresses+Inflammation+and+Pruritus+in+a+Mouse+Model+of+Allergic+Dermatitis&doi=10.1016%2Fj.jid.2017.07.853"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The N-Acylethanolamine Acid Amidase Inhibitor ARN077 Suppresses Inflammation and Pruritus in a Mouse Model of Allergic Dermatitis</span></div><div class="casAuthors">Sasso, O.; Summa, M.; Armirotti, A.; Pontis, S.; De Mei, C.; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Investigative Dermatology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">562-569</span>CODEN:
                <span class="NLM_cas:coden">JIDEAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-202X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">N-acylethanolamine acid amidase (NAAA), a cysteine hydrolase highly expressed in macrophages and B lymphocytes, catalyzes the degrdn. of palmitoylethanolamide.  Palmitoylethanolamide is an agonist of PPAR-α and an important regulator of pain and innate immunity.  In this study, we investigated the properties of the NAAA inhibitor, ARN077, in a mouse model of allergic contact dermatitis.  Acute topical applications of ARN077 attenuated key signs of DNFB-induced dermatitis in a dose-dependent manner.  Moreover, ARN077 increased tissue palmitoylethanolamide content and normalized circulating levels of cytokines and IgE.  No such effect was seen in PPAR-α-deficient mice.  Moreover, mice lacking NAAA failed to develop edema or scratching behavior after challenge with DNFB, confirming that this enzyme plays an important role in dermatitis.  Consistent with this conclusion, subchronic applications of ARN077 suppressed DNFB-induced inflammation when administered either before or after the DNFB challenge.  The effects of subchronic ARN077 were dose dependent and comparable in size to those produced by the steroids clobetasol and dexamethasone.  Unlike the latter, however, ARN077 did not cause skin atrophy.  The results identify NAAA as a promising target for the development of effective and safe treatments for atopic dermatitis and other inflammatory disorders of the skin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGKONQ-rQpLbVg90H21EOLACvtfcHk0lgEPbr4cbJVJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitl2qtr8%253D&md5=47e862197856ce83e51fc7c8a34ada85</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.jid.2017.07.853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jid.2017.07.853%26sid%3Dliteratum%253Aachs%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DDe%2BMei%26aufirst%3DC.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DThe%2520N-Acylethanolamine%2520Acid%2520Amidase%2520Inhibitor%2520ARN077%2520Suppresses%2520Inflammation%2520and%2520Pruritus%2520in%2520a%2520Mouse%2520Model%2520of%2520Allergic%2520Dermatitis%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2018%26volume%3D138%26spage%3D562%26epage%3D569%26doi%3D10.1016%2Fj.jid.2017.07.853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-Sanz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martucci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dionisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengatto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duranti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertorelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">350</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2012.10.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.pain.2012.10.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=23218523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivF2jtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=350-360&author=O.+Sassoauthor=G.+Moreno-Sanzauthor=C.+Martucciauthor=N.+Realiniauthor=M.+Dionisiauthor=L.+Mengattoauthor=A.+Durantiauthor=G.+Tarozzoauthor=G.+Tarziaauthor=M.+Morauthor=R.+Bertorelliauthor=A.+Reggianiauthor=D.+Piomelli&title=Antinociceptive+effects+of+the+N-acylethanolamine+acid+amidase+inhibitor+ARN077+in+rodent+pain+models&doi=10.1016%2Fj.pain.2012.10.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models</span></div><div class="casAuthors">Sasso, Oscar; Moreno-Sanz, Guillermo; Martucci, Cataldo; Realini, Natalia; Dionisi, Mauro; Mengatto, Luisa; Duranti, Andrea; Tarozzo, Glauco; Tarzia, Giorgio; Mor, Marco; Bertorelli, Rosalia; Reggiani, Angelo; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">350-360</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Fatty acid ethanolamides (FAEs), which include palmitoylethanolamide (PEA) and oleoylethanolamide (OEA), are endogenous agonists of peroxisome proliferator-activated receptor-α (PPAR-α) and important regulators of the inflammatory response.  They are degraded in macrophages by the lysosomal cysteine amidase, N-acylethanolamine acid amidase (NAAA).  Previous studies have shown that pharmacol. inhibition of NAAA activity suppresses macrophage activation in vitro and causes marked anti-inflammatory effects in vivo, which is suggestive of a role for NAAA in the control of inflammation.  It is still unknown, however, whether NAAA-mediated FAE deactivation might regulate pain signaling.  The present study examd. the effects of ARN077, a potent and selective NAAA inhibitor recently disclosed by our group, in rodent models of hyperalgesia and allodynia caused by inflammation or nerve damage.  Topical administration of ARN077 attenuated, in a dose-dependent manner, heat hyperalgesia and mech. allodynia elicited in mice by carrageenan injection or sciatic nerve ligation.  The antinociceptive effects of ARN077 were prevented by the selective PPAR-α antagonist GW6471 and did not occur in PPAR-α-deficient mice.  Furthermore, topical ARN077 reversed the allodynia caused by UV B radiation in rats, and this effect was blocked by pretreatment with GW6471.  Sciatic nerve ligation or application of the proinflammatory phorbol ester 12-O-tetradecanoylphorbol 13-acetate decreased FAE levels in sciatic nerve and skin tissue, resp.  ARN077 reversed these biochem. effects.  The results identify ARN077 as a potent inhibitor of intracellular NAAA activity, which is active in vivo by topical administration.  The findings further suggest that NAAA regulates peripheral pain initiation by interrupting endogenous FAE signaling at PPAR-α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVAH4mpvyphbVg90H21EOLACvtfcHk0lgEPbr4cbJVJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivF2jtrk%253D&md5=08c067a44b1f75e7e0192fdbdeccccd4</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2012.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2012.10.018%26sid%3Dliteratum%253Aachs%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DMartucci%26aufirst%3DC.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DDionisi%26aufirst%3DM.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAntinociceptive%2520effects%2520of%2520the%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitor%2520ARN077%2520in%2520rodent%2520pain%2520models%26jtitle%3DPain%26date%3D2013%26volume%3D154%26spage%3D350%26epage%3D360%26doi%3D10.1016%2Fj.pain.2012.10.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span> <span> </span><span class="NLM_article-title">Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-alpha</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">13565</span>, <span class="refDoi"> DOI: 10.1038/srep13565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1038%2Fsrep13565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=26310614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKhtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=13565&author=L.+Yangauthor=L.+Liauthor=L.+Chenauthor=Y.+Liauthor=H.+Chenauthor=Y.+Liauthor=G.+Jiauthor=D.+Linauthor=Z.+Liuauthor=Y.+Qiu&title=Potential+analgesic+effects+of+a+novel+N-acylethanolamine+acid+amidase+inhibitor+F96+through+PPAR-alpha&doi=10.1038%2Fsrep13565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α</span></div><div class="casAuthors">Yang, Longhe; Li, Long; Chen, Ling; Li, Yanting; Chen, Huixia; Li, Yuhang; Ji, Guangnian; Lin, Donghai; Liu, Zuguo; Qiu, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13565</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Pharmacol. blockade of N-acylethanolamine acid amidase (NAAA) activity is an available approach for inflammation and pain control through restoring the ability of endogenous PEA.  But the recently reported NAAA inhibitors suffer from the chem. and biol. unstable properties, which restrict functions of NAAA inhibition in vivo.  It is still unrevealed whether systematic inhibition of NAAA could modulate PEA-mediated pain signalings.  Here we reported an oxazolidinone imide compd. 3-(6-phenylhexanoyl) oxazolidin-2-one (F96), which potently and selectively inhibited NAAA activity (IC50 = 270 nM).  I.p. (i.p.) injection of F96 (3-30 mg/kg) dose-dependently reduced ear edema and restored PEA levels of ear tissues in 12-O-Tetradecanoylphorbol-13-acetate (TPA) induced ear edema models.  Furthermore, F96 inhibited acetic acid-induced writhing and increased spared nerve injury induced tactile allodynia thresholds in a dose-dependent manner.  Pharmacol. effects of F96 (10 mg/kg, i.p.) on various animal models were abolished in PPAR-α-/- mice, and were prevented by PPAR-α antagonist MK886 but not by canabinoid receptor type 1 (CB1) antagonist Rimonabant nor canabinoid receptor type 2 (CB2) antagonist SR144528.  Zebrafish embryos expts. showed better security and lower toxicity for F96 than ibuprofen.  These results revealed that F96 might be useful in treating inflammatory and neuropathic pain by NAAA inhibition depending on PPAR-α receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsP6tlGryp3LVg90H21EOLACvtfcHk0lgEPbr4cbJVJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKhtLzK&md5=237e107001c9eef18e130d12a0724300</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fsrep13565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep13565%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DQiu%26aufirst%3DY.%26atitle%3DPotential%2520analgesic%2520effects%2520of%2520a%2520novel%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitor%2520F96%2520through%2520PPAR-alpha%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D13565%26doi%3D10.1038%2Fsrep13565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Migliore, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuentes
de Arriba, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrente, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Martino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzirani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanfranco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottonello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busquet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, K.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Guzman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heim, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis</span>. <i>Angew. Chem. Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">11193</span>– <span class="NLM_lpage">11197</span>, <span class="refDoi"> DOI: 10.1002/anie.201603746</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1002%2Fanie.201603746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFKmt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=11193-11197&author=M.+Miglioreauthor=S.+Pontisauthor=A.+L.+Fuentes%0Ade+Arribaauthor=N.+Realiniauthor=E.+Torrenteauthor=A.+Armirottiauthor=E.+Romeoauthor=S.+Di+Martinoauthor=D.+Russoauthor=D.+Pizziraniauthor=M.+Summaauthor=M.+Lanfrancoauthor=G.+Ottonelloauthor=P.+Busquetauthor=K.-M.+Jungauthor=M.+Garcia-Guzmanauthor=R.+Heimauthor=R.+Scarpelliauthor=D.+Piomelli&title=Second-Generation+Non-Covalent+NAAA+Inhibitors+are+Protective+in+a+Model+of+Multiple+Sclerosis&doi=10.1002%2Fanie.201603746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis</span></div><div class="casAuthors">Migliore, Marco; Pontis, Silvia; Fuentes de Arriba, Angel Luis; Realini, Natalia; Torrente, Esther; Armirotti, Andrea; Romeo, Elisa; Di Martino, Simona; Russo, Debora; Pizzirani, Daniela; Summa, Maria; Lanfranco, Massimiliano; Ottonello, Giuliana; Busquet, Perrine; Jung, Kwang-Mook; Garcia-Guzman, Miguel; Heim, Roger; Scarpelli, Rita; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">11193-11197</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) are endogenous lipid mediators that suppress inflammation.  Their actions are terminated by the intracellular cysteine amidase, N-acylethanolamine acid amidase (NAAA).  Even though NAAA may offer a new target for anti-inflammatory therapy, the lipid-like structures and reactive warheads of current NAAA inhibitors limit the use of these agents as oral drugs.  A series of novel benzothiazole-piperazine derivs. that inhibit NAAA in a potent and selective manner by a non-covalent mechanism are described.  A prototype member of this class (8) displays high oral bioavailability, access to the central nervous system (CNS), and strong activity in a mouse model of multiple sclerosis (MS).  This compd. exemplifies a second generation of non-covalent NAAA inhibitors that may be useful in the treatment of MS and other chronic CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuWcI9qbPxD7Vg90H21EOLACvtfcHk0lhmeCK896npmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFKmt77K&md5=3a0393efde3a858d2bef8af194b65a21</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fanie.201603746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201603746%26sid%3Dliteratum%253Aachs%26aulast%3DMigliore%26aufirst%3DM.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DFuentes%2Bde%2BArriba%26aufirst%3DA.%2BL.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DTorrente%26aufirst%3DE.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DDi%2BMartino%26aufirst%3DS.%26aulast%3DRusso%26aufirst%3DD.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DLanfranco%26aufirst%3DM.%26aulast%3DOttonello%26aufirst%3DG.%26aulast%3DBusquet%26aufirst%3DP.%26aulast%3DJung%26aufirst%3DK.-M.%26aulast%3DGarcia-Guzman%26aufirst%3DM.%26aulast%3DHeim%26aufirst%3DR.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DSecond-Generation%2520Non-Covalent%2520NAAA%2520Inhibitors%2520are%2520Protective%2520in%2520a%2520Model%2520of%2520Multiple%2520Sclerosis%26jtitle%3DAngew.%2520Chem.%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D11193%26epage%3D11197%26doi%3D10.1002%2Fanie.201603746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Advances in the discovery of N-acylethanolamine acid amidase inhibitors</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2014.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.phrs.2014.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=24798679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosFaqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=11-17&author=T.+Bandieraauthor=S.+Ponzanoauthor=D.+Piomelli&title=Advances+in+the+discovery+of+N-acylethanolamine+acid+amidase+inhibitors&doi=10.1016%2Fj.phrs.2014.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the discovery of N-acylethanolamine acid amidase inhibitors</span></div><div class="casAuthors">Bandiera, Tiziano; Ponzano, Stefano; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11-17</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  N-Acylethanolamine acid amidase (NAAA) is a cysteine amidase that hydrolyzes satd. or monounsatd. fatty acid ethanolamides, such as palmitoylethanolamide (PEA) and oleoylethanolamide (OEA).  PEA has been shown to exert analgesic and anti-inflammatory effects by engaging peroxisome proliferator-activated receptor-α.  Like other fatty acid ethanolamides, PEA is not stored in cells, but produced on demand from cell membrane precursors, and its actions are terminated by intracellular hydrolysis by either fatty acid amide hydrolase or NAAA.  Endogenous levels of PEA and OEA have been shown to decrease during inflammation.  Modulation of the tissue levels of PEA by inhibition of enzymes responsible for the breakdown of this lipid mediator may represent therefore a new therapeutic strategy for the treatment of pain and inflammation.  While a large no. of inhibitors of fatty acid amide hydrolase have been discovered, few compds. have been reported to inhibit NAAA activity.  Here, we describe the most representative NAAA inhibitors and briefly highlight their pharmacol. profile.  A recent study has shown that a NAAA inhibitor attenuated heat hyperalgesia and mech. allodynia caused by local inflammation or nerve damage in animal models of pain and inflammation.  This finding encourages further exploration of the pharmacol. of NAAA inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUwRrGiJPWfbVg90H21EOLACvtfcHk0lhmeCK896npmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosFaqur0%253D&md5=a8673471686df8f77b19ec318316e192</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2014.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2014.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAdvances%2520in%2520the%2520discovery%2520of%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitors%26jtitle%3DPharmacol.%2520Res.%26date%3D2014%26volume%3D86%26spage%3D11%26epage%3D17%26doi%3D10.1016%2Fj.phrs.2014.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scalvini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fotio, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spadoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span> <span> </span><span class="NLM_article-title">N-Acylethanolamine Acid Amidase (NAAA): Structure, Function, and Inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">7475</span>– <span class="NLM_lpage">7490</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlt1Ckuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=7475-7490&author=D.+Piomelliauthor=L.+Scalviniauthor=Y.+Fotioauthor=A.+Lodolaauthor=G.+Spadoniauthor=G.+Tarziaauthor=M.+Mor&title=N-Acylethanolamine+Acid+Amidase+%28NAAA%29%3A+Structure%2C+Function%2C+and+Inhibition&doi=10.1021%2Facs.jmedchem.0c00191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">N-Acylethanolamine acid amidase (NAAA): Structure, function, and inhibition</span></div><div class="casAuthors">Piomelli, Daniele; Scalvini, Laura; Fotio, Yannick; Lodola, Alessio; Spadoni, Gilberto; Tarzia, Giorgio; Mor, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">7475-7490</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  N-Acylethanolamine acid amidase (NAAA) is an N-terminal cysteine hydrolase primarily found in the endosomal-lysosomal compartment of innate and adaptive immune cells.  NAAA catalyzes the hydrolytic deactivation of palmitoylethanolamide (PEA), a lipid-derived peroxisome proliferator-activated receptor-α (PPAR-α) agonist that exerts profound anti-inflammatory effects in animal models.  Emerging evidence points to NAAA-regulated PEA signaling at PPAR-α as a crit. control point for the induction and the resoln. of inflammation and to NAAA itself as a target for anti-inflammatory medicines.  The present Perspective discusses three key aspects of this hypothesis: the role of NAAA in controlling the signaling activity of PEA; the structural bases for NAAA function and inhibition by covalent and noncovalent agents; and finally, the potential value of NAAA-targeting drugs in the treatment of human inflammatory disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD2-Hxvqw2MbVg90H21EOLACvtfcHk0lhmeCK896npmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlt1Ckuro%253D&md5=a3bf394222fc2902db2d0ffccf713143</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00191%26sid%3Dliteratum%253Aachs%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DScalvini%26aufirst%3DL.%26aulast%3DFotio%26aufirst%3DY.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DSpadoni%26aufirst%3DG.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26atitle%3DN-Acylethanolamine%2520Acid%2520Amidase%2520%2528NAAA%2529%253A%2520Structure%252C%2520Function%252C%2520and%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D7475%26epage%3D7490%26doi%3D10.1021%2Facs.jmedchem.0c00191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tuo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leleu-Chavain, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansook, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavatte, P.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00538</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00538" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWjsLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4-46&author=W.+Tuoauthor=N.+Leleu-Chavainauthor=J.+Spencerauthor=S.+Sansookauthor=R.+Milletauthor=P.+Chavatte&title=Therapeutic+Potential+of+Fatty+Acid+Amide+Hydrolase%2C+Monoacylglycerol+Lipase%2C+and+N-Acylethanolamine+Acid+Amidase+Inhibitors&doi=10.1021%2Facs.jmedchem.6b00538"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors</span></div><div class="casAuthors">Tuo, Wei; Leleu-Chavain, Natascha; Spencer, John; Sansook, Supojjanee; Millet, Regis; Chavatte, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-46</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Fatty acid ethanolamides (FAEs) and endocannabinoids (ECs) have been shown to alleviate pain and inflammation, regulate motility and appetite, and produce anti-cancer, anxiolytic, and neuroprotective efficacies via cannabinoid receptor type 1 (CB1) or type 2 (CB2), or via peroxisome proliferator-activated receptor α (PPAR-α) stimulation.  FAEs and ECs are synthesized by a series of endogenous enzymes, including N-acylphosphatidylethanolamine-phospholipase D (NAPE-PLD), diacylglycerol lipase (DAGL), or phospholipase C (PLC), and their metab. is mediated by several metabolic enzymes, including fatty acid amide hydrolase (FAAH), monoacylglycerol lipase (MAGL), N-acylethanolamine acid amidase (NAAA), or cyclooxygenase-2 (COX-2).  Over the last decades, increasing the concn. of FAEs and ECs through the inhibition of degrading enzymes has been considered to be a viable therapeutic approach to enhance their anti-nociceptive and anti-inflammatory effects, as well as protecting the nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoamrYPCqYEIbVg90H21EOLACvtfcHk0lj_HuvoP2er3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWjsLzI&md5=dd509179171644767726a67cb42dd074</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00538%26sid%3Dliteratum%253Aachs%26aulast%3DTuo%26aufirst%3DW.%26aulast%3DLeleu-Chavain%26aufirst%3DN.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DSansook%26aufirst%3DS.%26aulast%3DMillet%26aufirst%3DR.%26aulast%3DChavatte%26aufirst%3DP.%26atitle%3DTherapeutic%2520Potential%2520of%2520Fatty%2520Acid%2520Amide%2520Hydrolase%252C%2520Monoacylglycerol%2520Lipase%252C%2520and%2520N-Acylethanolamine%2520Acid%2520Amidase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4%26epage%3D46%26doi%3D10.1021%2Facs.jmedchem.6b00538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span> <span> </span><span class="NLM_article-title">Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">214</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.ejmech.2017.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=28802121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlarsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=214-221&author=Y.+Liauthor=Q.+Chenauthor=L.+Yangauthor=Y.+Liauthor=Y.+Zhangauthor=Y.+Qiuauthor=J.+Renauthor=C.+Lu&title=Identification+of+highly+potent+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors%3A+Optimization+of+the+terminal+phenyl+moiety+of+oxazolidone+derivatives&doi=10.1016%2Fj.ejmech.2017.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives</span></div><div class="casAuthors">Li, Yuhang; Chen, Qi; Yang, Longhe; Li, Yanting; Zhang, Yang; Qiu, Yan; Ren, Jie; Lu, Canzhong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">214-221</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">N-acylethanolamine acid amidase (NAAA) is a cysteine hydrolase that participates in the deactivation of fatty acid ethanolamides, such as palmitoylethanolamide (PEA).  NAAA inhibition may provide a potential therapeutic strategy for the treatment of diseases in which higher PEA level is desired.  In the present study, we reported the structure-activity relationship (SAR) studies for oxazolidone derivs. as NAAA inhibitors.  A series of substituents or alkyl replacements for the terminal Ph ring of oxazolidone derivs. were examd.  The results showed that the inhibition potency of these oxazolidone derivs. towards NAAA depends on the sizes, flexibility, and lipophilicity of the terminal groups.  SAR results suggested that small lipophilic 3-Ph substituents or hydroxy-contg. 4-Ph substituents were preferable for optimal potency.  Furthermore, the distal aliph. replacement is also preferred for high inhibitory potency.  Rapid diln. and kinetic anal. suggested that oxazolidone derivs. with different terminal Ph moieties inhibited NAAA via different mechanisms.  This study identified several highly potent NAAA inhibitors, including 1a (F215, IC50 = 0.009 μM), 1o (IC50 = 0.061 μM) and 2e (IC50 = 0.092 μM), and also detd. structural requirements of oxazolidone derivs. for potent inhibition against NAAA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCt5BDoxRb7LVg90H21EOLACvtfcHk0lj_HuvoP2er3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlarsrfF&md5=d4d34c95deea24435ceb35348c39d279</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DC.%26atitle%3DIdentification%2520of%2520highly%2520potent%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%253A%2520Optimization%2520of%2520the%2520terminal%2520phenyl%2520moiety%2520of%2520oxazolidone%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D139%26spage%3D214%26epage%3D221%26doi%3D10.1016%2Fj.ejmech.2017.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vitale, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottonello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petracca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berteotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dionisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span> <span> </span><span class="NLM_article-title">Synthesis, structure-activity, and structure-stability relationships of 2-substituted-N-(4-oxo-3-oxetanyl) N-acylethanolamine acid amidase (NAAA) inhibitors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">323</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1002%2Fcmdc.201300416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=24403170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvF2qtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=323-336&author=R.+Vitaleauthor=G.+Ottonelloauthor=R.+Petraccaauthor=S.+M.+Bertozziauthor=S.+Ponzanoauthor=A.+Armirottiauthor=A.+Berteottiauthor=M.+Dionisiauthor=A.+Cavalliauthor=D.+Piomelliauthor=T.+Bandieraauthor=F.+Bertozzi&title=Synthesis%2C+structure-activity%2C+and+structure-stability+relationships+of+2-substituted-N-%284-oxo-3-oxetanyl%29+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors&doi=10.1002%2Fcmdc.201300416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Structure-Activity, and Structure-Stability Relationships of 2-Substituted-N-(4-oxo-3-oxetanyl) N-Acylethanolamine Acid Amidase (NAAA) Inhibitors</span></div><div class="casAuthors">Vitale, Romina; Ottonello, Giuliana; Petracca, Rita; Bertozzi, Sine Mandrup; Ponzano, Stefano; Armirotti, Andrea; Berteotti, Anna; Dionisi, Mauro; Cavalli, Andrea; Piomelli, Daniele; Bandiera, Tiziano; Bertozzi, Fabio</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">323-336</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Racemic and nonracemic β-substituted α-amino-β-lactones such as I and II [R = Me, Et, i-Pr, t-Bu; R1 = R2, R3O; R2 = 4-PhCH2OC6H4, Ph(CH2)6; R3 = Ph(CH2)5, 4-PhC6H4CH2] were prepd. as inhibitors of N-acylethanolamine acid amidase (NAAA), a cysteine amidase that preferentially hydrolyzes satd. or monounsatd. fatty acid ethanolamide endogenous agonists of nuclear peroxisome proliferator-activated receptor-α, for potential use as antiinflammatory agents.  N-(alkoxycarbonylamino) β-lactones were both better inhibitors of NAAA and more stable than the corresponding N-acyl β-lactones; cis β-lactones I were more stable than the corresponding trans β-lactones II to both lactone hydrolysis and ring expansion to oxazolines.  Increasing the steric bulk of the β-substituent decreased inhibition of NAAA but improved hydrolytic stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhV2S-BL4VubVg90H21EOLACvtfcHk0lg58AAdP8_fsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvF2qtw%253D%253D&md5=8ada8ce8bcd7f2f40376be631217d615</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300416%26sid%3Dliteratum%253Aachs%26aulast%3DVitale%26aufirst%3DR.%26aulast%3DOttonello%26aufirst%3DG.%26aulast%3DPetracca%26aufirst%3DR.%26aulast%3DBertozzi%26aufirst%3DS.%2BM.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DBerteotti%26aufirst%3DA.%26aulast%3DDionisi%26aufirst%3DM.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DBertozzi%26aufirst%3DF.%26atitle%3DSynthesis%252C%2520structure-activity%252C%2520and%2520structure-stability%2520relationships%2520of%25202-substituted-N-%25284-oxo-3-oxetanyl%2529%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D323%26epage%3D336%26doi%3D10.1002%2Fcmdc.201300416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duranti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tontini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonietti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacondio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fioni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solorzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span> <span> </span><span class="NLM_article-title">N-(2-oxo-3-oxetanyl)carbamic acid esters as N-acylethanolamine acid amidase inhibitors: synthesis and structure-activity and structure-property relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4824</span>– <span class="NLM_lpage">4836</span>, <span class="refDoi"> DOI: 10.1021/jm300349j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300349j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC38XlslGrtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4824-4836&author=A.+Durantiauthor=A.+Tontiniauthor=F.+Antoniettiauthor=F.+Vacondioauthor=A.+Fioniauthor=C.+Silvaauthor=A.+Lodolaauthor=S.+Rivaraauthor=C.+Solorzanoauthor=D.+Piomelliauthor=G.+Tarziaauthor=M.+Mor&title=N-%282-oxo-3-oxetanyl%29carbamic+acid+esters+as+N-acylethanolamine+acid+amidase+inhibitors%3A+synthesis+and+structure-activity+and+structure-property+relationships&doi=10.1021%2Fjm300349j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">N-(2-Oxo-3-oxetanyl)carbamic acid esters as N-acylethanolamine acid amidase inhibitors: synthesis and structure-activity and structure-property relationships</span></div><div class="casAuthors">Duranti, Andrea; Tontini, Andrea; Antonietti, Francesca; Vacondio, Federica; Fioni, Alessandro; Silva, Claudia; Lodola, Alessio; Rivara, Silvia; Solorzano, Carlos; Piomelli, Daniele; Tarzia, Giorgio; Mor, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4824-4836</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The β-lactone ring of N-(2-oxo-3-oxetanyl)amides, a class of N-acylethanolamine acid amidase (NAAA) inhibitors endowed with anti-inflammatory properties, is responsible for both NAAA inhibition and low compd. stability.  Here, we investigate the structure-activity and structure-property relationships for a set of known and new β-lactone derivs., focusing on the new class of N-(2-oxo-3-oxetanyl)carbamates.  Replacement of the amide group with a carbamate one led to different stereoselectivity for NAAA inhibition and higher intrinsic stability, because of the reduced level of intramol. attack at the lactone ring.  The introduction of a syn Me at the β-position of the lactone further improved chem. stability.  A tert-Bu substituent in the side chain reduced the reactivity with bovine serum albumin.  Compd. I (URB913/ARN077) inhibited NAAA with good in vitro potency (IC50 = 127 nM) and showed improved stability.  It is rapidly cleaved in plasma, which supports its use for topical applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1ZiDApcso2rVg90H21EOLACvtfcHk0lg58AAdP8_fsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlslGrtLo%253D&md5=c60261cf6c43b497bc39f43adb9f177f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm300349j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300349j%26sid%3Dliteratum%253Aachs%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DAntonietti%26aufirst%3DF.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DFioni%26aufirst%3DA.%26aulast%3DSilva%26aufirst%3DC.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DSolorzano%26aufirst%3DC.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26atitle%3DN-%25282-oxo-3-oxetanyl%2529carbamic%2520acid%2520esters%2520as%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitors%253A%2520synthesis%2520and%2520structure-activity%2520and%2520structure-property%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4824%26epage%3D4836%26doi%3D10.1021%2Fjm300349j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengatto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dionisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karacsonyi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">beta-Lactones Inhibit N-acylethanolamine Acid Amidase by S-Acylation of the Catalytic N-Terminal Cysteine</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">422</span>– <span class="NLM_lpage">426</span>, <span class="refDoi"> DOI: 10.1021/ml300056y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300056y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1SnurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=422-426&author=A.+Armirottiauthor=E.+Romeoauthor=S.+Ponzanoauthor=L.+Mengattoauthor=M.+Dionisiauthor=C.+Karacsonyiauthor=F.+Bertozziauthor=G.+Garauauthor=G.+Tarozzoauthor=A.+Reggianiauthor=T.+Bandieraauthor=G.+Tarziaauthor=M.+Morauthor=D.+Piomelli&title=beta-Lactones+Inhibit+N-acylethanolamine+Acid+Amidase+by+S-Acylation+of+the+Catalytic+N-Terminal+Cysteine&doi=10.1021%2Fml300056y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">β-Lactones Inhibit N-acylethanolamine Acid Amidase by S-Acylation of the Catalytic N-Terminal Cysteine</span></div><div class="casAuthors">Armirotti, Andrea; Romeo, Elisa; Ponzano, Stefano; Mengatto, Luisa; Dionisi, Mauro; Karacsonyi, Claudia; Bertozzi, Fabio; Garau, Gianpiero; Tarozzo, Glauco; Reggiani, Angelo; Bandiera, Tiziano; Tarzia, Giorgio; Mor, Marco; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">422-426</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cysteine amidase N-acylethanolamine acid amidase (NAAA) is a member of the N-terminal nucleophile class of enzymes and a potential target for anti-inflammatory drugs.  We investigated the mechanism of inhibition of human NAAA by substituted β-lactones.  We characterized pharmacol. a representative member of this class, ARN077, and showed, using high-resoln. liq. chromatog.-tandem mass spectrometry, that this compd. forms a thioester bond with the N-terminal catalytic cysteine in human NAAA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooO8IxuG5LzLVg90H21EOLACvtfcHk0lg58AAdP8_fsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1SnurY%253D&md5=482d17b3fb0c13c8356f27a4b3f97e93</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fml300056y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300056y%26sid%3Dliteratum%253Aachs%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DDionisi%26aufirst%3DM.%26aulast%3DKaracsonyi%26aufirst%3DC.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DGarau%26aufirst%3DG.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3Dbeta-Lactones%2520Inhibit%2520N-acylethanolamine%2520Acid%2520Amidase%2520by%2520S-Acylation%2520of%2520the%2520Catalytic%2520N-Terminal%2520Cysteine%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D422%26epage%3D426%26doi%3D10.1021%2Fml300056y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nuzzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliuca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzirani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottonello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Potent alpha-amino-beta-lactam carbamic acid ester as NAAA inhibitors. Synthesis and structure-activity relationship (SAR) studies</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">138</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.01.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.ejmech.2016.01.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=26866968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVansL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2016&pages=138-159&author=A.+Nuzziauthor=A.+Fiasellaauthor=J.+A.+Ortegaauthor=C.+Pagliucaauthor=S.+Ponzanoauthor=D.+Pizziraniauthor=S.+M.+Bertozziauthor=G.+Ottonelloauthor=G.+Tarozzoauthor=A.+Reggianiauthor=T.+Bandieraauthor=F.+Bertozziauthor=D.+Piomelli&title=Potent+alpha-amino-beta-lactam+carbamic+acid+ester+as+NAAA+inhibitors.+Synthesis+and+structure-activity+relationship+%28SAR%29+studies&doi=10.1016%2Fj.ejmech.2016.01.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Potent α-amino-β-lactam carbamic acid ester as NAAA inhibitors. Synthesis and structure-activity relationship (SAR) studies</span></div><div class="casAuthors">Nuzzi, Andrea; Fiasella, Annalisa; Ortega, Jose Antonio; Pagliuca, Chiara; Ponzano, Stefano; Pizzirani, Daniela; Bertozzi, Sine Mandrup; Ottonello, Giuliana; Tarozzo, Glauco; Reggiani, Angelo; Bandiera, Tiziano; Bertozzi, Fabio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">138-159</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">4-Cyclohexylbutyl-N-[(S)-2-oxoazetidin-3-yl]carbamate I is a potent, selective and systemically active inhibitor of intracellular NAAA activity, which produces profound anti-inflammatory effects in animal models.  In the present work, the authors describe structure-activity relationship (SAR) studies on 3-aminoazetidin-2-one derivs., which have led to the identification of I, and expand these studies to elucidate the principal structural and stereochem. features needed to achieve effective NAAA inhibition.  Investigations on the influence of the substitution at the β-position of the 2-oxo-3-azetidinyl ring as well as on the effect of size and shape of the carbamic acid ester side chain led to the discovery of II, a novel inhibitor of human NAAA that shows an improved physicochem. and drug-like profile relative to I.  This favorable profile, along with the structural diversity of the carbamic acid chain of I, identify this compd. as a promising new tool to investigate the potential of NAAA inhibitors as therapeutic agents for the treatment of pain and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaN0JjRB6bmrVg90H21EOLACvtfcHk0liox2MxwWDx-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVansL4%253D&md5=639c2848d70ba68008db89244c2c8657</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.01.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.01.046%26sid%3Dliteratum%253Aachs%26aulast%3DNuzzi%26aufirst%3DA.%26aulast%3DFiasella%26aufirst%3DA.%26aulast%3DOrtega%26aufirst%3DJ.%2BA.%26aulast%3DPagliuca%26aufirst%3DC.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DBertozzi%26aufirst%3DS.%2BM.%26aulast%3DOttonello%26aufirst%3DG.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DPotent%2520alpha-amino-beta-lactam%2520carbamic%2520acid%2520ester%2520as%2520NAAA%2520inhibitors.%2520Synthesis%2520and%2520structure-activity%2520relationship%2520%2528SAR%2529%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D111%26spage%3D138%26epage%3D159%26doi%3D10.1016%2Fj.ejmech.2016.01.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fiasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuzzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">3-Aminoazetidin-2-one derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors suitable for systemic administration</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1602</span>– <span class="NLM_lpage">1614</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300546</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1002%2Fcmdc.201300546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=24828120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvF2ks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1602-1614&author=A.+Fiasellaauthor=A.+Nuzziauthor=M.+Summaauthor=A.+Armirottiauthor=G.+Tarozzoauthor=G.+Tarziaauthor=M.+Morauthor=F.+Bertozziauthor=T.+Bandieraauthor=D.+Piomelli&title=3-Aminoazetidin-2-one+derivatives+as+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors+suitable+for+systemic+administration&doi=10.1002%2Fcmdc.201300546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">3-Aminoazetidin-2-one Derivatives as N-Acylethanolamine Acid Amidase (NAAA) Inhibitors Suitable for Systemic Administration</span></div><div class="casAuthors">Fiasella, Annalisa; Nuzzi, Andrea; Summa, Maria; Armirotti, Andrea; Tarozzo, Glauco; Tarzia, Giorgio; Mor, Marco; Bertozzi, Fabio; Bandiera, Tiziano; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1602-1614</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">N-Acylethanolamine acid amidase (NAAA) is a cysteine hydrolase that catalyzes the hydrolysis of endogenous lipid mediators such as palmitoylethanolamide (PEA).  PEA has been shown to exert anti-inflammatory and antinociceptive effects in animals by engaging peroxisome proliferator-activated receptor α (PPAR-α).  Thus, preventing PEA degrdn. by inhibiting NAAA may provide a novel approach for the treatment of pain and inflammatory states.  Recently, 3-aminooxetan-2-one compds. were identified as a class of highly potent NAAA inhibitors.  The utility of these compds. is limited, however, by their low chem. and plasma stabilities.  In the present study, we synthesized and tested a series of N-(2-oxoazetidin-3-yl)amides as a novel class of NAAA inhibitors with good potency and improved physicochem. properties, suitable for systemic administration.  Moreover, we elucidated the main structural features of 3-aminoazetidin-2-one derivs. that are crit. for NAAA inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocn1G5QzPtHLVg90H21EOLACvtfcHk0liox2MxwWDx-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvF2ks74%253D&md5=beee5cde68184abb3c47e4631c56497f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300546%26sid%3Dliteratum%253Aachs%26aulast%3DFiasella%26aufirst%3DA.%26aulast%3DNuzzi%26aufirst%3DA.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3D3-Aminoazetidin-2-one%2520derivatives%2520as%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%2520suitable%2520for%2520systemic%2520administration%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D1602%26epage%3D1614%26doi%3D10.1002%2Fcmdc.201300546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minich, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bland, J. S.</span></span> <span> </span><span class="NLM_article-title">A review of the clinical efficacy and safety of cruciferous vegetable phytochemicals</span>. <i>Nutr. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1301/nr.2007.jun.259-267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1301%2Fnr.2007.jun.259-267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=17605302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A280%3ADC%252BD2szovVCiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2007&pages=259-267&author=D.+M.+Minichauthor=J.+S.+Bland&title=A+review+of+the+clinical+efficacy+and+safety+of+cruciferous+vegetable+phytochemicals&doi=10.1301%2Fnr.2007.jun.259-267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the clinical efficacy and safety of cruciferous vegetable phytochemicals</span></div><div class="casAuthors">Minich Deanna M; Bland Jeffrey S</div><div class="citationInfo"><span class="NLM_cas:title">Nutrition reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">6 Pt 1</span>),
    <span class="NLM_cas:pages">259-67</span>
        ISSN:<span class="NLM_cas:issn">0029-6643</span>.
    </div><div class="casAbstract">Supplementation with the crucifer-derived phytochemicals indole-3-carbinol (I3C) and 3,3'-diindolylmethane (DIM) has been an area of active interest due to their role in estrogen metabolism.  This review addresses the debate about which cruciferous compound to use clinically by evaluating their efficacy and safety.  Significantly more clinical trials are available for I3C than for DIM.  I3C leads to beneficial shifts in hormone markers, and limited evidence suggests that DIM may result in a similar effect.  More research in humans is needed to further address whether DIM poses any safety risk.  Current data do not suggest that DIM provides enhanced clinical benefits over I3C.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIamZicYCMh3l8icjszYl0fW6udTcc2eZU9ET3XKxomrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2szovVCiug%253D%253D&md5=de5a7b5be7a87b86ab55ebf93fa27624</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1301%2Fnr.2007.jun.259-267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1301%252Fnr.2007.jun.259-267%26sid%3Dliteratum%253Aachs%26aulast%3DMinich%26aufirst%3DD.%2BM.%26aulast%3DBland%26aufirst%3DJ.%2BS.%26atitle%3DA%2520review%2520of%2520the%2520clinical%2520efficacy%2520and%2520safety%2520of%2520cruciferous%2520vegetable%2520phytochemicals%26jtitle%3DNutr.%2520Rev.%26date%3D2007%26volume%3D65%26spage%3D259%26epage%3D267%26doi%3D10.1301%2Fnr.2007.jun.259-267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higdon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delage, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dashwood, R.</span></span> <span> </span><span class="NLM_article-title">Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">224</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2007.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.phrs.2007.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=17317210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFGnt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2007&pages=224-236&author=J.+Higdonauthor=B.+Delageauthor=D.+Williamsauthor=R.+Dashwood&title=Cruciferous+vegetables+and+human+cancer+risk%3A+epidemiologic+evidence+and+mechanistic+basis&doi=10.1016%2Fj.phrs.2007.01.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis</span></div><div class="casAuthors">Higdon, Jane V.; Delage, Barbara; Williams, David E.; Dashwood, Roderick H.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">224-236</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cruciferous vegetables are a rich source of glucosinolates and their hydrolysis products, including indoles and isothiocyanates, and high intake of cruciferous vegetables has been assocd. with lower risk of lung and colorectal cancer in some epidemiol. studies.  Glucosinolate hydrolysis products alter the metab. or activity of sex hormones in ways that could inhibit the development of hormone-sensitive cancers, but evidence of an inverse assocn. between cruciferous vegetable intake and breast or prostate cancer in humans is limited and inconsistent.  Organizations such as the National Cancer Institute recommend the consumption of five to nine servings of fruits and vegetables daily, but sep. recommendations for cruciferous vegetables have not been established.  Isothiocyanates and indoles derived from the hydrolysis of glucosinolates, such as sulforaphane and indole-3-carbinol (I3C), have been implicated in a variety of anticarcinogenic mechanisms, but deleterious effects also have been reported in some exptl. protocols, including tumor promotion over prolonged periods of exposure.  Epidemiol. studies indicate that human exposure to isothiocyanates and indoles through cruciferous vegetable consumption may decrease cancer risk, but the protective effects may be influenced by individual genetic variation (polymorphisms) in the metab. and elimination of isothiocyanates from the body.  Cooking procedures also affect the bioavailability and intake of glucosinolates and their derivs.  Supplementation with I3C or the related dimer 3,3'-diindolylmethane (DIM) alters urinary estrogen metabolite profiles in women, but the effects of I3C and DIM on breast cancer risk are not known.  Small preliminary trials in humans suggest that I3C supplementation may be beneficial in treating conditions related to human papilloma virus infection, such as cervical intraepithelial neoplasia and recurrent respiratory papillomatosis, but larger randomized controlled trials are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcKY2PKXhL_LVg90H21EOLACvtfcHk0lhdfQ3teIfnUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFGnt7c%253D&md5=34353c7a7a2bd24c16566313511e8a64</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2007.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2007.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DHigdon%26aufirst%3DJ.%26aulast%3DDelage%26aufirst%3DB.%26aulast%3DWilliams%26aufirst%3DD.%26aulast%3DDashwood%26aufirst%3DR.%26atitle%3DCruciferous%2520vegetables%2520and%2520human%2520cancer%2520risk%253A%2520epidemiologic%2520evidence%2520and%2520mechanistic%2520basis%26jtitle%3DPharmacol.%2520Res.%26date%3D2007%26volume%3D55%26spage%3D224%26epage%3D236%26doi%3D10.1016%2Fj.phrs.2007.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wattenberg, L. W.</span></span> <span> </span><span class="NLM_article-title">Inhibition of carcinogenic effects of polycyclic hydrocarbons by benzyl isothiocyanate and related compounds</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">398</span>, <span class="refDoi"> DOI: 10.1093/jnci/58.2.395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1093%2Fjnci%2F58.2.395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=401894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaE2sXhtleltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1977&pages=395-398&author=L.+W.+Wattenberg&title=Inhibition+of+carcinogenic+effects+of+polycyclic+hydrocarbons+by+benzyl+isothiocyanate+and+related+compounds&doi=10.1093%2Fjnci%2F58.2.395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of carcinogenic effects of polycyclic hydrocarbons by benzyl isothiocyanate and related compounds</span></div><div class="casAuthors">Wattenberg, Lee W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute (1940-1978)</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">395-8</span>CODEN:
                <span class="NLM_cas:coden">JNCIAM</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">Benzyl isothiocyanate [622-78-6], and phenethyl isothiocyanate [2257-09-2], compds. found in cruciferous plants, and phenyl isothiocyanate [103-72-0], a synthetic compd., all inhibited 7,12-dimethylbenz[a]anthracene (I) [57-97-6]-induced mammary tumor formation in female Sprague-Dawley rats when administered 4 h prior to I.  Comparable studies in which benzyl isothiocyanate was administered 24 h before or 4 h after I showed almost complete loss of inhibition.  Addns. of benzyl isothiocyanate or phenethyl isothiocyanate to a diet contg. I inhibited formation of neoplasms of the forestomach and pulmonary adenomas in female ICR/Ha mice.  Addn. of benzyl isothiocyanate to a diet contg. benzo[a]pyrene [50-32-8] also inhibited carcinogenesis of the mouse forestomach due to this carcinogen.  The finding of 2 addnl. anutrient dietary compds. which inhibit chem. carcinogenesis focuses on the possibility that dietary constituents of this nature may diminish the impact of exposures to chem. carcinogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_gOkiwCy_ibVg90H21EOLACvtfcHk0lhdfQ3teIfnUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXhtleltrs%253D&md5=70dc6ed28bbd302280f81edad4f888fa</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F58.2.395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F58.2.395%26sid%3Dliteratum%253Aachs%26aulast%3DWattenberg%26aufirst%3DL.%2BW.%26atitle%3DInhibition%2520of%2520carcinogenic%2520effects%2520of%2520polycyclic%2520hydrocarbons%2520by%2520benzyl%2520isothiocyanate%2520and%2520related%2520compounds%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1977%26volume%3D58%26spage%3D395%26epage%3D398%26doi%3D10.1093%2Fjnci%2F58.2.395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakubikova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cervi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nahar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klippel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cholujova, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leiba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delmore, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negri, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blotta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMillin, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedlak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsiades, C. S.</span></span> <span> </span><span class="NLM_article-title">Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma</span>. <i>Haematologica</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">1170</span>– <span class="NLM_lpage">1179</span>, <span class="refDoi"> DOI: 10.3324/haematol.2010.029363</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.3324%2Fhaematol.2010.029363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=21712538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1KmtrnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2011&pages=1170-1179&author=J.+Jakubikovaauthor=D.+Cerviauthor=M.+Ooiauthor=K.+Kimauthor=S.+Naharauthor=S.+Klippelauthor=D.+Cholujovaauthor=M.+Leibaauthor=J.+F.+Daleyauthor=J.+Delmoreauthor=J.+Negriauthor=S.+Blottaauthor=D.+W.+McMillinauthor=T.+Hideshimaauthor=P.+G.+Richardsonauthor=J.+Sedlakauthor=K.+C.+Andersonauthor=C.+S.+Mitsiades&title=Anti-tumor+activity+and+signaling+events+triggered+by+the+isothiocyanates%2C+sulforaphane+and+phenethyl+isothiocyanate%2C+in+multiple+myeloma&doi=10.3324%2Fhaematol.2010.029363"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma</span></div><div class="casAuthors">Jakubikova, Jana; Cervi, David; Ooi, Melissa; Kim, Kihyun; Nahar, Sabikun; Klippel, Steffen; Cholujova, Dana; Leiba, Merav; Daley, John F.; Delmore, Jake; Negri, Joseph; Blotta, Simona; McMillin, Douglas W.; Hideshima, Teru; Richardson, Paul G.; Sedlak, Jan; Anderson, Kenneth C.; Mitsiades, Constantine S.</div><div class="citationInfo"><span class="NLM_cas:title">Haematologica</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1170-1179</span>CODEN:
                <span class="NLM_cas:coden">HAEMAX</span>;
        ISSN:<span class="NLM_cas:issn">0390-6078</span>.
    
            (<span class="NLM_cas:orgname">Ferrata Storti Foundation</span>)
        </div><div class="casAbstract">Background. Isothiocyanates, a family of phytochems. found in cruciferous vegetables, have cytotoxic effects against several types of tumor cells.  Multiple myeloma is a fatal disease characterized by clonal proliferation of plasma cells in the bone marrow.  The growing body of preclin. information on the anti-cancer activity of isothiocyanates led us to investigate their anti-myeloma properties.  Design and Methods. We evaluated the anti-myeloma activity of the isothiocyanates, sulforaphane and phenethyl isothiocyanate, on a panel of human myeloma cell lines as well as primary myeloma tumor cells.  Cell viability, apoptosis, cell cycle alterations and cell proliferation were then analyzed in vitro and in a xenograft mouse model in vivo.  The mol. sequelae of isothiocyanate treatment in multiple myeloma cells were evaluated by multiplex analyses using bead arrays and western blotting.  Results. We obsd. that sulforaphane and phenylethyl isothiocyanate have activity against myeloma cell lines and patients' myeloma cells both in vitro and in vivo using a myeloma xenograft mouse model.  Isothiocyanates induced apoptotic death of myeloma cells; depletion of mitochondrial membrane potential; cleavage of PARP and caspases-3 and -9; as well as down-regulation of anti-apoptotic proteins including Mcl-1, X-IAP, c-IAP and survivin.  Isothiocyanates induced G2/M cell cycle arrest accompanied by mitotic phosphorylation of histone H3.  Multiplex anal. of phosphorylation of diverse components of signaling cascades revealed changes in MAPK activation; increased phosphorylation of c-jun and HSP27; as well as changes in the phosphorylation of Akt, and GSK3α/β and p53.  Isothiocyanates suppressed proliferation of myeloma cells alone and when co-cultured with HS-5 stromal cells.  Sulforaphane and phenylethyl isothiocyanate enhanced the in vitro anti-myeloma activity of several conventional and novel therapies used in multiple myeloma.  Conclusions. Our study shows that isothiocyanates have potent anti-myeloma activities and may enhance the activity of other anti-multiple myeloma agents.  These results indicate that isothiocyanates may have therapeutic potential in multiple myeloma and provide the preclin. framework for future clin. studies of isothiocyanates in multiple myeloma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGe_1GHimFZrVg90H21EOLACvtfcHk0lhdfQ3teIfnUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1KmtrnE&md5=50e1571bc636e0ed8425a9833fec510c</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2010.029363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2010.029363%26sid%3Dliteratum%253Aachs%26aulast%3DJakubikova%26aufirst%3DJ.%26aulast%3DCervi%26aufirst%3DD.%26aulast%3DOoi%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DNahar%26aufirst%3DS.%26aulast%3DKlippel%26aufirst%3DS.%26aulast%3DCholujova%26aufirst%3DD.%26aulast%3DLeiba%26aufirst%3DM.%26aulast%3DDaley%26aufirst%3DJ.%2BF.%26aulast%3DDelmore%26aufirst%3DJ.%26aulast%3DNegri%26aufirst%3DJ.%26aulast%3DBlotta%26aufirst%3DS.%26aulast%3DMcMillin%26aufirst%3DD.%2BW.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DSedlak%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DMitsiades%26aufirst%3DC.%2BS.%26atitle%3DAnti-tumor%2520activity%2520and%2520signaling%2520events%2520triggered%2520by%2520the%2520isothiocyanates%252C%2520sulforaphane%2520and%2520phenethyl%2520isothiocyanate%252C%2520in%2520multiple%2520myeloma%26jtitle%3DHaematologica%26date%3D2011%26volume%3D96%26spage%3D1170%26epage%3D1179%26doi%3D10.3324%2Fhaematol.2010.029363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntee, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecht, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, F.-L.</span></span> <span> </span><span class="NLM_article-title">Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">8548</span>– <span class="NLM_lpage">8557</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-05-0237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1158%2F0008-5472.can-05-0237" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=16166336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVShsbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=8548-8557&author=C.+C.+Conawayauthor=C.-X.+Wangauthor=B.+Pittmanauthor=Y.-M.+Yangauthor=J.+E.+Schwartzauthor=D.+Tianauthor=E.+J.+McInteeauthor=S.+S.+Hechtauthor=F.-L.+Chung&title=Phenethyl+isothiocyanate+and+sulforaphane+and+their+N-acetylcysteine+conjugates+inhibit+malignant+progression+of+lung+adenomas+induced+by+tobacco+carcinogens+in+A%2FJ+mice&doi=10.1158%2F0008-5472.can-05-0237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Phenethyl Isothiocyanate and Sulforaphane and their N-Acetylcysteine Conjugates Inhibit Malignant Progression of Lung Adenomas Induced by Tobacco Carcinogens in A/J Mice</span></div><div class="casAuthors">Conaway, C. Clifford; Wang, Chung-Xiou; Pittman, Brian; Yang, Yang-Ming; Schwartz, Joel E.; Tian, Defa; McIntee, Edward J.; Hecht, Stephen S.; Chung, Fung-Lung</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8548-8557</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We have shown previously that naturally occurring isothiocyanates derived from cruciferous vegetables and their N-acetylcysteine conjugates inhibit lung adenoma formation induced by tobacco carcinogens in A/J mice at the post-initiation stage.  The tumor-inhibitory activity by these compds. is linked with activation of activator protein and induction of apoptosis in lung tissues, suggesting that these compds. may also inhibit the development of adenomas to adenocarcinomas in lung.  In this study, the chemopreventive activity of phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates during progression of lung adenomas to malignant tumors was investigated in A/J mice.  Mice were divided into 14 groups and treated with a mixt. of 3 μmol benzo(a)pyrene [B(a)P] and 3 μmol 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) given by gavage once weekly for 8 wk.  Twenty weeks after the beginning of carcinogen administration, a total of 20 mice in the treatment groups were sacrificed with an av. yield of 7.3±4.5 lung adenomas per mouse.  The remaining mice in each group were fed diets contg. phenethyl isothiocyanate (3 and 1.5 mmol/kg diet), sulforaphane (3 and 1.5 mmol/kg diet), phenethyl isothiocyanate-N-acetylcysteine (8 and 4 mmol/kg diet), sulforaphane-N-acetylcysteine (8 and 4 mmol/kg diet) during weeks 21 to 42.  Four mice in each of the high-dose treatment groups were sacrificed during weeks 28 and 36 and the bioassay was terminated during week 42; lung tissues were harvested for histopathol. examn. of tumors and for cell proliferation (proliferating cell nuclear antigen) and apoptosis (caspase-3) assays using immunohistochem. staining.  At termination, the incidence of adenocarcinoma in the 3 mmol/kg diet phenethyl isothiocyanate group and 8 mmol/kg diet phenethyl isothiocyanate-N-acetylcysteine group was reduced to 19% and 13%, resp., compared with 42% in the carcinogen-treated control group.  At the lower doses, phenethyl isothiocyanate and its N-acetylcysteine conjugate also inhibited the incidences of lung adenocarcinoma, however, the decreases were not statistically significant.  The lung tumor incidences in groups treated with sulforaphane-N-acetylcysteine in the diet were also significantly reduced to 11% or 16%.  Furthermore, the malignant lung tumor multiplicity was significantly reduced from 1.0 tumor/mouse in the carcinogen-treated control group to 0.3 in the sulforaphane low-dose group, 0.3 and 0.4 in the two sulforaphane-N-acetylcysteine groups, and 0.4 in the phenethyl isothiocyanate high-dose group.  The malignant tumor multiplicities in other treatment groups were also reduced (0.5-0.8 tumors/mouse), but not significantly.  Unlike lung adenocarcinomas, both incidences and multiplicities of lung adenomas were not much affected by treatment with isothiocyanates or their conjugates.  Immunohistochem. examn. of the lung tumors from all time points indicated that significant redn. in proliferating cell nuclear antigen and induction of apoptosis (terminal nucleotidyl transferase-mediated nick end labeling and caspase-3) were obsd. in the isothiocyanate and isothiocyanate-N-acetylcysteine-treated groups that showed inhibition of the development of lung adenocarcinomas.  The results of the study provide a basis for future evaluation of the potential of phenethyl isothiocyanate and sulforaphane and their conjugates as chemopreventive agents in smokers and ex-smokers with early lung lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW3uBs1IlbLrVg90H21EOLACvtfcHk0lignjfoJWFPtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVShsbfE&md5=70ac8709d36d24601a4460377a219e8e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.can-05-0237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.can-05-0237%26sid%3Dliteratum%253Aachs%26aulast%3DConaway%26aufirst%3DC.%2BC.%26aulast%3DWang%26aufirst%3DC.-X.%26aulast%3DPittman%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DY.-M.%26aulast%3DSchwartz%26aufirst%3DJ.%2BE.%26aulast%3DTian%26aufirst%3DD.%26aulast%3DMcIntee%26aufirst%3DE.%2BJ.%26aulast%3DHecht%26aufirst%3DS.%2BS.%26aulast%3DChung%26aufirst%3DF.-L.%26atitle%3DPhenethyl%2520isothiocyanate%2520and%2520sulforaphane%2520and%2520their%2520N-acetylcysteine%2520conjugates%2520inhibit%2520malignant%2520progression%2520of%2520lung%2520adenomas%2520induced%2520by%2520tobacco%2520carcinogens%2520in%2520A%252FJ%2520mice%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D8548%26epage%3D8557%26doi%3D10.1158%2F0008-5472.can-05-0237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chung, F.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, B. S.</span></span> <span> </span><span class="NLM_article-title">Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2287</span>– <span class="NLM_lpage">2291</span>, <span class="refDoi"> DOI: 10.1093/carcin/21.12.2287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1093%2Fcarcin%2F21.12.2287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=11133820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFyrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=2287-2291&author=F.-L.+Chungauthor=C.+C.+Conawayauthor=C.+V.+Raoauthor=B.+S.+Reddy&title=Chemoprevention+of+colonic+aberrant+crypt+foci+in+Fischer+rats+by+sulforaphane+and+phenethyl+isothiocyanate&doi=10.1093%2Fcarcin%2F21.12.2287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate</span></div><div class="casAuthors">Chung, Fung-Lung; Conaway, C. Clifford; Rao, C. V.; Reddy, Bandaru S.</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2287-2291</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Epidemiol. studies have linked consumption of broccoli to a reduced risk of colon cancer in individuals with the glutathione S-transferase M1 (GSTM1) null genotype.  GSTs are involved in excretion and elimination of isothiocyanates (ITCs), which are major constituents of broccoli and other cruciferous vegetables and have cancer chemopreventive potential, so it is speculated that ITCs may play a role in protection against human colon cancer.  However, there is a lack of data from animal studies to support this.  We carried out a bioassay to examine whether sulforaphane (SFN) and phenethyl isothiocyanate (PEITC), major ITCs in broccoli and watercress, resp., and their corresponding N-acetylcysteine (NAC) conjugates, show any chemopreventive activity towards azoxymethane (AOM)-induced colonic aberrant crypt foci (ACF) in F344 rats.  Groups of six male F344 rats were treated with AOM s.c. (15 mg/kg body wt) once weekly for 2 wk.  SFN and PEITC and their NAC conjugates were administered by gavage either three times weekly for 8 wk (5 and 20 μmol, resp.) after AOM dosing (post-initiation stage) or once daily for 3 days (20 and 50 μmol, resp.) before AOM treatment (initiation stage).  The bioassay was terminated on week 10 after the second AOM dosing and ACF were quantified.  SFN, SFN-NAC, PEITC and PEITC-NAC all significantly reduced the formation of total ACF from 153 to 100-116 (P < 0.01) and multicrypt foci from 52 to 27-38 (more than four crypts/focus; P < 0.05) during the post-initiation treatment.  However, only SFN and PEITC were effective during the initiation phase, reducing the total ACF from 153 to 109-115 (P < 0.01) and multicrypt foci from 52 to 35 (more than four crypts/focus; P < 0.05).  The NAC conjugates were inactive as anti-initiators against AOM-induced ACF.  These findings provide important lab. evidence for a potential role of SFN and PEITC in the protection against colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGU3-bY7ZoULVg90H21EOLACvtfcHk0lignjfoJWFPtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFyrtw%253D%253D&md5=1d2f22065dfb4337c08e0601d96500d2</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2F21.12.2287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252F21.12.2287%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DF.-L.%26aulast%3DConaway%26aufirst%3DC.%2BC.%26aulast%3DRao%26aufirst%3DC.%2BV.%26aulast%3DReddy%26aufirst%3DB.%2BS.%26atitle%3DChemoprevention%2520of%2520colonic%2520aberrant%2520crypt%2520foci%2520in%2520Fischer%2520rats%2520by%2520sulforaphane%2520and%2520phenethyl%2520isothiocyanate%26jtitle%3DCarcinogenesis%26date%3D2000%26volume%3D21%26spage%3D2287%26epage%3D2291%26doi%3D10.1093%2Fcarcin%2F21.12.2287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krzeminski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, F.-L.</span></span> <span> </span><span class="NLM_article-title">Decomposition rates of isothiocyanate conjugates determine their activity as inhibitors of cytochrome p450 enzymes</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1170</span>– <span class="NLM_lpage">1176</span>, <span class="refDoi"> DOI: 10.1021/tx010029w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx010029w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsFehtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2001&pages=1170-1176&author=C.+C.+Conawayauthor=J.+Krzeminskiauthor=S.+Aminauthor=F.-L.+Chung&title=Decomposition+rates+of+isothiocyanate+conjugates+determine+their+activity+as+inhibitors+of+cytochrome+p450+enzymes&doi=10.1021%2Ftx010029w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Decomposition rates of isothiocyanate conjugates determine their activity as inhibitors of cytochrome p450 enzymes</span></div><div class="casAuthors">Conaway, C. Clifford; Krzeminski, Jacek; Amin, Shantu; Chung, Fung-Lung</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1170-1176</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Thiol conjugates of isothiocyanates (thiol-ITCs) are metabolites of ITCs formed in the mercapturic acid pathway in mammals.  They are effective chemopreventive agents in mouse lung tumor bioassays and in other models.  Thiol-ITCs are inhibitors of P450s, but it has not been detd. if P 450 inhibition is due to conjugates themselves or to parent ITCs released by deconjugation reactions.  In studies of mechanism of chemopreventive action of thiol-ITCs, rates of deconjugation of Cys, GSH, and N-acetyl-L-cysteine (NAC) conjugates of benzyl isothiocyanate (BITC), phenethyl isothiocyanate (PEITC), 6-phenylhexyl isothiocyanate (PHITC), and sulforaphane (SFN), expressed as the first-order rate const. k1 and the half-life of decompn. Dt1/2, were measured in aq. solns. at pH 7.4 and 37°.  The Dt1/2s for the Cys conjugates were severalfold shorter than the Dt1/2s for resp. GSH conjugates, while the Dt1/2s for the NAC conjugates were the longest.  Cleavage of thiol conjugates was pH dependent, much slower under acidic conditions than at pH 7.4.  Inhibition of P 450 enzymes by thiol-ITCs was followed using PROD (pentoxyresorufin O-dealkylation) for P 450 2B1 and EROD (ethoxyresorufin O-dealkylation) for P 450 1A1.  The inhibition of PROD and EROD by aq. thiol-ITCs increased with preincubation time and was roughly parallel to the extent of decompn. of the conjugate that had occurred, indicating that both potency of the resp. parent ITC and the rate of reductive cleavage of the conjugate influenced enzyme inhibition.  In the presence of 250-1000 μM GSH, comparable to physiol. levels, rates of deconjugation of thiol-ITCs were markedly reduced; inhibition of PROD was also proportionately reduced.  Slow rates of decompn. of thiol-ITCs anticipated in plasma and tissues suggests that inhibition of P 450 enzymes involved in carcinogen activation by ITCs released from thiol-ITCs may not be a principal mechanism for their tumor inhibitory activity; other mechanisms probably contribute to their chemopreventive activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfaJItIZeMarVg90H21EOLACvtfcHk0lignjfoJWFPtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsFehtrk%253D&md5=295f5cf88b55730fb8c07157b62c0c0a</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Ftx010029w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx010029w%26sid%3Dliteratum%253Aachs%26aulast%3DConaway%26aufirst%3DC.%2BC.%26aulast%3DKrzeminski%26aufirst%3DJ.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DChung%26aufirst%3DF.-L.%26atitle%3DDecomposition%2520rates%2520of%2520isothiocyanate%2520conjugates%2520determine%2520their%2520activity%2520as%2520inhibitors%2520of%2520cytochrome%2520p450%2520enzymes%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2001%26volume%3D14%26spage%3D1170%26epage%3D1176%26doi%3D10.1021%2Ftx010029w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eklind, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, F. L.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of isothiocyanates as mechanism-based inhibitors of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4327</span>– <span class="NLM_lpage">4333</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=8044780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaK2cXlsVygtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1994&pages=4327-4333&author=D.+Jiaoauthor=K.+I.+Eklindauthor=C.+I.+Choiauthor=D.+H.+Desaiauthor=S.+G.+Aminauthor=F.+L.+Chung&title=Structure-activity+relationships+of+isothiocyanates+as+mechanism-based+inhibitors+of+4-%28methylnitrosamino%29-1-%283-pyridyl%29-1-butanone-induced+lung+tumorigenesis+in+A%2FJ+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of isothiocyanates as mechanism-based inhibitors of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice</span></div><div class="casAuthors">Jiao, Ding; Eklind, Karin I.; Choi, Chang-In; Desai, Dhimant H.; Amin, Shantu G.; Chung, Fung-Lung</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4327-33</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">A structure-activity relationship study was carried out to identify structural features in arylalkyl and alkyl isothiocyanates that are assocd. with the inhibitory potency of these compds. against lung tumorigenesis induced in A/J mice by the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).  These features include the alkyl chain length, Ph substitution, and secondary isothiocyanates.  The naturally occurring allyl isothiocyanate, phenethyl isothiocyanate, and the synthetic analogs such as 6-phenylhexyl isothiocyanate, 8-phenyloctyl isothiocyanate, 10-phenyldecyl isothiocyanate, 1,2-diphenylethyl isothiocyanate, 2,2-diphenylethyl isothiocyanate, and alkyl isothiocyanates (with 1-hexyl, 2-hexyl, and 1-dodecyl as alkyl moieties) were assayed in mice for their tumor inhibitory potential.  The isothiocyanates were given in corn oil by gavage at doses of either 0.04, 0.1, and 0.2 μmol or 1 and 5 μmol 2 h prior to a single i.p. injection of 10 μmol NNK.  Mice were sacrificed 16 wk later and lung adenomas were counted.  At 0.2 μmol, 8-phenyloctyl isothiocyanate and 10-phenyldecyl isothiocyanate were stronger inhibitors than the previously tested 6-phenyldecyl isothiocyanate were stronger inhibitors than the previously tested 6-phenylhexyl isothiocyanate, but the difference in potency was not obvious at the lower doses.  At both 1 and 5 μmol, allyl isothiocyanate was inactive, while the other five synthetic isothiocyanates were considerably more potent than phenethyl isothiocyanate.  In the alkyl isothiocyanate series, 2-hexyl isothiocyanate was the most potent at 1 μmol, reducing tumor multiplicity in the group treated with NNK alone from 11.1 to the background level.  Also, 1,2-diphenylethyl isothiocyanate appeared to be a stronger inhibitor than 2,2-diphenylethyl isothiocyanate.  In this study the authors have shown that the Ph moiety is not essential for the inhibitory activity since alkyl isothiocyanates exhibit strong inhibitory effects against lung tumorigenesis.  The authors have also shown that secondary isothiocyanates possess a higher potency than their structural isomers bearing a primary isothiocyanate.  From results of this study and of seven previously studied isothiocyanates, the authors conclude that the obsd. inhibitory potency of isothiocyanates in the A/J mouse lung tumor model is correlated with their partition coeffs. (log P) and the pseudo first order rate consts. for the reaction of isothiocyanates toward glutathione (kobs).  These results reveal that both high lipophilicity and low reactivity of isothiocyanates are important for inhibitory activity toward NNK-induced lung tumorigenesis.  These observations provide a structural basis for the discovery of more effective chemopreventive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBPLP-fDqgWbVg90H21EOLACvtfcHk0lhR7nxKOtXOCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlsVygtrc%253D&md5=d26832955c75cff805b2338214d834ac</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiao%26aufirst%3DD.%26aulast%3DEklind%26aufirst%3DK.%2BI.%26aulast%3DChoi%26aufirst%3DC.%2BI.%26aulast%3DDesai%26aufirst%3DD.%2BH.%26aulast%3DAmin%26aufirst%3DS.%2BG.%26aulast%3DChung%26aufirst%3DF.%2BL.%26atitle%3DStructure-activity%2520relationships%2520of%2520isothiocyanates%2520as%2520mechanism-based%2520inhibitors%2520of%25204-%2528methylnitrosamino%2529-1-%25283-pyridyl%2529-1-butanone-induced%2520lung%2520tumorigenesis%2520in%2520A%252FJ%2520mice%26jtitle%3DCancer%2520Res.%26date%3D1994%26volume%3D54%26spage%3D4327%26epage%3D4333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D. K.</span></span> <span> </span><span class="NLM_article-title">Drug discovery for a new generation of covalent drugs</span>. <i>Expet Opin. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">581</span>, <span class="refDoi"> DOI: 10.1517/17460441.2012.688744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1517%2F17460441.2012.688744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=22607458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC38XptFWmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=561-581&author=A.+S.+Kalgutkarauthor=D.+K.+Dalvie&title=Drug+discovery+for+a+new+generation+of+covalent+drugs&doi=10.1517%2F17460441.2012.688744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery for a new generation of covalent drugs</span></div><div class="casAuthors">Kalgutkar, Amit S.; Dalvie, Deepak K.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">561-581</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The design of target-specific covalent inhibitors is conceptually attractive because of increased biochem. efficiency through covalency and increased duration of action that outlasts the pharmacokinetics of the agent.  Although many covalent inhibitors have been approved or are in advanced clin. trials to treat indications such as cancer and hepatitis C, there is a general tendency to avoid them as drug candidates because of concerns regarding immune-mediated toxicity that can arise from indiscriminate reactivity with off-target proteins.Areas covered: The review examines potential reason(s) for the excellent safety record of marketed covalent agents and advanced clin. candidates for emerging therapeutic targets.  A significant emphasis is placed on proteomic techniques and chem./biochem. reactivity assays that aim to provide a systematic rank ordering of pharmacol. selectivity relative to off-target protein reactivity of covalent inhibitors.Expert opinion: While tactics to examine selective covalent modification of the pharmacol. target are broadly applicable in drug discovery, it is unclear whether the output from such studies can prospectively predict idiosyncratic immune-mediated drug toxicity.  Opinions regarding an acceptable threshold of protein reactivity/body burden for a toxic electrophile and a non-toxic electrophilic covalent drug have not been defined.  Increasing confidence in proteomic and chem./biochem. reactivity screens will require a retrospective side-by-side profiling of marketed covalent drugs and electrophiles known to cause deleterious toxic effects via non-selective covalent binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowmXy20mDTPbVg90H21EOLACvtfcHk0lhR7nxKOtXOCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptFWmt7k%253D&md5=b7fc8e60b263dda5765dd8380f52df17</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1517%2F17460441.2012.688744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2012.688744%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26atitle%3DDrug%2520discovery%2520for%2520a%2520new%2520generation%2520of%2520covalent%2520drugs%26jtitle%3DExpet%2520Opin.%2520Drug%2520Discov.%26date%3D2012%26volume%3D7%26spage%3D561%26epage%3D581%26doi%3D10.1517%2F17460441.2012.688744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atsumi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takakusa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okazaki, O.</span></span> <span> </span><span class="NLM_article-title">A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1970</span>– <span class="NLM_lpage">1977</span>, <span class="refDoi"> DOI: 10.1124/dmd.109.027797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1124%2Fdmd.109.027797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=19487250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVOrsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1970-1977&author=S.+Nakayamaauthor=R.+Atsumiauthor=H.+Takakusaauthor=Y.+Kobayashiauthor=A.+Kuriharaauthor=Y.+Nagaiauthor=D.+Nakaiauthor=O.+Okazaki&title=A+zone+classification+system+for+risk+assessment+of+idiosyncratic+drug+toxicity+using+daily+dose+and+covalent+binding&doi=10.1124%2Fdmd.109.027797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding</span></div><div class="casAuthors">Nakayama, Shintaro; Atsumi, Ryo; Takakusa, Hideo; Kobayashi, Yoshimasa; Kurihara, Atsushi; Nagai, Yoko; Nakai, Daisuke; Okazaki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1970-1977</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The risk of idiosyncratic drug toxicity (IDT) is of great concern to the pharmaceutical industry.  Current hypotheses based on retrospective studies suggest that the occurrence of IDT is related to covalent binding and daily dose.  The authors detd. the covalent binding of 42 radiolabeled drugs in three test systems (human liver microsomes and hepatocytes in vitro and rat liver in vivo) to assess the risk of IDT.  On the basis of safety profiles given in official documentation, tested drugs were classified into the safety categories of safe, warning, black box warning, and withdrawn.  The covalent binding in each of the three test systems did not distinguish the safety categories clearly.  However, when the log-normalized covalent binding was plotted against the log-normalized daily dose, the distribution of the plot in the safety categories became clear.  An ordinal logistic regression anal. indicated that both covalent binding and daily dose were significantly correlated with safety category and that covalent binding in hepatocytes was the best predictor among the three systems.  When two sepn. lines were drawn on the correlation graph between covalent binding in human hepatocytes and daily dose by a regression anal. to create three zones, 30 of 37 tested drugs were located in zones corresponding to their resp. classified safety categories.  In conclusion, the authors established a zone classification system using covalent binding in human hepatocytes and daily dose for the risk assessment of IDTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtahZPkNJ3JbVg90H21EOLACvtfcHk0lhR7nxKOtXOCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVOrsrfO&md5=425119e0451fc50ec6ca95d5e3fe5fd3</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.027797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.027797%26sid%3Dliteratum%253Aachs%26aulast%3DNakayama%26aufirst%3DS.%26aulast%3DAtsumi%26aufirst%3DR.%26aulast%3DTakakusa%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DKurihara%26aufirst%3DA.%26aulast%3DNagai%26aufirst%3DY.%26aulast%3DNakai%26aufirst%3DD.%26aulast%3DOkazaki%26aufirst%3DO.%26atitle%3DA%2520zone%2520classification%2520system%2520for%2520risk%2520assessment%2520of%2520idiosyncratic%2520drug%2520toxicity%2520using%2520daily%2520dose%2520and%2520covalent%2520binding%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1970%26epage%3D1977%26doi%3D10.1124%2Fdmd.109.027797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farah, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelekoudas, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajarshi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyabe, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrashekhar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlopoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">115195</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2019.115195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.bmc.2019.115195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=31761726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1ars7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2020&pages=115195&author=M.+S.+Malamasauthor=S.+I.+Farahauthor=M.+Lamaniauthor=D.+N.+Pelekoudasauthor=N.+T.+Perryauthor=G.+Rajarshiauthor=C.+Y.+Miyabeauthor=H.+Chandrashekharauthor=J.+Westauthor=S.+Pavlopoulosauthor=A.+Makriyannis&title=Design+and+synthesis+of+cyanamides+as+potent+and+selective+N-acylethanolamine+acid+amidase+inhibitors&doi=10.1016%2Fj.bmc.2019.115195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Farah, Shrouq I.; Lamani, Manjunath; Pelekoudas, Dimitrios N.; Perry, Nicholas Thomas; Rajarshi, Girija; Miyabe, Christina Yume; Chandrashekhar, Honrao; West, Jay; Pavlopoulos, Spiro; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115195</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-acylethanolamine acid amidase (NAAA) inhibition represents an exciting novel approach to treat inflammation and pain.  NAAA is a cysteine amidase which preferentially hydrolyzes the endogenous biolipids palmitoylethanolamide (PEA) and oleoylethanolamide (OEA).  PEA is an endogenous agonist of the nuclear peroxisome proliferator-activated receptor-α (PPAR-α), which is a key regulator of inflammation and pain.  Thus, blocking the degrdn. of PEA with NAAA inhibitors results in augmentation of the PEA/PPAR-α signaling pathway and regulation of inflammatory and pain processes.  We have prepd. a new series of NAAA inhibitors exploring the azetidine-nitrile (cyanamide) pharmacophore that led to the discovery of highly potent and selective compds.  Key analogs demonstrated single-digit nanomolar potency for hNAAA and showed &amp;gt;100-fold selectivity against serine hydrolases FAAH, MGL and ABHD6, and cysteine protease cathepsin K.  Addnl., we have identified potent and selective dual NAAA-FAAH inhibitors to investigate a potential synergism between two distinct anti-inflammatory mol. pathways, the PEA/PPAR-α anti-inflammatory signaling pathway,1-4 and the cannabinoid receptors CB1 and CB2 pathways which are known for their antiinflammatory and antinociceptive properties.5-8 Our ligand design strategy followed a traditional structure-activity relationship (SAR) approach and was supported by mol. modeling studies of reported X-ray structures of hNAAA.  Several inhibitors were evaluated in stability assays and demonstrated very good plasma stability (t1/2 &amp;gt; 2 h; human and rodents).  The disclosed cyanamides represent promising new pharmacol. tools to investigate the potential role of NAAA inhibitors and dual NAAA-FAAH inhibitors as therapeutic agents for the treatment of inflammation and pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-A_C3n2MNkbVg90H21EOLACvtfcHk0liJ5nbxy-CQQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1ars7rE&md5=f5330d39907df730c82cca041803b7da</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2019.115195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2019.115195%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DFarah%26aufirst%3DS.%2BI.%26aulast%3DLamani%26aufirst%3DM.%26aulast%3DPelekoudas%26aufirst%3DD.%2BN.%26aulast%3DPerry%26aufirst%3DN.%2BT.%26aulast%3DRajarshi%26aufirst%3DG.%26aulast%3DMiyabe%26aufirst%3DC.%2BY.%26aulast%3DChandrashekhar%26aufirst%3DH.%26aulast%3DWest%26aufirst%3DJ.%26aulast%3DPavlopoulos%26aufirst%3DS.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520cyanamides%2520as%2520potent%2520and%2520selective%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2020%26volume%3D28%26spage%3D115195%26doi%3D10.1016%2Fj.bmc.2019.115195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. B.</span></span> <span> </span><span class="NLM_article-title">Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1962</span>,  <span class="NLM_volume"><i>237</i></span>,  <span class="NLM_fpage">3245</span>– <span class="NLM_lpage">3249</span>, <span class="refDoi"> DOI: 10.1016/s0021-9258(18)50153-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fs0021-9258%2818%2950153-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=14033211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaF38Xks1Cmsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=1962&pages=3245-3249&author=R.+Kitzauthor=I.+B.+Wilson&title=Esters+of+methanesulfonic+acid+as+irreversible+inhibitors+of+acetylcholinesterase&doi=10.1016%2Fs0021-9258%2818%2950153-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase</span></div><div class="casAuthors">Kitz, R.; Wilson, Irwin B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1962</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3245-49</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Nine esters (anhydrides) of methanesulfonic acid, analogs to well known carbamate (e.g. neostigmine) and phosphate (e.g. paraoxon) inhibitors, were examd. as possible irreversible inhibitors of acetylcholinesterase.  Five were active.  Of these, 4 formed initial reversible complexes.  The progressive development of irreversible inhibition was slowed by reversible inhibitors, indicating that the active site is involved.  The inhibited enzyme is not reactivated by water or by hydroxylamine, hydrazine, acetate, or pyridine-2-aldoxime methiodide.  It is reactivated by pyridine-3-aldoxime methiodide.  On the basis of the evidence presented, it may be concluded safely that the active methanesulfonates form methanesulfonyl enzyme derivs. and, therefore, belong to the class of acid-transferring or oxydiaphoric inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXvcQevCYwCbVg90H21EOLACvtfcHk0liJ5nbxy-CQQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF38Xks1Cmsrg%253D&md5=f3993cf79ebb66299fada0ad04b15860</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fs0021-9258%2818%2950153-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0021-9258%252818%252950153-8%26sid%3Dliteratum%253Aachs%26aulast%3DKitz%26aufirst%3DR.%26aulast%3DWilson%26aufirst%3DI.%2BB.%26atitle%3DEsters%2520of%2520methanesulfonic%2520acid%2520as%2520irreversible%2520inhibitors%2520of%2520acetylcholinesterase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1962%26volume%3D237%26spage%3D3245%26epage%3D3249%26doi%3D10.1016%2Fs0021-9258%2818%2950153-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gorelik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagar, B.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanism of activation of the immunoregulatory amidase NAAA</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">E10032</span>– <span class="NLM_lpage">E10040</span>, <span class="refDoi"> DOI: 10.1073/pnas.1811759115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1073%2Fpnas.1811759115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=30301806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVyhsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=E10032-E10040&author=A.+Gorelikauthor=A.+Gebaiauthor=K.+Illesauthor=D.+Piomelliauthor=B.+Nagar&title=Molecular+mechanism+of+activation+of+the+immunoregulatory+amidase+NAAA&doi=10.1073%2Fpnas.1811759115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanism of activation of the immunoregulatory amidase NAAA</span></div><div class="casAuthors">Gorelik, Alexei; Gebai, Ahmad; Illes, Katalin; Piomelli, Daniele; Nagar, Bhushan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">E10032-E10040</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Palmitoylethanolamide is a bioactive lipid that strongly alleviates pain and inflammation in animal models and in humans.  Its signaling activity is terminated through degrdn. by N-acylethanolamine acid amidase (NAAA), a cysteine hydrolase expressed at high levels in immune cells.  Pharmacol. inhibitors of NAAA activity exert profound analgesic and antiinflammatory effects in rodent models, pointing to this protein as a potential target for therapeutic drug discovery.  To facilitate these efforts and to better understand the mol. mechanism of action of NAAA, we detd. crystal structures of this enzyme in various activation states and in complex with several ligands, including both a covalent and a reversible inhibitor.  Self-proteolysis exposes the otherwise buried active site of NAAA to allow catalysis.  Formation of a stable substrate- or inhibitor-binding site appears to be conformationally coupled to the interaction of a pair of hydrophobic helixes in the enzyme with lipid membranes, resulting in the creation of a linear hydrophobic cavity near the active site that accommodates the liganda's acyl chain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe4SyudaY7MrVg90H21EOLACvtfcHk0liJ5nbxy-CQQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVyhsLvP&md5=9debd68d3239a82bd60849c9cf98e8ae</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1811759115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1811759115%26sid%3Dliteratum%253Aachs%26aulast%3DGorelik%26aufirst%3DA.%26aulast%3DGebai%26aufirst%3DA.%26aulast%3DIlles%26aufirst%3DK.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DNagar%26aufirst%3DB.%26atitle%3DMolecular%2520mechanism%2520of%2520activation%2520of%2520the%2520immunoregulatory%2520amidase%2520NAAA%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2018%26volume%3D115%26spage%3DE10032%26epage%3DE10040%26doi%3D10.1073%2Fpnas.1811759115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klicic, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoll, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenkin, P. S.</span></span> <span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1739</span>– <span class="NLM_lpage">1749</span>, <span class="refDoi"> DOI: 10.1021/jm0306430</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+Method+and+assessment+of+docking+accuracy&doi=10.1021%2Fjm0306430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0liJ5nbxy-CQQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520Method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749%26doi%3D10.1021%2Fjm0306430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pincus, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapp, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T. J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">A hierarchical approach to all-atom protein loop prediction</span>. <i>Proteins</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1002/prot.10613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1002%2Fprot.10613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=15048827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFKhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=351-367&author=M.+P.+Jacobsonauthor=D.+L.+Pincusauthor=C.+S.+Rappauthor=T.+J.+F.+Dayauthor=B.+Honigauthor=D.+E.+Shawauthor=R.+A.+Friesner&title=A+hierarchical+approach+to+all-atom+protein+loop+prediction&doi=10.1002%2Fprot.10613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">A hierarchical approach to all-atom protein loop prediction</span></div><div class="casAuthors">Jacobson, Matthew P.; Pincus, David L.; Rapp, Chaya S.; Day, Tyler J. F.; Honig, Barry; Shaw, David E.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">351-367</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The application of all-atom force fields (and explicit or implicit solvent models) to protein homol.-modeling tasks such as side-chain and loop prediction remains challenging both because of the expense of the individual energy calcns. and because of the difficulty of sampling the rugged all-atom energy surface.  Here the authors address this challenge for the problem of loop prediction through the development of numerous new algorithms, with an emphasis on multiscale and hierarchical techniques.  As a first step in evaluating the performance of the authors' loop prediction algorithm, the authors have applied it to the problem of reconstructing loops in native structures; the authors also explicitly include crystal packing to provide a fair comparison with crystal structures.  In brief, large nos. of loops are generated by using a dihedral angle-based buildup procedure followed by iterative cycles of clustering, side-chain optimization, and complete energy minimization of selected loop structures.  The authors evaluate this method by the largest test set yet used for validation of a loop prediction method, with a total of 833 loops ranging from 4 to 12 residues in length.  Av./median backbone root-mean-square deviations (RMSDs) to the native structures (superimposing the body of the protein, not the loop itself) are 0.42/0.24 Å for 5 residue loops, 1.00/0.44 Å for 8 residue loops, and 2.47/1.83 Å for 11 residue loops.  Median RMSDs are substantially lower than the avs. because of a small no. of outliers; the causes of these failures are examd. in some detail, and many can be attributed to errors in assignment of protonation states of titratable residues, omission of ligands from the simulation, and, in a few cases, probable errors in the exptl. detd. structures.  When these obvious problems in the data sets are filtered out, av. RMSDs to the native structures improve to 0.43 Å for 5 residue loops, 0.84 Å for 8 residue loops, and 1.63 Å for 11 residue loops.  In the vast majority of cases, the method locates energy min. that are lower than or equal to that of the minimized native loop, thus indicating that sampling rarely limits prediction accuracy.  The overall results are, to the authors' knowledge, the best reported to date, and the authors attribute this success to the combination of an accurate all-atom energy function, efficient methods for loop buildup and side-chain optimization, and, esp. for the longer loops, the hierarchical refinement protocol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHqYMnqaWXvLVg90H21EOLACvtfcHk0lj3RG7EHW5U3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFKhsrc%253D&md5=e0eff655eeefb30ea00ae041ea9099c8</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fprot.10613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.10613%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DPincus%26aufirst%3DD.%2BL.%26aulast%3DRapp%26aufirst%3DC.%2BS.%26aulast%3DDay%26aufirst%3DT.%2BJ.%2BF.%26aulast%3DHonig%26aufirst%3DB.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DA%2520hierarchical%2520approach%2520to%2520all-atom%2520protein%2520loop%2520prediction%26jtitle%3DProteins%26date%3D2004%26volume%3D55%26spage%3D351%26epage%3D367%26doi%3D10.1002%2Fprot.10613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borrelli, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farid, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span> <span> </span><span class="NLM_article-title">Docking covalent inhibitors: a parameter free approach to pose prediction and scoring</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1932</span>– <span class="NLM_lpage">1940</span>, <span class="refDoi"> DOI: 10.1021/ci500118s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci500118s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVKksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=1932-1940&author=K.+Zhuauthor=K.+W.+Borrelliauthor=J.+R.+Greenwoodauthor=T.+Dayauthor=R.+Abelauthor=R.+S.+Faridauthor=E.+Harder&title=Docking+covalent+inhibitors%3A+a+parameter+free+approach+to+pose+prediction+and+scoring&doi=10.1021%2Fci500118s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Docking Covalent Inhibitors: A Parameter Free Approach To Pose Prediction and Scoring</span></div><div class="casAuthors">Zhu, Kai; Borrelli, Kenneth W.; Greenwood, Jeremy R.; Day, Tyler; Abel, Robert; Farid, Ramy S.; Harder, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1932-1940</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although many popular docking programs include a facility to account for covalent ligands, large-scale systematic docking validation studies of covalent inhibitors have been sparse.  In this paper, we present the development and validation of a novel approach for docking and scoring covalent inhibitors, which consists of conventional noncovalent docking, heuristic formation of the covalent attachment point, and structural refinement of the protein-ligand complex.  This approach combines the strengths of the docking program Glide and the protein structure modeling program Prime and does not require any parameter fitting for the study of addnl. covalent reaction types.  We first test this method by predicting the native binding geometry of 38 covalently bound complexes.  The av. RMSD of the predicted poses is 1.52 Å, and 76% of test set inhibitors have an RMSD of less than 2.0 Å.  In addn., the apparent affinity score constructed herein is tested on a virtual screening study and the characterization of the SAR properties of two different series of congeneric compds. with satisfactory success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbtjEb3EqzQ7Vg90H21EOLACvtfcHk0lj3RG7EHW5U3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVKksLs%253D&md5=3633c29fa5dc29817b178fd10a4c7b15</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fci500118s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci500118s%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DBorrelli%26aufirst%3DK.%2BW.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFarid%26aufirst%3DR.%2BS.%26aulast%3DHarder%26aufirst%3DE.%26atitle%3DDocking%2520covalent%2520inhibitors%253A%2520a%2520parameter%2520free%2520approach%2520to%2520pose%2520prediction%2520and%2520scoring%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2014%26volume%3D54%26spage%3D1932%26epage%3D1940%26doi%3D10.1021%2Fci500118s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">But, T. Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toy, P. H.</span></span> <span> </span><span class="NLM_article-title">The Mitsunobu reaction: origin, mechanism, improvements, and applications</span>. <i>Chem. Asian J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1340</span>– <span class="NLM_lpage">1355</span>, <span class="refDoi"> DOI: 10.1002/asia.200700182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1002%2Fasia.200700182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=17890661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlemsrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1340-1355&author=T.+Y.+S.+Butauthor=P.+H.+Toy&title=The+Mitsunobu+reaction%3A+origin%2C+mechanism%2C+improvements%2C+and+applications&doi=10.1002%2Fasia.200700182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">The Mitsunobu reaction: origin, mechanism, improvements, and applications</span></div><div class="casAuthors">But, Tracy Yuen Sze; Toy, Patrick H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - An Asian Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1340-1355</span>CODEN:
                <span class="NLM_cas:coden">CAAJBI</span>;
        ISSN:<span class="NLM_cas:issn">1861-4728</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The Mitsunobu reaction is a widely used and versatile method for the dehydrative oxidn.-redn. condensation of an acid/pronucleophile usually with a primary or secondary alc. that requires the combination of a reducing phosphine reagent together with an oxidizing azo reagent.  The utility of this reaction stems from the fact that it is generally highly stereoselective and occurs with inversion of the stereochem. configuration of the alc. starting material.  Also, as carboxylic acids, phenols, imides, sulfonamides, and other compds. can be used as the acid/pronucleophile, this reaction is useful for the prepn. of a wide variety of functional groups.  This Focus Review of the Mitsunobu reaction summarizes its origins, the current understanding of its mechanism, and recent improvements and applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoww5iSnC5nFrVg90H21EOLACvtfcHk0lj3RG7EHW5U3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlemsrzO&md5=f1e6895da2bf160d44745c0c830ab747</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1002%2Fasia.200700182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fasia.200700182%26sid%3Dliteratum%253Aachs%26aulast%3DBut%26aufirst%3DT.%2BY.%2BS.%26aulast%3DToy%26aufirst%3DP.%2BH.%26atitle%3DThe%2520Mitsunobu%2520reaction%253A%2520origin%252C%2520mechanism%252C%2520improvements%252C%2520and%2520applications%26jtitle%3DChem.%2520Asian%2520J.%26date%3D2007%26volume%3D2%26spage%3D1340%26epage%3D1355%26doi%3D10.1002%2Fasia.200700182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">West, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitten, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vadivel, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Biochemical and mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase inhibition</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e43877</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0043877</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1371%2Fjournal.pone.0043877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=22952796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlSltr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=J.+M.+Westauthor=N.+Zvonokauthor=K.+M.+Whittenauthor=S.+K.+Vadivelauthor=A.+L.+Bowmanauthor=A.+Makriyannis&title=Biochemical+and+mass+spectrometric+characterization+of+human+N-acylethanolamine-hydrolyzing+acid+amidase+inhibition&doi=10.1371%2Fjournal.pone.0043877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase inhibition</span></div><div class="casAuthors">West, Jay M.; Zvonok, Nikolai; Whitten, Kyle M.; Vadivel, Subramanian K.; Bowman, Anna L.; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e43877</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The mechanism of inactivation of human enzyme N-acylethanolamine-hydrolyzing acid amidase (hNAAA), with selected inhibitors identified in a novel fluorescent based assay developed for characterization of both reversible and irreversible inhibitors, was investigated kinetically and using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS).  1-Isothiocyanatopentadecane (AM9023) was found to be a potent, selective and reversible hNAAA inhibitor, while two others, 5-((biphenyl-4-yl)methyl)-N,N-dimethyl-2H-tetrazole-2-carboxamide (AM6701) and N-Benzyloxycarbonyl--serine β-lactone (N-Cbz-serine β-lactone), inhibited hNAAA in a covalent and irreversible manner.  MS anal. of the hNAAA/covalent inhibitor complexes identified modification only of the N-terminal cysteine (Cys126) of the β-subunit, confirming a suggested mechanism of hNAAA inactivation by the β-lactone contg. inhibitors.  These expts. provide direct evidence of the key role of Cys126 in hNAAA inactivation by different classes of covalent inhibitors, confirming the essential role of cysteine for catalysis and inhibition in this cysteine N-terminal nucleophile hydrolase enzyme.  They also provide a methodol. for the rapid screening and characterization of large libraries of compds. as potential inhibitors of NAAA, and subsequent characterization or their mechanism through MALDI-TOF MS based bottom up-proteomics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgYtxfkhdQ5rVg90H21EOLACvtfcHk0lgMPkm6J5Nrqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlSltr7E&md5=f1cedb03b771c71caef095bf138627bd</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0043877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0043877%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DJ.%2BM.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DWhitten%26aufirst%3DK.%2BM.%26aulast%3DVadivel%26aufirst%3DS.%2BK.%26aulast%3DBowman%26aufirst%3DA.%2BL.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DBiochemical%2520and%2520mass%2520spectrometric%2520characterization%2520of%2520human%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520inhibition%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0043877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alapafuja, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikas, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharathan, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasr, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Sulfonyl fluoride inhibitors of fatty acid amide hydrolase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10074</span>– <span class="NLM_lpage">10089</span>, <span class="refDoi"> DOI: 10.1021/jm301205j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301205j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFChsrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10074-10089&author=S.+O.+Alapafujaauthor=S.+P.+Nikasauthor=I.+T.+Bharathanauthor=V.+G.+Shuklaauthor=M.+L.+Nasrauthor=A.+L.+Bowmanauthor=N.+Zvonokauthor=J.+Liauthor=X.+Shiauthor=J.+R.+Engenauthor=A.+Makriyannis&title=Sulfonyl+fluoride+inhibitors+of+fatty+acid+amide+hydrolase&doi=10.1021%2Fjm301205j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonyl Fluoride Inhibitors of Fatty Acid Amide Hydrolase</span></div><div class="casAuthors">Alapafuja, Shakiru O.; Nikas, Spyros P.; Bharathan, Indu T.; Shukla, Vidyanand G.; Nasr, Mahmoud L.; Bowman, Anna L.; Zvonok, Nikolai; Li, Jing; Shi, Xiaomeng; Engen, John R.; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10074-10089</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sulfonyl fluorides are known to inhibit esterases.  Early work from our lab. has identified hexadecyl sulfonylfluoride (AM374) as a potent in vitro and in vivo inhibitor of fatty acid amide hydrolase (FAAH).  We now report on later generation sulfonyl fluoride analogs that exhibit potent and selective inhibition of FAAH.  Using recombinant rat and human FAAH, we show that 5-(4-hydroxyphenyl)pentanesulfonyl fluoride (AM3506) has similar inhibitory activity for both the rat and the human enzyme, while rapid diln. assays and mass spectrometry anal. suggest that the compd. is a covalent modifier for FAAH and inhibits its action in an irreversible manner.  Our SAR results are highlighted by mol. docking of key analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpCw72isROHbVg90H21EOLACvtfcHk0lgMPkm6J5Nrqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFChsrfK&md5=789d239141f8a92ccff2de9cb77f4f8b</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm301205j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301205j%26sid%3Dliteratum%253Aachs%26aulast%3DAlapafuja%26aufirst%3DS.%2BO.%26aulast%3DNikas%26aufirst%3DS.%2BP.%26aulast%3DBharathan%26aufirst%3DI.%2BT.%26aulast%3DShukla%26aufirst%3DV.%2BG.%26aulast%3DNasr%26aufirst%3DM.%2BL.%26aulast%3DBowman%26aufirst%3DA.%2BL.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DEngen%26aufirst%3DJ.%2BR.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DSulfonyl%2520fluoride%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10074%26epage%3D10089%26doi%3D10.1021%2Fjm301205j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramarao, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M. W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bushell, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. D.</span></span> <span> </span><span class="NLM_article-title">A fluorescence-based assay for fatty acid amide hydrolase compatible with high-throughput screening</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>343</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2005.04.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.ab.2005.04.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=16018870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtFSnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2005&pages=143-151&author=M.+K.+Ramaraoauthor=E.+A.+Murphyauthor=M.+W.+H.+Shenauthor=Y.+Wangauthor=K.+N.+Bushellauthor=N.+Huangauthor=N.+Panauthor=C.+Williamsauthor=J.+D.+Clark&title=A+fluorescence-based+assay+for+fatty+acid+amide+hydrolase+compatible+with+high-throughput+screening&doi=10.1016%2Fj.ab.2005.04.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">A fluorescence-based assay for fatty acid amide hydrolase compatible with high-throughput screening</span></div><div class="casAuthors">Ramarao, Manjunath K.; Murphy, Elizabeth A.; Shen, Marina W. H.; Wang, Yuren; Bushell, Kristen N.; Huang, Nelson; Pan, Ning; Williams, Cara; Clark, James D.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">143-151</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A novel fluorescent assay to continuously monitor fatty acid amide hydrolase (FAAH) activity that is simple, sensitive, and amenable to high-throughput screening (HTS) of compd. libraries is described in this article.  Stable Chinese hamster ovary (CHO) cell lines expressing either human FAAH or an inactive mutant, FAAH-S241A, were established.  Arachidonyl 7-amino,4-Me coumarin amide (AAMCA), a novel fluorogenic substrate for FAAH, was designed and synthesized.  FAAH catalyzes the hydrolysis of AAMCA to generate arachidonic acid and a highly fluorescent 7-amino,4-Me coumarin (AMC).  The assay was done at 25° by incubating whole cell or microsomal prepns. from FAAH-expressing cells with AAMCA.  Release of AMC was monitored continuously using a fluorometer.  Microsomal FAAH catalyzed the hydrolysis of AAMCA with an apparent Km of 0.48 μM and V max of 58 pmol min-1 mg protein-1.  The assay is specific for FAAH given that microsomes prepd. from cells expressing FAAH-S241A or vector alone had no significant activity against AAMCA.  Furthermore, the activity was inhibited by URB-597, an FAAH-specific inhibitor, in a concn.-dependent manner with an IC50 of 33.5 nM.  The assay was optimized for HTS and had a Z' value ranging from 0.7 to 0.9.  The assay is also compatible with ex vivo anal. of FAAH activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLzJKCeUOYjbVg90H21EOLACvtfcHk0lgMPkm6J5Nrqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtFSnurg%253D&md5=ead8f22a137f769cd808b50c16b379fa</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2005.04.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2005.04.032%26sid%3Dliteratum%253Aachs%26aulast%3DRamarao%26aufirst%3DM.%2BK.%26aulast%3DMurphy%26aufirst%3DE.%2BA.%26aulast%3DShen%26aufirst%3DM.%2BW.%2BH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBushell%26aufirst%3DK.%2BN.%26aulast%3DHuang%26aufirst%3DN.%26aulast%3DPan%26aufirst%3DN.%26aulast%3DWilliams%26aufirst%3DC.%26aulast%3DClark%26aufirst%3DJ.%2BD.%26atitle%3DA%2520fluorescence-based%2520assay%2520for%2520fatty%2520acid%2520amide%2520hydrolase%2520compatible%2520with%2520high-throughput%2520screening%26jtitle%3DAnal.%2520Biochem.%26date%3D2005%26volume%3D343%26spage%3D143%26epage%3D151%26doi%3D10.1016%2Fj.ab.2005.04.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patricelli, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lashuel, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giang, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Comparative characterization of a wild type and transmembrane domain-deleted fatty acid amide hydrolase: identification of the transmembrane domain as a site for oligomerization</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">15177</span>– <span class="NLM_lpage">15187</span>, <span class="refDoi"> DOI: 10.1021/bi981733n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi981733n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaK1cXmsVWjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=15177-15187&author=M.+P.+Patricelliauthor=H.+A.+Lashuelauthor=D.+K.+Giangauthor=J.+W.+Kellyauthor=B.+F.+Cravatt&title=Comparative+characterization+of+a+wild+type+and+transmembrane+domain-deleted+fatty+acid+amide+hydrolase%3A+identification+of+the+transmembrane+domain+as+a+site+for+oligomerization&doi=10.1021%2Fbi981733n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative Characterization of a Wild Type and Transmembrane Domain-Deleted Fatty Acid Amide Hydrolase: Identification of the Transmembrane Domain as a Site for Oligomerization</span></div><div class="casAuthors">Patricelli, Matthew P.; Lashuel, Hilal A.; Giang, Dan K.; Kelly, Jeffery W.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">15177-15187</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) is an integral membrane protein responsible for the hydrolysis of a no. of primary and secondary fatty acid amides, including the neuromodulatory compds. anandamide and oleamide.  Anal. of FAAH's primary sequence reveals the presence of a single predicted transmembrane domain at the extreme N-terminus of the enzyme.  A mutant form of the rat FAAH protein lacking this N-terminal transmembrane domain (ΔTM-FAAH) was generated and, like wild type FAAH (WT-FAAH), was found to be tightly assocd. with membranes when expressed in COS-7 cells.  Recombinant forms of WT- and ΔTM-FAAH expressed and purified from Escherichia coli exhibited essentially identical enzymic properties which were also similar to those of the native enzyme from rat liver.  Anal. of the oligomerization states of WT- and ΔTM-FAAH by chem. crosslinking, sedimentation velocity anal. ultracentrifugation, and size exclusion chromatog. indicated that both enzymes were oligomeric when membrane-bound and after solubilization.  However, WT-FAAH consistently behaved as a larger oligomer than ΔTM-FAAH.  Addnl., SDS-PAGE anal. of the recombinant proteins identified the presence of SDS-resistant oligomers for WT-FAAH, but not for ΔTM-FAAH.  Self-assocn. through FAAH's transmembrane domain was further demonstrated by a FAAH transmembrane domain-GST fusion protein which formed SDS-resistant dimers and large oligomeric assemblies in soln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2WgrX7PkX8rVg90H21EOLACvtfcHk0lgjIRBTtAO4yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsVWjs7g%253D&md5=cf86234c390a09c08fdf6ca53db3865b</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fbi981733n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi981733n%26sid%3Dliteratum%253Aachs%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DLashuel%26aufirst%3DH.%2BA.%26aulast%3DGiang%26aufirst%3DD.%2BK.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DComparative%2520characterization%2520of%2520a%2520wild%2520type%2520and%2520transmembrane%2520domain-deleted%2520fatty%2520acid%2520amide%2520hydrolase%253A%2520identification%2520of%2520the%2520transmembrane%2520domain%2520as%2520a%2520site%2520for%2520oligomerization%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D15177%26epage%3D15187%26doi%3D10.1021%2Fbi981733n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandarinathan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karageorgos, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janero, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Covalent inhibitors of human monoacylglycerol lipase: ligand-assisted characterization of the catalytic site by mass spectrometry and mutational analysis</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">854</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2008.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.chembiol.2008.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=18721756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVejtbjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=854-862&author=N.+Zvonokauthor=L.+Pandarinathanauthor=J.+Williamsauthor=M.+Johnstonauthor=I.+Karageorgosauthor=D.+R.+Janeroauthor=S.+C.+Krishnanauthor=A.+Makriyannis&title=Covalent+inhibitors+of+human+monoacylglycerol+lipase%3A+ligand-assisted+characterization+of+the+catalytic+site+by+mass+spectrometry+and+mutational+analysis&doi=10.1016%2Fj.chembiol.2008.06.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent Inhibitors of Human Monoacylglycerol Lipase: Ligand-Assisted Characterization of the Catalytic Site by Mass Spectrometry and Mutational Analysis</span></div><div class="casAuthors">Zvonok, Nikolai; Pandarinathan, Lakshmipathi; Williams, John; Johnston, Meghan; Karageorgos, Ioannis; Janero, David R.; Krishnan, Srinivasan C.; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">854-862</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: The active site of recombinant hexa-histidine-tagged human monoacylglycerol lipase (hMGL) is characterized by mass spectrometry using the inhibitors 5-((biphenyl-4-yl)methyl)-N,N-dimethyl-2H-tetrazole-2-carboxamide (AM6701), and N-arachidonylmaleimide (NAM) as probes.  Carbamylation of Ser129 by AM6701 in the putative hMGL catalytic triad demonstrates this residue's essential role in catalysis.  Partial NAM alkylation of hMGL cysteine residues 215 and/or 249 was sufficient to achieve ∼80% enzyme inhibition.  Although Cys215 and/or Cys249 mutations to alanine(s) did not affect hMGL hydrolytic activity as compared with nonmutated hMGL, the C215A displayed heightened NAM sensitivity, whereas the C249A evidenced reduced NAM sensitivity.  These data conclusively demonstrate a sulfhydryl-based mechanism for NAM inhibition of hMGL in which Cys249 is of paramount importance.  Identification of amino acids crit. to the catalytic activity and pharmacol. modulation of hMGL informs the design of selective MGL inhibitors as potential drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp1gDK0IgZgLVg90H21EOLACvtfcHk0lgjIRBTtAO4yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVejtbjO&md5=d135103e4d1543b7d9846c64642e49fc</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2008.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2008.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DPandarinathan%26aufirst%3DL.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DJohnston%26aufirst%3DM.%26aulast%3DKarageorgos%26aufirst%3DI.%26aulast%3DJanero%26aufirst%3DD.%2BR.%26aulast%3DKrishnan%26aufirst%3DS.%2BC.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DCovalent%2520inhibitors%2520of%2520human%2520monoacylglycerol%2520lipase%253A%2520ligand-assisted%2520characterization%2520of%2520the%2520catalytic%2520site%2520by%2520mass%2520spectrometry%2520and%2520mutational%2520analysis%26jtitle%3DChem.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D854%26epage%3D862%26doi%3D10.1016%2Fj.chembiol.2008.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shields, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Biochemical and Proteomic Characterization of Recombinant Human alpha/beta Hydrolase Domain 6</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">890</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-36633-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1038%2Fs41598-018-36633-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=30696836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A280%3ADC%252BB3cjmslKlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=890&author=C.+M.+Shieldsauthor=N.+Zvonokauthor=A.+Zvonokauthor=A.+Makriyannis&title=Biochemical+and+Proteomic+Characterization+of+Recombinant+Human+alpha%2Fbeta+Hydrolase+Domain+6&doi=10.1038%2Fs41598-018-36633-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and Proteomic Characterization of Recombinant Human α/β Hydrolase Domain 6</span></div><div class="casAuthors">Shields Christina Miyabe; Zvonok Nikolai; Zvonok Alexander; Makriyannis Alexandros; Shields Christina Miyabe; Zvonok Nikolai; Zvonok Alexander; Makriyannis Alexandros; Makriyannis Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">890</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Human alpha/beta hydrolase domain 6 (hABHD6) is an enzyme that hydrolyzes 2-arachidonoylglycerol (2-AG), a potent agonist at both cannabinoid CB1 and CB2 receptors.  In vivo modulation of ABHD6 expression has been shown to have potential therapeutic applications, making the enzyme a promising drug target.  However, the lack of structural information on hABHD6 limits the discovery and design of selective inhibitors.  We have performed E. coli expression, purification and activity profiling screening of different hABHD6 constructs and identified a truncated variant without N-terminal transmembrane (TM) domain, hΔ29-3-ABHD6, as the most promising protein for further characterization.  The elimination of the TM domain did not affect 2-AG or fluorogenic arachidonoyl, 7-hydroxy-6-methoxy-4-methylcoumarin ester (AHMMCE) substrates hydrolysis, suggesting that the TM is not essential for enzyme catalytic activity.  The hΔ29-3-ABHD6 variant was purified in a single step using Immobilized Metal Affinity Chromatography (IMAC), in-solution trypsin digested, and proteomically characterized by Matrix Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS).  The N-terminal peptide without methionine was identified indicating on a post-translational modification of the recombinant protein.  The mechanism of inhibition of hABHD6 with AM6701 and WWL70 covalent probes was elucidated based on MS analysis of trypsin digested hABHD6 following the Ligand Assisted Protein Structure (LAPS) approach.  We identified the carbamylated peptides containing catalytic serine (Ser(148)) suggesting a selective carbamylation of the enzyme by AM6701 or WWL70 and confirming an essential role of this residue in catalysis.  The ability to produce substantial quantities of functional, pure hABHD6 will aid in the downstream structural characterization, and development of potent, selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSxpW977xfkzSO2kE7krGOBfW6udTcc2ea_uEyr1TeoOrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cjmslKlsg%253D%253D&md5=ead64a4e458ba638781a0ac39e6ed37d</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-36633-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-36633-4%26sid%3Dliteratum%253Aachs%26aulast%3DShields%26aufirst%3DC.%2BM.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DZvonok%26aufirst%3DA.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DBiochemical%2520and%2520Proteomic%2520Characterization%2520of%2520Recombinant%2520Human%2520alpha%252Fbeta%2520Hydrolase%2520Domain%25206%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26spage%3D890%26doi%3D10.1038%2Fs41598-018-36633-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abadji, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas-Lenard, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kendall, D. A.</span></span> <span> </span><span class="NLM_article-title">Involvement of the carboxyl terminus of the third intracellular loop of the cannabinoid CB1 receptor in constitutive activation of Gs</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">2032</span>– <span class="NLM_lpage">2038</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.1999.0722032.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1046%2Fj.1471-4159.1999.0722032.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10217281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaK1MXis12lt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1999&pages=2032-2038&author=V.+Abadjiauthor=J.+M.+Lucas-Lenardauthor=C.+Chinauthor=D.+A.+Kendall&title=Involvement+of+the+carboxyl+terminus+of+the+third+intracellular+loop+of+the+cannabinoid+CB1+receptor+in+constitutive+activation+of+Gs&doi=10.1046%2Fj.1471-4159.1999.0722032.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of the carboxyl terminus of the third intracellular loop of the cannabinoid CB1 receptor in constitutive activation of Gs</span></div><div class="casAuthors">Abadji, Vasiliki; Lucas-Lenard, Jean M.; Chin, Chen-Ni; Kendall, Debra A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2032-2038</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The human cannabinoid receptor CB1 functionally couples primarily to Gi-, but also to Gs-mediated pathways to modulate intracellular cAMP levels.  To probe the features of the receptor that may be involved in promoting interactions with one G protein type over another, we generated the L341A/A342L mutant CB1 receptor.  The double mutation involved the swap in position of two adjacent residues in the carboxyl-terminal segment of the third intracellular loop of CB1.  This resulted in partial constitutive activation of the receptor and an agonist-independent enhancement in cAMP levels.  Characterization following treatment with either pertussis or cholera toxin indicated that the constitutive activity is selective for a Gs- and not a Gi-mediated pathway.  Treatment with the CB1-specific inverse agonist SR 141716A inhibited the basal accumulation of cAMP in the presence of pertussis toxin, establishing that the effect is CB1 mediated.  The binding of the agonist CP-55940 to the L341A/A342L receptor was not markedly different from that for the wild-type receptor despite the constitutive Gs activity.  This may reflect a preference of this ligand for an activated receptor state assocd. with the Gi coupling form and underscores the potential for developing therapeutics that selectively activate one pathway over another.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRBqzCNLu7C7Vg90H21EOLACvtfcHk0liL-Vx0p9JzUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXis12lt70%253D&md5=8df24ece9201ce2a0694522503185a83</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1999.0722032.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1999.0722032.x%26sid%3Dliteratum%253Aachs%26aulast%3DAbadji%26aufirst%3DV.%26aulast%3DLucas-Lenard%26aufirst%3DJ.%2BM.%26aulast%3DChin%26aufirst%3DC.%26aulast%3DKendall%26aufirst%3DD.%2BA.%26atitle%3DInvolvement%2520of%2520the%2520carboxyl%2520terminus%2520of%2520the%2520third%2520intracellular%2520loop%2520of%2520the%2520cannabinoid%2520CB1%2520receptor%2520in%2520constitutive%2520activation%2520of%2520Gs%26jtitle%3DJ.%2520Neurochem.%26date%3D1999%26volume%3D72%26spage%3D2032%26epage%3D2038%26doi%3D10.1046%2Fj.1471-4159.1999.0722032.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oakley, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwardson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delaunoy, J.-P.</span></span> <span> </span><span class="NLM_article-title">A rapid method for preparing synaptosomes: comparison, with alternative procedures</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>226</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.1016/0006-8993(81)91086-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2F0006-8993%2881%2991086-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=7296283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaL38XkvVGntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=1981&pages=107-118&author=P.+R.+Doddauthor=J.+A.+Hardyauthor=A.+E.+Oakleyauthor=J.+A.+Edwardsonauthor=E.+K.+Perryauthor=J.-P.+Delaunoy&title=A+rapid+method+for+preparing+synaptosomes%3A+comparison%2C+with+alternative+procedures&doi=10.1016%2F0006-8993%2881%2991086-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid method for preparing synaptosomes:  comparison, with alternative procedures</span></div><div class="casAuthors">Dodd, P. R.; Hardy, J. A.; Oakley, A. E.; Edwardson, J. A.; Perry, E. K.; Delaunoy, J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">107-18</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">A sucrose d.-gradient centrifugation method for the rapid (1-1.5 h) prepn. of nerve ending particles (synaptosomes) from rat cerebral cortex is described.  The synaptosome fraction was characterized by quant. electron microscopy and enzyme distribution studies.  By these criteria, the fraction showed a degree of enrichment in synaptic structures which was comparable to that of the std. (4-5 h) prepn. and substantially better than an alternative fast (2-2.5 h) method.  On incubation, synaptosomes obtained by the new procedure accumulated a high tissue concn. of K and showed a high, linear rate of O uptake.  Depolarization by veratrine caused a significant increase in the rate of respiration and in the release of the physiol. active amino acids, glutamate, aspartate, and GABA, as well as a significant redn. in tissue K.  Thus, the new procedure compared favorably with alternative methods as judged by these indexes of metabolic and functional performance.  The new prepn. method was of value in metabolic studies of synaptosomes prepd. from human post-mortem brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgyn2pCmMr7rVg90H21EOLACvtfcHk0liL-Vx0p9JzUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XkvVGntw%253D%253D&md5=c591627a3f24cbe948e0d8c0cb0bf860</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2881%2991086-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252881%252991086-6%26sid%3Dliteratum%253Aachs%26aulast%3DDodd%26aufirst%3DP.%2BR.%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DOakley%26aufirst%3DA.%2BE.%26aulast%3DEdwardson%26aufirst%3DJ.%2BA.%26aulast%3DPerry%26aufirst%3DE.%2BK.%26aulast%3DDelaunoy%26aufirst%3DJ.-P.%26atitle%3DA%2520rapid%2520method%2520for%2520preparing%2520synaptosomes%253A%2520comparison%252C%2520with%2520alternative%2520procedures%26jtitle%3DBrain%2520Res.%26date%3D1981%26volume%3D226%26spage%3D107%26epage%3D118%26doi%3D10.1016%2F0006-8993%2881%2991086-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abadji, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morse, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">(-)-11-Hydroxy-7’-isothiocyanato-1’,1’-dimethylheptyl-delta 8-THC: a novel, high-affinity irreversible probe for the cannabinoid receptor in the brain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">3867</span>– <span class="NLM_lpage">3870</span>, <span class="refDoi"> DOI: 10.1021/jm00049a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00049a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaK2MXhs12nsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=3867-3870&author=Y.+Guoauthor=V.+Abadjiauthor=K.+L.+Morseauthor=D.+J.+Fournierauthor=X.+Liauthor=A.+Makriyannis&title=%28-%29-11-Hydroxy-7%E2%80%99-isothiocyanato-1%E2%80%99%2C1%E2%80%99-dimethylheptyl-delta+8-THC%3A+a+novel%2C+high-affinity+irreversible+probe+for+the+cannabinoid+receptor+in+the+brain&doi=10.1021%2Fjm00049a002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">(-)-11-Hydroxy-7'-isothiocyanato-1',1'- dimethylheptyl-Δ8-THC: A Novel, High-Affinity Irreversible Probe for the Cannabinoid Receptor in the Brain</span></div><div class="casAuthors">Guo, Yan; Abadji, Vasiliki; Morse, Kelley L.; Fournier, Donna J.; Li, Xiuyan; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3867-70</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">(-)-11-Hydroxy-7'-isothiocyanato-1',1'-dimethylheptyl-Δ8-THC (I) was synthesized from 4-hydroxymyrtenyl pivalate and 3,5-(HO)2C6H3CMe2(CH2)6Br in 4 steps and evaluated as an irreversible probe for the cannabinoid receptor(s) in the brain.  The affinity of I for the cannabinoid receptor(s) was detd. using rat forebrain membranes and I had an apparent IC50 of 1.6 ± 0.3 nM.  When the membrane prepn. was treated with 10 nM of I, 80% of the [3H]CP-55940 specific binding to the receptor was abolished.  Time-dependent studies demonstrated that the ligand reacts rapidly and irreversibly with the receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCTnkWGzbjhrVg90H21EOLACvtfcHk0lhj0bgXuv5HAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhs12nsLo%253D&md5=49c26e0a98bd57fa734d44ffb38fd593</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm00049a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00049a002%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DAbadji%26aufirst%3DV.%26aulast%3DMorse%26aufirst%3DK.%2BL.%26aulast%3DFournier%26aufirst%3DD.%2BJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3D%2528-%2529-11-Hydroxy-7%25E2%2580%2599-isothiocyanato-1%25E2%2580%2599%252C1%25E2%2580%2599-dimethylheptyl-delta%25208-THC%253A%2520a%2520novel%252C%2520high-affinity%2520irreversible%2520probe%2520for%2520the%2520cannabinoid%2520receptor%2520in%2520the%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D3867%26epage%3D3870%26doi%3D10.1021%2Fjm00049a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morse, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzybowska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">A novel electrophilic high affinity irreversible probe for the cannabinoid receptor</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1957</span>– <span class="NLM_lpage">1962</span>, <span class="refDoi"> DOI: 10.1016/0024-3205(95)00176-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2F0024-3205%2895%2900176-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=7776819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaK2MXlsF2mtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1995&pages=1957-1962&author=K.+L.+Morseauthor=D.+J.+Fournierauthor=X.+Liauthor=J.+Grzybowskaauthor=A.+Makriyannis&title=A+novel+electrophilic+high+affinity+irreversible+probe+for+the+cannabinoid+receptor&doi=10.1016%2F0024-3205%2895%2900176-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">A novel electrophilic high affinity irreversible probe for the cannabinoid receptor</span></div><div class="casAuthors">Morse, Kelley L.; Fournier, Donna J.; Li, Xiuyan; Grzybowska, Jolanta; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23/24</span>),
    <span class="NLM_cas:pages">1957-62</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In order to explore the structural requirements for cannabinoid activity we have been involved in the design and synthesis of stereochem. defined high affinity probes for the cannabinoid receptor.  This effort has involved the development of irreversible ligands which will allow us to obtain detailed information on the cannabinoid receptor active site(s).  The irreversible ligands, which incorporate highly reactive functional groups in a strategic position of the ligand, may form covalent bonds with amino acid residues at the receptor active site or in the neighborhood of this site.  We shall discuss the biochem. properties of one of these probes, which incorporates the electrophilic isothiocyanate group into the structure of the highly potent cannabinoid agonist (-)-1',1'-dimethylheptyl-Δ8-THC; this ligand (-)-7'-isothiocyanato-1',1'-dimethylheptyl-THC was evaluated for its affinity for cannabinoid binding sites using rat forebrain membrane prepns. and found to have an apparent IC50 value of 660 pM.  Incubation of the membrane prepn. with a ligand concn. of five times the apparent IC50 resulted in the irreversible occupation of nearly all of the receptor specific binding sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol9uFxlSTc8rVg90H21EOLACvtfcHk0lhj0bgXuv5HAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlsF2mtL4%253D&md5=0095f207a51839c553ba6177ff3e7a6d</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2895%2900176-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252895%252900176-7%26sid%3Dliteratum%253Aachs%26aulast%3DMorse%26aufirst%3DK.%2BL.%26aulast%3DFournier%26aufirst%3DD.%2BJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGrzybowska%26aufirst%3DJ.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DA%2520novel%2520electrophilic%2520high%2520affinity%2520irreversible%2520probe%2520for%2520the%2520cannabinoid%2520receptor%26jtitle%3DLife%2520Sci.%26date%3D1995%26volume%3D56%26spage%3D1957%26epage%3D1962%26doi%3D10.1016%2F0024-3205%2895%2900176-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernando, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCallion, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">769</span>– <span class="NLM_lpage">776</span>, <span class="refDoi"> DOI: 10.1021/jm980363y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm980363y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaK1MXosV2ksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=769-776&author=R.+Lanauthor=Q.+Liuauthor=P.+Fanauthor=S.+Linauthor=S.+R.+Fernandoauthor=D.+McCallionauthor=R.+Pertweeauthor=A.+Makriyannis&title=Structure-activity+relationships+of+pyrazole+derivatives+as+cannabinoid+receptor+antagonists&doi=10.1021%2Fjm980363y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships of Pyrazole Derivatives as Cannabinoid Receptor Antagonists</span></div><div class="casAuthors">Lan, Ruoxi; Liu, Qian; Fan, Pusheng; Lin, Sonyuan; Fernando, Susanthi R.; McCallion, Deirdre; Pertwee, Roger; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">769-776</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As a potent, specific antagonist for the brain cannabinoid receptor (CB1), the diarylpyrazole N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A; 1) was the lead compd. for initiating studies designed to examine the structure-activity relationships of related compds. and to search for more selective and potent cannabimimetic ligands.  A series of pyrazole derivs. was designed and synthesized to aid in the characterization of the cannabinoid receptor binding sites and also to serve as potentially useful pharmacol. probes.  Therapeutically, such compds. may have the ability to antagonize harmful side effects of cannabinoids and cannabimimetic agents.  Structural requirements for potent and selective brain cannabinoid CB1 receptor antagonistic activity included (a) a para-substituted Ph ring at the 5-position, (b) a carboxamido group at the 3-position, and (c) a 2,4-dichlorophenyl substituent at the 1-position of the pyrazole ring.  The most potent compd. of this series contained a p-iodophenyl group at the 5-position, a piperidinyl carboxamide at the 3-position, and a 2,4-dichlorophenyl group at the 1-position of the pyrazole ring.  The iodinated nature of this compd. offers addnl. utility as a γ-enriching SPECT (single photon emission computed tomog.) ligand that may be useful in characterizing brain CB1 receptor binding in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl-2XxTDUh5LVg90H21EOLACvtfcHk0lhAKDmIhiNAFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXosV2ksQ%253D%253D&md5=9ac628db8666c2aadef40fa04619d687</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm980363y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980363y%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DFan%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DFernando%26aufirst%3DS.%2BR.%26aulast%3DMcCallion%26aufirst%3DD.%26aulast%3DPertwee%26aufirst%3DR.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DStructure-activity%2520relationships%2520of%2520pyrazole%2520derivatives%2520as%2520cannabinoid%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D769%26epage%3D776%26doi%3D10.1021%2Fjm980363y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Structure and function of fatty acid amide hydrolase</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">432</span>, <span class="refDoi"> DOI: 10.1146/annurev.biochem.74.082803.133450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1146%2Fannurev.biochem.74.082803.133450" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=15952893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVensL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2005&pages=411-432&author=M.+K.+McKinneyauthor=B.+F.+Cravatt&title=Structure+and+function+of+fatty+acid+amide+hydrolase&doi=10.1146%2Fannurev.biochem.74.082803.133450"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of fatty acid amide hydrolase</span></div><div class="casAuthors">McKinney, Michele K.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">411-432</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Fatty acid amide hydrolase (FAAH) is a mammalian integral membrane enzyme that degrades the fatty acid amide family of endogenous signaling lipids, which includes the endogenous cannabinoid, anandamide, and the sleep-inducing substance, oleamide.  FAAH belongs to a large and diverse class of enzymes referred to as the amidase signature (AS) family.  Investigations into the structure and function of FAAH, in combination with complementary studies of other AS enzymes, have engendered provocative mol. models to explain how this enzyme integrates into cell membranes and terminates fatty acid amide signaling in vivo.  These studies, as well as their biol. and therapeutic implications, are the subject of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprO7TpUTr6n7Vg90H21EOLACvtfcHk0lhAKDmIhiNAFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVensL4%253D&md5=d28b43f14feb6894d48e907064087867</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.74.082803.133450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.74.082803.133450%26sid%3Dliteratum%253Aachs%26aulast%3DMcKinney%26aufirst%3DM.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DStructure%2520and%2520function%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2005%26volume%3D74%26spage%3D411%26epage%3D432%26doi%3D10.1146%2Fannurev.biochem.74.082803.133450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turk, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoka, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasiljeva, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, D.</span></span> <span> </span><span class="NLM_article-title">Cysteine cathepsins: from structure, function and regulation to new frontiers</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1824</i></span>,  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2011.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.bbapap.2011.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=22024571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOns7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1824&publication_year=2012&pages=68-88&author=V.+Turkauthor=V.+Stokaauthor=O.+Vasiljevaauthor=M.+Renkoauthor=T.+Sunauthor=B.+Turkauthor=D.+Turk&title=Cysteine+cathepsins%3A+from+structure%2C+function+and+regulation+to+new+frontiers&doi=10.1016%2Fj.bbapap.2011.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteine cathepsins: From structure, function and regulation to new frontiers</span></div><div class="casAuthors">Turk, Vito; Stoka, Veronika; Vasiljeva, Olga; Renko, Miha; Sun, Tao; Turk, Boris; Turk, Dusan</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1824</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-88</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  It is more than 50 years since the lysosome was discovered.  Since then its hydrolytic machinery, including proteases and other hydrolases, has been fairly well identified and characterized.  Among these are the cysteine cathepsins, members of the family of papain-like cysteine proteases.  They have unique reactive-site properties and an uneven tissue-specific expression pattern.  In living organisms, their activity is a delicate balance of expression, targeting, zymogen activation, inhibition by protein inhibitors and degrdn.  The specificity of their substrate binding sites, small-mol. inhibitor repertoire and crystal structures are providing new tools for research and development.  Their unique reactive-site properties have made it possible to confine the targets simply by the use of appropriate reactive groups.  The epoxysuccinyls still dominate the field, but now nitriles seem to be the most appropriate "warhead".  The view of cysteine cathepsins as lysosomal proteases is changing as there is now clear evidence of their localization in other cellular compartments.  Besides being involved in protein turnover, they build an important part of endosomal antigen presentation.  Together with the growing no. of non-endosomal roles of cysteine cathepsins is growing also the knowledge of their involvement in diseases such as cancer and rheumatoid arthritis, among others.  Finally, cysteine cathepsins are important regulators and signaling mols. of an unimaginable no. of biol. processes.  The current challenge is to identify their endogenous substrates, in order to gain an insight into the mechanisms of substrate degrdn. and processing.  In this review, some of the remarkable advances that have taken place in the past decade are presented.  This article is part of a Special Issue entitled: Proteolysis 50 years after the discovery of lysosome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUEZ0u2P21D7Vg90H21EOLACvtfcHk0lhAKDmIhiNAFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOns7rI&md5=8615c1f0205d66b0fad932d6ff874390</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2011.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2011.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DV.%26aulast%3DStoka%26aufirst%3DV.%26aulast%3DVasiljeva%26aufirst%3DO.%26aulast%3DRenko%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DT.%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DTurk%26aufirst%3DD.%26atitle%3DCysteine%2520cathepsins%253A%2520from%2520structure%252C%2520function%2520and%2520regulation%2520to%2520new%2520frontiers%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2012%26volume%3D1824%26spage%3D68%26epage%3D88%26doi%3D10.1016%2Fj.bbapap.2011.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheu, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmuth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fluhr, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Man, M.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feingold, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoonjans, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auwerx, J.</span></span> <span> </span><span class="NLM_article-title">Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models</span>. <i>J. Invest. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1046/j.0022-202x.2001.01626.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1046%2Fj.0022-202x.2001.01626.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=11851881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1Wgu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2002&pages=94-101&author=M.+Y.+Sheuauthor=A.+J.+Fowlerauthor=J.+Kaoauthor=M.+Schmuthauthor=J.+W.+Fluhrauthor=M.-Q.+Manauthor=P.+M.+Eliasauthor=K.+R.+Feingoldauthor=K.+Schoonjansauthor=J.+Auwerx&title=Topical+peroxisome+proliferator+activated+receptor-alpha+activators+reduce+inflammation+in+irritant+and+allergic+contact+dermatitis+models&doi=10.1046%2Fj.0022-202x.2001.01626.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Topical peroxisome proliferator activated receptor-α activators reduce inflammation in irritant and allergic contact dermatitis models</span></div><div class="casAuthors">Sheu, Mary Y.; Fowler, Ashley J.; Kao, Jack; Schmuth, Matthias; Schoonjans, Kristina; Auwerx, Johan; Fluhr, Joachim W.; Man, Mao-Qiang; Elias, Peter M.; Feingold, Kenneth R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Investigative Dermatology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">94-101</span>CODEN:
                <span class="NLM_cas:coden">JIDEAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-202X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science, Inc.</span>)
        </div><div class="casAbstract">Activators of peroxisome proliferator activated receptor-α, a nuclear hormone receptor that heterodimerizes with retinoid X receptor, stimulate epidermal differentiation and inhibit proliferation.  Here the authors detd. the anti-inflammatory effects of peroxisome proliferator activated receptor-α agonists in models of irritant and allergic contact dermatitis produced in mouse ears by topical treatment with 12-O-tetradecanoylphorbol-13-acetate and oxazolone, resp.  As expected, 12-O-tetradecanoylphorbol-13-acetate treatment resulted in a marked increase in the thickness and wt. of the ears and provoked an inflammatory cell infiltrate in the dermis.  Topical treatment with three different peroxisome proliferator activated receptor-α agonists, clofibrate, WY 14643, or linoleic acid, 45 min and 4 h after 12-O-tetradecanoylphorbol-13-acetate application, resulted in a marked decrease in ear thickness and wt. and a redn. in the no. of inflammatory cells in the dermis.  The redn. in inflammation by these peroxisome proliferator activated receptor-α agonists was of similar magnitude to that seen with a potent topical glucocorticoid, clobetasol.  In contrast, stearic acid, a free fatty acid that does not activate peroxisome proliferator activated receptor-α, had no effect on the 12-O-tetradecanoylphorbol-13-acetate-induced inflammation.  Moreover, clofibrate did not significantly alter ear thickness following 12-O-tetradecanoylphorbol-13-acetate treatment in peroxisome proliferator activated receptor-α-/- mice, indicating that the anti-inflammatory effect is mediated by peroxisome proliferator activated receptor-α.  As tumor necrosis factor-α and interleukin-1α are major mediators of cutaneous inflammation, the authors next used immunohistochem. to det. whether the peroxisome proliferator activated receptor-α agonists reduce the levels of these cytokines in 12-O-tetradecanoylphorbol-13-acetate-treated skin.  12-O-tetradecanoylphorbol-13-acetate treatment resulted in an increase in tumor necrosis factor and interleukin-1α staining in the epidermis that was reduced by clofibrate treatment.  Finally, clofibrate treatment also reduced ear thickness and wt. in oxazolone-induced allergic dermatitis, a change that was accompanied by a redn. in inflammatory cells in the dermis and a decrease in tumor necrosis factor-α and interleukin-1α levels in the oxazolone-treated epidermis.  These studies demonstrate that topically applied peroxisome proliferator activated receptor-α agonists possess receptor mediated, anti-inflammatory activity in both irritant and allergic contact dermatitis animal models.  The anti-inflammatory properties of peroxisome proliferator activated receptor-α agonists, coupled with their anti-proliferative and pro-differentiating effects, suggest that they could be beneficial for the treatment of a variety of cutaneous diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokKoesOGEuhrVg90H21EOLACvtfcHk0lhJV6naAwBGqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1Wgu7w%253D&md5=6c735d78b2ff642632299141c682fcef</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1046%2Fj.0022-202x.2001.01626.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0022-202x.2001.01626.x%26sid%3Dliteratum%253Aachs%26aulast%3DSheu%26aufirst%3DM.%2BY.%26aulast%3DFowler%26aufirst%3DA.%2BJ.%26aulast%3DKao%26aufirst%3DJ.%26aulast%3DSchmuth%26aufirst%3DM.%26aulast%3DFluhr%26aufirst%3DJ.%2BW.%26aulast%3DMan%26aufirst%3DM.-Q.%26aulast%3DElias%26aufirst%3DP.%2BM.%26aulast%3DFeingold%26aufirst%3DK.%2BR.%26aulast%3DSchoonjans%26aufirst%3DK.%26aulast%3DAuwerx%26aufirst%3DJ.%26atitle%3DTopical%2520peroxisome%2520proliferator%2520activated%2520receptor-alpha%2520activators%2520reduce%2520inflammation%2520in%2520irritant%2520and%2520allergic%2520contact%2520dermatitis%2520models%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2002%26volume%3D118%26spage%3D94%26epage%3D101%26doi%3D10.1046%2Fj.0022-202x.2001.01626.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genovese, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muià, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centorrino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caputi, A. P.</span></span> <span> </span><span class="NLM_article-title">Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-alpha) in the development of inflammatory bowel disease in mice</span>. <i>Lab. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">1643</span>– <span class="NLM_lpage">1654</span>, <span class="refDoi"> DOI: 10.1038/labinvest.3700185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1038%2Flabinvest.3700185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=15492755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFChtL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2004&pages=1643-1654&author=S.+Cuzzocreaauthor=R.+Di+Paolaauthor=E.+Mazzonauthor=T.+Genoveseauthor=C.+Mui%C3%A0author=T.+Centorrinoauthor=A.+P.+Caputi&title=Role+of+endogenous+and+exogenous+ligands+for+the+peroxisome+proliferators+activated+receptors+alpha+%28PPAR-alpha%29+in+the+development+of+inflammatory+bowel+disease+in+mice&doi=10.1038%2Flabinvest.3700185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-α) in the development of inflammatory bowel disease in mice</span></div><div class="casAuthors">Cuzzocrea, Salvatore; di Paola, Rosanna; Mazzon, Emanuela; Genovese, Tiziana; Muia, Carmelo; Centorrino, Tommaso; Caputi, Achille P.</div><div class="citationInfo"><span class="NLM_cas:title">Laboratory Investigation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1643-1654</span>CODEN:
                <span class="NLM_cas:coden">LAINAW</span>;
        ISSN:<span class="NLM_cas:issn">0023-6837</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The peroxisome proliferator-activated receptor-α (PPAR-α) is a member of the nuclear receptor superfamily of ligand-dependent transcription factors related to retinoid, steroid and thyroid hormone receptors.  The aim of the present study was to examine the effects of endogenous and exogenous PPAR-α ligand on the development of exptl. colitis.  To address this question, we used an exptl. model of colitis, induced by dinitrobenzene sulfonic acid (DNBS).  When compared to DNBS-treated PPAR-α wild-type (WT) mice, DNBS-treated PPAR-α knockout mice (PPAR-αKO) mice experienced a higher rate of the extent and severity of the histol. signs of colon injury.  After administration of DNBS PPAR-αWT mice experienced hemorrhagic diarrhea, wt. loss and large areas of necrosis in the mucosa of the colon were also obsd.  Neutrophil infiltration was assocd. with upregulation of ICAM-1.  Immunohistochem. for nitrotyrosine showed an intense staining in the inflamed colon.  Absence of a functional PPAR-α gene in PPAR-αKO mice resulted in a significant augmentation of all the above-described parameters.  On the contrary, the treatment of PPAR-αWT with Wy-14643 (1 mg/kg daily i.p) significantly reduced: (i) the degree of hemorrhagic diarrhea and wt. loss, (ii) the degree of colon injury, (iii) the rise in MPO activity (mucosa), (iv) the increase in staining (immunohistochem.) for nitrotyrosine, as well as (v) the upregulation of ICAM-1 caused by DNBS in the colon.  In order to elucidate whether the protective effects of Wy-14643 is related to activation of the PPAR-α receptor, we also investigated the effect the of Wy-14643 treatment on PPAR-α-deficient mice.  The absence of the PPAR-α receptor significantly abolished the protective effect of the PPAR-α agonist against DNBS-induced colitis.  Thus, endogenous and exogenous PPAR-α ligands reduce the degree of colitis caused by DNBS.  We propose that PPAR-α ligand may be useful in the treatment of inflammatory bowel disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph2TYuskT6PrVg90H21EOLACvtfcHk0lhJV6naAwBGqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFChtL3M&md5=f0eae11a30cd3d70dd95c47ae8042969</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Flabinvest.3700185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Flabinvest.3700185%26sid%3Dliteratum%253Aachs%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DDi%2BPaola%26aufirst%3DR.%26aulast%3DMazzon%26aufirst%3DE.%26aulast%3DGenovese%26aufirst%3DT.%26aulast%3DMui%25C3%25A0%26aufirst%3DC.%26aulast%3DCentorrino%26aufirst%3DT.%26aulast%3DCaputi%26aufirst%3DA.%2BP.%26atitle%3DRole%2520of%2520endogenous%2520and%2520exogenous%2520ligands%2520for%2520the%2520peroxisome%2520proliferators%2520activated%2520receptors%2520alpha%2520%2528PPAR-alpha%2529%2520in%2520the%2520development%2520of%2520inflammatory%2520bowel%2520disease%2520in%2520mice%26jtitle%3DLab.%2520Invest.%26date%3D2004%26volume%3D84%26spage%3D1643%26epage%3D1654%26doi%3D10.1038%2Flabinvest.3700185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calignano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Rana, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loubet-Lescoulié, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">A role for the endogenous cannabinoid system in the peripheral control of pain initiation</span>. <i>Prog. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">471</span>– <span class="NLM_lpage">482</span>, <span class="refDoi"> DOI: 10.1016/s0079-6123(00)29034-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fs0079-6123%2800%2929034-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=11098711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD3cXos1yjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2000&pages=471-482&author=A.+Calignanoauthor=G.+La+Ranaauthor=P.+Loubet-Lescouli%C3%A9author=D.+Piomelli&title=A+role+for+the+endogenous+cannabinoid+system+in+the+peripheral+control+of+pain+initiation&doi=10.1016%2Fs0079-6123%2800%2929034-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">A role for the endogenous cannabinoid system in the peripheral control of pain initiation</span></div><div class="casAuthors">Calignano, Antonio; La Rana, Giovanna; Loubet-Lescoulie, Patrick; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">Nervous System Plasticity and Chronic Pain</span>),
    <span class="NLM_cas:pages">471-482</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with 71 refs.  Topics discussed include endocannabinoid formation and inactivation; cannabinoid receptors; central modulation of pain signaling; peripheral modulation of pain signaling; palmitylethanolamide as a peripheral analgesic; and the synergistic inhibition of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNWalIvFXUebVg90H21EOLACvtfcHk0lhJV6naAwBGqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXos1yjt7g%253D&md5=9029bc00f7e5847741ec3d86be40404a</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fs0079-6123%2800%2929034-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0079-6123%252800%252929034-1%26sid%3Dliteratum%253Aachs%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DLoubet-Lescouli%25C3%25A9%26aufirst%3DP.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DA%2520role%2520for%2520the%2520endogenous%2520cannabinoid%2520system%2520in%2520the%2520peripheral%2520control%2520of%2520pain%2520initiation%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D2000%26volume%3D129%26spage%3D471%26epage%3D482%26doi%3D10.1016%2Fs0079-6123%2800%2929034-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandevoorde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diependaele, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govaerts, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, A. R.</span></span> <span> </span><span class="NLM_article-title">Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice</span>. <i>Epilepsia</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">321</span>, <span class="refDoi"> DOI: 10.1046/j.1528-1157.2001.41499.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1046%2Fj.1528-1157.2001.41499.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=11442148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1Oqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=321&author=D.+M.+Lambertauthor=S.+Vandevoordeauthor=G.+Diependaeleauthor=S.+J.+Govaertsauthor=A.+R.+Robert&title=Anticonvulsant+activity+of+N-palmitoylethanolamide%2C+a+putative+endocannabinoid%2C+in+mice&doi=10.1046%2Fj.1528-1157.2001.41499.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice</span></div><div class="casAuthors">Lambert, Didier M.; Vandevoorde, Severine; Diependaele, Gerald; Govaerts, Sophie J.; Robert, Annie R.</div><div class="citationInfo"><span class="NLM_cas:title">Epilepsia</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">321-327</span>CODEN:
                <span class="NLM_cas:coden">EPILAK</span>;
        ISSN:<span class="NLM_cas:issn">0013-9580</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science, Inc.</span>)
        </div><div class="casAbstract">The purpose of this study was to evaluate in mice the anticonvulsant potential of N-palmitoylethanolamide, a putative endocannabinoid that accumulates in the body during inflammatory processes.  N-palmitoylethanolamide was injected i.p. in mice and evaluated for anticonvulsant activity [in maximal electroshock seizure (MES) and chem.-induced convulsions] and for neurol. impairment (rotorod).  It was compared with anandamide and with different palmitic acid analogs as well as with ref. anticonvulsants (AEDs) injected under the same conditions.  The MES test showed, after i.p. administration to mice, that N-palmitoylethanolamide had a median ED (ED50) value comparable to that of phenytoin (PHT; 8.9 and 9.2 mg/kg, resp.).  In the s.c. pentylenetetrazol test and in the 3-mercaptopropionic acid test, it was effective only against tonic convulsions.  N-palmitoylethanolamide was devoid of neurol. impairment ≤250 mg/kg, yielding a high protective index.  N-palmitoylethanolamide, an endogenous compd. with antiinflammatory and analgesic activities, is a potent AED in mice.  Its precise mechanism of action remains to be elucidated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9ijVptdycIbVg90H21EOLACvtfcHk0ljOL0Z0bU-mjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1Oqt7s%253D&md5=5dc8d225903bb4782bed598532677017</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1046%2Fj.1528-1157.2001.41499.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1528-1157.2001.41499.x%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DVandevoorde%26aufirst%3DS.%26aulast%3DDiependaele%26aufirst%3DG.%26aulast%3DGovaerts%26aufirst%3DS.%2BJ.%26aulast%3DRobert%26aufirst%3DA.%2BR.%26atitle%3DAnticonvulsant%2520activity%2520of%2520N-palmitoylethanolamide%252C%2520a%2520putative%2520endocannabinoid%252C%2520in%2520mice%26jtitle%3DEpilepsia%26date%3D2001%26volume%3D42%26spage%3D321%26doi%3D10.1046%2Fj.1528-1157.2001.41499.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">West, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitten, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase</span>. <i>J. Proteome Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">972</span>– <span class="NLM_lpage">981</span>, <span class="refDoi"> DOI: 10.1021/pr200735a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr200735a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyhurnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=972-981&author=J.+M.+Westauthor=N.+Zvonokauthor=K.+M.+Whittenauthor=J.+T.+Woodauthor=A.+Makriyannis&title=Mass+spectrometric+characterization+of+human+N-acylethanolamine-hydrolyzing+acid+amidase&doi=10.1021%2Fpr200735a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Mass Spectrometric Characterization of Human N-Acylethanolamine-hydrolyzing Acid Amidase</span></div><div class="casAuthors">West, Jay M.; Zvonok, Nikolai; Whitten, Kyle M.; Wood, JodiAnne T.; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">972-981</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Acylethanolamine-hydrolyzing acid amidase (NAAA) is a lysosomal enzyme that primarily degrades palmitoylethanolamine (PEA), a lipid amide that inhibits inflammatory responses.  We developed a HEK293 cell line stably expressing the NAAA pro-enzyme (zymogen) and a single step chromatog. purifn. of the protein from the media.  Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry MALDI-TOF MS anal. of the zymogen (47.7 kDa) treated with peptide-N-glycosidase F (PNGase F) identified 4 glycosylation sites, and acid cleavage of the zymogen into α- and β-subunits (14.6 and 33.3 kDa) activated the enzyme.  Size exclusion chromatog. estd. the mass of the active enzyme as 45±3 kDa, suggesting formation of an α/β heterodimer.  MALDI-TOF MS fingerprinting covered more than 80% of the amino acid sequence, including the N-terminal peptides, and evidence for the lack of a disulfide bond between subunits.  The significance of the cysteine residues was established by their selective alkylation resulting in almost complete loss of activity.  The purified enzyme was kinetically characterized with PEA and a novel fluorogenic substrate, N-(4-Me coumarin) palmitamide (PAMCA).  The prodn. of sufficient quantities of NAAA and a high throughput assay could be useful in discovering novel inhibitors and detg. the structure and function of this enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsHb2ZNlA6QbVg90H21EOLACvtfcHk0ljOL0Z0bU-mjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyhurnL&md5=b90eb948e0d859a08f4a777114820c94</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fpr200735a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr200735a%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DJ.%2BM.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DWhitten%26aufirst%3DK.%2BM.%26aulast%3DWood%26aufirst%3DJ.%2BT.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DMass%2520spectrometric%2520characterization%2520of%2520human%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2012%26volume%3D11%26spage%3D972%26epage%3D981%26doi%3D10.1021%2Fpr200735a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mileni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everdeen, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pabst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nugent, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamtekar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure-guided inhibitor design for human FAAH by interspecies active site conversion</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">12820</span>– <span class="NLM_lpage">12824</span>, <span class="refDoi"> DOI: 10.1073/pnas.0806121105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1073%2Fpnas.0806121105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=18753625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSmtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=12820-12824&author=M.+Mileniauthor=D.+S.+Johnsonauthor=Z.+Wangauthor=D.+S.+Everdeenauthor=M.+Liimattaauthor=B.+Pabstauthor=K.+Bhattacharyaauthor=R.+A.+Nugentauthor=S.+Kamtekarauthor=B.+F.+Cravattauthor=K.+Ahnauthor=R.+C.+Stevens&title=Structure-guided+inhibitor+design+for+human+FAAH+by+interspecies+active+site+conversion&doi=10.1073%2Fpnas.0806121105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided inhibitor design for human FAAH by interspecies active site conversion</span></div><div class="casAuthors">Mileni, Mauro; Johnson, Douglas S.; Wang, Zhigang; Everdeen, Daniel S.; Liimatta, Marya; Pabst, Brandon; Bhattacharya, Keshab; Nugent, Richard A.; Kamtekar, Satwik; Cravatt, Benjamin F.; Ahn, Kay; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">12820-12824</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The integral membrane enzyme fatty acid amide hydrolase (FAAH) hydrolyzes the endocannabinoid anandamide and related amidated signaling lipids.  Genetic or pharmacol. inactivation of FAAH produces analgesic, anxiolytic, and antiinflammatory phenotypes but not the undesirable side effects of direct cannabinoid receptor agonists, indicating that FAAH may be a promising therapeutic target.  Structure-based inhibitor design has, however, been hampered by difficulties in expressing the human FAAH enzyme.  Here, we address this problem by interconverting the active sites of rat and human FAAH using site-directed mutagenesis.  The resulting humanized rat (h/r) FAAH protein exhibits the inhibitor sensitivity profiles of human FAAH but maintains the high-expression yield of the rat enzyme.  We report a 2.75-Å crystal structure of h/rFAAH complexed with an inhibitor, N-phenyl-4- (quinolin-3-ylmethyl)piperidine-1-carboxamide (PF-750), that shows strong preference for human FAAH.  This structure offers compelling insights to explain the species selectivity of FAAH inhibitors, which should guide future drug design programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq16BzSUEI2DbVg90H21EOLACvtfcHk0ljOL0Z0bU-mjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSmtrvP&md5=bebc9409a5e71734f651c5ab89303fad</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0806121105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0806121105%26sid%3Dliteratum%253Aachs%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DEverdeen%26aufirst%3DD.%2BS.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DPabst%26aufirst%3DB.%26aulast%3DBhattacharya%26aufirst%3DK.%26aulast%3DNugent%26aufirst%3DR.%2BA.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure-guided%2520inhibitor%2520design%2520for%2520human%2520FAAH%2520by%2520interspecies%2520active%2520site%2520conversion%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D12820%26epage%3D12824%26doi%3D10.1073%2Fpnas.0806121105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mileni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beidler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weerapana, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadagopan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazerwith, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiff, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamtekar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaney, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Becelaere, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">420</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2009.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.chembiol.2009.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=19389627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVCms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=411-420&author=K.+Ahnauthor=D.+S.+Johnsonauthor=M.+Mileniauthor=D.+Beidlerauthor=J.+Z.+Longauthor=M.+K.+McKinneyauthor=E.+Weerapanaauthor=N.+Sadagopanauthor=M.+Liimattaauthor=S.+E.+Smithauthor=S.+Lazerwithauthor=C.+Stiffauthor=S.+Kamtekarauthor=K.+Bhattacharyaauthor=Y.+Zhangauthor=S.+Swaneyauthor=K.+Van+Becelaereauthor=R.+C.+Stevensauthor=B.+F.+Cravatt&title=Discovery+and+characterization+of+a+highly+selective+FAAH+inhibitor+that+reduces+inflammatory+pain&doi=10.1016%2Fj.chembiol.2009.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain</span></div><div class="casAuthors">Ahn, Kay; Johnson, Douglas S.; Mileni, Mauro; Beidler, David; Long, Jonathan Z.; McKinney, Michele K.; Weerapana, Eranthie; Sadagopan, Nalini; Liimatta, Marya; Smith, Sarah E.; Lazerwith, Scott; Stiff, Cory; Kamtekar, Satwik; Bhattacharya, Keshab; Zhang, Yanhua; Swaney, Stephen; Van Becelaere, Keri; Stevens, Raymond C.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">411-420</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Endocannabinoids are lipid signaling mols. that regulate a wide range of mammalian behaviors, including pain, inflammation, and cognitive/emotional state.  The endocannabinoid anandamide is principally degraded by the integral membrane enzyme fatty acid amide hydrolase (FAAH), and there is currently much interest in developing FAAH inhibitors to augment endocannabinoid signaling in vivo.  Here, we report the discovery and detailed characterization of a highly efficacious and selective FAAH inhibitor, PF-3845.  Mechanistic and structural studies confirm that PF-3845 is a covalent inhibitor that carbamylates FAAH's serine nucleophile.  PF-3845 selectively inhibits FAAH in vivo, as detd. by activity-based protein profiling; raises brain anandamide levels for up to 24 h; and produces significant cannabinoid receptor-dependent redns. in inflammatory pain.  These data thus designate PF-3845 as a valuable pharmacol. tool for in vivo characterization of the endocannabinoid system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWANdntofbhbVg90H21EOLACvtfcHk0lhQW4_2wg-A_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVCms7w%253D&md5=c418dbdf626109415af7001db5a7cb93</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DMcKinney%26aufirst%3DM.%2BK.%26aulast%3DWeerapana%26aufirst%3DE.%26aulast%3DSadagopan%26aufirst%3DN.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DLazerwith%26aufirst%3DS.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DBhattacharya%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSwaney%26aufirst%3DS.%26aulast%3DVan%2BBecelaere%26aufirst%3DK.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520a%2520highly%2520selective%2520FAAH%2520inhibitor%2520that%2520reduces%2520inflammatory%2520pain%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D411%26epage%3D420%26doi%3D10.1016%2Fj.chembiol.2009.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falgueyret, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesolowski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydzewski, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasit, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riendeau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodan, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percival, M. D.</span></span> <span> </span><span class="NLM_article-title">Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1021/jm0003440</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0003440" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD3cXos1ajs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=94-104&author=J.-P.+Falgueyretauthor=R.+M.+Oballaauthor=O.+Okamotoauthor=G.+Wesolowskiauthor=Y.+Aubinauthor=R.+M.+Rydzewskiauthor=P.+Prasitauthor=D.+Riendeauauthor=S.+B.+Rodanauthor=M.+D.+Percival&title=Novel%2C+nonpeptidic+cyanamides+as+potent+and+reversible+inhibitors+of+human+cathepsins+K+and+L&doi=10.1021%2Fjm0003440"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Novel, Nonpeptidic Cyanamides as Potent and Reversible Inhibitors of Human Cathepsins K and L</span></div><div class="casAuthors">Falgueyret, Jean-Pierre; Oballa, Renata M.; Okamoto, Osamu; Wesolowski, Gregg; Aubin, Yves; Rydzewski, Robert M.; Prasit, Peppi; Riendeau, Denis; Rodan, Sevgi B.; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">94-104</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compds. contg. a 1-cyanopyrrolidinyl ring were identified as potent and reversible inhibitors of cathepsins K and L.  The original lead compd. I inhibits cathepsins K and L with IC50 values of 0.37 and 0.45 μM, resp.  Modification of compd. I by replacement of the quinoline moiety led to the synthesis of N-(1-cyano-3-pyrrolidinyl)benzenesulfonamide (2).  Compd. II was found to be a potent inhibitor of cathepsins K and L with a Ki value of 50 nM for cathepsin K.  Replacement of the 1-cyanopyrrolidine of compd. II by a 1-cyanoazetidine increased the potency of the inhibitor by 10-fold.  This increase in potency is probably due to an enhanced chem. reactivity of the compd. toward the thiolate of the active site of the enzyme.  This is demonstrated when the assay is performed in the presence of glutathione at pH 7.0 which favors the formation of a GSH thiolate anion.  Under these assay conditions, there is a loss of potency in the 1-cyanoazetidine series due to the formation of an inactive complex between the GSH thiolate and the 1-cyanoazetidine inhibitors. 1-Cyanopyrrolidinyl inhibitors exhibited time-dependent inhibition which allowed us to det. the assocn. and dissocn. rate consts. with human cathepsin K.  The kinetic data obtained showed that the increase of potency obsd. between different 1-cyanopyrrolidinyl inhibitors is due to an increase of kon values and that the assocn. of the compd. with the enzyme fits an apparent one-step mechanism. 13C NMR expts. performed with the enzyme papain showed that compd. 2 forms a covalent isothiourea ester adduct with the enzyme.  As predicted by the kinetic anal., the addn. of the irreversible inhibitor E64 to the enzyme-cyanopyrrolidinyl complex totally abolished the signal of the isothiourea bond as obsd. by 13C NMR, thereby demonstrating that the formation of the covalent bond with the active site cysteine residue is reversible. Finally, compd. II inhibits bone resorption in an in vitro assay involving rabbit osteoclasts and bovine bone with an IC50 value of 0.7 μM. 1-Cyanopyrrolidine represents a new class of nonpeptidic compds. that inhibit cathepsin K and L activity and proteolysis of bone collagen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWnsb8us0GkrVg90H21EOLACvtfcHk0lhQW4_2wg-A_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXos1ajs7g%253D&md5=aed27c1353797e413890ea02d900095b</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm0003440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0003440%26sid%3Dliteratum%253Aachs%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DOkamoto%26aufirst%3DO.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DAubin%26aufirst%3DY.%26aulast%3DRydzewski%26aufirst%3DR.%2BM.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DNovel%252C%2520nonpeptidic%2520cyanamides%2520as%2520potent%2520and%2520reversible%2520inhibitors%2520of%2520human%2520cathepsins%2520K%2520and%2520L%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D94%26epage%3D104%26doi%3D10.1021%2Fjm0003440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28K1%29+and+the+concentration+of+inhibitor+which+causes+50+per+cent+inhibition+%28I50%29+of+an+enzymatic+reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0lhQW4_2wg-A_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528K1%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2520per%2520cent%2520inhibition%2520%2528I50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hale, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigelow, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormack, J. J.</span></span> <span> </span><span class="NLM_article-title">Analytical and pharmacokinetic studies with 5-chloro-2’-deoxycytidine</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">1493</span>– <span class="NLM_lpage">1502</span>, <span class="refDoi"> DOI: 10.1016/s0006-2952(02)01413-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fs0006-2952%2802%2901413-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=12417262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD38Xotl2mur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2002&pages=1493-1502&author=J.+T.+Haleauthor=J.+C.+Bigelowauthor=L.+A.+Mathewsauthor=J.+J.+McCormack&title=Analytical+and+pharmacokinetic+studies+with+5-chloro-2%E2%80%99-deoxycytidine&doi=10.1016%2Fs0006-2952%2802%2901413-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Analytical and pharmacokinetic studies with 5-chloro-2'-deoxycytidine</span></div><div class="casAuthors">Hale, JodiAnne T.; Bigelow, James C.; Mathews, Linda A.; McCormack, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1493-1502</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">5-Chloro-2'-deoxycytidine (NSC 371331, CDC) is in development as a possible radiosensitizing agent for cancer treatment.  This paper describes preclin. studies to det. the pharmacokinetic properties of CDC and the disposition of the drug, both alone and in the presence of the metabolic modulator tetrahydrouridine (THU), a cytidine deaminase inhibitor.  Detection of the drug in biol. fluids was performed by HPLC on a C-18 column, gradient elution with solvents composed of aq. F3CCO2H and MeCN, and UV absorbance at 290 nm.  Samples were processed by treatment with (NH4)2SO4 prior to injection into the HPLC system.  CDC was stable in aq. soln. and in mouse plasma.  High doses of CDC (100 mg/kg) were given i.v. or i.p. to mice for the detn. of plasma CDC half-life (10 min).  CDC was not detectable in plasma after oral administration.  It was converted rapidly to 5-chloro-2'-deoxyuridine (CDU) by cytidine deaminase, and CDU was readily discernable in plasma and urine collected after i.v. and i.p. administration of CDC.  When CDC in doses ranging 5-100 mg/kg was given with 100 mg THU/kg, increased plasma levels of CDC were seen.  CDC was eliminated through the kidneys, as well as by enzymic deamination, and did not bind to plasma proteins.  The initial steps of the CDC metabolic pathway were detd. in vitro with isolated enzymes.  Cytidine deaminase from mouse kidney converted CDC to CDU; thymidine phosphorylase converted CDU to 5-chlorouracil.  The conclusions of these studies are: CDC is a drug with a short half-life, and it is excreted through the kidneys, mainly in metabolite form.  Administration of THU substantially increased the concns. of CDC in mouse plasma, supporting proposals that the combination of THU with CDC should be evaluated in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC2_-xCofazLVg90H21EOLACvtfcHk0lgfuV0oM0CEsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xotl2mur0%253D&md5=debac7fad27c8a8f9658ffecf212ce80</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fs0006-2952%2802%2901413-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0006-2952%252802%252901413-2%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DJ.%2BT.%26aulast%3DBigelow%26aufirst%3DJ.%2BC.%26aulast%3DMathews%26aufirst%3DL.%2BA.%26aulast%3DMcCormack%26aufirst%3DJ.%2BJ.%26atitle%3DAnalytical%2520and%2520pharmacokinetic%2520studies%2520with%25205-chloro-2%25E2%2580%2599-deoxycytidine%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2002%26volume%3D64%26spage%3D1493%26epage%3D1502%26doi%3D10.1016%2Fs0006-2952%2802%2901413-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janero, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Therapeutic modulation of cannabinoid lipid signaling: metabolic profiling of a novel antinociceptive cannabinoid-2 receptor agonist</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">482</span>– <span class="NLM_lpage">491</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2012.06.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.lfs.2012.06.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=22749867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVyksb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2013&pages=482-491&author=J.+T.+Woodauthor=D.+M.+Smithauthor=D.+R.+Janeroauthor=A.+M.+Zvonokauthor=A.+Makriyannis&title=Therapeutic+modulation+of+cannabinoid+lipid+signaling%3A+metabolic+profiling+of+a+novel+antinociceptive+cannabinoid-2+receptor+agonist&doi=10.1016%2Fj.lfs.2012.06.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic modulation of cannabinoid lipid signaling: Metabolic profiling of a novel antinociceptive cannabinoid-2 receptor agonist</span></div><div class="casAuthors">Wood, JodiAnne T.; Smith, Dustin M.; Janero, David R.; Zvonok, Alexander M.; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">8-9</span>),
    <span class="NLM_cas:pages">482-491</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">AM-1241, a novel, racemic cannabinoid-2 receptor (CB2) ligand, is the primary exptl. agonist used to characterize the role of CB2-mediated lipid signaling in health and disease, including substance abuse disorders.  In vivo pharmacol. effects have been used as indirect proxies for AM-1241 biotransformation processes that could modulate CB2 activity.  We report the initial pre-clin. characterization of AM-1241 biotransformation and in vivo distribution.AM-1241 metab. was characterized in a variety of predictive in vitro systems (Caco-2 cells; mouse, rat and human microsomes) and in the mouse in vivo.  Liq. chromatog. and mass spectrometry techniques were used to quantify AM-1241 tissue distribution and metabolic conversion.AM-1241 bound extensively to plasma protein/albumin.  A pharmacol. AM-1241 dose (25 mg/kg, i.v.) was administered to mice for direct detn. of its plasma half-life (37 min), following which AM-1241 was quantified in brain, spleen, liver, and kidney.  After p.o. administration, AM-1241 was detected in plasma, spleen, and kidney; its oral bioavailability was ∼ 21%.  From Caco-2 permeability studies and microsomal-based hepatic clearance ests., in vivo AM-1241 absorption was moderate.  Hepatic microsomal metab. of AM-1241 in vitro generated hydroxylation and demethylation metabolites.  Species-dependent differences were discovered in AM-1241's predicted hepatic clearance.  Our data demonstrate that AM-1241 has the following characteristics: a) short plasma half-life; b) limited oral bioavailability; c) extensive plasma/albumin binding; d) metabolic substrate for hepatic hydroxylation and demethylation; e) moderate hepatic clearance.These results should help inform the design, optimization, and pre-clin. profiling of CB2 ligands as pharmacol. tools and medicines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq_9lYdOdaXLVg90H21EOLACvtfcHk0lgfuV0oM0CEsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVyksb%252FI&md5=8b2e3023e1fd8eb9ebfdef3646b4935f</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2012.06.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2012.06.019%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BT.%26aulast%3DSmith%26aufirst%3DD.%2BM.%26aulast%3DJanero%26aufirst%3DD.%2BR.%26aulast%3DZvonok%26aufirst%3DA.%2BM.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DTherapeutic%2520modulation%2520of%2520cannabinoid%2520lipid%2520signaling%253A%2520metabolic%2520profiling%2520of%2520a%2520novel%2520antinociceptive%2520cannabinoid-2%2520receptor%2520agonist%26jtitle%3DLife%2520Sci.%26date%3D2013%26volume%3D92%26spage%3D482%26epage%3D491%26doi%3D10.1016%2Fj.lfs.2012.06.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mohutsky, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ring, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrighton, S. A.</span></span> <span> </span><span class="NLM_article-title">Predictions of the in vivo clearance of drugs from rate of loss using human liver microsomes for phase I and phase II biotransformations</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">654</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1007/s11095-006-9663-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1007%2Fs11095-006-9663-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=16550474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD28XktFWjsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2006&pages=654-662&author=M.+A.+Mohutskyauthor=J.+Y.+Chienauthor=B.+J.+Ringauthor=S.+A.+Wrighton&title=Predictions+of+the+in+vivo+clearance+of+drugs+from+rate+of+loss+using+human+liver+microsomes+for+phase+I+and+phase+II+biotransformations&doi=10.1007%2Fs11095-006-9663-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Predictions of the In Vivo Clearance of Drugs from Rate of Loss Using Human Liver Microsomes for Phase I and Phase II Biotransformations</span></div><div class="casAuthors">Mohutsky, Michael A.; Chien, Jenny Y.; Ring, Barbara J.; Wrighton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">654-662</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The utility of in vitro metab. to accurately predict the clearance of hepatically metabolized drugs was evaluated.  Three major goals were: (1) to optimize substrate concn. for the accurate prediction of clearance by comparing to Km value, (2) to prove that clearance of drugs by both oxidn. and glucuronidation may be predicted by this method, and (3) to det. the effects of nonspecific microsomal binding and plasma protein binding.  The apparent Km values for five compds. along with scaled intrinsic clearances and predicted hepatic clearances for eight compds. were detd. using a substrate loss method.  Nonspecific binding to both plasma and microsomal matrixes were also examd. in the clearance calcns.  The Km values were well within the 2-fold variability expected for between lab. comparisons.  Using both phase I and/or phase II glucuronidation incubation conditions, the predictions of in vivo clearance using the substrate loss method were shown to correlate with published human clearance values.  Of particular interest, for highly bound drugs (>95% plasma protein bound), the addn. of a plasma protein binding term increased the accuracy of the prediction of in vivo clearance.  The substrate loss method may be used to accurately predict hepatic clearance of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnnepLV-J41bVg90H21EOLACvtfcHk0lgfuV0oM0CEsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktFWjsL0%253D&md5=f620602ff7a48edfcac290891505c289</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1007%2Fs11095-006-9663-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-006-9663-4%26sid%3Dliteratum%253Aachs%26aulast%3DMohutsky%26aufirst%3DM.%2BA.%26aulast%3DChien%26aufirst%3DJ.%2BY.%26aulast%3DRing%26aufirst%3DB.%2BJ.%26aulast%3DWrighton%26aufirst%3DS.%2BA.%26atitle%3DPredictions%2520of%2520the%2520in%2520vivo%2520clearance%2520of%2520drugs%2520from%2520rate%2520of%2520loss%2520using%2520human%2520liver%2520microsomes%2520for%2520phase%2520I%2520and%2520phase%2520II%2520biotransformations%26jtitle%3DPharm.%2520Res.%26date%3D2006%26volume%3D23%26spage%3D654%26epage%3D662%26doi%3D10.1007%2Fs11095-006-9663-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1350</span>– <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10534321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1350-1359&author=R.+S.+Obach&title=Prediction+of+human+clearance+of+twenty-nine+drugs+from+hepatic+microsomal+intrinsic+clearance+data%3A+An+examination+of+in+vitro+half-life+approach+and+nonspecific+binding+to+microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1350-1359</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Twenty-nine drugs of disparate structures and physicochem. properties were used in an examn. of the capability of human liver microsomal lability data ("in vitro T1/2" approach) to be useful in the prediction of human clearance.  Addnl., the potential importance of nonspecific binding to microsomes in the in vitro incubation milieu for the accurate prediction of human clearance was investigated.  The compds. examd. demonstrated a wide range of microsomal metabolic labilities with scaled intrinsic clearance values ranging from less than 0.5 mL/min/kg to 189 mL/min/kg.  Microsomal binding was detd. at microsomal protein concns. used in the lability incubations.  For the 29 compds. studied, unbound fractions in microsomes ranged from 0.11 to 1.0.  Generally, basic compds. demonstrated the greatest extent of binding and neutral and acidic compds. the least extent of binding.  In the projection of human clearance values, basic and neutral compds. were well predicted when all binding considerations (blood and microsome) were disregarded, however, including both binding considerations also yielded reasonable predictions.  Including only blood binding yielded very poor projections of human clearance for these two types of compds.  However, for acidic compds., disregarding all binding considerations yielded poor predictions of human clearance.  It was generally most difficult to accurately predict clearance for this class of compds.; however the accuracy was best when all binding considerations were included.  Overall, inclusion of both blood and microsome binding values gave the best agreement between in vivo clearance values and clearance values projected from in vitro intrinsic clearance data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWp2hUTOxyubVg90H21EOLACvtfcHk0ljMo8tmHQmFUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D&md5=7804cd4dfb131caac45aff9b7a1df901</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPrediction%2520of%2520human%2520clearance%2520of%2520twenty-nine%2520drugs%2520from%2520hepatic%2520microsomal%2520intrinsic%2520clearance%2520data%253A%2520An%2520examination%2520of%2520in%2520vitro%2520half-life%2520approach%2520and%2520nonspecific%2520binding%2520to%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1999%26volume%3D27%26spage%3D1350%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span> <i>LigPrep</i>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+LigPrep%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2017."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DLigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farid, R.</span></span> <span> </span><span class="NLM_article-title">Novel procedure for modeling ligand/receptor induced fit effects</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">534</span>– <span class="NLM_lpage">553</span>, <span class="refDoi"> DOI: 10.1021/jm050540c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050540c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCgsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=534-553&author=W.+Shermanauthor=T.+Dayauthor=M.+P.+Jacobsonauthor=R.+A.+Friesnerauthor=R.+Farid&title=Novel+procedure+for+modeling+ligand%2Freceptor+induced+fit+effects&doi=10.1021%2Fjm050540c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Procedure for Modeling Ligand/Receptor Induced Fit Effects</span></div><div class="casAuthors">Sherman, Woody; Day, Tyler; Jacobson, Matthew P.; Friesner, Richard A.; Farid, Ramy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">534-553</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present a novel protein-ligand docking method that accurately accounts for both ligand and receptor flexibility by iteratively combining rigid receptor docking (Glide) with protein structure prediction (Prime) techniques.  While traditional rigid-receptor docking methods are useful when the receptor structure does not change substantially upon ligand binding, success is limited when the protein must be "induced" into the correct binding conformation for a given ligand.  We provide an in-depth description of our novel methodol. and present results for 21 pharmaceutically relevant examples.  Traditional rigid-receptor docking for these 21 cases yields an av. RMSD of 5.5 Å.  The av. ligand RMSD for docking to a flexible receptor for the 21 pairs is 1.4 Å; the RMSD is ≤1.8 Å for 18 of the cases.  For the three cases with RMSDs greater than 1.8 Å, the core of the ligand is properly docked and all key protein/ligand interactions are captured.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm3E6ctnPGSrVg90H21EOLACvtfcHk0ljMo8tmHQmFUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCgsr7I&md5=388811ead5cee1fd460951263de486cb</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjm050540c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050540c%26sid%3Dliteratum%253Aachs%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DFarid%26aufirst%3DR.%26atitle%3DNovel%2520procedure%2520for%2520modeling%2520ligand%252Freceptor%2520induced%2520fit%2520effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D534%26epage%3D553%26doi%3D10.1021%2Fjm050540c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maple, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reboul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupyan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaus, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerutti, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krilov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.5b00864</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=281-296&author=E.+Harderauthor=W.+Dammauthor=J.+Mapleauthor=C.+Wuauthor=M.+Reboulauthor=J.+Y.+Xiangauthor=L.+Wangauthor=D.+Lupyanauthor=M.+K.+Dahlgrenauthor=J.+L.+Knightauthor=J.+W.+Kausauthor=D.+S.+Ceruttiauthor=G.+Krilovauthor=W.+L.+Jorgensenauthor=R.+Abelauthor=R.+A.+Friesner&title=OPLS3%3A+A+Force+Field+Providing+Broad+Coverage+of+Drug-like+Small+Molecules+and+Proteins&doi=10.1021%2Facs.jctc.5b00864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span></div><div class="casAuthors">Harder, Edward; Damm, Wolfgang; Maple, Jon; Wu, Chuanjie; Reboul, Mark; Xiang, Jin Yu; Wang, Lingle; Lupyan, Dmitry; Dahlgren, Markus K.; Knight, Jennifer L.; Kaus, Joseph W.; Cerutti, David S.; Krilov, Goran; Jorgensen, William L.; Abel, Robert; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-296</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and validation of the OPLS3 force field for small mols. and proteins are reported.  Enhancements with respect to the previous version (OPLS2.1) include the addn. of off-atom charge sites to represent halogen bonding and aryl nitrogen lone pairs as well as a complete refit of peptide dihedral parameters to better model the native structure of proteins.  To adequately cover medicinal chem. space, OPLS3 employs over an order of magnitude more ref. data and assocd. parameter types relative to other commonly used small mol. force fields (e.g., MMFF and OPLS_2005).  As a consequence, OPLS3 achieves a high level of accuracy across performance benchmarks that assess small mol. conformational propensities and solvation.  The newly fitted peptide dihedrals lead to significant improvements in the representation of secondary structure elements in simulated peptides and native structure stability over a no. of proteins.  Together, the improvements made to both the small mol. and protein force field lead to a high level of accuracy in predicting protein-ligand binding measured over a wide range of targets and ligands (less than 1 kcal/mol RMS error) representing a 30% improvement over earlier variants of the OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_jrOhcBRgrVg90H21EOLACvtfcHk0ljMo8tmHQmFUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE&md5=42663f8cfa84b80a67132bbb13b9b7ce</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00864%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DMaple%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DReboul%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DKaus%26aufirst%3DJ.%2BW.%26aulast%3DCerutti%26aufirst%3DD.%2BS.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DOPLS3%253A%2520A%2520Force%2520Field%2520Providing%2520Broad%2520Coverage%2520of%2520Drug-like%2520Small%2520Molecules%2520and%2520Proteins%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2016%26volume%3D12%26spage%3D281%26epage%3D296%26doi%3D10.1021%2Facs.jctc.5b00864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanschagrin, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span> <span> </span><span class="NLM_article-title">Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6177</span>– <span class="NLM_lpage">6196</span>, <span class="refDoi"> DOI: 10.1021/jm051256o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051256o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6177-6196&author=R.+A.+Friesnerauthor=R.+B.+Murphyauthor=M.+P.+Repaskyauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=T.+A.+Halgrenauthor=P.+C.+Sanschagrinauthor=D.+T.+Mainz&title=Extra+precision+glide%3A+docking+and+scoring+incorporating+a+model+of+hydrophobic+enclosure+for+protein-ligand+complexes&doi=10.1021%2Fjm051256o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span></div><div class="casAuthors">Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P.; Frye, Leah L.; Greenwood, Jeremy R.; Halgren, Thomas A.; Sanschagrin, Paul C.; Mainz, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6177-6196</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel scoring function to est. protein-ligand binding affinities has been developed and implemented as the Glide 4.0 XP scoring function and docking protocol.  In addn. to unique water desolvation energy terms, protein-ligand structural motifs leading to enhanced binding affinity are included:(1) hydrophobic enclosure where groups of lipophilic ligand atoms are enclosed on opposite faces by lipophilic protein atoms, (2) neutral-neutral single or correlated hydrogen bonds in a hydrophobically enclosed environment, and (3) five categories of charged-charged hydrogen bonds.  The XP scoring function and docking protocol have been developed to reproduce exptl. binding affinities for a set of 198 complexes (RMSDs of 2.26 and 1.73 kcal/mol over all and well-docked ligands, resp.) and to yield quality enrichments for a set of fifteen screens of pharmaceutical importance.  Enrichment results demonstrate the importance of the novel XP mol. recognition and water scoring in sepg. active and inactive ligands and avoiding false positives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZiwN12vaY7Vg90H21EOLACvtfcHk0liZP4ZgisjsAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D&md5=ea428c82ead0d8c27f8c1a7b694a1edf</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm051256o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051256o%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DSanschagrin%26aufirst%3DP.%2BC.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26atitle%3DExtra%2520precision%2520glide%253A%2520docking%2520and%2520scoring%2520incorporating%2520a%2520model%2520of%2520hydrophobic%2520enclosure%2520for%2520protein-ligand%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6177%26epage%3D6196%26doi%3D10.1021%2Fjm051256o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Known NAAA inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of isothiocyanate NAAA inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Induced-fit docking of <b>36</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) with a hNAAA structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DXX">6DXX</a>.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> A Connolly surface is used to represent the shape of the binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Interaction diagram of <b>36</b> with hNAAA (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DXX">6DXX</a><a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a>). The ligand orients toward the catalytic region (Cys126) making several hydrophobic contacts with residues Tyr146, Tyr177, Trp181, and Phe174.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Covalent docking of <b>36</b> with a hNAAA crystal structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DXX">6DXX</a><a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a>) forming a carbonimidodithioate adduct.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>10–55</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) and <b>78–91</b> (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) 4-Br-benzyl bromide, NaH, and THF; (b) Ar-B(OH)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, and H<sub>2</sub>O; (c) TFA and CH<sub>2</sub>Cl<sub>2</sub>; and (d) 1,1′-thiocarbonyldi-2(1<i>H</i>)-pyridone, Et<sub>3</sub>N, and CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>53</b> (<a class="ref internalNav" href="#sch2" aria-label="Table 2">Table 2</a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) 4-BrPhOH, DIAD, and Ph<sub>3</sub>P; (b) Ar-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, and K<sub>2</sub>CO<sub>3</sub>; (c) TFA and CH<sub>2</sub>Cl<sub>2</sub>; and (d) 1,1′-thiocarbonyldi-(1<i>H</i>)-pyridone, Et<sub>3</sub>N.</p></p></figure><figure data-id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>57–60</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) Na(OAC)<sub>3</sub>BH, AcOH, and THF; (b) R<sub>3</sub>-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, and K<sub>2</sub>CO<sub>3</sub>; (c) TFA and CH<sub>2</sub>Cl<sub>2</sub>; and (d) 1,1′-thiocarbonyldi-(1<i>H</i>)-pyridone and Et<sub>3</sub>N.</p></p></figure><figure data-id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>61–68</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) and <b>69–71</b>, <b>74–76</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) Aryl carboxylic acid, EDC, DIEA, HOBt, and DMF; (b) Aryl sulfonyl chloride, DIEA, and CH<sub>2</sub>Cl<sub>2</sub>; (c) Ar-B(OH)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, and H<sub>2</sub>O; (d) TFA and CH<sub>2</sub>Cl<sub>2</sub>; and (e) 1,1′-thiocarbonyldi-2(1<i>H</i>)-pyridone, Et<sub>3</sub>N, and CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Identification of metabolites of NAAA inhibitor <b>47</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/medium/jm1c00076_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Microsomal metabolic studies of <b>47</b> with cysteine as the trapping nucleophile.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00076/20210506/images/large/jm1c00076_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00076&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42637" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42637" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 86 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capoccia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turco, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palumbo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steardo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuomo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarnelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steardo, L.</span></span> <span> </span><span class="NLM_article-title">Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-alpha activation</span>. <i>Gut</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">1300</span>– <span class="NLM_lpage">1312</span>, <span class="refDoi"> DOI: 10.1136/gutjnl-2013-305005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1136%2Fgutjnl-2013-305005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=24082036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFGhurrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2014&pages=1300-1312&author=G.+Espositoauthor=E.+Capocciaauthor=F.+Turcoauthor=I.+Palumboauthor=J.+Luauthor=A.+Steardoauthor=R.+Cuomoauthor=G.+Sarnelliauthor=L.+Steardo&title=Palmitoylethanolamide+improves+colon+inflammation+through+an+enteric+glia%2Ftoll+like+receptor+4-dependent+PPAR-alpha+activation&doi=10.1136%2Fgutjnl-2013-305005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Palmitoylethanolamide improves colon inflammation through an enteric glial toll like receptor 4-dependent PPAR-α activation</span></div><div class="casAuthors">Esposito, Giuseppe; Capoccia, Elena; Turco, Fabio; Palumbo, Ilaria; Lu, Jie; Steardo, Antonio; Cuomo, Rosario; Sarnelli, Giovanni; Steardo, Luca</div><div class="citationInfo"><span class="NLM_cas:title">Gut</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1300-1312</span>CODEN:
                <span class="NLM_cas:coden">GUTTAK</span>;
        ISSN:<span class="NLM_cas:issn">0017-5749</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Objective Enteric glia activation has been reported to amplify intestinal inflammation via the enteroglial-specific S100B protein.  This neurotrophin promotes macrophage recruitment in the mucosa, amplify colonic inflammation and interacts with toll-like receptors (TLR).  Mols. inhibiting S100B-driven enteric activation might mitigate the course of ulcerative colitis (UC).  This study aims to investigate the effects of palmitoylethanolamide (PEA), a drug able to counteract astroglial activation in the central nervous system, on intestinal inflammation, in humans and mice.  Design Mouse models of dextran sodium sulfate (DSS)-induced colitis, colonic biopsies deriving from UC patients and primary cultures of mouse and human enteric glial cells (EGC), have been used to assess the effects of PEA, alone or in the presence of specific PPARα or PPARγ antagonists, on: macroscopic signs of UC (DAI score, colon length, spleen wt., macrophages/neutrophils infiltration); the expression and release of proinflammatory markers typical of UC; LR pathway in EGCs.  Results PEA treatment improves all macroscopic signs of UC and decreases the expression and release of all the proinflammatory markers tested.  PEA antiinflammatory effects are mediated by the selective targeting of the S100B/TLR4 axis on ECG, causing a downstream inhibition of nuclear factor kappa B (NF-kB)-dependent inflammation.  Antagonists at PPARα, but not PPARγ, abolished PEA effects, in mice and in humans.  Conclusions Because of its lack of toxicity, its ability in reducing inflammation and its selective PPARα action, PEA might be an innovative mol. to broaden pharmacol. strategies against UC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAh5Kh3wU4bLVg90H21EOLACvtfcHk0liRZY99yQeTbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFGhurrN&md5=3f6e45aee26a81578e9a88beece89ba5</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1136%2Fgutjnl-2013-305005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fgutjnl-2013-305005%26sid%3Dliteratum%253Aachs%26aulast%3DEsposito%26aufirst%3DG.%26aulast%3DCapoccia%26aufirst%3DE.%26aulast%3DTurco%26aufirst%3DF.%26aulast%3DPalumbo%26aufirst%3DI.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DSteardo%26aufirst%3DA.%26aulast%3DCuomo%26aufirst%3DR.%26aulast%3DSarnelli%26aufirst%3DG.%26aulast%3DSteardo%26aufirst%3DL.%26atitle%3DPalmitoylethanolamide%2520improves%2520colon%2520inflammation%2520through%2520an%2520enteric%2520glia%252Ftoll%2520like%2520receptor%25204-dependent%2520PPAR-alpha%2520activation%26jtitle%3DGut%26date%3D2014%26volume%3D63%26spage%3D1300%26epage%3D1312%26doi%3D10.1136%2Fgutjnl-2013-305005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Costa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giagnoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colleoni, M.</span></span> <span> </span><span class="NLM_article-title">Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">420</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0704900</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1038%2Fsj.bjp.0704900" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=12359622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD38XotFeltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2002&pages=413-420&author=B.+Costaauthor=S.+Contiauthor=G.+Giagnoniauthor=M.+Colleoni&title=Therapeutic+effect+of+the+endogenous+fatty+acid+amide%2C+palmitoylethanolamide%2C+in+rat+acute+inflammation%3A+inhibition+of+nitric+oxide+and+cyclo-oxygenase+systems&doi=10.1038%2Fsj.bjp.0704900"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems</span></div><div class="casAuthors">Costa, Barbara; Conti, Silvia; Giagnoni, Gabriella; Colleoni, Mariapia</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">413-420</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The anti-inflammatory activity of the endogenous fatty acid amide palmitoylethanolamide and its relationship to cyclo-oxygenase (COX) activity, nitric oxide (NO) and oxygen free radical prodn. were investigated in the rat model of carrageenan-induced acute paw inflammation and compared with the nonsteroidal anti-inflammatory drug (NSAID) indomethacin.  Palmitoylethanolamide (1, 3, 5, 10 mg kg-1; p.o.) and indomethacin (5 mg kg-1; p.o.) were administered daily after the onset of inflammation for three days and the paw edema was measured daily; 24 h after the last dose (fourth day) the rats were killed and the COX activity and the content of nitrite/nitrate (NO2-/NO3-), malondialdehyde (MDA), endothelial and inducible nitric oxide synthase (eNOS and iNOS) were evaluated in the paw tissues.  Palmitoylethanolamide had a curative effect on inflammation, inhibiting the carrageenan-induced edema in a dose- and time-dependent manner.  This effect was not reversed by the selective CB2 receptor antagonist (N-[(1S)-endo-1,3,3-trimethylbicyclo[2.2.1]heptan-2yl]-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)pyrazole-3 carboxamide) (SR144528), 3 mg kg-1 p.o.  On the fourth day after carrageenan injection, COX activity and the level of NO2-/NO3-, eNOS and MDA were increased in the inflamed paw, but iNOS was not present.  Palmitoylethanolamide (10 mg kg-1) and indomethacin markedly reduced these increases.  Our findings show, for the first time, that palmitoylethanolamide has a curative effect in a model of acute inflammation.  The inhibition of COX activity and of NO and free radical prodn. at the site of inflammation might account for this activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRSouzarUmDLVg90H21EOLACvtfcHk0liRZY99yQeTbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotFeltrg%253D&md5=0a989953faac096ccd8291b5a02732ef</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704900%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DB.%26aulast%3DConti%26aufirst%3DS.%26aulast%3DGiagnoni%26aufirst%3DG.%26aulast%3DColleoni%26aufirst%3DM.%26atitle%3DTherapeutic%2520effect%2520of%2520the%2520endogenous%2520fatty%2520acid%2520amide%252C%2520palmitoylethanolamide%252C%2520in%2520rat%2520acute%2520inflammation%253A%2520inhibition%2520of%2520nitric%2520oxide%2520and%2520cyclo-oxygenase%2520systems%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D137%26spage%3D413%26epage%3D420%26doi%3D10.1038%2Fsj.bjp.0704900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calignano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rana, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuffrida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Control of pain initiation by endogenous cannabinoids</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>394</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1038/28393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1038%2F28393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=9685157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaK1cXkvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=1998&pages=277-281&author=A.+Calignanoauthor=G.+L.+Ranaauthor=A.+Giuffridaauthor=D.+Piomelli&title=Control+of+pain+initiation+by+endogenous+cannabinoids&doi=10.1038%2F28393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Control of pain initiation by endogenous cannabinoids</span></div><div class="casAuthors">Calignano, Antonio; La Rana, Giovanna; Giuffrida, Andrea; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">394</span>
        (<span class="NLM_cas:issue">6690</span>),
    <span class="NLM_cas:pages">277-281</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The potent analgesic effects of cannabis-like drugs and the presence of CB1-type cannabinoid receptors in pain-processing areas of the brain and spinal cord indicate that endogenous cannabinoids such as anandamide may contribute to the control of pain transmission within the central nervous system (CNS).  Here the authors show that anandamide attenuates the pain behavior produced by chem. damage to cutaneous tissue by interacting with CB1-like cannabinoid receptors located outside the CNS.  Palmitylethanolamide (PEA), which is released together with anandamide from a common phospholipid precursor, exerts a similar effect by activating peripheral CB2-like receptors.  When administered together, the two compds. at synergistically reducing pain responses 100-fold more potently than does each compd. alone.  Gas-chromatog./mass-spectrometry measurements indicate that the levels of anandamide and PEA in the skin are enough to cause a tonic activation of local cannabinoid receptors.  In agreement with this possibility, the CB1 antagonist SR141716A and the CB2 antagonist SR144528 prolong and enhance the pain behavior produced by tissue damage.  These results indicate that peripheral CB1-like and CB2-like receptors participate in the intrinsic control of pain initiation and that locally generated anandamide and PEA may mediate this effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpKwHMI3BI9LVg90H21EOLACvtfcHk0lhvab9_mwPnpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvVKjt7w%253D&md5=811026d275d0cba5c01567bdebe16ec8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F28393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F28393%26sid%3Dliteratum%253Aachs%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DRana%26aufirst%3DG.%2BL.%26aulast%3DGiuffrida%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DControl%2520of%2520pain%2520initiation%2520by%2520endogenous%2520cannabinoids%26jtitle%3DNature%26date%3D1998%26volume%3D394%26spage%3D277%26epage%3D281%26doi%3D10.1038%2F28393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaggar, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasnie, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellaturay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, A. S. C.</span></span> <span> </span><span class="NLM_article-title">The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1016/s0304-3959(98)00041-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fs0304-3959%2898%2900041-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=9696473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaK1cXjtVKqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1998&pages=189-199&author=S.+I.+Jaggarauthor=F.+S.+Hasnieauthor=S.+Sellaturayauthor=A.+S.+C.+Rice&title=The+anti-hyperalgesic+actions+of+the+cannabinoid+anandamide+and+the+putative+CB2+receptor+agonist+palmitoylethanolamide+in+visceral+and+somatic+inflammatory+pain&doi=10.1016%2Fs0304-3959%2898%2900041-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain</span></div><div class="casAuthors">Jaggar, Sian I.; Hasnie, Fauzia S.; Sellaturay, Senthy; Rice, Andrew S. C.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">189-199</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">This study assessed the effects of two N-acylethanolamides in established rat models of visceral and somatic inflammatory pain.  (1) The therapeutic effects of the cannabinoid anandamide and the putative CB2 agonist palmitoylethanolamide were tested in a model of persistent visceral pain (turpentine inflammation of the urinary bladder).  Both anandamide (at a dose of 25 mg/kg) and palmitoylethanolamide (at doses of 10-30 mg/kg) were able to attenuate the viscero-visceral hyper-reflexia (VVH) induced by inflammation of the urinary bladder.  (2) The effects of the same compds. on the behavioral response to s.c. formalin injection were assessed.  The characteristic biphasic response was obsd. in control animals.  Anandamide (dose range 5-25 mg/kg) and palmitoylethanolamide (dose range 5-10 mg/kg) both reduced the second phase of the response.  The results confirm the analgesic potential of endogenous ligands at cannabinoid receptor sites.  The anti-nociceptive effect of the putative CB2 receptor agonist, palmitoylethanolamide, is particularly interesting since it is believed to be a peripherally mediated effect.  This observation might be exploited to sep. central psychotropic effects from peripheral analgesic actions of the cannabinoids, under inflammatory conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHpLobKz0KYLVg90H21EOLACvtfcHk0lhvab9_mwPnpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtVKqsL0%253D&md5=8f9d3751ab85b7455bdf5c7515676971</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fs0304-3959%2898%2900041-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0304-3959%252898%252900041-4%26sid%3Dliteratum%253Aachs%26aulast%3DJaggar%26aufirst%3DS.%2BI.%26aulast%3DHasnie%26aufirst%3DF.%2BS.%26aulast%3DSellaturay%26aufirst%3DS.%26aulast%3DRice%26aufirst%3DA.%2BS.%2BC.%26atitle%3DThe%2520anti-hyperalgesic%2520actions%2520of%2520the%2520cannabinoid%2520anandamide%2520and%2520the%2520putative%2520CB2%2520receptor%2520agonist%2520palmitoylethanolamide%2520in%2520visceral%2520and%2520somatic%2520inflammatory%2520pain%26jtitle%3DPain%26date%3D1998%26volume%3D76%26spage%3D189%26epage%3D199%26doi%3D10.1016%2Fs0304-3959%2898%2900041-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barrie, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manolios, N.</span></span> <span> </span><span class="NLM_article-title">The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease</span>. <i>Eur. J. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">210</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.5152/eurjrheum.2017.17025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.5152%2Feurjrheum.2017.17025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=29164003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A280%3ADC%252BC1M3jvVeisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2017&pages=210-218&author=N.+Barrieauthor=N.+Manolios&title=The+endocannabinoid+system+in+pain+and+inflammation%3A+Its+relevance+to+rheumatic+disease&doi=10.5152%2Feurjrheum.2017.17025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease</span></div><div class="casAuthors">Barrie Nicola; Manolios Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">European journal of rheumatology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">210-218</span>
        ISSN:<span class="NLM_cas:issn">2147-9720</span>.
    </div><div class="casAbstract">Pain is the most common manifestation of both acute and chronic inflammation that often challenges patients with rheumatic disease.  Simply, we attribute this to local joint changes of pH in joints, the formation of radicals, enhanced joint pressure, or cytokine release acting on local nerves to produce pain.  However, there is a more complex interplay of interactions between cytokines, mediators of inflammation, and ion channels that influence the final immune response and our perception of pain.  Endocannabinoids, a group of less well-known endogenous bioactive lipids, have such manifold immunomodulatory effects able to influence both inflammation and pain.  In this review, we overview the endocannabinoid system, its role in pain, inflammation, and immune regulation, and highlight the emerging challenges and therapeutic hopes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRx9429BdJqzmmbXvSEQle5fW6udTcc2eZh01gBMy3UoLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3jvVeisQ%253D%253D&md5=19f76725788e79428e07179e45aa46d8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.5152%2Feurjrheum.2017.17025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5152%252Feurjrheum.2017.17025%26sid%3Dliteratum%253Aachs%26aulast%3DBarrie%26aufirst%3DN.%26aulast%3DManolios%26aufirst%3DN.%26atitle%3DThe%2520endocannabinoid%2520system%2520in%2520pain%2520and%2520inflammation%253A%2520Its%2520relevance%2520to%2520rheumatic%2520disease%26jtitle%3DEur.%2520J.%2520Rheumatol.%26date%3D2017%26volume%3D4%26spage%3D210%26epage%3D218%26doi%3D10.5152%2Feurjrheum.2017.17025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Micale, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drago, F.</span></span> <span> </span><span class="NLM_article-title">Endocannabinoids and neurodegenerative diseases</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">382</span>– <span class="NLM_lpage">392</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2007.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.phrs.2007.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=17950616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KgsbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2007&pages=382-392&author=V.+Micaleauthor=C.+Mazzolaauthor=F.+Drago&title=Endocannabinoids+and+neurodegenerative+diseases&doi=10.1016%2Fj.phrs.2007.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoids and neurodegenerative diseases</span></div><div class="casAuthors">Micale, Vincenzo; Mazzola, Carmen; Drago, Filippo</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">382-392</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The cannabinoid CB1 and CB2 receptors, the endogenous endocannabinoid (EC) ligands anandamide (AEA) and 2-arachidonylethanolamide, and the degradative enzymes fatty acid amide hydrolase (FAAH) and monoglyceride lipase (ML) are key elements of the EC system implicated in different physiol. functions including cognition, motor activity and immune responses.  Thus, both the possible neuroprotective role of ECs and their modulating action on neurotransmitter systems affected in several neurodegenerative diseases such as Alzheimer's disease (AD), Huntington's disease (HD) and multiple sclerosis (MS) are currently under investigation.  Accumulating data show an unbalance in the EC system (i.e. decrease of neuronal cannabinoid CB1 receptors, increase of glial cannabinoid CB2 receptors and over-expression of FAAH in astrocytes) in exptl. models of AD as well as in post-mortem brain tissue of AD patients, suggesting its possible role in inflammatory processes and in neuroprotection.  However, the mechanisms of the EC modulation of immune response are not fully understood.  By contrast, in HD a reduced EC signaling, given both by the loss of cannabinoid CB1 receptors and decrease of ECs in brain structures involved in movement control as basal ganglia, has been well documented in preclin. and clin. studies.  Thus, in the present review we discuss recent data concerning the role of the EC system in the pathophysiol. of AD and HD, two neurodegenerative diseases characterized by cognitive deficit and motor impairment, resp.  We focus on the effects of compds. modulating the EC system (agonists/antagonists of cannabinoid CB1 and CB2 receptors, or inhibitors of ECs metab. processes) on the symptoms and/or progression of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYW5Alqe2qoLVg90H21EOLACvtfcHk0liLsjNiM8vxQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KgsbzN&md5=b7bb6d6e1edf2c0b4165da9408db9aa4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2007.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2007.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DMicale%26aufirst%3DV.%26aulast%3DMazzola%26aufirst%3DC.%26aulast%3DDrago%26aufirst%3DF.%26atitle%3DEndocannabinoids%2520and%2520neurodegenerative%2520diseases%26jtitle%3DPharmacol.%2520Res.%26date%3D2007%26volume%3D56%26spage%3D382%26epage%3D392%26doi%3D10.1016%2Fj.phrs.2007.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sagheddu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congiu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadda, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pistis, M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2018.11.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.neuropharm.2018.11.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=30439418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1CrsLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2019&pages=327-336&author=C.+Saghedduauthor=M.+Schermaauthor=M.+Congiuauthor=P.+Faddaauthor=G.+Cartaauthor=S.+Banniauthor=J.+T.+Woodauthor=A.+Makriyannisauthor=M.+S.+Malamasauthor=M.+Pistis&title=Inhibition+of+N-acylethanolamine+acid+amidase+reduces+nicotine-induced+dopamine+activation+and+reward&doi=10.1016%2Fj.neuropharm.2018.11.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward</span></div><div class="casAuthors">Sagheddu, Claudia; Scherma, Maria; Congiu, Mauro; Fadda, Paola; Carta, Gianfranca; Banni, Sebastiano; Wood, JodiAnne T.; Makriyannis, Alexandros; Malamas, Michael S.; Pistis, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">327-336</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tobacco smoke is the leading preventable cause of death in the world and treatments aimed to increase success rate in smoking cessation by reducing nicotine dependence are sought.  Activation of peroxisome proliferator-activated receptor-alpha (PPARα) by synthetic or endogenous agonists was shown to suppress nicotine-induced activation of mesolimbic dopamine system, one of the major neurobiol. substrates of nicotine dependence, and nicotine-seeking behavior in rats and monkeys.  An alternative indirect way to activate PPARα is inhibition of N-acylethanolamine acid amidase (NAAA), one of the major hydrolyzing enzyme for its endogenous agonists palmitoylethanolamide (PEA) and oleoylethanolamide (OEA).  We synthesized a novel specific brain permeable NAAA inhibitor, AM11095.  We administered AM11095 to rats and carried out brain lipid anal., a functional observational battery (FOB) to assess toxicity, in vivo electrophysiol. recording from dopamine cells in the ventral tegmental area, brain microdialysis in the nucleus accumbens shell and behavioral expts. to assess its effect on nicotine -induced conditioned place preference (CPP).  AM11095 (5 and 25 mg/kg, i.p.) was devoid of neurotoxic and behavioral effects and did not affect motor behavior and coordination.  This NAAA inhibitor (5 mg/kg i.p.) increased OEA and PEA levels in the hippocampus and cortex, prevented nicotine-induced activation of mesolimbic dopamine neurons in the ventral tegmental area, nicotine-induced elevation of dopamine levels in the nucleus accumbens shell and decreased the expression of nicotine CPP.  Our results indicate that NAAA inhibitors represent a new class of pharmacol. tools to modulate brain PEA/PPARa signalling and show potential in the treatment of nicotine dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWtP3kL6bfBbVg90H21EOLACvtfcHk0liLsjNiM8vxQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1CrsLzM&md5=4a4f4bfe9da9993097774135f12308a4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2018.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2018.11.013%26sid%3Dliteratum%253Aachs%26aulast%3DSagheddu%26aufirst%3DC.%26aulast%3DScherma%26aufirst%3DM.%26aulast%3DCongiu%26aufirst%3DM.%26aulast%3DFadda%26aufirst%3DP.%26aulast%3DCarta%26aufirst%3DG.%26aulast%3DBanni%26aufirst%3DS.%26aulast%3DWood%26aufirst%3DJ.%2BT.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DPistis%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520N-acylethanolamine%2520acid%2520amidase%2520reduces%2520nicotine-induced%2520dopamine%2520activation%2520and%2520reward%26jtitle%3DNeuropharmacology%26date%3D2019%26volume%3D144%26spage%3D327%26epage%3D336%26doi%3D10.1016%2Fj.neuropharm.2018.11.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panlilio, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Justinova, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, S. R.</span></span> <span> </span><span class="NLM_article-title">Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2013.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.pharmthera.2013.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=23333350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitlamsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2013&pages=84-102&author=L.+V.+Panlilioauthor=Z.+Justinovaauthor=S.+R.+Goldberg&title=Inhibition+of+FAAH+and+activation+of+PPAR%3A+new+approaches+to+the+treatment+of+cognitive+dysfunction+and+drug+addiction&doi=10.1016%2Fj.pharmthera.2013.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction</span></div><div class="casAuthors">Panlilio, Leigh V.; Justinova, Zuzana; Goldberg, Steven R.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84-102</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Enhancing the effects of endogenously-released cannabinoid ligands in the brain might provide therapeutic effects more safely and effectively than administering drugs that act directly at the cannabinoid receptor.  Inhibitors of fatty acid amide hydrolase (FAAH) prevent the breakdown of endogenous ligands for cannabinoid receptors and peroxisome proliferator-activated receptors (PPAR), prolonging and enhancing the effects of these ligands when they are naturally released.  This review considers recent research on the effects of FAAH inhibitors and PPAR activators in animal models of addiction and cognition (specifically learning and memory).  These studies show that FAAH inhibitors can produce potentially therapeutic effects, some through cannabinoid receptors and some through PPAR.  These effects include enhancing certain forms of learning, counteracting the rewarding effects of nicotine and alc., relieving symptoms of withdrawal from cannabis and other drugs, and protecting against relapse-like reinstatement of drug self-administration.  Since FAAH inhibition might have a wide range of therapeutic actions but might also share some of the adverse effects of cannabis, it is noteworthy that at least one FAAH-inhibiting drug (URB597) has been found to have potentially beneficial effects but no indication of liability for abuse or dependence.  Although these areas of research are new, the preliminary evidence indicates that they might lead to improved therapeutic interventions and a better understanding of the brain mechanisms underlying addiction and memory.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVfd0ns0RUZrVg90H21EOLACvtfcHk0liLsjNiM8vxQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitlamsrc%253D&md5=a13bc121f2523849c97c8029d279e8a7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2013.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2013.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DPanlilio%26aufirst%3DL.%2BV.%26aulast%3DJustinova%26aufirst%3DZ.%26aulast%3DGoldberg%26aufirst%3DS.%2BR.%26atitle%3DInhibition%2520of%2520FAAH%2520and%2520activation%2520of%2520PPAR%253A%2520new%2520approaches%2520to%2520the%2520treatment%2520of%2520cognitive%2520dysfunction%2520and%2520drug%2520addiction%26jtitle%3DPharmacol.%2520Ther.%26date%3D2013%26volume%3D138%26spage%3D84%26epage%3D102%26doi%3D10.1016%2Fj.pharmthera.2013.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Melis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pistis, M.</span></span> <span> </span><span class="NLM_article-title">Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: therapeutic perspectives</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2014.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.phrs.2014.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=24704146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvVWqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=42-49&author=M.+Melisauthor=M.+Pistis&title=Targeting+the+interaction+between+fatty+acid+ethanolamides+and+nicotinic+receptors%3A+therapeutic+perspectives&doi=10.1016%2Fj.phrs.2014.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: Therapeutic perspectives</span></div><div class="casAuthors">Melis, Miriam; Pistis, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">42-49</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Nicotine is one of the drugs of abuse that frequently causes addiction and relapse during abstinence.  Nicotine's strong addicting properties reside in its ability to enhance dopamine transmission, and to induce specific changes in synaptic plasticity.  Currently, approved therapies for smoking cessation increase the chances of remaining abstinent, but lack high levels of efficacy and are assocd. with significant adverse side effects.  As a result, there is an urgent need for more effective antismoking medications.  Studies have revealed that drugs targeting the peroxisome proliferator-activated-receptor-α (PPARα) show promise for the treatment of nicotine addiction.  These drugs include synthetic PPARα ligands, such as the clin. available hypolipidemic fibrates, and drugs that increase levels of endogenous endocannabinoid-like fatty acid ethanolamides (FAEs) that act as PPARα agonists.  In this review, we will discuss the specific interaction between PPARα and nicotine, and the mol. mechanisms whereby these intracellular receptors regulate nicotinic acetylcholine receptor functions in neurons.  Modulation of neurophysiol., neurochem. and behavioral effects of nicotine by PPARα will be also reviewed.  Indeed, a picture is emerging where FAEs are endogenous regulators of acetylcholine transmission.  Notably, the implications of this specific cross talk extend beyond nicotine addiction, and might bear relevance for psychiatric disorders and epilepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxOH2ZeV_YubVg90H21EOLACvtfcHk0lif9HICePDzzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvVWqs7o%253D&md5=17d3aa519dac43786749155ed9126e60</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2014.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2014.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DMelis%26aufirst%3DM.%26aulast%3DPistis%26aufirst%3DM.%26atitle%3DTargeting%2520the%2520interaction%2520between%2520fatty%2520acid%2520ethanolamides%2520and%2520nicotinic%2520receptors%253A%2520therapeutic%2520perspectives%26jtitle%3DPharmacol.%2520Res.%26date%3D2014%26volume%3D86%26spage%3D42%26epage%3D49%26doi%3D10.1016%2Fj.phrs.2014.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Stelt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veldhuis, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bär, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolay, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veldink, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vliegenthart, J. F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, H. S.</span></span> <span> </span><span class="NLM_article-title">Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases</span>. <i>Neurotox. Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">183</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1007/bf03033139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1007%2Fbf03033139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=12835123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A280%3ADC%252BD3szgslynug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=183-199&author=M.+van%0Ader+Steltauthor=H.+H.+Hansenauthor=W.+B.+Veldhuisauthor=P.+R.+B%C3%A4rauthor=K.+Nicolayauthor=G.+A.+Veldinkauthor=J.+F.+G.+Vliegenthartauthor=H.+S.+Hansen&title=Biosynthesis+of+endocannabinoids+and+their+modes+of+action+in+neurodegenerative+diseases&doi=10.1007%2Fbf03033139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases</span></div><div class="casAuthors">van der Stelt Mario; Hansen Henrik H; Veldhuis Wouter B; Bar Peter R; Nicolay Klaas; Veldink Gerrit A; Vliegenthart Johannes F G; Hansen Harald S</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicity research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">183-200</span>
        ISSN:<span class="NLM_cas:issn">1029-8428</span>.
    </div><div class="casAbstract">Endocannabinoids are thought to function as retrograde messengers, which modulate neurotransmitter release by activating presynaptic cannabinoid receptors.  Anandamide and 2-arachidonoylglycerol (2-AG) are the two best studied endogenous lipids which can act as endocannabinoids.  Together with the proteins responsible for their biosynthesis, inactivation and the cannabinoid receptors, these lipids constitute the endocannabinoid system.  This system is proposed to be involved in various neurodegenerative diseases such as Parkinson's and Huntington's diseases as well as Multiple Sclerosis.  It has been demonstrated that the endocannabinoid system can protect neurons against glutamate excitotoxicity and acute neuronal damage in both in vitro and in vivo models.  In this paper we review the data concerning the involvement of the endocannabinoid system in neurodegenerative diseases in which neuronal cell death may be elicited by excitotoxicity.  We focus on the biosynthesis of endocannabinoids and on their modes of action in animal models of these neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRWXnazzQtAeP6xYuD7tu2XfW6udTcc2ebEsEfZjZy7NLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3szgslynug%253D%253D&md5=f77f20491cd213d737628817921dd91f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fbf03033139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fbf03033139%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BStelt%26aufirst%3DM.%26aulast%3DHansen%26aufirst%3DH.%2BH.%26aulast%3DVeldhuis%26aufirst%3DW.%2BB.%26aulast%3DB%25C3%25A4r%26aufirst%3DP.%2BR.%26aulast%3DNicolay%26aufirst%3DK.%26aulast%3DVeldink%26aufirst%3DG.%2BA.%26aulast%3DVliegenthart%26aufirst%3DJ.%2BF.%2BG.%26aulast%3DHansen%26aufirst%3DH.%2BS.%26atitle%3DBiosynthesis%2520of%2520endocannabinoids%2520and%2520their%2520modes%2520of%2520action%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNeurotox.%2520Res.%26date%3D2003%26volume%3D5%26spage%3D183%26epage%3D199%26doi%3D10.1007%2Fbf03033139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turcotte, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chouinard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefebvre, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flamand, N.</span></span> <span> </span><span class="NLM_article-title">Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites</span>. <i>J. Leukoc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">1049</span>– <span class="NLM_lpage">1070</span>, <span class="refDoi"> DOI: 10.1189/jlb.3ru0115-021r</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1189%2Fjlb.3ru0115-021r" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=25877930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVGgtbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2015&pages=1049-1070&author=C.+Turcotteauthor=F.+Chouinardauthor=J.+S.+Lefebvreauthor=N.+Flamand&title=Regulation+of+inflammation+by+cannabinoids%2C+the+endocannabinoids+2-arachidonoyl-glycerol+and+arachidonoyl-ethanolamide%2C+and+their+metabolites&doi=10.1189%2Fjlb.3ru0115-021r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites</span></div><div class="casAuthors">Turcotte, Caroline; Chouinard, Francois; Lefebvre, Julie S.; Flamand, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1049-1070</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Society for Leukocyte Biology</span>)
        </div><div class="casAbstract">2-Arachidonoyl-glycerol (2-AG) and arachidonyl-ethanolamide (AEA) are endocannabinoids that have been implicated in many physiol. disorders, including obesity, metabolic syndromes, hepatic diseases, pain, neurol. disorders, and inflammation.  Their immunomodulatory effects are numerous and are not always mediated by cannabinoid receptors, reflecting the presence of an arachidonic acid (AA) mol. in their structure, the latter being the precursor of numerous bioactive lipids that are pro- or anti-inflammatory.  2-AG and AEA can thus serve as a source of AA but can also be metabolized by most eicosanoid biosynthetic enzymes, yielding addnl. lipids.  In this regard, enhancing endocannabinoid levels by using endocannabinoid hydrolysis inhibitors is likely to augment the levels of these lipids that could regulate inflammatory cell functions.  This review summarizes the metabolic pathways involved in the biosynthesis and metab. of AEA and 2-AG, as well as the biol. effects of the 2-AG and AEA lipidomes in the regulation of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsACPa4v3wHrVg90H21EOLACvtfcHk0lif9HICePDzzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVGgtbvF&md5=cd0e1dcd26a044d3ce3cabb956ed3358</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1189%2Fjlb.3ru0115-021r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.3ru0115-021r%26sid%3Dliteratum%253Aachs%26aulast%3DTurcotte%26aufirst%3DC.%26aulast%3DChouinard%26aufirst%3DF.%26aulast%3DLefebvre%26aufirst%3DJ.%2BS.%26aulast%3DFlamand%26aufirst%3DN.%26atitle%3DRegulation%2520of%2520inflammation%2520by%2520cannabinoids%252C%2520the%2520endocannabinoids%25202-arachidonoyl-glycerol%2520and%2520arachidonoyl-ethanolamide%252C%2520and%2520their%2520metabolites%26jtitle%3DJ.%2520Leukoc.%2520Biol.%26date%3D2015%26volume%3D97%26spage%3D1049%26epage%3D1070%26doi%3D10.1189%2Fjlb.3ru0115-021r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LoVerme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Rana, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calignano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">The search for the palmitoylethanolamide receptor</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">1685</span>– <span class="NLM_lpage">1698</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2005.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.lfs.2005.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=15963531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvVGit7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2005&pages=1685-1698&author=J.+LoVermeauthor=G.+La+Ranaauthor=R.+Russoauthor=A.+Calignanoauthor=D.+Piomelli&title=The+search+for+the+palmitoylethanolamide+receptor&doi=10.1016%2Fj.lfs.2005.05.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The search for the palmitoylethanolamide receptor</span></div><div class="casAuthors">LoVerme, Jesse; La Rana, Giovanna; Russo, Roberto; Calignano, Antonio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1685-1698</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Palmitoylethanolamide (PEA), the naturally occurring amide of ethanolamine and palmitic acid, is an endogenous lipid that modulates pain and inflammation.  Although the anti-inflammatory effects of PEA were first characterized nearly 50 years ago, the identity of the receptor mediating these actions has long remained elusive.  We recently identified the ligand-activated transcription factor, peroxisome proliferator-activated receptor-alpha (PPAR-α), as the receptor mediating the anti-inflammatory actions of this lipid amide.  Here we outline the history of PEA, starting with its initial discovery in the 1950s, and discuss the pharmacol. properties of this compd., particularly in regards to its ability to activate PPAR-α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvNrDB4VpEv7Vg90H21EOLACvtfcHk0lgQO_lzFKsimQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvVGit7c%253D&md5=5aff137dd05089d62a32cefe637b83b9</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2005.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2005.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DLoVerme%26aufirst%3DJ.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DThe%2520search%2520for%2520the%2520palmitoylethanolamide%2520receptor%26jtitle%3DLife%2520Sci.%26date%3D2005%26volume%3D77%26spage%3D1685%26epage%3D1698%26doi%3D10.1016%2Fj.lfs.2005.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scuderi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stecca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronzuoli, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartoli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steardo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pompili, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fumagalli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campolongo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steardo, L.</span></span> <span> </span><span class="NLM_article-title">Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer’s disease</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e1419</span> <span class="refDoi"> DOI: 10.1038/cddis.2014.376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1038%2Fcddis.2014.376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=25210802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFyit73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&author=C.+Scuderiauthor=C.+Steccaauthor=M.+Valenzaauthor=P.+Ratanoauthor=M.+R.+Bronzuoliauthor=S.+Bartoliauthor=L.+Steardoauthor=E.+Pompiliauthor=L.+Fumagalliauthor=P.+Campolongoauthor=L.+Steardo&title=Palmitoylethanolamide+controls+reactive+gliosis+and+exerts+neuroprotective+functions+in+a+rat+model+of+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fcddis.2014.376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer's disease</span></div><div class="casAuthors">Scuderi, C.; Stecca, C.; Valenza, M.; Ratano, P.; Bronzuoli, M. R.; Bartoli, S.; Steardo, L.; Pompili, E.; Fumagalli, L.; Campolongo, P.; Steardo, L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e1419</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Given the complex heterogeneity of pathol. changes occurring in Alzheimer's disease (AD), any therapeutic effort absolutely requires a multi-targeted approach, because attempts addressing only a single event may result ineffective.  Palmitoylethanolamide (PEA), a naturally occurring lipid amide between palmitic acid and ethanolamine, seems to be a compd. able to fulfill the criteria of a multi-factorial therapeutic approach.  Here, we describe the anti-inflammatory and neuroprotective activities of systemic administration of PEA in adult male rats given intrahippocampal injection of beta amyloid 1-42 (Aβ 1-42).  Moreover, to investigate the mol. mechanisms responsible for the effects induced by PEA, we co-administered PEA with the GW6471, an antagonist of peroxisome proliferator-activated receptor-α (PPAR-α).  We found that Aβ 1-42 infusion results in severe changes of biochem. markers related to reactive gliosis, amyloidogenesis, and tau protein hyperphosphorylation.  Interestingly, PEA was able to restore the Aβ 1-42-induced alterations through PPAR-α involvement.  In addn., results from the Morris water maze task highlighted a mild cognitive deficit during the reversal learning phase of the behavioral study.  Similarly to the biochem. data, also amnestic deficits were reduced by PEA treatment.  These data disclose novel findings about the therapeutic potential of PEA, and suggest novel strategies that hopefully could have the potential not just to alleviate the symptoms but also to modify disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt3FJJBwoW47Vg90H21EOLACvtfcHk0lgQO_lzFKsimQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFyit73J&md5=dd825f970b31d33f9b11fcce433940e7</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.376%26sid%3Dliteratum%253Aachs%26aulast%3DScuderi%26aufirst%3DC.%26aulast%3DStecca%26aufirst%3DC.%26aulast%3DValenza%26aufirst%3DM.%26aulast%3DRatano%26aufirst%3DP.%26aulast%3DBronzuoli%26aufirst%3DM.%2BR.%26aulast%3DBartoli%26aufirst%3DS.%26aulast%3DSteardo%26aufirst%3DL.%26aulast%3DPompili%26aufirst%3DE.%26aulast%3DFumagalli%26aufirst%3DL.%26aulast%3DCampolongo%26aufirst%3DP.%26aulast%3DSteardo%26aufirst%3DL.%26atitle%3DPalmitoylethanolamide%2520controls%2520reactive%2520gliosis%2520and%2520exerts%2520neuroprotective%2520functions%2520in%2520a%2520rat%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26doi%3D10.1038%2Fcddis.2014.376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beggiato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasini, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraro, L.</span></span> <span> </span><span class="NLM_article-title">Chronic Oral Palmitoylethanolamide Administration Rescues Cognitive Deficit and Reduces Neuroinflammation, Oxidative Stress, and Glutamate Levels in A Transgenic Murine Model of Alzheimer’s Disease</span>. <i>J. Clin. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">428</span>, <span class="refDoi"> DOI: 10.3390/jcm9020428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.3390%2Fjcm9020428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BB3cXms1WntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2020&pages=428&author=S.+Beggiatoauthor=M.+C.+Tomasiniauthor=T.+Cassanoauthor=L.+Ferraro&title=Chronic+Oral+Palmitoylethanolamide+Administration+Rescues+Cognitive+Deficit+and+Reduces+Neuroinflammation%2C+Oxidative+Stress%2C+and+Glutamate+Levels+in+A+Transgenic+Murine+Model+of+Alzheimer%E2%80%99s+Disease&doi=10.3390%2Fjcm9020428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic Oral Palmitoylethanolamide Administration Rescues Cognitive Deficit and Reduces Neuroinflammation, Oxidative Stress, and Glutamate Levels in A Transgenic Murine Model of Alzheimer's Disease</span></div><div class="casAuthors">Beggiato, Sarah; Tomasini, Maria Cristina; Cassano, Tommaso; Ferraro, Luca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">428</span>CODEN:
                <span class="NLM_cas:coden">JCMOHK</span>;
        ISSN:<span class="NLM_cas:issn">2077-0383</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">N-palmitoylethanolamide (PEA) is a lipid mediator belonging to the class of the N-acylethanolamine.  Products contg. PEA, also in ultramicronized formulation (um-PEA), are already licensed for use in humans for its analgesic and anti-inflammatory properties, and demonstrated high safety and tolerability.  Preclin. studies indicate that PEA, esp. in the ultramicronized form, could be a potential therapeutic agent for Alzheimer's disease (AD).  In this study, we evaluated the neuroprotective and antioxidant effects of chronic (three months) um-PEA administration in an animal model of AD (3xTg-AD mice).  For translation purposes, the compd. has been orally administered.  Cognitive performance as well as biochem. markers [(interleukin-16 (IL-16) and tumor necrosis factor-α (TNF-α)] levels, reactive oxygen species (ROS) prodn., synaptophysin and glutamate levels) have been evaluated at the end of um-PEA treatment.  The results indicate that orally administered um-PEA was adsorbed and distributed in the mice brain.  The chronic treatment with um-PEA (100 mg/kg/day for three months) rescued cognitive deficit, restrained neuroinflammation and oxidative stress, and reduced the increase in hippocampal glutamate levels obsd. in 3 x Tg-AD mice.  Overall, these data reinforce the concept that um-PEA exerts beneficial effects in 3xTg-AD mice.  The fact that PEA is already licensed for the use in humans strongly supports its rapid translation in clin. practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1OTGNJNc_0rVg90H21EOLACvtfcHk0lgQO_lzFKsimQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXms1WntrY%253D&md5=3bf8e10fa27c085d5df5517acfc63c7e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.3390%2Fjcm9020428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcm9020428%26sid%3Dliteratum%253Aachs%26aulast%3DBeggiato%26aufirst%3DS.%26aulast%3DTomasini%26aufirst%3DM.%2BC.%26aulast%3DCassano%26aufirst%3DT.%26aulast%3DFerraro%26aufirst%3DL.%26atitle%3DChronic%2520Oral%2520Palmitoylethanolamide%2520Administration%2520Rescues%2520Cognitive%2520Deficit%2520and%2520Reduces%2520Neuroinflammation%252C%2520Oxidative%2520Stress%252C%2520and%2520Glutamate%2520Levels%2520in%2520A%2520Transgenic%2520Murine%2520Model%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Clin.%2520Med.%26date%3D2020%26volume%3D9%26spage%3D428%26doi%3D10.3390%2Fjcm9020428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beggiato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasini, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraro, L.</span></span> <span> </span><span class="NLM_article-title">Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s Disease</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">821</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.3389%2Ffphar.2019.00821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=31396087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksVaks7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=821&author=S.+Beggiatoauthor=M.+C.+Tomasiniauthor=L.+Ferraro&title=Palmitoylethanolamide+%28PEA%29+as+a+Potential+Therapeutic+Agent+in+Alzheimer%E2%80%99s+Disease&doi=10.3389%2Ffphar.2019.00821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Palmitoylethanolamide (PEA) as a potential therapeutic agent in Alzheimer's disease</span></div><div class="casAuthors">Beggiato, Sarah; Tomasini, Maria Cristina; Ferraro, Luca</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">821</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">N-Palmitoylethanolamide (PEA) is a non-endocannabinoid lipid mediator belonging to the class of the N-acylethanolamine phospolipids and was firstly isolated from soy lecithin, egg yolk, and peanut meal.  Either preclin. or clin. studies indicate that PEA is potentially useful in a wide range of therapeutic areas, including eczema, pain, and neurodegeneration.  PEA-contg. products are already licensed for use in humans as a nutraceutical, a food supplement, or a food for medical purposes, depending on the country.  PEA is esp. used in humans for its analgesic and anti-inflammatory properties and has demonstrated high safety and tolerability.  Several preclin. in vitro and in vivo studies have proven that PEA can induce its biol. effects by acting on several mol. targets in both central and peripheral nervous systems.  These multiple mechanisms of action clearly differentiate PEA from classic anti-inflammatory drugs and are attributed to the compd. that has quite unique anti(neuro)inflammatory properties.  According to this view, preclin. studies indicate that PEA, esp. in micronized or ultramicronized forms (i.e., formulations that maximize PEA bioavailability and efficacy), could be a potential therapeutic agent for the effective treatment of different pathologies characterized by neurodegeneration, (neuro) inflammation, and pain.  In particular, the potential neuroprotective effects of PEA have been demonstrated in several exptl. models of Alzheimer's disease.  Interestingly, a singlephoton emission computed tomog. (SPECT) case study reported that a mild cognitive impairment (MCI) patient, treated for 9 mo with ultramicronized-PEA/luteolin, presented an improvement of cognitive performances.  In the present review, we summarized the current preclin. and clin. evidence of PEA as a possible therapeutic agent in Alzheimer's disease.  The possible PEA neuroprotective mechanism(s) of action is also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVzMaU8QASwbVg90H21EOLACvtfcHk0lgqcXjyrMn21Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksVaks7Y%253D&md5=03a7763672770bf5836eeb028502d035</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00821%26sid%3Dliteratum%253Aachs%26aulast%3DBeggiato%26aufirst%3DS.%26aulast%3DTomasini%26aufirst%3DM.%2BC.%26aulast%3DFerraro%26aufirst%3DL.%26atitle%3DPalmitoylethanolamide%2520%2528PEA%2529%2520as%2520a%2520Potential%2520Therapeutic%2520Agent%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D821%26doi%3D10.3389%2Ffphar.2019.00821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uyama, T.</span></span> <span> </span><span class="NLM_article-title">Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">1874</span>– <span class="NLM_lpage">1894</span>, <span class="refDoi"> DOI: 10.1111/febs.12152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1111%2Ffebs.12152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=23425575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsFWgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=1874-1894&author=N.+Uedaauthor=K.+Tsuboiauthor=T.+Uyama&title=Metabolism+of+endocannabinoids+and+related+N-acylethanolamines%3A+canonical+and+alternative+pathways&doi=10.1111%2Ffebs.12152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of endocannabinoids and related N-acylethanolamines: Canonical and alternative pathways</span></div><div class="casAuthors">Ueda, Natsuo; Tsuboi, Kazuhito; Uyama, Toru</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1874-1894</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Endocannabinoids are endogenous ligands of the cannabinoid receptors CB1 and CB2.  Two arachidonic acid derivs., arachidonoylethanolamide (anandamide) and 2-arachidonoyl glycerol, are considered to be physiol. important endocannabinoids.  In the known metabolic pathway in mammals, anandamide and other bioactive N-acylethanolamines, such as palmitoylethanolamide and oleoylethanolamide, are biosynthesized from glycerophospholipids by a combination of Ca2+-dependent N-acyltransferase and N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D, and are degraded by fatty acid amide hydrolase.  However, recent studies have shown the involvement of other enzymes and pathways, which include the members of the tumor suppressor HRASLS family (the phospholipase A/acyltransferase family) functioning as Ca2+-independent N-acyltransferases, N-acyl-phosphatidylethanolamine-hydrolyzing phospholipaseD-independent multistep pathways via N-acylated lysophospholipid, and N-acylethanolamine-hydrolyzing acid amidase, a lysosomal enzyme that preferentially hydrolyzes palmitoylethanolamide.  Although their physiol. significance is poorly understood, these new enzymes/pathways may serve as novel targets for the development of therapeutic drugs.  For example, selective N-acylethanolamine-hydrolyzing acid amidase inhibitors are expected to be new anti-inflammatory and analgesic drugs.  In this minireview, we focus on advances in the understanding of these enzymes/pathways.  In addn., recent findings on 2-arachidonoyl glycerol metab. are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXGslrDcd7BrVg90H21EOLACvtfcHk0lgqcXjyrMn21Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsFWgur4%253D&md5=8ad15d152019255551ab6e5bac9817d1</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12152%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DN.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DUyama%26aufirst%3DT.%26atitle%3DMetabolism%2520of%2520endocannabinoids%2520and%2520related%2520N-acylethanolamines%253A%2520canonical%2520and%2520alternative%2520pathways%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D1874%26epage%3D1894%26doi%3D10.1111%2Ffebs.12152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span> <span> </span><span class="NLM_article-title">Molecular characterization of a phospholipase D generating anandamide and its congeners</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">5298</span>– <span class="NLM_lpage">5305</span>, <span class="refDoi"> DOI: 10.1074/jbc.m306642200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1074%2Fjbc.m306642200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=14634025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFeqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=5298-5305&author=Y.+Okamotoauthor=J.+Morishitaauthor=K.+Tsuboiauthor=T.+Tonaiauthor=N.+Ueda&title=Molecular+characterization+of+a+phospholipase+D+generating+anandamide+and+its+congeners&doi=10.1074%2Fjbc.m306642200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners</span></div><div class="casAuthors">Okamoto, Yasuo; Morishita, Jun; Tsuboi, Kazuhito; Tonai, Takeharu; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">5298-5305</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Anandamide (N-arachidonoylethanolamine) is known to be an endogenous ligand of cannabinoid and vanilloid receptors.  Its congeners (collectively referred to as N-acylethanolamines) also show a variety of biol. activities.  These compds. are principally formed from their corresponding N-acylphosphatidylethanolamines by a phosphodiesterase of the phospholipase D-type in animal tissues.  The authors purified the enzyme from rat heart, and by the use of the sequences of its internal peptides cloned its cDNAs from mouse, rat, and human.  The deduced amino acid sequences were composed of 393-396 residues, and showed that the enzyme has no homol. with the known phospholipase D enzymes but is classified as a member of the zinc metallohydrolase family of the β-lactamase fold.  As was overexpressed in COS-7 cells, the recombinant enzyme generated anandamide and other N-acylethanolamines from their corresponding N-acylphosphatidylethanolamines at comparable rates.  In contrast, the enzyme was inactive with phosphatidylcholine and phosphatidylethanolamine.  Assays of the enzyme activity and the mRNA and protein levels revealed its wide distribution in murine organs with higher contents in the brain, kidney, and testis.  These results confirm that a specific phospholipase D is responsible for the generation of N-acylethanolamines including anandamide, strongly suggesting the physiol. importance of lipid mols. of this class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK_-VVe-jk7rVg90H21EOLACvtfcHk0lgqcXjyrMn21Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFeqtrY%253D&md5=f1c00a4d0e21163c03b5a70d2f46c721</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m306642200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m306642200%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DMorishita%26aufirst%3DJ.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DTonai%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DMolecular%2520characterization%2520of%2520a%2520phospholipase%2520D%2520generating%2520anandamide%2520and%2520its%2520congeners%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D5298%26epage%3D5305%26doi%3D10.1074%2Fjbc.m306642200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giang, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayfield, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilula, N. B.</span></span> <span> </span><span class="NLM_article-title">Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>384</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1038/384083a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1038%2F384083a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=8900284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaK28XmvVegt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=1996&pages=83-87&author=B.+F.+Cravattauthor=D.+K.+Giangauthor=S.+P.+Mayfieldauthor=D.+L.+Bogerauthor=R.+A.+Lernerauthor=N.+B.+Gilula&title=Molecular+characterization+of+an+enzyme+that+degrades+neuromodulatory+fatty-acid+amides&doi=10.1038%2F384083a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides</span></div><div class="casAuthors">Cravatt, Benjamin F.; Giang, Dan K.; Mayfield, Stephen P.; Boger, Dale L.; Lerner, Richard A.; Gilula, Norton B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">6604</span>),
    <span class="NLM_cas:pages">83-87</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Endogenous neuromodulatory mols.. are commonly couples to specific metabolic enzymes to ensure rapid signal inactivation.  Thus, acetylcholine is hydrolyzed by acetylcholine esterase and tryptamine neurotransmitters like serotonin are degraded by monoamine oxidases.  Previously, we reported the structure and sleep-deproved cats.  Cis-9-Octadecenamide, or oleamide, has since been shown to affect serotonergic systems and block gap-junction communication in glial cells (our unpublished results).  We also identified a membrane-bound enzyme activity that hydrolyses oleamide to its inactive acid, oleic acid.  We now report the mechanism-based isolation, cloning and expression of this enzyme activity, originally named oleamide hydrolase, from rat liver plasma membranes.  We also show that oleamide hydrolase converts anandamide, a fatty-acid amide identified as the endogenous ligand for the cannabinoid receptor, to arachidonic acid, indicating that oleamide hydrolase may serve as the general inactivating enzyme for a growing family of bioactive signalling mols., the fatty-acid amides.  Therefore we will hereafter refer to oelamide hydrolase as fatty-acid amide hydrolase, in recognition of the plurality of fatty-acid amide hydrolase, in recognition of the plurality of fatty-acid amides that the enzyme can accept as substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEhJfsk7jdmLVg90H21EOLACvtfcHk0lgqcXjyrMn21Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmvVegt7s%253D&md5=155095116ad61669c06c4b6dcc25e28a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2F384083a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F384083a0%26sid%3Dliteratum%253Aachs%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DGiang%26aufirst%3DD.%2BK.%26aulast%3DMayfield%26aufirst%3DS.%2BP.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DLerner%26aufirst%3DR.%2BA.%26aulast%3DGilula%26aufirst%3DN.%2BB.%26atitle%3DMolecular%2520characterization%2520of%2520an%2520enzyme%2520that%2520degrades%2520neuromodulatory%2520fatty-acid%2520amides%26jtitle%3DNature%26date%3D1996%26volume%3D384%26spage%3D83%26epage%3D87%26doi%3D10.1038%2F384083a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, S.</span></span> <span> </span><span class="NLM_article-title">Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">35552</span>– <span class="NLM_lpage">35557</span>, <span class="refDoi"> DOI: 10.1074/jbc.m106261200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1074%2Fjbc.m106261200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=11463796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntFahs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=35552-35557&author=N.+Uedaauthor=K.+Yamanakaauthor=S.+Yamamoto&title=Purification+and+characterization+of+an+acid+amidase+selective+for+N-palmitoylethanolamine%2C+a+putative+endogenous+anti-inflammatory+substance&doi=10.1074%2Fjbc.m106261200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance</span></div><div class="casAuthors">Ueda, Natsuo; Yamanaka, Kenji; Yamamoto, Shozo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">35552-35557</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">N-Arachidonoylethanolamine (anandamide) is cannabimimetic, and N-palmitoylethanolamine is anti-inflammatory and immunosuppressive.  We found an amidase that is more active with the latter than the former in contrast to the previously known anandamide amidohydrolase for which N-palmitoylethanolamine is a poor substrate.  Proteins solubilized by freezing and thawing from the 12,000 × g pellet of various rat organs hydrolyzed [14C]N-palmitoylethanolamine to palmitic acid and ethanolamine.  The specific enzyme activity was higher in the order of lung > spleen > small intestine > thymus > cecum, and high activity was found in peritoneal and alveolar macrophages.  The enzyme with a mol. mass of 31 kDa was purified from rat lung to a specific activity of 1.8 μmol/min/mg protein.  Relative reactivities of the enzyme with various N-acylethanolamines (100 μM) were as follows: N-palmitoylethanolamine, 100%; N-myristoylethanolamine, 48%; N-stearoylethanolamine, 21%; N-oleoylethanolamine, 20%; N-linoleoylethanolamine, 13%; anandamide, 8%.  The enzyme was the most active at pH 5 and was activated 7-fold by Triton X-100.  The enzyme was almost insensitive to Me arachidonyl fluorophosphonate, which inhibited anandamide amidohydrolase potently.  Thus, the new enzyme referred to as N-palmitoylethanolamine hydrolase was clearly distinguishable from anandamide amidohydrolase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5UIYxO9poNrVg90H21EOLACvtfcHk0ljBYdUAemk01Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntFahs7g%253D&md5=b7bb8c14c642547023582e27c4c1d79e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m106261200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m106261200%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DN.%26aulast%3DYamanaka%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DS.%26atitle%3DPurification%2520and%2520characterization%2520of%2520an%2520acid%2520amidase%2520selective%2520for%2520N-palmitoylethanolamine%252C%2520a%2520putative%2520endogenous%2520anti-inflammatory%2520substance%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D35552%26epage%3D35557%26doi%3D10.1074%2Fjbc.m106261200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takezaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span> <span> </span><span class="NLM_article-title">The N-acylethanolamine-hydrolyzing acid amidase (NAAA)</span>. <i>Chem. Biodivers.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1914</span>– <span class="NLM_lpage">1925</span>, <span class="refDoi"> DOI: 10.1002/cbdv.200790159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1002%2Fcbdv.200790159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=17712833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A280%3ADC%252BD2svpvF2qtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=1914-1925&author=K.+Tsuboiauthor=N.+Takezakiauthor=N.+Ueda&title=The+N-acylethanolamine-hydrolyzing+acid+amidase+%28NAAA%29&doi=10.1002%2Fcbdv.200790159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The N-acylethanolamine-hydrolyzing acid amidase (NAAA)</span></div><div class="casAuthors">Tsuboi Kazuhito; Takezaki Naoko; Ueda Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & biodiversity</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1914-25</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Bioactive N-acylethanolamines, including the endocannabinoid anandamide and anti-inflammatory N-palmitoylethanolamine, are hydrolyzed to fatty acids and ethanolamine in animal tissues by the catalysis of fatty acid amide hydrolase (FAAH).  We recently cloned cDNA of N-acylethanolamine-hydrolyzing acid amidase (NAAA), another enzyme catalyzing the same reaction, from human, rat, and mouse.  NAAA reveals no sequence homology with FAAH and belongs to the choloylglycine hydrolase family.  The most striking catalytic property of NAAA is pH optimum at 4.5-5, which is consistent with its immunocytochemical localization in lysosomes.  In rat, NAAA is highly expressed in lung, spleen, thymus, and intestine.  Notably, the expression level of NAAA is exceptionally high in rat alveolar macrophages.  The primary structure of NAAA exhibits 33-35% amino acid identity to that of acid ceramidase, a lysosomal enzyme hydrolyzing ceramide to fatty acid and sphingosine.  NAAA actually showed a low, but detectable ceramide-hydrolyzing activity, while acid ceramidase hydrolyzed N-lauroylethanolamine.  Thus, NAAA is a novel lysosomal hydrolase, which is structurally and functionally similar to acid ceramidase.  These results suggest a unique role of NAAA in the degradation of N-acylethanolamines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTphOU5U8yJf2xpATR2EQURfW6udTcc2ebHN5equSKK-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svpvF2qtw%253D%253D&md5=440267d95b6b0755fa6c3476e54272de</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.200790159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.200790159%26sid%3Dliteratum%253Aachs%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DTakezaki%26aufirst%3DN.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DThe%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520%2528NAAA%2529%26jtitle%3DChem.%2520Biodivers.%26date%3D2007%26volume%3D4%26spage%3D1914%26epage%3D1925%26doi%3D10.1002%2Fcbdv.200790159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span> <span> </span><span class="NLM_article-title">Inflammation-restricted anti-inflammatory activities of a N-acylethanolamine acid amidase (NAAA) inhibitor F215</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2018.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.phrs.2018.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=29572189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntFOqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2018&pages=7-14&author=Y.+Liauthor=P.+Zhouauthor=H.+Chenauthor=Q.+Chenauthor=X.+Kuangauthor=C.+Luauthor=J.+Renauthor=Y.+Qiu&title=Inflammation-restricted+anti-inflammatory+activities+of+a+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitor+F215&doi=10.1016%2Fj.phrs.2018.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation-restricted anti-inflammatory activities of a N-acylethanolamine acid amidase (NAAA) inhibitor F215</span></div><div class="casAuthors">Li, Yuhang; Zhou, Pan; Chen, Huixia; Chen, Qi; Kuang, Xiaofei; Lu, Canzhong; Ren, Jie; Qiu, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7-14</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">N-Acylethanolamine acid amidase (NAAA) is a cysteine enzyme that catalyzes the hydrolysis of palmitoylethanolamide (PEA).  Pharmacol. blockage of NAAA elevates PEA levels and exerts powerful anti-inflammatory activities.  We have recently identified a highly potent NAAA inhibitor F215.  Here, we demonstrated that F215 was an unusual inflammation-restricted NAAA inhibitor.  In lipopolysaccharides (LPS) induced acute lung injury (ALI) model, F215 markedly accelerated inflammation resoln., promoted clearance of neutrophils infiltration and alveolar repair in the lungs.  F215 efficiently inhibited NAAA and protected endogenous PEA from degrdn. in ALI model, but it cannot readily suppress the NAAA activity in naive mice.  The inflammation-restricted effect of F215 was further confirmed in the alveolar macrophage, F215 only increased PEA levels and exerted anti-inflammatory effects in activated macrophages, but not in unstimulated macrophages.  Moreover, we also showed that the pharmacol. effects of F215 were restricted to the local inflamed skin elicited by 12-o-tetradecanoylphorbol-13-acetate (TPA), but not the normal tissues.  We believe that F215 could be a useful probe to investigate the function of NAAA, as well as a potent anti-inflammatory agent, and its inflammation-restricted feature might offer a new approach to prevent potential side effects of systemic enzyme inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8L-Zp8dasMrVg90H21EOLACvtfcHk0ljBYdUAemk01Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntFOqsbg%253D&md5=e23ae7e46426bf1394ac68b6a6881674</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2018.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2018.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DKuang%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DY.%26atitle%3DInflammation-restricted%2520anti-inflammatory%2520activities%2520of%2520a%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitor%2520F215%26jtitle%3DPharmacol.%2520Res.%26date%3D2018%26volume%3D132%26spage%3D7%26epage%3D14%26doi%3D10.1016%2Fj.phrs.2018.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petrosino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campolo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Impellizzeri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paterniti, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gugliandolo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Amico, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siracusa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span> <span> </span><span class="NLM_article-title">2-Pentadecyl-2-Oxazoline, the Oxazoline of Pea, Modulates Carrageenan-Induced Acute Inflammation</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">308</span>, <span class="refDoi"> DOI: 10.3389/fphar.2017.00308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.3389%2Ffphar.2017.00308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=28611664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFenu7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=308&author=S.+Petrosinoauthor=M.+Campoloauthor=D.+Impellizzeriauthor=I.+Paternitiauthor=M.+Allaraauthor=E.+Gugliandoloauthor=R.+D%E2%80%99Amicoauthor=R.+Siracusaauthor=M.+Cordaroauthor=E.+Espositoauthor=V.+Di+Marzoauthor=S.+Cuzzocrea&title=2-Pentadecyl-2-Oxazoline%2C+the+Oxazoline+of+Pea%2C+Modulates+Carrageenan-Induced+Acute+Inflammation&doi=10.3389%2Ffphar.2017.00308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">2-Pentadecyl-2-oxazoline, the oxazoline of pea, modulates carrageenan-induced acute inflammation</span></div><div class="casAuthors">Petrosino, Stefania; Campolo, Michela; Impellizzeri, Daniela; Paterniti, Irene; Allara, Marco; Gugliandolo, Enrico; D'amico, Ramona; Siracusa, Rosalba; Cordaro, Marika; Esposito, Emanuela; Di Marzo, Vincenzo; Cuzzocrea, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">308/1-308/16</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">N-acylethanolamines (NAEs) involve a family of lipid mols. existent in animal and plant, with N-palmitoylethanolamide (PEA) that arouses great attention owing to its anti- inflammatory, analgesic and neuroprotective activities.  Because PEA is produced on demand and exerts pleiotropic effects, the modulation of specific amidases for NAEs (and in particular NAE-hydrolyzing acid amidase NAAA, which is more selective for PEA) could be a condition to preserve its levels.  Here we investigate the effect of 2-Pentadecyl-2-oxazoline (PEA-OXA) the oxazoline of PEA, on human recombinant NAAA in vitro and in an established model of Carrageenan (CAR)-induced rat paw inflammation.  PEA-OXA dose-dependently significantly inhibited recombinant NAAA and, orally administered to rats (10 mg/kg), limiting histol. damage, thermal hyperalgesia and the increase of infiltrating inflammatory cells after CAR injection in the rat right hindpaw, compared to ultramicronized PEA given orally at the same dose (10 mg/kg).  These effects were accompanied by elevation of paw PEA levels.  Moreover, PEA-OXA markedly reduced neutrophil infiltration and pro-inflammatory cytokine release and prevented CAR-induced IκB-α degrdn., nuclear translocation of NF-κB p65, the increase of inducible nitric oxide synthase, cyclooxygenase-2, intercellular adhesion mol.-1, and mast cell activation.  Expts. in PPAR-α knockout mice showed that the anti-inflammatory effects of PEA-OXA were not dependent on the presence of PPAR-α receptors.  In conclusion, NAAA modulators as PEA-OXA could help to maximize the tissue availability of PEA by increasing its levels and anti-inflammatory effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn273XvrvHbbVg90H21EOLACvtfcHk0ljBawtyX7Eg_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFenu7vF&md5=23898efd143bd1506d64425dbe349a52</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2017.00308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2017.00308%26sid%3Dliteratum%253Aachs%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DCampolo%26aufirst%3DM.%26aulast%3DImpellizzeri%26aufirst%3DD.%26aulast%3DPaterniti%26aufirst%3DI.%26aulast%3DAllara%26aufirst%3DM.%26aulast%3DGugliandolo%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DR.%26aulast%3DSiracusa%26aufirst%3DR.%26aulast%3DCordaro%26aufirst%3DM.%26aulast%3DEsposito%26aufirst%3DE.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DCuzzocrea%26aufirst%3DS.%26atitle%3D2-Pentadecyl-2-Oxazoline%252C%2520the%2520Oxazoline%2520of%2520Pea%252C%2520Modulates%2520Carrageenan-Induced%2520Acute%2520Inflammation%26jtitle%3DFront.%2520Pharmacol.%26date%3D2017%26volume%3D8%26spage%3D308%26doi%3D10.3389%2Ffphar.2017.00308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengatto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiurchiù, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capurro, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuzzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-Sanz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccarrone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1838</span>– <span class="NLM_lpage">1846</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00114</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00114" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsV2lsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1838-1846&author=A.+Ribeiroauthor=S.+Pontisauthor=L.+Mengattoauthor=A.+Armirottiauthor=V.+Chiurchi%C3%B9author=V.+Capurroauthor=A.+Fiasellaauthor=A.+Nuzziauthor=E.+Romeoauthor=G.+Moreno-Sanzauthor=M.+Maccarroneauthor=A.+Reggianiauthor=G.+Tarziaauthor=M.+Morauthor=F.+Bertozziauthor=T.+Bandieraauthor=D.+Piomelli&title=A+Potent+Systemically+Active+N-Acylethanolamine+Acid+Amidase+Inhibitor+that+Suppresses+Inflammation+and+Human+Macrophage+Activation&doi=10.1021%2Facschembio.5b00114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation</span></div><div class="casAuthors">Ribeiro, Alison; Pontis, Silvia; Mengatto, Luisa; Armirotti, Andrea; Chiurchiu, Valerio; Capurro, Valeria; Fiasella, Annalisa; Nuzzi, Andrea; Romeo, Elisa; Moreno-Sanz, Guillermo; Maccarrone, Mauro; Reggiani, Angelo; Tarzia, Giorgio; Mor, Marco; Bertozzi, Fabio; Bandiera, Tiziano; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1838-1846</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid ethanolamides such as palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) are lipid-derived mediators that potently inhibit pain and inflammation by ligating type-α peroxisome proliferator-activated receptors (PPAR-α).  These bioactive substances are preferentially degraded by the cysteine hydrolase, N-acylethanolamine acid amidase (NAAA), which is highly expressed in macrophages.  Here, we describe a new class of β-lactam derivs. that are potent, selective, and systemically active inhibitors of intracellular NAAA activity.  The prototype of this class deactivates NAAA by covalently binding the enzyme's catalytic cysteine and exerts profound anti-inflammatory effects in both mouse models and human macrophages.  This agent may be used to probe the functions of NAAA in health and disease and as a starting point to discover better anti-inflammatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD6Y2cNKursLVg90H21EOLACvtfcHk0ljBawtyX7Eg_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsV2lsrw%253D&md5=a240d871adfc85b99c7e148600573217</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00114%26sid%3Dliteratum%253Aachs%26aulast%3DRibeiro%26aufirst%3DA.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DChiurchi%25C3%25B9%26aufirst%3DV.%26aulast%3DCapurro%26aufirst%3DV.%26aulast%3DFiasella%26aufirst%3DA.%26aulast%3DNuzzi%26aufirst%3DA.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DMaccarrone%26aufirst%3DM.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DA%2520Potent%2520Systemically%2520Active%2520N-Acylethanolamine%2520Acid%2520Amidase%2520Inhibitor%2520that%2520Suppresses%2520Inflammation%2520and%2520Human%2520Macrophage%2520Activation%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D1838%26epage%3D1846%26doi%3D10.1021%2Facschembio.5b00114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonezzi, F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuzzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">An Important Role for N-Acylethanolamine Acid Amidase in the Complete Freund’s Adjuvant Rat Model of Arthritis</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>356</i></span>,  <span class="NLM_fpage">656</span>– <span class="NLM_lpage">663</span>, <span class="refDoi"> DOI: 10.1124/jpet.115.230516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1124%2Fjpet.115.230516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=26769918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvVeks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2016&pages=656-663&author=F.+T.+Bonezziauthor=O.+Sassoauthor=S.+Pontisauthor=N.+Realiniauthor=E.+Romeoauthor=S.+Ponzanoauthor=A.+Nuzziauthor=A.+Fiasellaauthor=F.+Bertozziauthor=D.+Piomelli&title=An+Important+Role+for+N-Acylethanolamine+Acid+Amidase+in+the+Complete+Freund%E2%80%99s+Adjuvant+Rat+Model+of+Arthritis&doi=10.1124%2Fjpet.115.230516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">An important role for N-acylethanolamine acid amidase in the complete Freund's adjuvant rat model of arthritis</span></div><div class="casAuthors">Bonezzi, F. T.; Sasso, O.; Pontis, S.; Realini, N.; Romeo, E.; Ponzano, S.; Nuzzi, A.; Fiasella, A.; Bertozzi, F.; Piomelli, D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">656-663</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The endogenous lipid amides, palmitoylethanolamide (PEA) and oleoylethanolamide (OEA), exert marked antinociceptive and anti-inflammatory effects in animal models by engaging nuclear peroxisome proliferator-activated receptor-α.  PEA and OEA are produced by macrophages and other host-defense cells and are deactivated by the cysteine amidase, N-acylethanolamine acid amidase (NAAA), which is highly expressed in macrophages and B-lymphocytes.  In the present study, we examd. whether (a) NAAA might be involved in the inflammatory reaction triggered by injection of complete Freund's adjuvant (CFA) into the rat paw and (b) administration of 4-cyclohexylbutyl-N-[(S)-2-oxoazetidin-3-yl]-carbamate (ARN726), a novel systemically active NAAA inhibitor, attenuates such reaction.  Injection of CFA into the paw produced local edema and heat hyperalgesia, which were accompanied by decreased PEA and OEA content (assessed by liq. chromatog./mass spectrometry) and increased NAAA levels (assessed by Western blot and ex vivo enzyme activity measurements) in paw tissue.  Administration of undec-10-ynyl-N-[(3S)-2-oxoazetidin-3-yl] carbamate (ARN14686), a NAAA-preferring activity-based probe, revealed that NAAA was catalytically active in CFA-treated paws.  Administration of ARN726 reduced NAAA activity and restored PEA and OEA levels in inflamed tissues, and significantly decreased CFA-induced inflammatory symptoms, including pus prodn. and myeloperoxidase activity.  The results confirm the usefulness of ARN726 as a probe to investigate the functions of NAAA in health and disease and suggest that this enzyme may provide a new mol. target for the treatment of arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG6IIltfdLQbVg90H21EOLACvtfcHk0lghlx9RBPW7CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvVeks7s%253D&md5=5ce843469c81ad112b95c9a59a8bfbe5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.230516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.230516%26sid%3Dliteratum%253Aachs%26aulast%3DBonezzi%26aufirst%3DF.%2BT.%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DNuzzi%26aufirst%3DA.%26aulast%3DFiasella%26aufirst%3DA.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAn%2520Important%2520Role%2520for%2520N-Acylethanolamine%2520Acid%2520Amidase%2520in%2520the%2520Complete%2520Freund%25E2%2580%2599s%2520Adjuvant%2520Rat%2520Model%2520of%2520Arthritis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D356%26spage%3D656%26epage%3D663%26doi%3D10.1124%2Fjpet.115.230516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solorzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonietti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duranti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tontini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacondio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of N-(2-oxo-3-oxetanyl)amides as N-acylethanolamine-hydrolyzing acid amidase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5770</span>– <span class="NLM_lpage">5781</span>, <span class="refDoi"> DOI: 10.1021/jm100582w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100582w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVGhsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5770-5781&author=C.+Solorzanoauthor=F.+Antoniettiauthor=A.+Durantiauthor=A.+Tontiniauthor=S.+Rivaraauthor=A.+Lodolaauthor=F.+Vacondioauthor=G.+Tarziaauthor=D.+Piomelliauthor=M.+Mor&title=Synthesis+and+structure-activity+relationships+of+N-%282-oxo-3-oxetanyl%29amides+as+N-acylethanolamine-hydrolyzing+acid+amidase+inhibitors&doi=10.1021%2Fjm100582w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationships of N-(2-Oxo-3-oxetanyl)amides as N-Acylethanolamine-hydrolyzing Acid Amidase Inhibitors</span></div><div class="casAuthors">Solorzano, Carlos; Antonietti, Francesca; Duranti, Andrea; Tontini, Andrea; Rivara, Silvia; Lodola, Alessio; Vacondio, Federica; Tarzia, Giorgio; Piomelli, Daniele; Mor, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5770-5781</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The fatty acid ethanolamides (FAEs) are a family of bioactive lipid mediators that include the endogenous agonist of peroxisome proliferator-activated receptor-α, palmitoylethanolamide (PEA).  FAEs are hydrolyzed intracellularly by either fatty acid amide hydrolase or N-acylethanolamine-hydrolyzing acid amidase (NAAA).  Selective inhibition of NAAA by I [R = PhCH2CH2 (II)] was found to prevent PEA degrdn. in mouse leukocytes and attenuated responses to proinflammatory stimuli.  Starting from the structure of II, a series of β-lactones was prepd. and tested on recombinant rat NAAA to explore structure-activity relationships (SARs) for this class of inhibitors and improve their in vitro potency.  Following the hypothesis that these compds. inhibited NAAA by acylation of the catalytic cysteine, several requirements for recognition at the active site were identified and new potent inhibitors obtained.  In particular, I [R = 4-PhC6H4 (III)] was more potent than II at inhibiting recombinant rat NAAA activity (II, IC50 = 420 nM; III, IC50 = 115 nM) in vitro and at reducing carrageenan-induced leukocyte infiltration in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgnb77O8b6N7Vg90H21EOLACvtfcHk0lghlx9RBPW7CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVGhsLw%253D&md5=205063c7b40e432bd79a2254ec7d448c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm100582w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100582w%26sid%3Dliteratum%253Aachs%26aulast%3DSolorzano%26aufirst%3DC.%26aulast%3DAntonietti%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DMor%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520N-%25282-oxo-3-oxetanyl%2529amides%2520as%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5770%26epage%3D5781%26doi%3D10.1021%2Fjm100582w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alhouayek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottemanne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cani, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muccioli, G. G.</span></span> <span> </span><span class="NLM_article-title">N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">650</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1096/fj.14-255208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1096%2Ffj.14-255208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=25384424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislGis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=650-661&author=M.+Alhouayekauthor=P.+Bottemanneauthor=K.+V.+Subramanianauthor=D.+M.+Lambertauthor=A.+Makriyannisauthor=P.+D.+Caniauthor=G.+G.+Muccioli&title=N-Acylethanolamine-hydrolyzing+acid+amidase+inhibition+increases+colon+N-palmitoylethanolamine+levels+and+counteracts+murine+colitis&doi=10.1096%2Ffj.14-255208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">N-acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis</span></div><div class="casAuthors">Alhouayek, Mireille; Bottemanne, Pauline; Subramanian, Kumar V.; Lambert, Didier M.; Makriyannis, Alexandros; Cani, Patrice D.; Muccioli, Giulio G.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">650-661, 10.1096/fj.14-255208</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">N-Palmitoylethanolamine or palmitoylethanolamide (PEA) is an anti-inflammatory compd. that was recently shown to exert peroxisome proliferator-activated receptor-α-dependent beneficial effects on colon inflammation.  The actions of PEA are terminated following hydrolysis by 2 enzymes: fatty acid amide hydrolase (FAAH), and the less-studied N-acylethanolamine-hydrolyzing acid amidase (NAAA).  This study aims to investigate the effects of inhibiting the enzymes responsible for PEA hydrolysis in colon inflammation in order to propose a potential therapeutic target for inflammatory bowel diseases (IBDs).  Two murine models of IBD were used to assess the effects of NAAA inhibition, FAAH inhibition, and PEA on macroscopic signs of colon inflammation, macrophage/neutrophil infiltration, and the expression of proinflammatory mediators in the colon, as well as on the colitis-related systemic inflammation.  NAAA inhibition increases PEA levels in the colon and reduces colon inflammation and systemic inflammation, similarly to PEA.  FAAH inhibition, however, does not increase PEA levels in the colon and does not affect the macroscopic signs of colon inflammation or immune cell infiltration.  This is the first report of an anti-inflammatory effect of a systemically administered NAAA inhibitor.  Because NAAA is the enzyme responsible for the control of PEA levels in the colon, we put forth this enzyme as a potential therapeutic target in chronic inflammation in general and IBD in particular.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1s3Cs4nu0sbVg90H21EOLACvtfcHk0lghlx9RBPW7CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislGis7Y%253D&md5=608b15a459887f1cde27f68e241d85b2</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1096%2Ffj.14-255208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.14-255208%26sid%3Dliteratum%253Aachs%26aulast%3DAlhouayek%26aufirst%3DM.%26aulast%3DBottemanne%26aufirst%3DP.%26aulast%3DSubramanian%26aufirst%3DK.%2BV.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DCani%26aufirst%3DP.%2BD.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26atitle%3DN-Acylethanolamine-hydrolyzing%2520acid%2520amidase%2520inhibition%2520increases%2520colon%2520N-palmitoylethanolamine%2520levels%2520and%2520counteracts%2520murine%2520colitis%26jtitle%3DFASEB%2520J.%26date%3D2015%26volume%3D29%26spage%3D650%26epage%3D661%26doi%3D10.1096%2Ffj.14-255208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Mei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">The N-Acylethanolamine Acid Amidase Inhibitor ARN077 Suppresses Inflammation and Pruritus in a Mouse Model of Allergic Dermatitis</span>. <i>J. Invest. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">562</span>– <span class="NLM_lpage">569</span>, <span class="refDoi"> DOI: 10.1016/j.jid.2017.07.853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.jid.2017.07.853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=29054595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitl2qtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2018&pages=562-569&author=O.+Sassoauthor=M.+Summaauthor=A.+Armirottiauthor=S.+Pontisauthor=C.+De+Meiauthor=D.+Piomelli&title=The+N-Acylethanolamine+Acid+Amidase+Inhibitor+ARN077+Suppresses+Inflammation+and+Pruritus+in+a+Mouse+Model+of+Allergic+Dermatitis&doi=10.1016%2Fj.jid.2017.07.853"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The N-Acylethanolamine Acid Amidase Inhibitor ARN077 Suppresses Inflammation and Pruritus in a Mouse Model of Allergic Dermatitis</span></div><div class="casAuthors">Sasso, O.; Summa, M.; Armirotti, A.; Pontis, S.; De Mei, C.; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Investigative Dermatology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">562-569</span>CODEN:
                <span class="NLM_cas:coden">JIDEAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-202X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">N-acylethanolamine acid amidase (NAAA), a cysteine hydrolase highly expressed in macrophages and B lymphocytes, catalyzes the degrdn. of palmitoylethanolamide.  Palmitoylethanolamide is an agonist of PPAR-α and an important regulator of pain and innate immunity.  In this study, we investigated the properties of the NAAA inhibitor, ARN077, in a mouse model of allergic contact dermatitis.  Acute topical applications of ARN077 attenuated key signs of DNFB-induced dermatitis in a dose-dependent manner.  Moreover, ARN077 increased tissue palmitoylethanolamide content and normalized circulating levels of cytokines and IgE.  No such effect was seen in PPAR-α-deficient mice.  Moreover, mice lacking NAAA failed to develop edema or scratching behavior after challenge with DNFB, confirming that this enzyme plays an important role in dermatitis.  Consistent with this conclusion, subchronic applications of ARN077 suppressed DNFB-induced inflammation when administered either before or after the DNFB challenge.  The effects of subchronic ARN077 were dose dependent and comparable in size to those produced by the steroids clobetasol and dexamethasone.  Unlike the latter, however, ARN077 did not cause skin atrophy.  The results identify NAAA as a promising target for the development of effective and safe treatments for atopic dermatitis and other inflammatory disorders of the skin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGKONQ-rQpLbVg90H21EOLACvtfcHk0lh_uVvELj1jcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitl2qtr8%253D&md5=47e862197856ce83e51fc7c8a34ada85</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.jid.2017.07.853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jid.2017.07.853%26sid%3Dliteratum%253Aachs%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DDe%2BMei%26aufirst%3DC.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DThe%2520N-Acylethanolamine%2520Acid%2520Amidase%2520Inhibitor%2520ARN077%2520Suppresses%2520Inflammation%2520and%2520Pruritus%2520in%2520a%2520Mouse%2520Model%2520of%2520Allergic%2520Dermatitis%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2018%26volume%3D138%26spage%3D562%26epage%3D569%26doi%3D10.1016%2Fj.jid.2017.07.853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-Sanz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martucci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dionisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengatto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duranti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertorelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">350</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2012.10.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.pain.2012.10.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=23218523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivF2jtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=350-360&author=O.+Sassoauthor=G.+Moreno-Sanzauthor=C.+Martucciauthor=N.+Realiniauthor=M.+Dionisiauthor=L.+Mengattoauthor=A.+Durantiauthor=G.+Tarozzoauthor=G.+Tarziaauthor=M.+Morauthor=R.+Bertorelliauthor=A.+Reggianiauthor=D.+Piomelli&title=Antinociceptive+effects+of+the+N-acylethanolamine+acid+amidase+inhibitor+ARN077+in+rodent+pain+models&doi=10.1016%2Fj.pain.2012.10.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models</span></div><div class="casAuthors">Sasso, Oscar; Moreno-Sanz, Guillermo; Martucci, Cataldo; Realini, Natalia; Dionisi, Mauro; Mengatto, Luisa; Duranti, Andrea; Tarozzo, Glauco; Tarzia, Giorgio; Mor, Marco; Bertorelli, Rosalia; Reggiani, Angelo; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">350-360</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Fatty acid ethanolamides (FAEs), which include palmitoylethanolamide (PEA) and oleoylethanolamide (OEA), are endogenous agonists of peroxisome proliferator-activated receptor-α (PPAR-α) and important regulators of the inflammatory response.  They are degraded in macrophages by the lysosomal cysteine amidase, N-acylethanolamine acid amidase (NAAA).  Previous studies have shown that pharmacol. inhibition of NAAA activity suppresses macrophage activation in vitro and causes marked anti-inflammatory effects in vivo, which is suggestive of a role for NAAA in the control of inflammation.  It is still unknown, however, whether NAAA-mediated FAE deactivation might regulate pain signaling.  The present study examd. the effects of ARN077, a potent and selective NAAA inhibitor recently disclosed by our group, in rodent models of hyperalgesia and allodynia caused by inflammation or nerve damage.  Topical administration of ARN077 attenuated, in a dose-dependent manner, heat hyperalgesia and mech. allodynia elicited in mice by carrageenan injection or sciatic nerve ligation.  The antinociceptive effects of ARN077 were prevented by the selective PPAR-α antagonist GW6471 and did not occur in PPAR-α-deficient mice.  Furthermore, topical ARN077 reversed the allodynia caused by UV B radiation in rats, and this effect was blocked by pretreatment with GW6471.  Sciatic nerve ligation or application of the proinflammatory phorbol ester 12-O-tetradecanoylphorbol 13-acetate decreased FAE levels in sciatic nerve and skin tissue, resp.  ARN077 reversed these biochem. effects.  The results identify ARN077 as a potent inhibitor of intracellular NAAA activity, which is active in vivo by topical administration.  The findings further suggest that NAAA regulates peripheral pain initiation by interrupting endogenous FAE signaling at PPAR-α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVAH4mpvyphbVg90H21EOLACvtfcHk0lh_uVvELj1jcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivF2jtrk%253D&md5=08c067a44b1f75e7e0192fdbdeccccd4</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2012.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2012.10.018%26sid%3Dliteratum%253Aachs%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DMartucci%26aufirst%3DC.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DDionisi%26aufirst%3DM.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAntinociceptive%2520effects%2520of%2520the%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitor%2520ARN077%2520in%2520rodent%2520pain%2520models%26jtitle%3DPain%26date%3D2013%26volume%3D154%26spage%3D350%26epage%3D360%26doi%3D10.1016%2Fj.pain.2012.10.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span> <span> </span><span class="NLM_article-title">Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-alpha</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">13565</span>, <span class="refDoi"> DOI: 10.1038/srep13565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1038%2Fsrep13565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=26310614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKhtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=13565&author=L.+Yangauthor=L.+Liauthor=L.+Chenauthor=Y.+Liauthor=H.+Chenauthor=Y.+Liauthor=G.+Jiauthor=D.+Linauthor=Z.+Liuauthor=Y.+Qiu&title=Potential+analgesic+effects+of+a+novel+N-acylethanolamine+acid+amidase+inhibitor+F96+through+PPAR-alpha&doi=10.1038%2Fsrep13565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α</span></div><div class="casAuthors">Yang, Longhe; Li, Long; Chen, Ling; Li, Yanting; Chen, Huixia; Li, Yuhang; Ji, Guangnian; Lin, Donghai; Liu, Zuguo; Qiu, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13565</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Pharmacol. blockade of N-acylethanolamine acid amidase (NAAA) activity is an available approach for inflammation and pain control through restoring the ability of endogenous PEA.  But the recently reported NAAA inhibitors suffer from the chem. and biol. unstable properties, which restrict functions of NAAA inhibition in vivo.  It is still unrevealed whether systematic inhibition of NAAA could modulate PEA-mediated pain signalings.  Here we reported an oxazolidinone imide compd. 3-(6-phenylhexanoyl) oxazolidin-2-one (F96), which potently and selectively inhibited NAAA activity (IC50 = 270 nM).  I.p. (i.p.) injection of F96 (3-30 mg/kg) dose-dependently reduced ear edema and restored PEA levels of ear tissues in 12-O-Tetradecanoylphorbol-13-acetate (TPA) induced ear edema models.  Furthermore, F96 inhibited acetic acid-induced writhing and increased spared nerve injury induced tactile allodynia thresholds in a dose-dependent manner.  Pharmacol. effects of F96 (10 mg/kg, i.p.) on various animal models were abolished in PPAR-α-/- mice, and were prevented by PPAR-α antagonist MK886 but not by canabinoid receptor type 1 (CB1) antagonist Rimonabant nor canabinoid receptor type 2 (CB2) antagonist SR144528.  Zebrafish embryos expts. showed better security and lower toxicity for F96 than ibuprofen.  These results revealed that F96 might be useful in treating inflammatory and neuropathic pain by NAAA inhibition depending on PPAR-α receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsP6tlGryp3LVg90H21EOLACvtfcHk0lh_uVvELj1jcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKhtLzK&md5=237e107001c9eef18e130d12a0724300</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fsrep13565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep13565%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DQiu%26aufirst%3DY.%26atitle%3DPotential%2520analgesic%2520effects%2520of%2520a%2520novel%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitor%2520F96%2520through%2520PPAR-alpha%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D13565%26doi%3D10.1038%2Fsrep13565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Migliore, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuentes
de Arriba, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrente, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Martino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzirani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanfranco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottonello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busquet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, K.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Guzman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heim, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis</span>. <i>Angew. Chem. Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">11193</span>– <span class="NLM_lpage">11197</span>, <span class="refDoi"> DOI: 10.1002/anie.201603746</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1002%2Fanie.201603746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFKmt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=11193-11197&author=M.+Miglioreauthor=S.+Pontisauthor=A.+L.+Fuentes%0Ade+Arribaauthor=N.+Realiniauthor=E.+Torrenteauthor=A.+Armirottiauthor=E.+Romeoauthor=S.+Di+Martinoauthor=D.+Russoauthor=D.+Pizziraniauthor=M.+Summaauthor=M.+Lanfrancoauthor=G.+Ottonelloauthor=P.+Busquetauthor=K.-M.+Jungauthor=M.+Garcia-Guzmanauthor=R.+Heimauthor=R.+Scarpelliauthor=D.+Piomelli&title=Second-Generation+Non-Covalent+NAAA+Inhibitors+are+Protective+in+a+Model+of+Multiple+Sclerosis&doi=10.1002%2Fanie.201603746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis</span></div><div class="casAuthors">Migliore, Marco; Pontis, Silvia; Fuentes de Arriba, Angel Luis; Realini, Natalia; Torrente, Esther; Armirotti, Andrea; Romeo, Elisa; Di Martino, Simona; Russo, Debora; Pizzirani, Daniela; Summa, Maria; Lanfranco, Massimiliano; Ottonello, Giuliana; Busquet, Perrine; Jung, Kwang-Mook; Garcia-Guzman, Miguel; Heim, Roger; Scarpelli, Rita; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">11193-11197</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) are endogenous lipid mediators that suppress inflammation.  Their actions are terminated by the intracellular cysteine amidase, N-acylethanolamine acid amidase (NAAA).  Even though NAAA may offer a new target for anti-inflammatory therapy, the lipid-like structures and reactive warheads of current NAAA inhibitors limit the use of these agents as oral drugs.  A series of novel benzothiazole-piperazine derivs. that inhibit NAAA in a potent and selective manner by a non-covalent mechanism are described.  A prototype member of this class (8) displays high oral bioavailability, access to the central nervous system (CNS), and strong activity in a mouse model of multiple sclerosis (MS).  This compd. exemplifies a second generation of non-covalent NAAA inhibitors that may be useful in the treatment of MS and other chronic CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuWcI9qbPxD7Vg90H21EOLACvtfcHk0lhHzWlTcCrTzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFKmt77K&md5=3a0393efde3a858d2bef8af194b65a21</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fanie.201603746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201603746%26sid%3Dliteratum%253Aachs%26aulast%3DMigliore%26aufirst%3DM.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DFuentes%2Bde%2BArriba%26aufirst%3DA.%2BL.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DTorrente%26aufirst%3DE.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DDi%2BMartino%26aufirst%3DS.%26aulast%3DRusso%26aufirst%3DD.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DLanfranco%26aufirst%3DM.%26aulast%3DOttonello%26aufirst%3DG.%26aulast%3DBusquet%26aufirst%3DP.%26aulast%3DJung%26aufirst%3DK.-M.%26aulast%3DGarcia-Guzman%26aufirst%3DM.%26aulast%3DHeim%26aufirst%3DR.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DSecond-Generation%2520Non-Covalent%2520NAAA%2520Inhibitors%2520are%2520Protective%2520in%2520a%2520Model%2520of%2520Multiple%2520Sclerosis%26jtitle%3DAngew.%2520Chem.%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D11193%26epage%3D11197%26doi%3D10.1002%2Fanie.201603746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Advances in the discovery of N-acylethanolamine acid amidase inhibitors</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2014.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.phrs.2014.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=24798679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosFaqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=11-17&author=T.+Bandieraauthor=S.+Ponzanoauthor=D.+Piomelli&title=Advances+in+the+discovery+of+N-acylethanolamine+acid+amidase+inhibitors&doi=10.1016%2Fj.phrs.2014.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the discovery of N-acylethanolamine acid amidase inhibitors</span></div><div class="casAuthors">Bandiera, Tiziano; Ponzano, Stefano; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11-17</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  N-Acylethanolamine acid amidase (NAAA) is a cysteine amidase that hydrolyzes satd. or monounsatd. fatty acid ethanolamides, such as palmitoylethanolamide (PEA) and oleoylethanolamide (OEA).  PEA has been shown to exert analgesic and anti-inflammatory effects by engaging peroxisome proliferator-activated receptor-α.  Like other fatty acid ethanolamides, PEA is not stored in cells, but produced on demand from cell membrane precursors, and its actions are terminated by intracellular hydrolysis by either fatty acid amide hydrolase or NAAA.  Endogenous levels of PEA and OEA have been shown to decrease during inflammation.  Modulation of the tissue levels of PEA by inhibition of enzymes responsible for the breakdown of this lipid mediator may represent therefore a new therapeutic strategy for the treatment of pain and inflammation.  While a large no. of inhibitors of fatty acid amide hydrolase have been discovered, few compds. have been reported to inhibit NAAA activity.  Here, we describe the most representative NAAA inhibitors and briefly highlight their pharmacol. profile.  A recent study has shown that a NAAA inhibitor attenuated heat hyperalgesia and mech. allodynia caused by local inflammation or nerve damage in animal models of pain and inflammation.  This finding encourages further exploration of the pharmacol. of NAAA inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUwRrGiJPWfbVg90H21EOLACvtfcHk0lhHzWlTcCrTzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosFaqur0%253D&md5=a8673471686df8f77b19ec318316e192</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2014.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2014.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAdvances%2520in%2520the%2520discovery%2520of%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitors%26jtitle%3DPharmacol.%2520Res.%26date%3D2014%26volume%3D86%26spage%3D11%26epage%3D17%26doi%3D10.1016%2Fj.phrs.2014.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scalvini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fotio, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spadoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span> <span> </span><span class="NLM_article-title">N-Acylethanolamine Acid Amidase (NAAA): Structure, Function, and Inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">7475</span>– <span class="NLM_lpage">7490</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlt1Ckuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=7475-7490&author=D.+Piomelliauthor=L.+Scalviniauthor=Y.+Fotioauthor=A.+Lodolaauthor=G.+Spadoniauthor=G.+Tarziaauthor=M.+Mor&title=N-Acylethanolamine+Acid+Amidase+%28NAAA%29%3A+Structure%2C+Function%2C+and+Inhibition&doi=10.1021%2Facs.jmedchem.0c00191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">N-Acylethanolamine acid amidase (NAAA): Structure, function, and inhibition</span></div><div class="casAuthors">Piomelli, Daniele; Scalvini, Laura; Fotio, Yannick; Lodola, Alessio; Spadoni, Gilberto; Tarzia, Giorgio; Mor, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">7475-7490</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  N-Acylethanolamine acid amidase (NAAA) is an N-terminal cysteine hydrolase primarily found in the endosomal-lysosomal compartment of innate and adaptive immune cells.  NAAA catalyzes the hydrolytic deactivation of palmitoylethanolamide (PEA), a lipid-derived peroxisome proliferator-activated receptor-α (PPAR-α) agonist that exerts profound anti-inflammatory effects in animal models.  Emerging evidence points to NAAA-regulated PEA signaling at PPAR-α as a crit. control point for the induction and the resoln. of inflammation and to NAAA itself as a target for anti-inflammatory medicines.  The present Perspective discusses three key aspects of this hypothesis: the role of NAAA in controlling the signaling activity of PEA; the structural bases for NAAA function and inhibition by covalent and noncovalent agents; and finally, the potential value of NAAA-targeting drugs in the treatment of human inflammatory disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD2-Hxvqw2MbVg90H21EOLACvtfcHk0lhHzWlTcCrTzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlt1Ckuro%253D&md5=a3bf394222fc2902db2d0ffccf713143</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00191%26sid%3Dliteratum%253Aachs%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DScalvini%26aufirst%3DL.%26aulast%3DFotio%26aufirst%3DY.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DSpadoni%26aufirst%3DG.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26atitle%3DN-Acylethanolamine%2520Acid%2520Amidase%2520%2528NAAA%2529%253A%2520Structure%252C%2520Function%252C%2520and%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D7475%26epage%3D7490%26doi%3D10.1021%2Facs.jmedchem.0c00191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tuo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leleu-Chavain, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansook, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavatte, P.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00538</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00538" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWjsLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4-46&author=W.+Tuoauthor=N.+Leleu-Chavainauthor=J.+Spencerauthor=S.+Sansookauthor=R.+Milletauthor=P.+Chavatte&title=Therapeutic+Potential+of+Fatty+Acid+Amide+Hydrolase%2C+Monoacylglycerol+Lipase%2C+and+N-Acylethanolamine+Acid+Amidase+Inhibitors&doi=10.1021%2Facs.jmedchem.6b00538"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors</span></div><div class="casAuthors">Tuo, Wei; Leleu-Chavain, Natascha; Spencer, John; Sansook, Supojjanee; Millet, Regis; Chavatte, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-46</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Fatty acid ethanolamides (FAEs) and endocannabinoids (ECs) have been shown to alleviate pain and inflammation, regulate motility and appetite, and produce anti-cancer, anxiolytic, and neuroprotective efficacies via cannabinoid receptor type 1 (CB1) or type 2 (CB2), or via peroxisome proliferator-activated receptor α (PPAR-α) stimulation.  FAEs and ECs are synthesized by a series of endogenous enzymes, including N-acylphosphatidylethanolamine-phospholipase D (NAPE-PLD), diacylglycerol lipase (DAGL), or phospholipase C (PLC), and their metab. is mediated by several metabolic enzymes, including fatty acid amide hydrolase (FAAH), monoacylglycerol lipase (MAGL), N-acylethanolamine acid amidase (NAAA), or cyclooxygenase-2 (COX-2).  Over the last decades, increasing the concn. of FAEs and ECs through the inhibition of degrading enzymes has been considered to be a viable therapeutic approach to enhance their anti-nociceptive and anti-inflammatory effects, as well as protecting the nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoamrYPCqYEIbVg90H21EOLACvtfcHk0lgbpnlrS2F2sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWjsLzI&md5=dd509179171644767726a67cb42dd074</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00538%26sid%3Dliteratum%253Aachs%26aulast%3DTuo%26aufirst%3DW.%26aulast%3DLeleu-Chavain%26aufirst%3DN.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DSansook%26aufirst%3DS.%26aulast%3DMillet%26aufirst%3DR.%26aulast%3DChavatte%26aufirst%3DP.%26atitle%3DTherapeutic%2520Potential%2520of%2520Fatty%2520Acid%2520Amide%2520Hydrolase%252C%2520Monoacylglycerol%2520Lipase%252C%2520and%2520N-Acylethanolamine%2520Acid%2520Amidase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4%26epage%3D46%26doi%3D10.1021%2Facs.jmedchem.6b00538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span> <span> </span><span class="NLM_article-title">Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">214</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.ejmech.2017.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=28802121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlarsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=214-221&author=Y.+Liauthor=Q.+Chenauthor=L.+Yangauthor=Y.+Liauthor=Y.+Zhangauthor=Y.+Qiuauthor=J.+Renauthor=C.+Lu&title=Identification+of+highly+potent+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors%3A+Optimization+of+the+terminal+phenyl+moiety+of+oxazolidone+derivatives&doi=10.1016%2Fj.ejmech.2017.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives</span></div><div class="casAuthors">Li, Yuhang; Chen, Qi; Yang, Longhe; Li, Yanting; Zhang, Yang; Qiu, Yan; Ren, Jie; Lu, Canzhong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">214-221</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">N-acylethanolamine acid amidase (NAAA) is a cysteine hydrolase that participates in the deactivation of fatty acid ethanolamides, such as palmitoylethanolamide (PEA).  NAAA inhibition may provide a potential therapeutic strategy for the treatment of diseases in which higher PEA level is desired.  In the present study, we reported the structure-activity relationship (SAR) studies for oxazolidone derivs. as NAAA inhibitors.  A series of substituents or alkyl replacements for the terminal Ph ring of oxazolidone derivs. were examd.  The results showed that the inhibition potency of these oxazolidone derivs. towards NAAA depends on the sizes, flexibility, and lipophilicity of the terminal groups.  SAR results suggested that small lipophilic 3-Ph substituents or hydroxy-contg. 4-Ph substituents were preferable for optimal potency.  Furthermore, the distal aliph. replacement is also preferred for high inhibitory potency.  Rapid diln. and kinetic anal. suggested that oxazolidone derivs. with different terminal Ph moieties inhibited NAAA via different mechanisms.  This study identified several highly potent NAAA inhibitors, including 1a (F215, IC50 = 0.009 μM), 1o (IC50 = 0.061 μM) and 2e (IC50 = 0.092 μM), and also detd. structural requirements of oxazolidone derivs. for potent inhibition against NAAA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCt5BDoxRb7LVg90H21EOLACvtfcHk0lgbpnlrS2F2sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlarsrfF&md5=d4d34c95deea24435ceb35348c39d279</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DC.%26atitle%3DIdentification%2520of%2520highly%2520potent%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%253A%2520Optimization%2520of%2520the%2520terminal%2520phenyl%2520moiety%2520of%2520oxazolidone%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D139%26spage%3D214%26epage%3D221%26doi%3D10.1016%2Fj.ejmech.2017.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vitale, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottonello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petracca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berteotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dionisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span> <span> </span><span class="NLM_article-title">Synthesis, structure-activity, and structure-stability relationships of 2-substituted-N-(4-oxo-3-oxetanyl) N-acylethanolamine acid amidase (NAAA) inhibitors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">323</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1002%2Fcmdc.201300416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=24403170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvF2qtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=323-336&author=R.+Vitaleauthor=G.+Ottonelloauthor=R.+Petraccaauthor=S.+M.+Bertozziauthor=S.+Ponzanoauthor=A.+Armirottiauthor=A.+Berteottiauthor=M.+Dionisiauthor=A.+Cavalliauthor=D.+Piomelliauthor=T.+Bandieraauthor=F.+Bertozzi&title=Synthesis%2C+structure-activity%2C+and+structure-stability+relationships+of+2-substituted-N-%284-oxo-3-oxetanyl%29+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors&doi=10.1002%2Fcmdc.201300416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Structure-Activity, and Structure-Stability Relationships of 2-Substituted-N-(4-oxo-3-oxetanyl) N-Acylethanolamine Acid Amidase (NAAA) Inhibitors</span></div><div class="casAuthors">Vitale, Romina; Ottonello, Giuliana; Petracca, Rita; Bertozzi, Sine Mandrup; Ponzano, Stefano; Armirotti, Andrea; Berteotti, Anna; Dionisi, Mauro; Cavalli, Andrea; Piomelli, Daniele; Bandiera, Tiziano; Bertozzi, Fabio</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">323-336</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Racemic and nonracemic β-substituted α-amino-β-lactones such as I and II [R = Me, Et, i-Pr, t-Bu; R1 = R2, R3O; R2 = 4-PhCH2OC6H4, Ph(CH2)6; R3 = Ph(CH2)5, 4-PhC6H4CH2] were prepd. as inhibitors of N-acylethanolamine acid amidase (NAAA), a cysteine amidase that preferentially hydrolyzes satd. or monounsatd. fatty acid ethanolamide endogenous agonists of nuclear peroxisome proliferator-activated receptor-α, for potential use as antiinflammatory agents.  N-(alkoxycarbonylamino) β-lactones were both better inhibitors of NAAA and more stable than the corresponding N-acyl β-lactones; cis β-lactones I were more stable than the corresponding trans β-lactones II to both lactone hydrolysis and ring expansion to oxazolines.  Increasing the steric bulk of the β-substituent decreased inhibition of NAAA but improved hydrolytic stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhV2S-BL4VubVg90H21EOLACvtfcHk0lgbpnlrS2F2sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvF2qtw%253D%253D&md5=8ada8ce8bcd7f2f40376be631217d615</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300416%26sid%3Dliteratum%253Aachs%26aulast%3DVitale%26aufirst%3DR.%26aulast%3DOttonello%26aufirst%3DG.%26aulast%3DPetracca%26aufirst%3DR.%26aulast%3DBertozzi%26aufirst%3DS.%2BM.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DBerteotti%26aufirst%3DA.%26aulast%3DDionisi%26aufirst%3DM.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DBertozzi%26aufirst%3DF.%26atitle%3DSynthesis%252C%2520structure-activity%252C%2520and%2520structure-stability%2520relationships%2520of%25202-substituted-N-%25284-oxo-3-oxetanyl%2529%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D323%26epage%3D336%26doi%3D10.1002%2Fcmdc.201300416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duranti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tontini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonietti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacondio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fioni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solorzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span> <span> </span><span class="NLM_article-title">N-(2-oxo-3-oxetanyl)carbamic acid esters as N-acylethanolamine acid amidase inhibitors: synthesis and structure-activity and structure-property relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4824</span>– <span class="NLM_lpage">4836</span>, <span class="refDoi"> DOI: 10.1021/jm300349j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300349j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC38XlslGrtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4824-4836&author=A.+Durantiauthor=A.+Tontiniauthor=F.+Antoniettiauthor=F.+Vacondioauthor=A.+Fioniauthor=C.+Silvaauthor=A.+Lodolaauthor=S.+Rivaraauthor=C.+Solorzanoauthor=D.+Piomelliauthor=G.+Tarziaauthor=M.+Mor&title=N-%282-oxo-3-oxetanyl%29carbamic+acid+esters+as+N-acylethanolamine+acid+amidase+inhibitors%3A+synthesis+and+structure-activity+and+structure-property+relationships&doi=10.1021%2Fjm300349j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">N-(2-Oxo-3-oxetanyl)carbamic acid esters as N-acylethanolamine acid amidase inhibitors: synthesis and structure-activity and structure-property relationships</span></div><div class="casAuthors">Duranti, Andrea; Tontini, Andrea; Antonietti, Francesca; Vacondio, Federica; Fioni, Alessandro; Silva, Claudia; Lodola, Alessio; Rivara, Silvia; Solorzano, Carlos; Piomelli, Daniele; Tarzia, Giorgio; Mor, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4824-4836</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The β-lactone ring of N-(2-oxo-3-oxetanyl)amides, a class of N-acylethanolamine acid amidase (NAAA) inhibitors endowed with anti-inflammatory properties, is responsible for both NAAA inhibition and low compd. stability.  Here, we investigate the structure-activity and structure-property relationships for a set of known and new β-lactone derivs., focusing on the new class of N-(2-oxo-3-oxetanyl)carbamates.  Replacement of the amide group with a carbamate one led to different stereoselectivity for NAAA inhibition and higher intrinsic stability, because of the reduced level of intramol. attack at the lactone ring.  The introduction of a syn Me at the β-position of the lactone further improved chem. stability.  A tert-Bu substituent in the side chain reduced the reactivity with bovine serum albumin.  Compd. I (URB913/ARN077) inhibited NAAA with good in vitro potency (IC50 = 127 nM) and showed improved stability.  It is rapidly cleaved in plasma, which supports its use for topical applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1ZiDApcso2rVg90H21EOLACvtfcHk0lgJG42AMrUEHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlslGrtLo%253D&md5=c60261cf6c43b497bc39f43adb9f177f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm300349j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300349j%26sid%3Dliteratum%253Aachs%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DAntonietti%26aufirst%3DF.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DFioni%26aufirst%3DA.%26aulast%3DSilva%26aufirst%3DC.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DSolorzano%26aufirst%3DC.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26atitle%3DN-%25282-oxo-3-oxetanyl%2529carbamic%2520acid%2520esters%2520as%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitors%253A%2520synthesis%2520and%2520structure-activity%2520and%2520structure-property%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4824%26epage%3D4836%26doi%3D10.1021%2Fjm300349j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengatto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dionisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karacsonyi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">beta-Lactones Inhibit N-acylethanolamine Acid Amidase by S-Acylation of the Catalytic N-Terminal Cysteine</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">422</span>– <span class="NLM_lpage">426</span>, <span class="refDoi"> DOI: 10.1021/ml300056y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300056y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1SnurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=422-426&author=A.+Armirottiauthor=E.+Romeoauthor=S.+Ponzanoauthor=L.+Mengattoauthor=M.+Dionisiauthor=C.+Karacsonyiauthor=F.+Bertozziauthor=G.+Garauauthor=G.+Tarozzoauthor=A.+Reggianiauthor=T.+Bandieraauthor=G.+Tarziaauthor=M.+Morauthor=D.+Piomelli&title=beta-Lactones+Inhibit+N-acylethanolamine+Acid+Amidase+by+S-Acylation+of+the+Catalytic+N-Terminal+Cysteine&doi=10.1021%2Fml300056y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">β-Lactones Inhibit N-acylethanolamine Acid Amidase by S-Acylation of the Catalytic N-Terminal Cysteine</span></div><div class="casAuthors">Armirotti, Andrea; Romeo, Elisa; Ponzano, Stefano; Mengatto, Luisa; Dionisi, Mauro; Karacsonyi, Claudia; Bertozzi, Fabio; Garau, Gianpiero; Tarozzo, Glauco; Reggiani, Angelo; Bandiera, Tiziano; Tarzia, Giorgio; Mor, Marco; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">422-426</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cysteine amidase N-acylethanolamine acid amidase (NAAA) is a member of the N-terminal nucleophile class of enzymes and a potential target for anti-inflammatory drugs.  We investigated the mechanism of inhibition of human NAAA by substituted β-lactones.  We characterized pharmacol. a representative member of this class, ARN077, and showed, using high-resoln. liq. chromatog.-tandem mass spectrometry, that this compd. forms a thioester bond with the N-terminal catalytic cysteine in human NAAA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooO8IxuG5LzLVg90H21EOLACvtfcHk0lgJG42AMrUEHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1SnurY%253D&md5=482d17b3fb0c13c8356f27a4b3f97e93</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fml300056y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300056y%26sid%3Dliteratum%253Aachs%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DDionisi%26aufirst%3DM.%26aulast%3DKaracsonyi%26aufirst%3DC.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DGarau%26aufirst%3DG.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3Dbeta-Lactones%2520Inhibit%2520N-acylethanolamine%2520Acid%2520Amidase%2520by%2520S-Acylation%2520of%2520the%2520Catalytic%2520N-Terminal%2520Cysteine%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D422%26epage%3D426%26doi%3D10.1021%2Fml300056y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nuzzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliuca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzirani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottonello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Potent alpha-amino-beta-lactam carbamic acid ester as NAAA inhibitors. Synthesis and structure-activity relationship (SAR) studies</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">138</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.01.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.ejmech.2016.01.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=26866968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVansL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2016&pages=138-159&author=A.+Nuzziauthor=A.+Fiasellaauthor=J.+A.+Ortegaauthor=C.+Pagliucaauthor=S.+Ponzanoauthor=D.+Pizziraniauthor=S.+M.+Bertozziauthor=G.+Ottonelloauthor=G.+Tarozzoauthor=A.+Reggianiauthor=T.+Bandieraauthor=F.+Bertozziauthor=D.+Piomelli&title=Potent+alpha-amino-beta-lactam+carbamic+acid+ester+as+NAAA+inhibitors.+Synthesis+and+structure-activity+relationship+%28SAR%29+studies&doi=10.1016%2Fj.ejmech.2016.01.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Potent α-amino-β-lactam carbamic acid ester as NAAA inhibitors. Synthesis and structure-activity relationship (SAR) studies</span></div><div class="casAuthors">Nuzzi, Andrea; Fiasella, Annalisa; Ortega, Jose Antonio; Pagliuca, Chiara; Ponzano, Stefano; Pizzirani, Daniela; Bertozzi, Sine Mandrup; Ottonello, Giuliana; Tarozzo, Glauco; Reggiani, Angelo; Bandiera, Tiziano; Bertozzi, Fabio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">138-159</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">4-Cyclohexylbutyl-N-[(S)-2-oxoazetidin-3-yl]carbamate I is a potent, selective and systemically active inhibitor of intracellular NAAA activity, which produces profound anti-inflammatory effects in animal models.  In the present work, the authors describe structure-activity relationship (SAR) studies on 3-aminoazetidin-2-one derivs., which have led to the identification of I, and expand these studies to elucidate the principal structural and stereochem. features needed to achieve effective NAAA inhibition.  Investigations on the influence of the substitution at the β-position of the 2-oxo-3-azetidinyl ring as well as on the effect of size and shape of the carbamic acid ester side chain led to the discovery of II, a novel inhibitor of human NAAA that shows an improved physicochem. and drug-like profile relative to I.  This favorable profile, along with the structural diversity of the carbamic acid chain of I, identify this compd. as a promising new tool to investigate the potential of NAAA inhibitors as therapeutic agents for the treatment of pain and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaN0JjRB6bmrVg90H21EOLACvtfcHk0li7GCs1aNdPvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVansL4%253D&md5=639c2848d70ba68008db89244c2c8657</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.01.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.01.046%26sid%3Dliteratum%253Aachs%26aulast%3DNuzzi%26aufirst%3DA.%26aulast%3DFiasella%26aufirst%3DA.%26aulast%3DOrtega%26aufirst%3DJ.%2BA.%26aulast%3DPagliuca%26aufirst%3DC.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DBertozzi%26aufirst%3DS.%2BM.%26aulast%3DOttonello%26aufirst%3DG.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DPotent%2520alpha-amino-beta-lactam%2520carbamic%2520acid%2520ester%2520as%2520NAAA%2520inhibitors.%2520Synthesis%2520and%2520structure-activity%2520relationship%2520%2528SAR%2529%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D111%26spage%3D138%26epage%3D159%26doi%3D10.1016%2Fj.ejmech.2016.01.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fiasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuzzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">3-Aminoazetidin-2-one derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors suitable for systemic administration</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1602</span>– <span class="NLM_lpage">1614</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300546</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1002%2Fcmdc.201300546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=24828120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvF2ks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1602-1614&author=A.+Fiasellaauthor=A.+Nuzziauthor=M.+Summaauthor=A.+Armirottiauthor=G.+Tarozzoauthor=G.+Tarziaauthor=M.+Morauthor=F.+Bertozziauthor=T.+Bandieraauthor=D.+Piomelli&title=3-Aminoazetidin-2-one+derivatives+as+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors+suitable+for+systemic+administration&doi=10.1002%2Fcmdc.201300546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">3-Aminoazetidin-2-one Derivatives as N-Acylethanolamine Acid Amidase (NAAA) Inhibitors Suitable for Systemic Administration</span></div><div class="casAuthors">Fiasella, Annalisa; Nuzzi, Andrea; Summa, Maria; Armirotti, Andrea; Tarozzo, Glauco; Tarzia, Giorgio; Mor, Marco; Bertozzi, Fabio; Bandiera, Tiziano; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1602-1614</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">N-Acylethanolamine acid amidase (NAAA) is a cysteine hydrolase that catalyzes the hydrolysis of endogenous lipid mediators such as palmitoylethanolamide (PEA).  PEA has been shown to exert anti-inflammatory and antinociceptive effects in animals by engaging peroxisome proliferator-activated receptor α (PPAR-α).  Thus, preventing PEA degrdn. by inhibiting NAAA may provide a novel approach for the treatment of pain and inflammatory states.  Recently, 3-aminooxetan-2-one compds. were identified as a class of highly potent NAAA inhibitors.  The utility of these compds. is limited, however, by their low chem. and plasma stabilities.  In the present study, we synthesized and tested a series of N-(2-oxoazetidin-3-yl)amides as a novel class of NAAA inhibitors with good potency and improved physicochem. properties, suitable for systemic administration.  Moreover, we elucidated the main structural features of 3-aminoazetidin-2-one derivs. that are crit. for NAAA inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocn1G5QzPtHLVg90H21EOLACvtfcHk0li7GCs1aNdPvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvF2ks74%253D&md5=beee5cde68184abb3c47e4631c56497f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300546%26sid%3Dliteratum%253Aachs%26aulast%3DFiasella%26aufirst%3DA.%26aulast%3DNuzzi%26aufirst%3DA.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3D3-Aminoazetidin-2-one%2520derivatives%2520as%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%2520suitable%2520for%2520systemic%2520administration%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D1602%26epage%3D1614%26doi%3D10.1002%2Fcmdc.201300546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minich, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bland, J. S.</span></span> <span> </span><span class="NLM_article-title">A review of the clinical efficacy and safety of cruciferous vegetable phytochemicals</span>. <i>Nutr. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1301/nr.2007.jun.259-267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1301%2Fnr.2007.jun.259-267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=17605302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A280%3ADC%252BD2szovVCiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2007&pages=259-267&author=D.+M.+Minichauthor=J.+S.+Bland&title=A+review+of+the+clinical+efficacy+and+safety+of+cruciferous+vegetable+phytochemicals&doi=10.1301%2Fnr.2007.jun.259-267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the clinical efficacy and safety of cruciferous vegetable phytochemicals</span></div><div class="casAuthors">Minich Deanna M; Bland Jeffrey S</div><div class="citationInfo"><span class="NLM_cas:title">Nutrition reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">6 Pt 1</span>),
    <span class="NLM_cas:pages">259-67</span>
        ISSN:<span class="NLM_cas:issn">0029-6643</span>.
    </div><div class="casAbstract">Supplementation with the crucifer-derived phytochemicals indole-3-carbinol (I3C) and 3,3'-diindolylmethane (DIM) has been an area of active interest due to their role in estrogen metabolism.  This review addresses the debate about which cruciferous compound to use clinically by evaluating their efficacy and safety.  Significantly more clinical trials are available for I3C than for DIM.  I3C leads to beneficial shifts in hormone markers, and limited evidence suggests that DIM may result in a similar effect.  More research in humans is needed to further address whether DIM poses any safety risk.  Current data do not suggest that DIM provides enhanced clinical benefits over I3C.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIamZicYCMh3l8icjszYl0fW6udTcc2eYvH0A5rJXXBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2szovVCiug%253D%253D&md5=de5a7b5be7a87b86ab55ebf93fa27624</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1301%2Fnr.2007.jun.259-267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1301%252Fnr.2007.jun.259-267%26sid%3Dliteratum%253Aachs%26aulast%3DMinich%26aufirst%3DD.%2BM.%26aulast%3DBland%26aufirst%3DJ.%2BS.%26atitle%3DA%2520review%2520of%2520the%2520clinical%2520efficacy%2520and%2520safety%2520of%2520cruciferous%2520vegetable%2520phytochemicals%26jtitle%3DNutr.%2520Rev.%26date%3D2007%26volume%3D65%26spage%3D259%26epage%3D267%26doi%3D10.1301%2Fnr.2007.jun.259-267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higdon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delage, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dashwood, R.</span></span> <span> </span><span class="NLM_article-title">Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">224</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2007.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.phrs.2007.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=17317210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFGnt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2007&pages=224-236&author=J.+Higdonauthor=B.+Delageauthor=D.+Williamsauthor=R.+Dashwood&title=Cruciferous+vegetables+and+human+cancer+risk%3A+epidemiologic+evidence+and+mechanistic+basis&doi=10.1016%2Fj.phrs.2007.01.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis</span></div><div class="casAuthors">Higdon, Jane V.; Delage, Barbara; Williams, David E.; Dashwood, Roderick H.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">224-236</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cruciferous vegetables are a rich source of glucosinolates and their hydrolysis products, including indoles and isothiocyanates, and high intake of cruciferous vegetables has been assocd. with lower risk of lung and colorectal cancer in some epidemiol. studies.  Glucosinolate hydrolysis products alter the metab. or activity of sex hormones in ways that could inhibit the development of hormone-sensitive cancers, but evidence of an inverse assocn. between cruciferous vegetable intake and breast or prostate cancer in humans is limited and inconsistent.  Organizations such as the National Cancer Institute recommend the consumption of five to nine servings of fruits and vegetables daily, but sep. recommendations for cruciferous vegetables have not been established.  Isothiocyanates and indoles derived from the hydrolysis of glucosinolates, such as sulforaphane and indole-3-carbinol (I3C), have been implicated in a variety of anticarcinogenic mechanisms, but deleterious effects also have been reported in some exptl. protocols, including tumor promotion over prolonged periods of exposure.  Epidemiol. studies indicate that human exposure to isothiocyanates and indoles through cruciferous vegetable consumption may decrease cancer risk, but the protective effects may be influenced by individual genetic variation (polymorphisms) in the metab. and elimination of isothiocyanates from the body.  Cooking procedures also affect the bioavailability and intake of glucosinolates and their derivs.  Supplementation with I3C or the related dimer 3,3'-diindolylmethane (DIM) alters urinary estrogen metabolite profiles in women, but the effects of I3C and DIM on breast cancer risk are not known.  Small preliminary trials in humans suggest that I3C supplementation may be beneficial in treating conditions related to human papilloma virus infection, such as cervical intraepithelial neoplasia and recurrent respiratory papillomatosis, but larger randomized controlled trials are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcKY2PKXhL_LVg90H21EOLACvtfcHk0li7GCs1aNdPvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFGnt7c%253D&md5=34353c7a7a2bd24c16566313511e8a64</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2007.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2007.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DHigdon%26aufirst%3DJ.%26aulast%3DDelage%26aufirst%3DB.%26aulast%3DWilliams%26aufirst%3DD.%26aulast%3DDashwood%26aufirst%3DR.%26atitle%3DCruciferous%2520vegetables%2520and%2520human%2520cancer%2520risk%253A%2520epidemiologic%2520evidence%2520and%2520mechanistic%2520basis%26jtitle%3DPharmacol.%2520Res.%26date%3D2007%26volume%3D55%26spage%3D224%26epage%3D236%26doi%3D10.1016%2Fj.phrs.2007.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wattenberg, L. W.</span></span> <span> </span><span class="NLM_article-title">Inhibition of carcinogenic effects of polycyclic hydrocarbons by benzyl isothiocyanate and related compounds</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">398</span>, <span class="refDoi"> DOI: 10.1093/jnci/58.2.395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1093%2Fjnci%2F58.2.395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=401894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaE2sXhtleltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1977&pages=395-398&author=L.+W.+Wattenberg&title=Inhibition+of+carcinogenic+effects+of+polycyclic+hydrocarbons+by+benzyl+isothiocyanate+and+related+compounds&doi=10.1093%2Fjnci%2F58.2.395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of carcinogenic effects of polycyclic hydrocarbons by benzyl isothiocyanate and related compounds</span></div><div class="casAuthors">Wattenberg, Lee W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute (1940-1978)</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">395-8</span>CODEN:
                <span class="NLM_cas:coden">JNCIAM</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">Benzyl isothiocyanate [622-78-6], and phenethyl isothiocyanate [2257-09-2], compds. found in cruciferous plants, and phenyl isothiocyanate [103-72-0], a synthetic compd., all inhibited 7,12-dimethylbenz[a]anthracene (I) [57-97-6]-induced mammary tumor formation in female Sprague-Dawley rats when administered 4 h prior to I.  Comparable studies in which benzyl isothiocyanate was administered 24 h before or 4 h after I showed almost complete loss of inhibition.  Addns. of benzyl isothiocyanate or phenethyl isothiocyanate to a diet contg. I inhibited formation of neoplasms of the forestomach and pulmonary adenomas in female ICR/Ha mice.  Addn. of benzyl isothiocyanate to a diet contg. benzo[a]pyrene [50-32-8] also inhibited carcinogenesis of the mouse forestomach due to this carcinogen.  The finding of 2 addnl. anutrient dietary compds. which inhibit chem. carcinogenesis focuses on the possibility that dietary constituents of this nature may diminish the impact of exposures to chem. carcinogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_gOkiwCy_ibVg90H21EOLACvtfcHk0liMRgVB_9_e8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXhtleltrs%253D&md5=70dc6ed28bbd302280f81edad4f888fa</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F58.2.395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F58.2.395%26sid%3Dliteratum%253Aachs%26aulast%3DWattenberg%26aufirst%3DL.%2BW.%26atitle%3DInhibition%2520of%2520carcinogenic%2520effects%2520of%2520polycyclic%2520hydrocarbons%2520by%2520benzyl%2520isothiocyanate%2520and%2520related%2520compounds%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1977%26volume%3D58%26spage%3D395%26epage%3D398%26doi%3D10.1093%2Fjnci%2F58.2.395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakubikova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cervi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nahar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klippel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cholujova, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leiba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delmore, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negri, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blotta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMillin, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedlak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsiades, C. S.</span></span> <span> </span><span class="NLM_article-title">Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma</span>. <i>Haematologica</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">1170</span>– <span class="NLM_lpage">1179</span>, <span class="refDoi"> DOI: 10.3324/haematol.2010.029363</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.3324%2Fhaematol.2010.029363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=21712538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1KmtrnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2011&pages=1170-1179&author=J.+Jakubikovaauthor=D.+Cerviauthor=M.+Ooiauthor=K.+Kimauthor=S.+Naharauthor=S.+Klippelauthor=D.+Cholujovaauthor=M.+Leibaauthor=J.+F.+Daleyauthor=J.+Delmoreauthor=J.+Negriauthor=S.+Blottaauthor=D.+W.+McMillinauthor=T.+Hideshimaauthor=P.+G.+Richardsonauthor=J.+Sedlakauthor=K.+C.+Andersonauthor=C.+S.+Mitsiades&title=Anti-tumor+activity+and+signaling+events+triggered+by+the+isothiocyanates%2C+sulforaphane+and+phenethyl+isothiocyanate%2C+in+multiple+myeloma&doi=10.3324%2Fhaematol.2010.029363"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma</span></div><div class="casAuthors">Jakubikova, Jana; Cervi, David; Ooi, Melissa; Kim, Kihyun; Nahar, Sabikun; Klippel, Steffen; Cholujova, Dana; Leiba, Merav; Daley, John F.; Delmore, Jake; Negri, Joseph; Blotta, Simona; McMillin, Douglas W.; Hideshima, Teru; Richardson, Paul G.; Sedlak, Jan; Anderson, Kenneth C.; Mitsiades, Constantine S.</div><div class="citationInfo"><span class="NLM_cas:title">Haematologica</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1170-1179</span>CODEN:
                <span class="NLM_cas:coden">HAEMAX</span>;
        ISSN:<span class="NLM_cas:issn">0390-6078</span>.
    
            (<span class="NLM_cas:orgname">Ferrata Storti Foundation</span>)
        </div><div class="casAbstract">Background. Isothiocyanates, a family of phytochems. found in cruciferous vegetables, have cytotoxic effects against several types of tumor cells.  Multiple myeloma is a fatal disease characterized by clonal proliferation of plasma cells in the bone marrow.  The growing body of preclin. information on the anti-cancer activity of isothiocyanates led us to investigate their anti-myeloma properties.  Design and Methods. We evaluated the anti-myeloma activity of the isothiocyanates, sulforaphane and phenethyl isothiocyanate, on a panel of human myeloma cell lines as well as primary myeloma tumor cells.  Cell viability, apoptosis, cell cycle alterations and cell proliferation were then analyzed in vitro and in a xenograft mouse model in vivo.  The mol. sequelae of isothiocyanate treatment in multiple myeloma cells were evaluated by multiplex analyses using bead arrays and western blotting.  Results. We obsd. that sulforaphane and phenylethyl isothiocyanate have activity against myeloma cell lines and patients' myeloma cells both in vitro and in vivo using a myeloma xenograft mouse model.  Isothiocyanates induced apoptotic death of myeloma cells; depletion of mitochondrial membrane potential; cleavage of PARP and caspases-3 and -9; as well as down-regulation of anti-apoptotic proteins including Mcl-1, X-IAP, c-IAP and survivin.  Isothiocyanates induced G2/M cell cycle arrest accompanied by mitotic phosphorylation of histone H3.  Multiplex anal. of phosphorylation of diverse components of signaling cascades revealed changes in MAPK activation; increased phosphorylation of c-jun and HSP27; as well as changes in the phosphorylation of Akt, and GSK3α/β and p53.  Isothiocyanates suppressed proliferation of myeloma cells alone and when co-cultured with HS-5 stromal cells.  Sulforaphane and phenylethyl isothiocyanate enhanced the in vitro anti-myeloma activity of several conventional and novel therapies used in multiple myeloma.  Conclusions. Our study shows that isothiocyanates have potent anti-myeloma activities and may enhance the activity of other anti-multiple myeloma agents.  These results indicate that isothiocyanates may have therapeutic potential in multiple myeloma and provide the preclin. framework for future clin. studies of isothiocyanates in multiple myeloma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGe_1GHimFZrVg90H21EOLACvtfcHk0liMRgVB_9_e8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1KmtrnE&md5=50e1571bc636e0ed8425a9833fec510c</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2010.029363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2010.029363%26sid%3Dliteratum%253Aachs%26aulast%3DJakubikova%26aufirst%3DJ.%26aulast%3DCervi%26aufirst%3DD.%26aulast%3DOoi%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DNahar%26aufirst%3DS.%26aulast%3DKlippel%26aufirst%3DS.%26aulast%3DCholujova%26aufirst%3DD.%26aulast%3DLeiba%26aufirst%3DM.%26aulast%3DDaley%26aufirst%3DJ.%2BF.%26aulast%3DDelmore%26aufirst%3DJ.%26aulast%3DNegri%26aufirst%3DJ.%26aulast%3DBlotta%26aufirst%3DS.%26aulast%3DMcMillin%26aufirst%3DD.%2BW.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DSedlak%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DMitsiades%26aufirst%3DC.%2BS.%26atitle%3DAnti-tumor%2520activity%2520and%2520signaling%2520events%2520triggered%2520by%2520the%2520isothiocyanates%252C%2520sulforaphane%2520and%2520phenethyl%2520isothiocyanate%252C%2520in%2520multiple%2520myeloma%26jtitle%3DHaematologica%26date%3D2011%26volume%3D96%26spage%3D1170%26epage%3D1179%26doi%3D10.3324%2Fhaematol.2010.029363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntee, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecht, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, F.-L.</span></span> <span> </span><span class="NLM_article-title">Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">8548</span>– <span class="NLM_lpage">8557</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-05-0237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1158%2F0008-5472.can-05-0237" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=16166336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVShsbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=8548-8557&author=C.+C.+Conawayauthor=C.-X.+Wangauthor=B.+Pittmanauthor=Y.-M.+Yangauthor=J.+E.+Schwartzauthor=D.+Tianauthor=E.+J.+McInteeauthor=S.+S.+Hechtauthor=F.-L.+Chung&title=Phenethyl+isothiocyanate+and+sulforaphane+and+their+N-acetylcysteine+conjugates+inhibit+malignant+progression+of+lung+adenomas+induced+by+tobacco+carcinogens+in+A%2FJ+mice&doi=10.1158%2F0008-5472.can-05-0237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Phenethyl Isothiocyanate and Sulforaphane and their N-Acetylcysteine Conjugates Inhibit Malignant Progression of Lung Adenomas Induced by Tobacco Carcinogens in A/J Mice</span></div><div class="casAuthors">Conaway, C. Clifford; Wang, Chung-Xiou; Pittman, Brian; Yang, Yang-Ming; Schwartz, Joel E.; Tian, Defa; McIntee, Edward J.; Hecht, Stephen S.; Chung, Fung-Lung</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8548-8557</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We have shown previously that naturally occurring isothiocyanates derived from cruciferous vegetables and their N-acetylcysteine conjugates inhibit lung adenoma formation induced by tobacco carcinogens in A/J mice at the post-initiation stage.  The tumor-inhibitory activity by these compds. is linked with activation of activator protein and induction of apoptosis in lung tissues, suggesting that these compds. may also inhibit the development of adenomas to adenocarcinomas in lung.  In this study, the chemopreventive activity of phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates during progression of lung adenomas to malignant tumors was investigated in A/J mice.  Mice were divided into 14 groups and treated with a mixt. of 3 μmol benzo(a)pyrene [B(a)P] and 3 μmol 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) given by gavage once weekly for 8 wk.  Twenty weeks after the beginning of carcinogen administration, a total of 20 mice in the treatment groups were sacrificed with an av. yield of 7.3±4.5 lung adenomas per mouse.  The remaining mice in each group were fed diets contg. phenethyl isothiocyanate (3 and 1.5 mmol/kg diet), sulforaphane (3 and 1.5 mmol/kg diet), phenethyl isothiocyanate-N-acetylcysteine (8 and 4 mmol/kg diet), sulforaphane-N-acetylcysteine (8 and 4 mmol/kg diet) during weeks 21 to 42.  Four mice in each of the high-dose treatment groups were sacrificed during weeks 28 and 36 and the bioassay was terminated during week 42; lung tissues were harvested for histopathol. examn. of tumors and for cell proliferation (proliferating cell nuclear antigen) and apoptosis (caspase-3) assays using immunohistochem. staining.  At termination, the incidence of adenocarcinoma in the 3 mmol/kg diet phenethyl isothiocyanate group and 8 mmol/kg diet phenethyl isothiocyanate-N-acetylcysteine group was reduced to 19% and 13%, resp., compared with 42% in the carcinogen-treated control group.  At the lower doses, phenethyl isothiocyanate and its N-acetylcysteine conjugate also inhibited the incidences of lung adenocarcinoma, however, the decreases were not statistically significant.  The lung tumor incidences in groups treated with sulforaphane-N-acetylcysteine in the diet were also significantly reduced to 11% or 16%.  Furthermore, the malignant lung tumor multiplicity was significantly reduced from 1.0 tumor/mouse in the carcinogen-treated control group to 0.3 in the sulforaphane low-dose group, 0.3 and 0.4 in the two sulforaphane-N-acetylcysteine groups, and 0.4 in the phenethyl isothiocyanate high-dose group.  The malignant tumor multiplicities in other treatment groups were also reduced (0.5-0.8 tumors/mouse), but not significantly.  Unlike lung adenocarcinomas, both incidences and multiplicities of lung adenomas were not much affected by treatment with isothiocyanates or their conjugates.  Immunohistochem. examn. of the lung tumors from all time points indicated that significant redn. in proliferating cell nuclear antigen and induction of apoptosis (terminal nucleotidyl transferase-mediated nick end labeling and caspase-3) were obsd. in the isothiocyanate and isothiocyanate-N-acetylcysteine-treated groups that showed inhibition of the development of lung adenocarcinomas.  The results of the study provide a basis for future evaluation of the potential of phenethyl isothiocyanate and sulforaphane and their conjugates as chemopreventive agents in smokers and ex-smokers with early lung lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW3uBs1IlbLrVg90H21EOLACvtfcHk0lgPo08Q6V293w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVShsbfE&md5=70ac8709d36d24601a4460377a219e8e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.can-05-0237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.can-05-0237%26sid%3Dliteratum%253Aachs%26aulast%3DConaway%26aufirst%3DC.%2BC.%26aulast%3DWang%26aufirst%3DC.-X.%26aulast%3DPittman%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DY.-M.%26aulast%3DSchwartz%26aufirst%3DJ.%2BE.%26aulast%3DTian%26aufirst%3DD.%26aulast%3DMcIntee%26aufirst%3DE.%2BJ.%26aulast%3DHecht%26aufirst%3DS.%2BS.%26aulast%3DChung%26aufirst%3DF.-L.%26atitle%3DPhenethyl%2520isothiocyanate%2520and%2520sulforaphane%2520and%2520their%2520N-acetylcysteine%2520conjugates%2520inhibit%2520malignant%2520progression%2520of%2520lung%2520adenomas%2520induced%2520by%2520tobacco%2520carcinogens%2520in%2520A%252FJ%2520mice%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D8548%26epage%3D8557%26doi%3D10.1158%2F0008-5472.can-05-0237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chung, F.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, B. S.</span></span> <span> </span><span class="NLM_article-title">Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2287</span>– <span class="NLM_lpage">2291</span>, <span class="refDoi"> DOI: 10.1093/carcin/21.12.2287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1093%2Fcarcin%2F21.12.2287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=11133820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFyrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=2287-2291&author=F.-L.+Chungauthor=C.+C.+Conawayauthor=C.+V.+Raoauthor=B.+S.+Reddy&title=Chemoprevention+of+colonic+aberrant+crypt+foci+in+Fischer+rats+by+sulforaphane+and+phenethyl+isothiocyanate&doi=10.1093%2Fcarcin%2F21.12.2287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate</span></div><div class="casAuthors">Chung, Fung-Lung; Conaway, C. Clifford; Rao, C. V.; Reddy, Bandaru S.</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2287-2291</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Epidemiol. studies have linked consumption of broccoli to a reduced risk of colon cancer in individuals with the glutathione S-transferase M1 (GSTM1) null genotype.  GSTs are involved in excretion and elimination of isothiocyanates (ITCs), which are major constituents of broccoli and other cruciferous vegetables and have cancer chemopreventive potential, so it is speculated that ITCs may play a role in protection against human colon cancer.  However, there is a lack of data from animal studies to support this.  We carried out a bioassay to examine whether sulforaphane (SFN) and phenethyl isothiocyanate (PEITC), major ITCs in broccoli and watercress, resp., and their corresponding N-acetylcysteine (NAC) conjugates, show any chemopreventive activity towards azoxymethane (AOM)-induced colonic aberrant crypt foci (ACF) in F344 rats.  Groups of six male F344 rats were treated with AOM s.c. (15 mg/kg body wt) once weekly for 2 wk.  SFN and PEITC and their NAC conjugates were administered by gavage either three times weekly for 8 wk (5 and 20 μmol, resp.) after AOM dosing (post-initiation stage) or once daily for 3 days (20 and 50 μmol, resp.) before AOM treatment (initiation stage).  The bioassay was terminated on week 10 after the second AOM dosing and ACF were quantified.  SFN, SFN-NAC, PEITC and PEITC-NAC all significantly reduced the formation of total ACF from 153 to 100-116 (P < 0.01) and multicrypt foci from 52 to 27-38 (more than four crypts/focus; P < 0.05) during the post-initiation treatment.  However, only SFN and PEITC were effective during the initiation phase, reducing the total ACF from 153 to 109-115 (P < 0.01) and multicrypt foci from 52 to 35 (more than four crypts/focus; P < 0.05).  The NAC conjugates were inactive as anti-initiators against AOM-induced ACF.  These findings provide important lab. evidence for a potential role of SFN and PEITC in the protection against colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGU3-bY7ZoULVg90H21EOLACvtfcHk0lgPo08Q6V293w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFyrtw%253D%253D&md5=1d2f22065dfb4337c08e0601d96500d2</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2F21.12.2287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252F21.12.2287%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DF.-L.%26aulast%3DConaway%26aufirst%3DC.%2BC.%26aulast%3DRao%26aufirst%3DC.%2BV.%26aulast%3DReddy%26aufirst%3DB.%2BS.%26atitle%3DChemoprevention%2520of%2520colonic%2520aberrant%2520crypt%2520foci%2520in%2520Fischer%2520rats%2520by%2520sulforaphane%2520and%2520phenethyl%2520isothiocyanate%26jtitle%3DCarcinogenesis%26date%3D2000%26volume%3D21%26spage%3D2287%26epage%3D2291%26doi%3D10.1093%2Fcarcin%2F21.12.2287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krzeminski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, F.-L.</span></span> <span> </span><span class="NLM_article-title">Decomposition rates of isothiocyanate conjugates determine their activity as inhibitors of cytochrome p450 enzymes</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1170</span>– <span class="NLM_lpage">1176</span>, <span class="refDoi"> DOI: 10.1021/tx010029w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx010029w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsFehtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2001&pages=1170-1176&author=C.+C.+Conawayauthor=J.+Krzeminskiauthor=S.+Aminauthor=F.-L.+Chung&title=Decomposition+rates+of+isothiocyanate+conjugates+determine+their+activity+as+inhibitors+of+cytochrome+p450+enzymes&doi=10.1021%2Ftx010029w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Decomposition rates of isothiocyanate conjugates determine their activity as inhibitors of cytochrome p450 enzymes</span></div><div class="casAuthors">Conaway, C. Clifford; Krzeminski, Jacek; Amin, Shantu; Chung, Fung-Lung</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1170-1176</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Thiol conjugates of isothiocyanates (thiol-ITCs) are metabolites of ITCs formed in the mercapturic acid pathway in mammals.  They are effective chemopreventive agents in mouse lung tumor bioassays and in other models.  Thiol-ITCs are inhibitors of P450s, but it has not been detd. if P 450 inhibition is due to conjugates themselves or to parent ITCs released by deconjugation reactions.  In studies of mechanism of chemopreventive action of thiol-ITCs, rates of deconjugation of Cys, GSH, and N-acetyl-L-cysteine (NAC) conjugates of benzyl isothiocyanate (BITC), phenethyl isothiocyanate (PEITC), 6-phenylhexyl isothiocyanate (PHITC), and sulforaphane (SFN), expressed as the first-order rate const. k1 and the half-life of decompn. Dt1/2, were measured in aq. solns. at pH 7.4 and 37°.  The Dt1/2s for the Cys conjugates were severalfold shorter than the Dt1/2s for resp. GSH conjugates, while the Dt1/2s for the NAC conjugates were the longest.  Cleavage of thiol conjugates was pH dependent, much slower under acidic conditions than at pH 7.4.  Inhibition of P 450 enzymes by thiol-ITCs was followed using PROD (pentoxyresorufin O-dealkylation) for P 450 2B1 and EROD (ethoxyresorufin O-dealkylation) for P 450 1A1.  The inhibition of PROD and EROD by aq. thiol-ITCs increased with preincubation time and was roughly parallel to the extent of decompn. of the conjugate that had occurred, indicating that both potency of the resp. parent ITC and the rate of reductive cleavage of the conjugate influenced enzyme inhibition.  In the presence of 250-1000 μM GSH, comparable to physiol. levels, rates of deconjugation of thiol-ITCs were markedly reduced; inhibition of PROD was also proportionately reduced.  Slow rates of decompn. of thiol-ITCs anticipated in plasma and tissues suggests that inhibition of P 450 enzymes involved in carcinogen activation by ITCs released from thiol-ITCs may not be a principal mechanism for their tumor inhibitory activity; other mechanisms probably contribute to their chemopreventive activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfaJItIZeMarVg90H21EOLACvtfcHk0lgPo08Q6V293w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsFehtrk%253D&md5=295f5cf88b55730fb8c07157b62c0c0a</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Ftx010029w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx010029w%26sid%3Dliteratum%253Aachs%26aulast%3DConaway%26aufirst%3DC.%2BC.%26aulast%3DKrzeminski%26aufirst%3DJ.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DChung%26aufirst%3DF.-L.%26atitle%3DDecomposition%2520rates%2520of%2520isothiocyanate%2520conjugates%2520determine%2520their%2520activity%2520as%2520inhibitors%2520of%2520cytochrome%2520p450%2520enzymes%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2001%26volume%3D14%26spage%3D1170%26epage%3D1176%26doi%3D10.1021%2Ftx010029w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eklind, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, F. L.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of isothiocyanates as mechanism-based inhibitors of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4327</span>– <span class="NLM_lpage">4333</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=8044780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaK2cXlsVygtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1994&pages=4327-4333&author=D.+Jiaoauthor=K.+I.+Eklindauthor=C.+I.+Choiauthor=D.+H.+Desaiauthor=S.+G.+Aminauthor=F.+L.+Chung&title=Structure-activity+relationships+of+isothiocyanates+as+mechanism-based+inhibitors+of+4-%28methylnitrosamino%29-1-%283-pyridyl%29-1-butanone-induced+lung+tumorigenesis+in+A%2FJ+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of isothiocyanates as mechanism-based inhibitors of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice</span></div><div class="casAuthors">Jiao, Ding; Eklind, Karin I.; Choi, Chang-In; Desai, Dhimant H.; Amin, Shantu G.; Chung, Fung-Lung</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4327-33</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">A structure-activity relationship study was carried out to identify structural features in arylalkyl and alkyl isothiocyanates that are assocd. with the inhibitory potency of these compds. against lung tumorigenesis induced in A/J mice by the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).  These features include the alkyl chain length, Ph substitution, and secondary isothiocyanates.  The naturally occurring allyl isothiocyanate, phenethyl isothiocyanate, and the synthetic analogs such as 6-phenylhexyl isothiocyanate, 8-phenyloctyl isothiocyanate, 10-phenyldecyl isothiocyanate, 1,2-diphenylethyl isothiocyanate, 2,2-diphenylethyl isothiocyanate, and alkyl isothiocyanates (with 1-hexyl, 2-hexyl, and 1-dodecyl as alkyl moieties) were assayed in mice for their tumor inhibitory potential.  The isothiocyanates were given in corn oil by gavage at doses of either 0.04, 0.1, and 0.2 μmol or 1 and 5 μmol 2 h prior to a single i.p. injection of 10 μmol NNK.  Mice were sacrificed 16 wk later and lung adenomas were counted.  At 0.2 μmol, 8-phenyloctyl isothiocyanate and 10-phenyldecyl isothiocyanate were stronger inhibitors than the previously tested 6-phenyldecyl isothiocyanate were stronger inhibitors than the previously tested 6-phenylhexyl isothiocyanate, but the difference in potency was not obvious at the lower doses.  At both 1 and 5 μmol, allyl isothiocyanate was inactive, while the other five synthetic isothiocyanates were considerably more potent than phenethyl isothiocyanate.  In the alkyl isothiocyanate series, 2-hexyl isothiocyanate was the most potent at 1 μmol, reducing tumor multiplicity in the group treated with NNK alone from 11.1 to the background level.  Also, 1,2-diphenylethyl isothiocyanate appeared to be a stronger inhibitor than 2,2-diphenylethyl isothiocyanate.  In this study the authors have shown that the Ph moiety is not essential for the inhibitory activity since alkyl isothiocyanates exhibit strong inhibitory effects against lung tumorigenesis.  The authors have also shown that secondary isothiocyanates possess a higher potency than their structural isomers bearing a primary isothiocyanate.  From results of this study and of seven previously studied isothiocyanates, the authors conclude that the obsd. inhibitory potency of isothiocyanates in the A/J mouse lung tumor model is correlated with their partition coeffs. (log P) and the pseudo first order rate consts. for the reaction of isothiocyanates toward glutathione (kobs).  These results reveal that both high lipophilicity and low reactivity of isothiocyanates are important for inhibitory activity toward NNK-induced lung tumorigenesis.  These observations provide a structural basis for the discovery of more effective chemopreventive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBPLP-fDqgWbVg90H21EOLACvtfcHk0lhGCIBh8Rxs-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlsVygtrc%253D&md5=d26832955c75cff805b2338214d834ac</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiao%26aufirst%3DD.%26aulast%3DEklind%26aufirst%3DK.%2BI.%26aulast%3DChoi%26aufirst%3DC.%2BI.%26aulast%3DDesai%26aufirst%3DD.%2BH.%26aulast%3DAmin%26aufirst%3DS.%2BG.%26aulast%3DChung%26aufirst%3DF.%2BL.%26atitle%3DStructure-activity%2520relationships%2520of%2520isothiocyanates%2520as%2520mechanism-based%2520inhibitors%2520of%25204-%2528methylnitrosamino%2529-1-%25283-pyridyl%2529-1-butanone-induced%2520lung%2520tumorigenesis%2520in%2520A%252FJ%2520mice%26jtitle%3DCancer%2520Res.%26date%3D1994%26volume%3D54%26spage%3D4327%26epage%3D4333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D. K.</span></span> <span> </span><span class="NLM_article-title">Drug discovery for a new generation of covalent drugs</span>. <i>Expet Opin. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">581</span>, <span class="refDoi"> DOI: 10.1517/17460441.2012.688744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1517%2F17460441.2012.688744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=22607458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC38XptFWmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=561-581&author=A.+S.+Kalgutkarauthor=D.+K.+Dalvie&title=Drug+discovery+for+a+new+generation+of+covalent+drugs&doi=10.1517%2F17460441.2012.688744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery for a new generation of covalent drugs</span></div><div class="casAuthors">Kalgutkar, Amit S.; Dalvie, Deepak K.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">561-581</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The design of target-specific covalent inhibitors is conceptually attractive because of increased biochem. efficiency through covalency and increased duration of action that outlasts the pharmacokinetics of the agent.  Although many covalent inhibitors have been approved or are in advanced clin. trials to treat indications such as cancer and hepatitis C, there is a general tendency to avoid them as drug candidates because of concerns regarding immune-mediated toxicity that can arise from indiscriminate reactivity with off-target proteins.Areas covered: The review examines potential reason(s) for the excellent safety record of marketed covalent agents and advanced clin. candidates for emerging therapeutic targets.  A significant emphasis is placed on proteomic techniques and chem./biochem. reactivity assays that aim to provide a systematic rank ordering of pharmacol. selectivity relative to off-target protein reactivity of covalent inhibitors.Expert opinion: While tactics to examine selective covalent modification of the pharmacol. target are broadly applicable in drug discovery, it is unclear whether the output from such studies can prospectively predict idiosyncratic immune-mediated drug toxicity.  Opinions regarding an acceptable threshold of protein reactivity/body burden for a toxic electrophile and a non-toxic electrophilic covalent drug have not been defined.  Increasing confidence in proteomic and chem./biochem. reactivity screens will require a retrospective side-by-side profiling of marketed covalent drugs and electrophiles known to cause deleterious toxic effects via non-selective covalent binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowmXy20mDTPbVg90H21EOLACvtfcHk0lhGCIBh8Rxs-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptFWmt7k%253D&md5=b7fc8e60b263dda5765dd8380f52df17</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1517%2F17460441.2012.688744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2012.688744%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26atitle%3DDrug%2520discovery%2520for%2520a%2520new%2520generation%2520of%2520covalent%2520drugs%26jtitle%3DExpet%2520Opin.%2520Drug%2520Discov.%26date%3D2012%26volume%3D7%26spage%3D561%26epage%3D581%26doi%3D10.1517%2F17460441.2012.688744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atsumi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takakusa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okazaki, O.</span></span> <span> </span><span class="NLM_article-title">A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1970</span>– <span class="NLM_lpage">1977</span>, <span class="refDoi"> DOI: 10.1124/dmd.109.027797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1124%2Fdmd.109.027797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=19487250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVOrsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1970-1977&author=S.+Nakayamaauthor=R.+Atsumiauthor=H.+Takakusaauthor=Y.+Kobayashiauthor=A.+Kuriharaauthor=Y.+Nagaiauthor=D.+Nakaiauthor=O.+Okazaki&title=A+zone+classification+system+for+risk+assessment+of+idiosyncratic+drug+toxicity+using+daily+dose+and+covalent+binding&doi=10.1124%2Fdmd.109.027797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding</span></div><div class="casAuthors">Nakayama, Shintaro; Atsumi, Ryo; Takakusa, Hideo; Kobayashi, Yoshimasa; Kurihara, Atsushi; Nagai, Yoko; Nakai, Daisuke; Okazaki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1970-1977</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The risk of idiosyncratic drug toxicity (IDT) is of great concern to the pharmaceutical industry.  Current hypotheses based on retrospective studies suggest that the occurrence of IDT is related to covalent binding and daily dose.  The authors detd. the covalent binding of 42 radiolabeled drugs in three test systems (human liver microsomes and hepatocytes in vitro and rat liver in vivo) to assess the risk of IDT.  On the basis of safety profiles given in official documentation, tested drugs were classified into the safety categories of safe, warning, black box warning, and withdrawn.  The covalent binding in each of the three test systems did not distinguish the safety categories clearly.  However, when the log-normalized covalent binding was plotted against the log-normalized daily dose, the distribution of the plot in the safety categories became clear.  An ordinal logistic regression anal. indicated that both covalent binding and daily dose were significantly correlated with safety category and that covalent binding in hepatocytes was the best predictor among the three systems.  When two sepn. lines were drawn on the correlation graph between covalent binding in human hepatocytes and daily dose by a regression anal. to create three zones, 30 of 37 tested drugs were located in zones corresponding to their resp. classified safety categories.  In conclusion, the authors established a zone classification system using covalent binding in human hepatocytes and daily dose for the risk assessment of IDTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtahZPkNJ3JbVg90H21EOLACvtfcHk0lhGCIBh8Rxs-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVOrsrfO&md5=425119e0451fc50ec6ca95d5e3fe5fd3</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.027797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.027797%26sid%3Dliteratum%253Aachs%26aulast%3DNakayama%26aufirst%3DS.%26aulast%3DAtsumi%26aufirst%3DR.%26aulast%3DTakakusa%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DKurihara%26aufirst%3DA.%26aulast%3DNagai%26aufirst%3DY.%26aulast%3DNakai%26aufirst%3DD.%26aulast%3DOkazaki%26aufirst%3DO.%26atitle%3DA%2520zone%2520classification%2520system%2520for%2520risk%2520assessment%2520of%2520idiosyncratic%2520drug%2520toxicity%2520using%2520daily%2520dose%2520and%2520covalent%2520binding%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1970%26epage%3D1977%26doi%3D10.1124%2Fdmd.109.027797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farah, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelekoudas, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajarshi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyabe, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrashekhar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlopoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">115195</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2019.115195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.bmc.2019.115195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=31761726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1ars7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2020&pages=115195&author=M.+S.+Malamasauthor=S.+I.+Farahauthor=M.+Lamaniauthor=D.+N.+Pelekoudasauthor=N.+T.+Perryauthor=G.+Rajarshiauthor=C.+Y.+Miyabeauthor=H.+Chandrashekharauthor=J.+Westauthor=S.+Pavlopoulosauthor=A.+Makriyannis&title=Design+and+synthesis+of+cyanamides+as+potent+and+selective+N-acylethanolamine+acid+amidase+inhibitors&doi=10.1016%2Fj.bmc.2019.115195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Farah, Shrouq I.; Lamani, Manjunath; Pelekoudas, Dimitrios N.; Perry, Nicholas Thomas; Rajarshi, Girija; Miyabe, Christina Yume; Chandrashekhar, Honrao; West, Jay; Pavlopoulos, Spiro; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115195</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-acylethanolamine acid amidase (NAAA) inhibition represents an exciting novel approach to treat inflammation and pain.  NAAA is a cysteine amidase which preferentially hydrolyzes the endogenous biolipids palmitoylethanolamide (PEA) and oleoylethanolamide (OEA).  PEA is an endogenous agonist of the nuclear peroxisome proliferator-activated receptor-α (PPAR-α), which is a key regulator of inflammation and pain.  Thus, blocking the degrdn. of PEA with NAAA inhibitors results in augmentation of the PEA/PPAR-α signaling pathway and regulation of inflammatory and pain processes.  We have prepd. a new series of NAAA inhibitors exploring the azetidine-nitrile (cyanamide) pharmacophore that led to the discovery of highly potent and selective compds.  Key analogs demonstrated single-digit nanomolar potency for hNAAA and showed &amp;gt;100-fold selectivity against serine hydrolases FAAH, MGL and ABHD6, and cysteine protease cathepsin K.  Addnl., we have identified potent and selective dual NAAA-FAAH inhibitors to investigate a potential synergism between two distinct anti-inflammatory mol. pathways, the PEA/PPAR-α anti-inflammatory signaling pathway,1-4 and the cannabinoid receptors CB1 and CB2 pathways which are known for their antiinflammatory and antinociceptive properties.5-8 Our ligand design strategy followed a traditional structure-activity relationship (SAR) approach and was supported by mol. modeling studies of reported X-ray structures of hNAAA.  Several inhibitors were evaluated in stability assays and demonstrated very good plasma stability (t1/2 &amp;gt; 2 h; human and rodents).  The disclosed cyanamides represent promising new pharmacol. tools to investigate the potential role of NAAA inhibitors and dual NAAA-FAAH inhibitors as therapeutic agents for the treatment of inflammation and pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-A_C3n2MNkbVg90H21EOLACvtfcHk0lhIt-aFmsq6ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1ars7rE&md5=f5330d39907df730c82cca041803b7da</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2019.115195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2019.115195%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DFarah%26aufirst%3DS.%2BI.%26aulast%3DLamani%26aufirst%3DM.%26aulast%3DPelekoudas%26aufirst%3DD.%2BN.%26aulast%3DPerry%26aufirst%3DN.%2BT.%26aulast%3DRajarshi%26aufirst%3DG.%26aulast%3DMiyabe%26aufirst%3DC.%2BY.%26aulast%3DChandrashekhar%26aufirst%3DH.%26aulast%3DWest%26aufirst%3DJ.%26aulast%3DPavlopoulos%26aufirst%3DS.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520cyanamides%2520as%2520potent%2520and%2520selective%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2020%26volume%3D28%26spage%3D115195%26doi%3D10.1016%2Fj.bmc.2019.115195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. B.</span></span> <span> </span><span class="NLM_article-title">Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1962</span>,  <span class="NLM_volume"><i>237</i></span>,  <span class="NLM_fpage">3245</span>– <span class="NLM_lpage">3249</span>, <span class="refDoi"> DOI: 10.1016/s0021-9258(18)50153-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fs0021-9258%2818%2950153-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=14033211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaF38Xks1Cmsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=1962&pages=3245-3249&author=R.+Kitzauthor=I.+B.+Wilson&title=Esters+of+methanesulfonic+acid+as+irreversible+inhibitors+of+acetylcholinesterase&doi=10.1016%2Fs0021-9258%2818%2950153-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase</span></div><div class="casAuthors">Kitz, R.; Wilson, Irwin B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1962</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3245-49</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Nine esters (anhydrides) of methanesulfonic acid, analogs to well known carbamate (e.g. neostigmine) and phosphate (e.g. paraoxon) inhibitors, were examd. as possible irreversible inhibitors of acetylcholinesterase.  Five were active.  Of these, 4 formed initial reversible complexes.  The progressive development of irreversible inhibition was slowed by reversible inhibitors, indicating that the active site is involved.  The inhibited enzyme is not reactivated by water or by hydroxylamine, hydrazine, acetate, or pyridine-2-aldoxime methiodide.  It is reactivated by pyridine-3-aldoxime methiodide.  On the basis of the evidence presented, it may be concluded safely that the active methanesulfonates form methanesulfonyl enzyme derivs. and, therefore, belong to the class of acid-transferring or oxydiaphoric inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXvcQevCYwCbVg90H21EOLACvtfcHk0lhIt-aFmsq6ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF38Xks1Cmsrg%253D&md5=f3993cf79ebb66299fada0ad04b15860</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fs0021-9258%2818%2950153-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0021-9258%252818%252950153-8%26sid%3Dliteratum%253Aachs%26aulast%3DKitz%26aufirst%3DR.%26aulast%3DWilson%26aufirst%3DI.%2BB.%26atitle%3DEsters%2520of%2520methanesulfonic%2520acid%2520as%2520irreversible%2520inhibitors%2520of%2520acetylcholinesterase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1962%26volume%3D237%26spage%3D3245%26epage%3D3249%26doi%3D10.1016%2Fs0021-9258%2818%2950153-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gorelik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagar, B.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanism of activation of the immunoregulatory amidase NAAA</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">E10032</span>– <span class="NLM_lpage">E10040</span>, <span class="refDoi"> DOI: 10.1073/pnas.1811759115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1073%2Fpnas.1811759115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=30301806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVyhsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=E10032-E10040&author=A.+Gorelikauthor=A.+Gebaiauthor=K.+Illesauthor=D.+Piomelliauthor=B.+Nagar&title=Molecular+mechanism+of+activation+of+the+immunoregulatory+amidase+NAAA&doi=10.1073%2Fpnas.1811759115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanism of activation of the immunoregulatory amidase NAAA</span></div><div class="casAuthors">Gorelik, Alexei; Gebai, Ahmad; Illes, Katalin; Piomelli, Daniele; Nagar, Bhushan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">E10032-E10040</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Palmitoylethanolamide is a bioactive lipid that strongly alleviates pain and inflammation in animal models and in humans.  Its signaling activity is terminated through degrdn. by N-acylethanolamine acid amidase (NAAA), a cysteine hydrolase expressed at high levels in immune cells.  Pharmacol. inhibitors of NAAA activity exert profound analgesic and antiinflammatory effects in rodent models, pointing to this protein as a potential target for therapeutic drug discovery.  To facilitate these efforts and to better understand the mol. mechanism of action of NAAA, we detd. crystal structures of this enzyme in various activation states and in complex with several ligands, including both a covalent and a reversible inhibitor.  Self-proteolysis exposes the otherwise buried active site of NAAA to allow catalysis.  Formation of a stable substrate- or inhibitor-binding site appears to be conformationally coupled to the interaction of a pair of hydrophobic helixes in the enzyme with lipid membranes, resulting in the creation of a linear hydrophobic cavity near the active site that accommodates the liganda's acyl chain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe4SyudaY7MrVg90H21EOLACvtfcHk0lhIt-aFmsq6ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVyhsLvP&md5=9debd68d3239a82bd60849c9cf98e8ae</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1811759115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1811759115%26sid%3Dliteratum%253Aachs%26aulast%3DGorelik%26aufirst%3DA.%26aulast%3DGebai%26aufirst%3DA.%26aulast%3DIlles%26aufirst%3DK.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DNagar%26aufirst%3DB.%26atitle%3DMolecular%2520mechanism%2520of%2520activation%2520of%2520the%2520immunoregulatory%2520amidase%2520NAAA%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2018%26volume%3D115%26spage%3DE10032%26epage%3DE10040%26doi%3D10.1073%2Fpnas.1811759115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klicic, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoll, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenkin, P. S.</span></span> <span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1739</span>– <span class="NLM_lpage">1749</span>, <span class="refDoi"> DOI: 10.1021/jm0306430</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+Method+and+assessment+of+docking+accuracy&doi=10.1021%2Fjm0306430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0lgVP63B3oVj5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520Method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749%26doi%3D10.1021%2Fjm0306430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pincus, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapp, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T. J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">A hierarchical approach to all-atom protein loop prediction</span>. <i>Proteins</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1002/prot.10613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1002%2Fprot.10613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=15048827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFKhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=351-367&author=M.+P.+Jacobsonauthor=D.+L.+Pincusauthor=C.+S.+Rappauthor=T.+J.+F.+Dayauthor=B.+Honigauthor=D.+E.+Shawauthor=R.+A.+Friesner&title=A+hierarchical+approach+to+all-atom+protein+loop+prediction&doi=10.1002%2Fprot.10613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">A hierarchical approach to all-atom protein loop prediction</span></div><div class="casAuthors">Jacobson, Matthew P.; Pincus, David L.; Rapp, Chaya S.; Day, Tyler J. F.; Honig, Barry; Shaw, David E.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">351-367</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The application of all-atom force fields (and explicit or implicit solvent models) to protein homol.-modeling tasks such as side-chain and loop prediction remains challenging both because of the expense of the individual energy calcns. and because of the difficulty of sampling the rugged all-atom energy surface.  Here the authors address this challenge for the problem of loop prediction through the development of numerous new algorithms, with an emphasis on multiscale and hierarchical techniques.  As a first step in evaluating the performance of the authors' loop prediction algorithm, the authors have applied it to the problem of reconstructing loops in native structures; the authors also explicitly include crystal packing to provide a fair comparison with crystal structures.  In brief, large nos. of loops are generated by using a dihedral angle-based buildup procedure followed by iterative cycles of clustering, side-chain optimization, and complete energy minimization of selected loop structures.  The authors evaluate this method by the largest test set yet used for validation of a loop prediction method, with a total of 833 loops ranging from 4 to 12 residues in length.  Av./median backbone root-mean-square deviations (RMSDs) to the native structures (superimposing the body of the protein, not the loop itself) are 0.42/0.24 Å for 5 residue loops, 1.00/0.44 Å for 8 residue loops, and 2.47/1.83 Å for 11 residue loops.  Median RMSDs are substantially lower than the avs. because of a small no. of outliers; the causes of these failures are examd. in some detail, and many can be attributed to errors in assignment of protonation states of titratable residues, omission of ligands from the simulation, and, in a few cases, probable errors in the exptl. detd. structures.  When these obvious problems in the data sets are filtered out, av. RMSDs to the native structures improve to 0.43 Å for 5 residue loops, 0.84 Å for 8 residue loops, and 1.63 Å for 11 residue loops.  In the vast majority of cases, the method locates energy min. that are lower than or equal to that of the minimized native loop, thus indicating that sampling rarely limits prediction accuracy.  The overall results are, to the authors' knowledge, the best reported to date, and the authors attribute this success to the combination of an accurate all-atom energy function, efficient methods for loop buildup and side-chain optimization, and, esp. for the longer loops, the hierarchical refinement protocol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHqYMnqaWXvLVg90H21EOLACvtfcHk0lgVP63B3oVj5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFKhsrc%253D&md5=e0eff655eeefb30ea00ae041ea9099c8</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fprot.10613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.10613%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DPincus%26aufirst%3DD.%2BL.%26aulast%3DRapp%26aufirst%3DC.%2BS.%26aulast%3DDay%26aufirst%3DT.%2BJ.%2BF.%26aulast%3DHonig%26aufirst%3DB.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DA%2520hierarchical%2520approach%2520to%2520all-atom%2520protein%2520loop%2520prediction%26jtitle%3DProteins%26date%3D2004%26volume%3D55%26spage%3D351%26epage%3D367%26doi%3D10.1002%2Fprot.10613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borrelli, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farid, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span> <span> </span><span class="NLM_article-title">Docking covalent inhibitors: a parameter free approach to pose prediction and scoring</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1932</span>– <span class="NLM_lpage">1940</span>, <span class="refDoi"> DOI: 10.1021/ci500118s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci500118s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVKksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=1932-1940&author=K.+Zhuauthor=K.+W.+Borrelliauthor=J.+R.+Greenwoodauthor=T.+Dayauthor=R.+Abelauthor=R.+S.+Faridauthor=E.+Harder&title=Docking+covalent+inhibitors%3A+a+parameter+free+approach+to+pose+prediction+and+scoring&doi=10.1021%2Fci500118s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Docking Covalent Inhibitors: A Parameter Free Approach To Pose Prediction and Scoring</span></div><div class="casAuthors">Zhu, Kai; Borrelli, Kenneth W.; Greenwood, Jeremy R.; Day, Tyler; Abel, Robert; Farid, Ramy S.; Harder, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1932-1940</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although many popular docking programs include a facility to account for covalent ligands, large-scale systematic docking validation studies of covalent inhibitors have been sparse.  In this paper, we present the development and validation of a novel approach for docking and scoring covalent inhibitors, which consists of conventional noncovalent docking, heuristic formation of the covalent attachment point, and structural refinement of the protein-ligand complex.  This approach combines the strengths of the docking program Glide and the protein structure modeling program Prime and does not require any parameter fitting for the study of addnl. covalent reaction types.  We first test this method by predicting the native binding geometry of 38 covalently bound complexes.  The av. RMSD of the predicted poses is 1.52 Å, and 76% of test set inhibitors have an RMSD of less than 2.0 Å.  In addn., the apparent affinity score constructed herein is tested on a virtual screening study and the characterization of the SAR properties of two different series of congeneric compds. with satisfactory success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbtjEb3EqzQ7Vg90H21EOLACvtfcHk0lgVP63B3oVj5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVKksLs%253D&md5=3633c29fa5dc29817b178fd10a4c7b15</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fci500118s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci500118s%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DBorrelli%26aufirst%3DK.%2BW.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFarid%26aufirst%3DR.%2BS.%26aulast%3DHarder%26aufirst%3DE.%26atitle%3DDocking%2520covalent%2520inhibitors%253A%2520a%2520parameter%2520free%2520approach%2520to%2520pose%2520prediction%2520and%2520scoring%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2014%26volume%3D54%26spage%3D1932%26epage%3D1940%26doi%3D10.1021%2Fci500118s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">But, T. Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toy, P. H.</span></span> <span> </span><span class="NLM_article-title">The Mitsunobu reaction: origin, mechanism, improvements, and applications</span>. <i>Chem. Asian J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1340</span>– <span class="NLM_lpage">1355</span>, <span class="refDoi"> DOI: 10.1002/asia.200700182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1002%2Fasia.200700182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=17890661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlemsrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1340-1355&author=T.+Y.+S.+Butauthor=P.+H.+Toy&title=The+Mitsunobu+reaction%3A+origin%2C+mechanism%2C+improvements%2C+and+applications&doi=10.1002%2Fasia.200700182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">The Mitsunobu reaction: origin, mechanism, improvements, and applications</span></div><div class="casAuthors">But, Tracy Yuen Sze; Toy, Patrick H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - An Asian Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1340-1355</span>CODEN:
                <span class="NLM_cas:coden">CAAJBI</span>;
        ISSN:<span class="NLM_cas:issn">1861-4728</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The Mitsunobu reaction is a widely used and versatile method for the dehydrative oxidn.-redn. condensation of an acid/pronucleophile usually with a primary or secondary alc. that requires the combination of a reducing phosphine reagent together with an oxidizing azo reagent.  The utility of this reaction stems from the fact that it is generally highly stereoselective and occurs with inversion of the stereochem. configuration of the alc. starting material.  Also, as carboxylic acids, phenols, imides, sulfonamides, and other compds. can be used as the acid/pronucleophile, this reaction is useful for the prepn. of a wide variety of functional groups.  This Focus Review of the Mitsunobu reaction summarizes its origins, the current understanding of its mechanism, and recent improvements and applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoww5iSnC5nFrVg90H21EOLACvtfcHk0lhf-BdxqRc3KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlemsrzO&md5=f1e6895da2bf160d44745c0c830ab747</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1002%2Fasia.200700182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fasia.200700182%26sid%3Dliteratum%253Aachs%26aulast%3DBut%26aufirst%3DT.%2BY.%2BS.%26aulast%3DToy%26aufirst%3DP.%2BH.%26atitle%3DThe%2520Mitsunobu%2520reaction%253A%2520origin%252C%2520mechanism%252C%2520improvements%252C%2520and%2520applications%26jtitle%3DChem.%2520Asian%2520J.%26date%3D2007%26volume%3D2%26spage%3D1340%26epage%3D1355%26doi%3D10.1002%2Fasia.200700182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">West, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitten, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vadivel, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Biochemical and mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase inhibition</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e43877</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0043877</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1371%2Fjournal.pone.0043877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=22952796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlSltr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=J.+M.+Westauthor=N.+Zvonokauthor=K.+M.+Whittenauthor=S.+K.+Vadivelauthor=A.+L.+Bowmanauthor=A.+Makriyannis&title=Biochemical+and+mass+spectrometric+characterization+of+human+N-acylethanolamine-hydrolyzing+acid+amidase+inhibition&doi=10.1371%2Fjournal.pone.0043877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase inhibition</span></div><div class="casAuthors">West, Jay M.; Zvonok, Nikolai; Whitten, Kyle M.; Vadivel, Subramanian K.; Bowman, Anna L.; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e43877</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The mechanism of inactivation of human enzyme N-acylethanolamine-hydrolyzing acid amidase (hNAAA), with selected inhibitors identified in a novel fluorescent based assay developed for characterization of both reversible and irreversible inhibitors, was investigated kinetically and using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS).  1-Isothiocyanatopentadecane (AM9023) was found to be a potent, selective and reversible hNAAA inhibitor, while two others, 5-((biphenyl-4-yl)methyl)-N,N-dimethyl-2H-tetrazole-2-carboxamide (AM6701) and N-Benzyloxycarbonyl--serine β-lactone (N-Cbz-serine β-lactone), inhibited hNAAA in a covalent and irreversible manner.  MS anal. of the hNAAA/covalent inhibitor complexes identified modification only of the N-terminal cysteine (Cys126) of the β-subunit, confirming a suggested mechanism of hNAAA inactivation by the β-lactone contg. inhibitors.  These expts. provide direct evidence of the key role of Cys126 in hNAAA inactivation by different classes of covalent inhibitors, confirming the essential role of cysteine for catalysis and inhibition in this cysteine N-terminal nucleophile hydrolase enzyme.  They also provide a methodol. for the rapid screening and characterization of large libraries of compds. as potential inhibitors of NAAA, and subsequent characterization or their mechanism through MALDI-TOF MS based bottom up-proteomics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgYtxfkhdQ5rVg90H21EOLACvtfcHk0lhf-BdxqRc3KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlSltr7E&md5=f1cedb03b771c71caef095bf138627bd</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0043877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0043877%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DJ.%2BM.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DWhitten%26aufirst%3DK.%2BM.%26aulast%3DVadivel%26aufirst%3DS.%2BK.%26aulast%3DBowman%26aufirst%3DA.%2BL.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DBiochemical%2520and%2520mass%2520spectrometric%2520characterization%2520of%2520human%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520inhibition%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0043877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alapafuja, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikas, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharathan, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasr, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Sulfonyl fluoride inhibitors of fatty acid amide hydrolase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10074</span>– <span class="NLM_lpage">10089</span>, <span class="refDoi"> DOI: 10.1021/jm301205j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301205j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFChsrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10074-10089&author=S.+O.+Alapafujaauthor=S.+P.+Nikasauthor=I.+T.+Bharathanauthor=V.+G.+Shuklaauthor=M.+L.+Nasrauthor=A.+L.+Bowmanauthor=N.+Zvonokauthor=J.+Liauthor=X.+Shiauthor=J.+R.+Engenauthor=A.+Makriyannis&title=Sulfonyl+fluoride+inhibitors+of+fatty+acid+amide+hydrolase&doi=10.1021%2Fjm301205j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonyl Fluoride Inhibitors of Fatty Acid Amide Hydrolase</span></div><div class="casAuthors">Alapafuja, Shakiru O.; Nikas, Spyros P.; Bharathan, Indu T.; Shukla, Vidyanand G.; Nasr, Mahmoud L.; Bowman, Anna L.; Zvonok, Nikolai; Li, Jing; Shi, Xiaomeng; Engen, John R.; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10074-10089</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sulfonyl fluorides are known to inhibit esterases.  Early work from our lab. has identified hexadecyl sulfonylfluoride (AM374) as a potent in vitro and in vivo inhibitor of fatty acid amide hydrolase (FAAH).  We now report on later generation sulfonyl fluoride analogs that exhibit potent and selective inhibition of FAAH.  Using recombinant rat and human FAAH, we show that 5-(4-hydroxyphenyl)pentanesulfonyl fluoride (AM3506) has similar inhibitory activity for both the rat and the human enzyme, while rapid diln. assays and mass spectrometry anal. suggest that the compd. is a covalent modifier for FAAH and inhibits its action in an irreversible manner.  Our SAR results are highlighted by mol. docking of key analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpCw72isROHbVg90H21EOLACvtfcHk0lhf-BdxqRc3KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFChsrfK&md5=789d239141f8a92ccff2de9cb77f4f8b</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm301205j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301205j%26sid%3Dliteratum%253Aachs%26aulast%3DAlapafuja%26aufirst%3DS.%2BO.%26aulast%3DNikas%26aufirst%3DS.%2BP.%26aulast%3DBharathan%26aufirst%3DI.%2BT.%26aulast%3DShukla%26aufirst%3DV.%2BG.%26aulast%3DNasr%26aufirst%3DM.%2BL.%26aulast%3DBowman%26aufirst%3DA.%2BL.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DEngen%26aufirst%3DJ.%2BR.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DSulfonyl%2520fluoride%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10074%26epage%3D10089%26doi%3D10.1021%2Fjm301205j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramarao, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M. W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bushell, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. D.</span></span> <span> </span><span class="NLM_article-title">A fluorescence-based assay for fatty acid amide hydrolase compatible with high-throughput screening</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>343</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2005.04.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.ab.2005.04.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=16018870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtFSnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2005&pages=143-151&author=M.+K.+Ramaraoauthor=E.+A.+Murphyauthor=M.+W.+H.+Shenauthor=Y.+Wangauthor=K.+N.+Bushellauthor=N.+Huangauthor=N.+Panauthor=C.+Williamsauthor=J.+D.+Clark&title=A+fluorescence-based+assay+for+fatty+acid+amide+hydrolase+compatible+with+high-throughput+screening&doi=10.1016%2Fj.ab.2005.04.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">A fluorescence-based assay for fatty acid amide hydrolase compatible with high-throughput screening</span></div><div class="casAuthors">Ramarao, Manjunath K.; Murphy, Elizabeth A.; Shen, Marina W. H.; Wang, Yuren; Bushell, Kristen N.; Huang, Nelson; Pan, Ning; Williams, Cara; Clark, James D.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">143-151</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A novel fluorescent assay to continuously monitor fatty acid amide hydrolase (FAAH) activity that is simple, sensitive, and amenable to high-throughput screening (HTS) of compd. libraries is described in this article.  Stable Chinese hamster ovary (CHO) cell lines expressing either human FAAH or an inactive mutant, FAAH-S241A, were established.  Arachidonyl 7-amino,4-Me coumarin amide (AAMCA), a novel fluorogenic substrate for FAAH, was designed and synthesized.  FAAH catalyzes the hydrolysis of AAMCA to generate arachidonic acid and a highly fluorescent 7-amino,4-Me coumarin (AMC).  The assay was done at 25° by incubating whole cell or microsomal prepns. from FAAH-expressing cells with AAMCA.  Release of AMC was monitored continuously using a fluorometer.  Microsomal FAAH catalyzed the hydrolysis of AAMCA with an apparent Km of 0.48 μM and V max of 58 pmol min-1 mg protein-1.  The assay is specific for FAAH given that microsomes prepd. from cells expressing FAAH-S241A or vector alone had no significant activity against AAMCA.  Furthermore, the activity was inhibited by URB-597, an FAAH-specific inhibitor, in a concn.-dependent manner with an IC50 of 33.5 nM.  The assay was optimized for HTS and had a Z' value ranging from 0.7 to 0.9.  The assay is also compatible with ex vivo anal. of FAAH activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLzJKCeUOYjbVg90H21EOLACvtfcHk0ljDMAZXC8uMTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtFSnurg%253D&md5=ead8f22a137f769cd808b50c16b379fa</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2005.04.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2005.04.032%26sid%3Dliteratum%253Aachs%26aulast%3DRamarao%26aufirst%3DM.%2BK.%26aulast%3DMurphy%26aufirst%3DE.%2BA.%26aulast%3DShen%26aufirst%3DM.%2BW.%2BH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBushell%26aufirst%3DK.%2BN.%26aulast%3DHuang%26aufirst%3DN.%26aulast%3DPan%26aufirst%3DN.%26aulast%3DWilliams%26aufirst%3DC.%26aulast%3DClark%26aufirst%3DJ.%2BD.%26atitle%3DA%2520fluorescence-based%2520assay%2520for%2520fatty%2520acid%2520amide%2520hydrolase%2520compatible%2520with%2520high-throughput%2520screening%26jtitle%3DAnal.%2520Biochem.%26date%3D2005%26volume%3D343%26spage%3D143%26epage%3D151%26doi%3D10.1016%2Fj.ab.2005.04.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patricelli, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lashuel, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giang, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Comparative characterization of a wild type and transmembrane domain-deleted fatty acid amide hydrolase: identification of the transmembrane domain as a site for oligomerization</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">15177</span>– <span class="NLM_lpage">15187</span>, <span class="refDoi"> DOI: 10.1021/bi981733n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi981733n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaK1cXmsVWjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=15177-15187&author=M.+P.+Patricelliauthor=H.+A.+Lashuelauthor=D.+K.+Giangauthor=J.+W.+Kellyauthor=B.+F.+Cravatt&title=Comparative+characterization+of+a+wild+type+and+transmembrane+domain-deleted+fatty+acid+amide+hydrolase%3A+identification+of+the+transmembrane+domain+as+a+site+for+oligomerization&doi=10.1021%2Fbi981733n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative Characterization of a Wild Type and Transmembrane Domain-Deleted Fatty Acid Amide Hydrolase: Identification of the Transmembrane Domain as a Site for Oligomerization</span></div><div class="casAuthors">Patricelli, Matthew P.; Lashuel, Hilal A.; Giang, Dan K.; Kelly, Jeffery W.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">15177-15187</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) is an integral membrane protein responsible for the hydrolysis of a no. of primary and secondary fatty acid amides, including the neuromodulatory compds. anandamide and oleamide.  Anal. of FAAH's primary sequence reveals the presence of a single predicted transmembrane domain at the extreme N-terminus of the enzyme.  A mutant form of the rat FAAH protein lacking this N-terminal transmembrane domain (ΔTM-FAAH) was generated and, like wild type FAAH (WT-FAAH), was found to be tightly assocd. with membranes when expressed in COS-7 cells.  Recombinant forms of WT- and ΔTM-FAAH expressed and purified from Escherichia coli exhibited essentially identical enzymic properties which were also similar to those of the native enzyme from rat liver.  Anal. of the oligomerization states of WT- and ΔTM-FAAH by chem. crosslinking, sedimentation velocity anal. ultracentrifugation, and size exclusion chromatog. indicated that both enzymes were oligomeric when membrane-bound and after solubilization.  However, WT-FAAH consistently behaved as a larger oligomer than ΔTM-FAAH.  Addnl., SDS-PAGE anal. of the recombinant proteins identified the presence of SDS-resistant oligomers for WT-FAAH, but not for ΔTM-FAAH.  Self-assocn. through FAAH's transmembrane domain was further demonstrated by a FAAH transmembrane domain-GST fusion protein which formed SDS-resistant dimers and large oligomeric assemblies in soln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2WgrX7PkX8rVg90H21EOLACvtfcHk0ljDMAZXC8uMTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsVWjs7g%253D&md5=cf86234c390a09c08fdf6ca53db3865b</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fbi981733n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi981733n%26sid%3Dliteratum%253Aachs%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DLashuel%26aufirst%3DH.%2BA.%26aulast%3DGiang%26aufirst%3DD.%2BK.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DComparative%2520characterization%2520of%2520a%2520wild%2520type%2520and%2520transmembrane%2520domain-deleted%2520fatty%2520acid%2520amide%2520hydrolase%253A%2520identification%2520of%2520the%2520transmembrane%2520domain%2520as%2520a%2520site%2520for%2520oligomerization%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D15177%26epage%3D15187%26doi%3D10.1021%2Fbi981733n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandarinathan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karageorgos, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janero, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Covalent inhibitors of human monoacylglycerol lipase: ligand-assisted characterization of the catalytic site by mass spectrometry and mutational analysis</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">854</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2008.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.chembiol.2008.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=18721756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVejtbjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=854-862&author=N.+Zvonokauthor=L.+Pandarinathanauthor=J.+Williamsauthor=M.+Johnstonauthor=I.+Karageorgosauthor=D.+R.+Janeroauthor=S.+C.+Krishnanauthor=A.+Makriyannis&title=Covalent+inhibitors+of+human+monoacylglycerol+lipase%3A+ligand-assisted+characterization+of+the+catalytic+site+by+mass+spectrometry+and+mutational+analysis&doi=10.1016%2Fj.chembiol.2008.06.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent Inhibitors of Human Monoacylglycerol Lipase: Ligand-Assisted Characterization of the Catalytic Site by Mass Spectrometry and Mutational Analysis</span></div><div class="casAuthors">Zvonok, Nikolai; Pandarinathan, Lakshmipathi; Williams, John; Johnston, Meghan; Karageorgos, Ioannis; Janero, David R.; Krishnan, Srinivasan C.; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">854-862</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: The active site of recombinant hexa-histidine-tagged human monoacylglycerol lipase (hMGL) is characterized by mass spectrometry using the inhibitors 5-((biphenyl-4-yl)methyl)-N,N-dimethyl-2H-tetrazole-2-carboxamide (AM6701), and N-arachidonylmaleimide (NAM) as probes.  Carbamylation of Ser129 by AM6701 in the putative hMGL catalytic triad demonstrates this residue's essential role in catalysis.  Partial NAM alkylation of hMGL cysteine residues 215 and/or 249 was sufficient to achieve ∼80% enzyme inhibition.  Although Cys215 and/or Cys249 mutations to alanine(s) did not affect hMGL hydrolytic activity as compared with nonmutated hMGL, the C215A displayed heightened NAM sensitivity, whereas the C249A evidenced reduced NAM sensitivity.  These data conclusively demonstrate a sulfhydryl-based mechanism for NAM inhibition of hMGL in which Cys249 is of paramount importance.  Identification of amino acids crit. to the catalytic activity and pharmacol. modulation of hMGL informs the design of selective MGL inhibitors as potential drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp1gDK0IgZgLVg90H21EOLACvtfcHk0ljDMAZXC8uMTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVejtbjO&md5=d135103e4d1543b7d9846c64642e49fc</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2008.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2008.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DPandarinathan%26aufirst%3DL.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DJohnston%26aufirst%3DM.%26aulast%3DKarageorgos%26aufirst%3DI.%26aulast%3DJanero%26aufirst%3DD.%2BR.%26aulast%3DKrishnan%26aufirst%3DS.%2BC.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DCovalent%2520inhibitors%2520of%2520human%2520monoacylglycerol%2520lipase%253A%2520ligand-assisted%2520characterization%2520of%2520the%2520catalytic%2520site%2520by%2520mass%2520spectrometry%2520and%2520mutational%2520analysis%26jtitle%3DChem.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D854%26epage%3D862%26doi%3D10.1016%2Fj.chembiol.2008.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shields, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Biochemical and Proteomic Characterization of Recombinant Human alpha/beta Hydrolase Domain 6</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">890</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-36633-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1038%2Fs41598-018-36633-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=30696836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A280%3ADC%252BB3cjmslKlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=890&author=C.+M.+Shieldsauthor=N.+Zvonokauthor=A.+Zvonokauthor=A.+Makriyannis&title=Biochemical+and+Proteomic+Characterization+of+Recombinant+Human+alpha%2Fbeta+Hydrolase+Domain+6&doi=10.1038%2Fs41598-018-36633-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and Proteomic Characterization of Recombinant Human α/β Hydrolase Domain 6</span></div><div class="casAuthors">Shields Christina Miyabe; Zvonok Nikolai; Zvonok Alexander; Makriyannis Alexandros; Shields Christina Miyabe; Zvonok Nikolai; Zvonok Alexander; Makriyannis Alexandros; Makriyannis Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">890</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Human alpha/beta hydrolase domain 6 (hABHD6) is an enzyme that hydrolyzes 2-arachidonoylglycerol (2-AG), a potent agonist at both cannabinoid CB1 and CB2 receptors.  In vivo modulation of ABHD6 expression has been shown to have potential therapeutic applications, making the enzyme a promising drug target.  However, the lack of structural information on hABHD6 limits the discovery and design of selective inhibitors.  We have performed E. coli expression, purification and activity profiling screening of different hABHD6 constructs and identified a truncated variant without N-terminal transmembrane (TM) domain, hΔ29-3-ABHD6, as the most promising protein for further characterization.  The elimination of the TM domain did not affect 2-AG or fluorogenic arachidonoyl, 7-hydroxy-6-methoxy-4-methylcoumarin ester (AHMMCE) substrates hydrolysis, suggesting that the TM is not essential for enzyme catalytic activity.  The hΔ29-3-ABHD6 variant was purified in a single step using Immobilized Metal Affinity Chromatography (IMAC), in-solution trypsin digested, and proteomically characterized by Matrix Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS).  The N-terminal peptide without methionine was identified indicating on a post-translational modification of the recombinant protein.  The mechanism of inhibition of hABHD6 with AM6701 and WWL70 covalent probes was elucidated based on MS analysis of trypsin digested hABHD6 following the Ligand Assisted Protein Structure (LAPS) approach.  We identified the carbamylated peptides containing catalytic serine (Ser(148)) suggesting a selective carbamylation of the enzyme by AM6701 or WWL70 and confirming an essential role of this residue in catalysis.  The ability to produce substantial quantities of functional, pure hABHD6 will aid in the downstream structural characterization, and development of potent, selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSxpW977xfkzSO2kE7krGOBfW6udTcc2ebkhL5IsXncs7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cjmslKlsg%253D%253D&md5=ead64a4e458ba638781a0ac39e6ed37d</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-36633-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-36633-4%26sid%3Dliteratum%253Aachs%26aulast%3DShields%26aufirst%3DC.%2BM.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DZvonok%26aufirst%3DA.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DBiochemical%2520and%2520Proteomic%2520Characterization%2520of%2520Recombinant%2520Human%2520alpha%252Fbeta%2520Hydrolase%2520Domain%25206%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26spage%3D890%26doi%3D10.1038%2Fs41598-018-36633-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abadji, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas-Lenard, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kendall, D. A.</span></span> <span> </span><span class="NLM_article-title">Involvement of the carboxyl terminus of the third intracellular loop of the cannabinoid CB1 receptor in constitutive activation of Gs</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">2032</span>– <span class="NLM_lpage">2038</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.1999.0722032.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1046%2Fj.1471-4159.1999.0722032.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10217281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaK1MXis12lt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1999&pages=2032-2038&author=V.+Abadjiauthor=J.+M.+Lucas-Lenardauthor=C.+Chinauthor=D.+A.+Kendall&title=Involvement+of+the+carboxyl+terminus+of+the+third+intracellular+loop+of+the+cannabinoid+CB1+receptor+in+constitutive+activation+of+Gs&doi=10.1046%2Fj.1471-4159.1999.0722032.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of the carboxyl terminus of the third intracellular loop of the cannabinoid CB1 receptor in constitutive activation of Gs</span></div><div class="casAuthors">Abadji, Vasiliki; Lucas-Lenard, Jean M.; Chin, Chen-Ni; Kendall, Debra A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2032-2038</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The human cannabinoid receptor CB1 functionally couples primarily to Gi-, but also to Gs-mediated pathways to modulate intracellular cAMP levels.  To probe the features of the receptor that may be involved in promoting interactions with one G protein type over another, we generated the L341A/A342L mutant CB1 receptor.  The double mutation involved the swap in position of two adjacent residues in the carboxyl-terminal segment of the third intracellular loop of CB1.  This resulted in partial constitutive activation of the receptor and an agonist-independent enhancement in cAMP levels.  Characterization following treatment with either pertussis or cholera toxin indicated that the constitutive activity is selective for a Gs- and not a Gi-mediated pathway.  Treatment with the CB1-specific inverse agonist SR 141716A inhibited the basal accumulation of cAMP in the presence of pertussis toxin, establishing that the effect is CB1 mediated.  The binding of the agonist CP-55940 to the L341A/A342L receptor was not markedly different from that for the wild-type receptor despite the constitutive Gs activity.  This may reflect a preference of this ligand for an activated receptor state assocd. with the Gi coupling form and underscores the potential for developing therapeutics that selectively activate one pathway over another.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRBqzCNLu7C7Vg90H21EOLACvtfcHk0lj1RlKp0lI0ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXis12lt70%253D&md5=8df24ece9201ce2a0694522503185a83</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1999.0722032.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1999.0722032.x%26sid%3Dliteratum%253Aachs%26aulast%3DAbadji%26aufirst%3DV.%26aulast%3DLucas-Lenard%26aufirst%3DJ.%2BM.%26aulast%3DChin%26aufirst%3DC.%26aulast%3DKendall%26aufirst%3DD.%2BA.%26atitle%3DInvolvement%2520of%2520the%2520carboxyl%2520terminus%2520of%2520the%2520third%2520intracellular%2520loop%2520of%2520the%2520cannabinoid%2520CB1%2520receptor%2520in%2520constitutive%2520activation%2520of%2520Gs%26jtitle%3DJ.%2520Neurochem.%26date%3D1999%26volume%3D72%26spage%3D2032%26epage%3D2038%26doi%3D10.1046%2Fj.1471-4159.1999.0722032.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oakley, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwardson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delaunoy, J.-P.</span></span> <span> </span><span class="NLM_article-title">A rapid method for preparing synaptosomes: comparison, with alternative procedures</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>226</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.1016/0006-8993(81)91086-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2F0006-8993%2881%2991086-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=7296283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaL38XkvVGntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=1981&pages=107-118&author=P.+R.+Doddauthor=J.+A.+Hardyauthor=A.+E.+Oakleyauthor=J.+A.+Edwardsonauthor=E.+K.+Perryauthor=J.-P.+Delaunoy&title=A+rapid+method+for+preparing+synaptosomes%3A+comparison%2C+with+alternative+procedures&doi=10.1016%2F0006-8993%2881%2991086-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid method for preparing synaptosomes:  comparison, with alternative procedures</span></div><div class="casAuthors">Dodd, P. R.; Hardy, J. A.; Oakley, A. E.; Edwardson, J. A.; Perry, E. K.; Delaunoy, J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">107-18</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">A sucrose d.-gradient centrifugation method for the rapid (1-1.5 h) prepn. of nerve ending particles (synaptosomes) from rat cerebral cortex is described.  The synaptosome fraction was characterized by quant. electron microscopy and enzyme distribution studies.  By these criteria, the fraction showed a degree of enrichment in synaptic structures which was comparable to that of the std. (4-5 h) prepn. and substantially better than an alternative fast (2-2.5 h) method.  On incubation, synaptosomes obtained by the new procedure accumulated a high tissue concn. of K and showed a high, linear rate of O uptake.  Depolarization by veratrine caused a significant increase in the rate of respiration and in the release of the physiol. active amino acids, glutamate, aspartate, and GABA, as well as a significant redn. in tissue K.  Thus, the new procedure compared favorably with alternative methods as judged by these indexes of metabolic and functional performance.  The new prepn. method was of value in metabolic studies of synaptosomes prepd. from human post-mortem brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgyn2pCmMr7rVg90H21EOLACvtfcHk0ljZuy2T6tX5pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XkvVGntw%253D%253D&md5=c591627a3f24cbe948e0d8c0cb0bf860</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2881%2991086-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252881%252991086-6%26sid%3Dliteratum%253Aachs%26aulast%3DDodd%26aufirst%3DP.%2BR.%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DOakley%26aufirst%3DA.%2BE.%26aulast%3DEdwardson%26aufirst%3DJ.%2BA.%26aulast%3DPerry%26aufirst%3DE.%2BK.%26aulast%3DDelaunoy%26aufirst%3DJ.-P.%26atitle%3DA%2520rapid%2520method%2520for%2520preparing%2520synaptosomes%253A%2520comparison%252C%2520with%2520alternative%2520procedures%26jtitle%3DBrain%2520Res.%26date%3D1981%26volume%3D226%26spage%3D107%26epage%3D118%26doi%3D10.1016%2F0006-8993%2881%2991086-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abadji, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morse, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">(-)-11-Hydroxy-7’-isothiocyanato-1’,1’-dimethylheptyl-delta 8-THC: a novel, high-affinity irreversible probe for the cannabinoid receptor in the brain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">3867</span>– <span class="NLM_lpage">3870</span>, <span class="refDoi"> DOI: 10.1021/jm00049a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00049a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaK2MXhs12nsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=3867-3870&author=Y.+Guoauthor=V.+Abadjiauthor=K.+L.+Morseauthor=D.+J.+Fournierauthor=X.+Liauthor=A.+Makriyannis&title=%28-%29-11-Hydroxy-7%E2%80%99-isothiocyanato-1%E2%80%99%2C1%E2%80%99-dimethylheptyl-delta+8-THC%3A+a+novel%2C+high-affinity+irreversible+probe+for+the+cannabinoid+receptor+in+the+brain&doi=10.1021%2Fjm00049a002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">(-)-11-Hydroxy-7'-isothiocyanato-1',1'- dimethylheptyl-Δ8-THC: A Novel, High-Affinity Irreversible Probe for the Cannabinoid Receptor in the Brain</span></div><div class="casAuthors">Guo, Yan; Abadji, Vasiliki; Morse, Kelley L.; Fournier, Donna J.; Li, Xiuyan; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3867-70</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">(-)-11-Hydroxy-7'-isothiocyanato-1',1'-dimethylheptyl-Δ8-THC (I) was synthesized from 4-hydroxymyrtenyl pivalate and 3,5-(HO)2C6H3CMe2(CH2)6Br in 4 steps and evaluated as an irreversible probe for the cannabinoid receptor(s) in the brain.  The affinity of I for the cannabinoid receptor(s) was detd. using rat forebrain membranes and I had an apparent IC50 of 1.6 ± 0.3 nM.  When the membrane prepn. was treated with 10 nM of I, 80% of the [3H]CP-55940 specific binding to the receptor was abolished.  Time-dependent studies demonstrated that the ligand reacts rapidly and irreversibly with the receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCTnkWGzbjhrVg90H21EOLACvtfcHk0ljZuy2T6tX5pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhs12nsLo%253D&md5=49c26e0a98bd57fa734d44ffb38fd593</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm00049a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00049a002%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DAbadji%26aufirst%3DV.%26aulast%3DMorse%26aufirst%3DK.%2BL.%26aulast%3DFournier%26aufirst%3DD.%2BJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3D%2528-%2529-11-Hydroxy-7%25E2%2580%2599-isothiocyanato-1%25E2%2580%2599%252C1%25E2%2580%2599-dimethylheptyl-delta%25208-THC%253A%2520a%2520novel%252C%2520high-affinity%2520irreversible%2520probe%2520for%2520the%2520cannabinoid%2520receptor%2520in%2520the%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D3867%26epage%3D3870%26doi%3D10.1021%2Fjm00049a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morse, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzybowska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">A novel electrophilic high affinity irreversible probe for the cannabinoid receptor</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1957</span>– <span class="NLM_lpage">1962</span>, <span class="refDoi"> DOI: 10.1016/0024-3205(95)00176-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2F0024-3205%2895%2900176-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=7776819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaK2MXlsF2mtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1995&pages=1957-1962&author=K.+L.+Morseauthor=D.+J.+Fournierauthor=X.+Liauthor=J.+Grzybowskaauthor=A.+Makriyannis&title=A+novel+electrophilic+high+affinity+irreversible+probe+for+the+cannabinoid+receptor&doi=10.1016%2F0024-3205%2895%2900176-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">A novel electrophilic high affinity irreversible probe for the cannabinoid receptor</span></div><div class="casAuthors">Morse, Kelley L.; Fournier, Donna J.; Li, Xiuyan; Grzybowska, Jolanta; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23/24</span>),
    <span class="NLM_cas:pages">1957-62</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In order to explore the structural requirements for cannabinoid activity we have been involved in the design and synthesis of stereochem. defined high affinity probes for the cannabinoid receptor.  This effort has involved the development of irreversible ligands which will allow us to obtain detailed information on the cannabinoid receptor active site(s).  The irreversible ligands, which incorporate highly reactive functional groups in a strategic position of the ligand, may form covalent bonds with amino acid residues at the receptor active site or in the neighborhood of this site.  We shall discuss the biochem. properties of one of these probes, which incorporates the electrophilic isothiocyanate group into the structure of the highly potent cannabinoid agonist (-)-1',1'-dimethylheptyl-Δ8-THC; this ligand (-)-7'-isothiocyanato-1',1'-dimethylheptyl-THC was evaluated for its affinity for cannabinoid binding sites using rat forebrain membrane prepns. and found to have an apparent IC50 value of 660 pM.  Incubation of the membrane prepn. with a ligand concn. of five times the apparent IC50 resulted in the irreversible occupation of nearly all of the receptor specific binding sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol9uFxlSTc8rVg90H21EOLACvtfcHk0ljZuy2T6tX5pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlsF2mtL4%253D&md5=0095f207a51839c553ba6177ff3e7a6d</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2895%2900176-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252895%252900176-7%26sid%3Dliteratum%253Aachs%26aulast%3DMorse%26aufirst%3DK.%2BL.%26aulast%3DFournier%26aufirst%3DD.%2BJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGrzybowska%26aufirst%3DJ.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DA%2520novel%2520electrophilic%2520high%2520affinity%2520irreversible%2520probe%2520for%2520the%2520cannabinoid%2520receptor%26jtitle%3DLife%2520Sci.%26date%3D1995%26volume%3D56%26spage%3D1957%26epage%3D1962%26doi%3D10.1016%2F0024-3205%2895%2900176-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernando, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCallion, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">769</span>– <span class="NLM_lpage">776</span>, <span class="refDoi"> DOI: 10.1021/jm980363y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm980363y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaK1MXosV2ksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=769-776&author=R.+Lanauthor=Q.+Liuauthor=P.+Fanauthor=S.+Linauthor=S.+R.+Fernandoauthor=D.+McCallionauthor=R.+Pertweeauthor=A.+Makriyannis&title=Structure-activity+relationships+of+pyrazole+derivatives+as+cannabinoid+receptor+antagonists&doi=10.1021%2Fjm980363y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships of Pyrazole Derivatives as Cannabinoid Receptor Antagonists</span></div><div class="casAuthors">Lan, Ruoxi; Liu, Qian; Fan, Pusheng; Lin, Sonyuan; Fernando, Susanthi R.; McCallion, Deirdre; Pertwee, Roger; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">769-776</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As a potent, specific antagonist for the brain cannabinoid receptor (CB1), the diarylpyrazole N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A; 1) was the lead compd. for initiating studies designed to examine the structure-activity relationships of related compds. and to search for more selective and potent cannabimimetic ligands.  A series of pyrazole derivs. was designed and synthesized to aid in the characterization of the cannabinoid receptor binding sites and also to serve as potentially useful pharmacol. probes.  Therapeutically, such compds. may have the ability to antagonize harmful side effects of cannabinoids and cannabimimetic agents.  Structural requirements for potent and selective brain cannabinoid CB1 receptor antagonistic activity included (a) a para-substituted Ph ring at the 5-position, (b) a carboxamido group at the 3-position, and (c) a 2,4-dichlorophenyl substituent at the 1-position of the pyrazole ring.  The most potent compd. of this series contained a p-iodophenyl group at the 5-position, a piperidinyl carboxamide at the 3-position, and a 2,4-dichlorophenyl group at the 1-position of the pyrazole ring.  The iodinated nature of this compd. offers addnl. utility as a γ-enriching SPECT (single photon emission computed tomog.) ligand that may be useful in characterizing brain CB1 receptor binding in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl-2XxTDUh5LVg90H21EOLACvtfcHk0lhBzi25Wt2ssw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXosV2ksQ%253D%253D&md5=9ac628db8666c2aadef40fa04619d687</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm980363y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980363y%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DFan%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DFernando%26aufirst%3DS.%2BR.%26aulast%3DMcCallion%26aufirst%3DD.%26aulast%3DPertwee%26aufirst%3DR.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DStructure-activity%2520relationships%2520of%2520pyrazole%2520derivatives%2520as%2520cannabinoid%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D769%26epage%3D776%26doi%3D10.1021%2Fjm980363y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Structure and function of fatty acid amide hydrolase</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">432</span>, <span class="refDoi"> DOI: 10.1146/annurev.biochem.74.082803.133450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1146%2Fannurev.biochem.74.082803.133450" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=15952893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVensL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2005&pages=411-432&author=M.+K.+McKinneyauthor=B.+F.+Cravatt&title=Structure+and+function+of+fatty+acid+amide+hydrolase&doi=10.1146%2Fannurev.biochem.74.082803.133450"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of fatty acid amide hydrolase</span></div><div class="casAuthors">McKinney, Michele K.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">411-432</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Fatty acid amide hydrolase (FAAH) is a mammalian integral membrane enzyme that degrades the fatty acid amide family of endogenous signaling lipids, which includes the endogenous cannabinoid, anandamide, and the sleep-inducing substance, oleamide.  FAAH belongs to a large and diverse class of enzymes referred to as the amidase signature (AS) family.  Investigations into the structure and function of FAAH, in combination with complementary studies of other AS enzymes, have engendered provocative mol. models to explain how this enzyme integrates into cell membranes and terminates fatty acid amide signaling in vivo.  These studies, as well as their biol. and therapeutic implications, are the subject of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprO7TpUTr6n7Vg90H21EOLACvtfcHk0lhBzi25Wt2ssw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVensL4%253D&md5=d28b43f14feb6894d48e907064087867</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.74.082803.133450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.74.082803.133450%26sid%3Dliteratum%253Aachs%26aulast%3DMcKinney%26aufirst%3DM.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DStructure%2520and%2520function%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2005%26volume%3D74%26spage%3D411%26epage%3D432%26doi%3D10.1146%2Fannurev.biochem.74.082803.133450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turk, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoka, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasiljeva, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, D.</span></span> <span> </span><span class="NLM_article-title">Cysteine cathepsins: from structure, function and regulation to new frontiers</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1824</i></span>,  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2011.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.bbapap.2011.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=22024571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOns7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1824&publication_year=2012&pages=68-88&author=V.+Turkauthor=V.+Stokaauthor=O.+Vasiljevaauthor=M.+Renkoauthor=T.+Sunauthor=B.+Turkauthor=D.+Turk&title=Cysteine+cathepsins%3A+from+structure%2C+function+and+regulation+to+new+frontiers&doi=10.1016%2Fj.bbapap.2011.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteine cathepsins: From structure, function and regulation to new frontiers</span></div><div class="casAuthors">Turk, Vito; Stoka, Veronika; Vasiljeva, Olga; Renko, Miha; Sun, Tao; Turk, Boris; Turk, Dusan</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1824</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-88</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  It is more than 50 years since the lysosome was discovered.  Since then its hydrolytic machinery, including proteases and other hydrolases, has been fairly well identified and characterized.  Among these are the cysteine cathepsins, members of the family of papain-like cysteine proteases.  They have unique reactive-site properties and an uneven tissue-specific expression pattern.  In living organisms, their activity is a delicate balance of expression, targeting, zymogen activation, inhibition by protein inhibitors and degrdn.  The specificity of their substrate binding sites, small-mol. inhibitor repertoire and crystal structures are providing new tools for research and development.  Their unique reactive-site properties have made it possible to confine the targets simply by the use of appropriate reactive groups.  The epoxysuccinyls still dominate the field, but now nitriles seem to be the most appropriate "warhead".  The view of cysteine cathepsins as lysosomal proteases is changing as there is now clear evidence of their localization in other cellular compartments.  Besides being involved in protein turnover, they build an important part of endosomal antigen presentation.  Together with the growing no. of non-endosomal roles of cysteine cathepsins is growing also the knowledge of their involvement in diseases such as cancer and rheumatoid arthritis, among others.  Finally, cysteine cathepsins are important regulators and signaling mols. of an unimaginable no. of biol. processes.  The current challenge is to identify their endogenous substrates, in order to gain an insight into the mechanisms of substrate degrdn. and processing.  In this review, some of the remarkable advances that have taken place in the past decade are presented.  This article is part of a Special Issue entitled: Proteolysis 50 years after the discovery of lysosome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUEZ0u2P21D7Vg90H21EOLACvtfcHk0ljcv9P6MpMa8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOns7rI&md5=8615c1f0205d66b0fad932d6ff874390</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2011.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2011.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DV.%26aulast%3DStoka%26aufirst%3DV.%26aulast%3DVasiljeva%26aufirst%3DO.%26aulast%3DRenko%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DT.%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DTurk%26aufirst%3DD.%26atitle%3DCysteine%2520cathepsins%253A%2520from%2520structure%252C%2520function%2520and%2520regulation%2520to%2520new%2520frontiers%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2012%26volume%3D1824%26spage%3D68%26epage%3D88%26doi%3D10.1016%2Fj.bbapap.2011.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheu, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmuth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fluhr, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Man, M.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feingold, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoonjans, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auwerx, J.</span></span> <span> </span><span class="NLM_article-title">Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models</span>. <i>J. Invest. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1046/j.0022-202x.2001.01626.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1046%2Fj.0022-202x.2001.01626.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=11851881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1Wgu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2002&pages=94-101&author=M.+Y.+Sheuauthor=A.+J.+Fowlerauthor=J.+Kaoauthor=M.+Schmuthauthor=J.+W.+Fluhrauthor=M.-Q.+Manauthor=P.+M.+Eliasauthor=K.+R.+Feingoldauthor=K.+Schoonjansauthor=J.+Auwerx&title=Topical+peroxisome+proliferator+activated+receptor-alpha+activators+reduce+inflammation+in+irritant+and+allergic+contact+dermatitis+models&doi=10.1046%2Fj.0022-202x.2001.01626.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Topical peroxisome proliferator activated receptor-α activators reduce inflammation in irritant and allergic contact dermatitis models</span></div><div class="casAuthors">Sheu, Mary Y.; Fowler, Ashley J.; Kao, Jack; Schmuth, Matthias; Schoonjans, Kristina; Auwerx, Johan; Fluhr, Joachim W.; Man, Mao-Qiang; Elias, Peter M.; Feingold, Kenneth R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Investigative Dermatology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">94-101</span>CODEN:
                <span class="NLM_cas:coden">JIDEAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-202X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science, Inc.</span>)
        </div><div class="casAbstract">Activators of peroxisome proliferator activated receptor-α, a nuclear hormone receptor that heterodimerizes with retinoid X receptor, stimulate epidermal differentiation and inhibit proliferation.  Here the authors detd. the anti-inflammatory effects of peroxisome proliferator activated receptor-α agonists in models of irritant and allergic contact dermatitis produced in mouse ears by topical treatment with 12-O-tetradecanoylphorbol-13-acetate and oxazolone, resp.  As expected, 12-O-tetradecanoylphorbol-13-acetate treatment resulted in a marked increase in the thickness and wt. of the ears and provoked an inflammatory cell infiltrate in the dermis.  Topical treatment with three different peroxisome proliferator activated receptor-α agonists, clofibrate, WY 14643, or linoleic acid, 45 min and 4 h after 12-O-tetradecanoylphorbol-13-acetate application, resulted in a marked decrease in ear thickness and wt. and a redn. in the no. of inflammatory cells in the dermis.  The redn. in inflammation by these peroxisome proliferator activated receptor-α agonists was of similar magnitude to that seen with a potent topical glucocorticoid, clobetasol.  In contrast, stearic acid, a free fatty acid that does not activate peroxisome proliferator activated receptor-α, had no effect on the 12-O-tetradecanoylphorbol-13-acetate-induced inflammation.  Moreover, clofibrate did not significantly alter ear thickness following 12-O-tetradecanoylphorbol-13-acetate treatment in peroxisome proliferator activated receptor-α-/- mice, indicating that the anti-inflammatory effect is mediated by peroxisome proliferator activated receptor-α.  As tumor necrosis factor-α and interleukin-1α are major mediators of cutaneous inflammation, the authors next used immunohistochem. to det. whether the peroxisome proliferator activated receptor-α agonists reduce the levels of these cytokines in 12-O-tetradecanoylphorbol-13-acetate-treated skin.  12-O-tetradecanoylphorbol-13-acetate treatment resulted in an increase in tumor necrosis factor and interleukin-1α staining in the epidermis that was reduced by clofibrate treatment.  Finally, clofibrate treatment also reduced ear thickness and wt. in oxazolone-induced allergic dermatitis, a change that was accompanied by a redn. in inflammatory cells in the dermis and a decrease in tumor necrosis factor-α and interleukin-1α levels in the oxazolone-treated epidermis.  These studies demonstrate that topically applied peroxisome proliferator activated receptor-α agonists possess receptor mediated, anti-inflammatory activity in both irritant and allergic contact dermatitis animal models.  The anti-inflammatory properties of peroxisome proliferator activated receptor-α agonists, coupled with their anti-proliferative and pro-differentiating effects, suggest that they could be beneficial for the treatment of a variety of cutaneous diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokKoesOGEuhrVg90H21EOLACvtfcHk0li__LKBwtIbDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1Wgu7w%253D&md5=6c735d78b2ff642632299141c682fcef</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1046%2Fj.0022-202x.2001.01626.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0022-202x.2001.01626.x%26sid%3Dliteratum%253Aachs%26aulast%3DSheu%26aufirst%3DM.%2BY.%26aulast%3DFowler%26aufirst%3DA.%2BJ.%26aulast%3DKao%26aufirst%3DJ.%26aulast%3DSchmuth%26aufirst%3DM.%26aulast%3DFluhr%26aufirst%3DJ.%2BW.%26aulast%3DMan%26aufirst%3DM.-Q.%26aulast%3DElias%26aufirst%3DP.%2BM.%26aulast%3DFeingold%26aufirst%3DK.%2BR.%26aulast%3DSchoonjans%26aufirst%3DK.%26aulast%3DAuwerx%26aufirst%3DJ.%26atitle%3DTopical%2520peroxisome%2520proliferator%2520activated%2520receptor-alpha%2520activators%2520reduce%2520inflammation%2520in%2520irritant%2520and%2520allergic%2520contact%2520dermatitis%2520models%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2002%26volume%3D118%26spage%3D94%26epage%3D101%26doi%3D10.1046%2Fj.0022-202x.2001.01626.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genovese, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muià, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centorrino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caputi, A. P.</span></span> <span> </span><span class="NLM_article-title">Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-alpha) in the development of inflammatory bowel disease in mice</span>. <i>Lab. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">1643</span>– <span class="NLM_lpage">1654</span>, <span class="refDoi"> DOI: 10.1038/labinvest.3700185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1038%2Flabinvest.3700185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=15492755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFChtL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2004&pages=1643-1654&author=S.+Cuzzocreaauthor=R.+Di+Paolaauthor=E.+Mazzonauthor=T.+Genoveseauthor=C.+Mui%C3%A0author=T.+Centorrinoauthor=A.+P.+Caputi&title=Role+of+endogenous+and+exogenous+ligands+for+the+peroxisome+proliferators+activated+receptors+alpha+%28PPAR-alpha%29+in+the+development+of+inflammatory+bowel+disease+in+mice&doi=10.1038%2Flabinvest.3700185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-α) in the development of inflammatory bowel disease in mice</span></div><div class="casAuthors">Cuzzocrea, Salvatore; di Paola, Rosanna; Mazzon, Emanuela; Genovese, Tiziana; Muia, Carmelo; Centorrino, Tommaso; Caputi, Achille P.</div><div class="citationInfo"><span class="NLM_cas:title">Laboratory Investigation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1643-1654</span>CODEN:
                <span class="NLM_cas:coden">LAINAW</span>;
        ISSN:<span class="NLM_cas:issn">0023-6837</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The peroxisome proliferator-activated receptor-α (PPAR-α) is a member of the nuclear receptor superfamily of ligand-dependent transcription factors related to retinoid, steroid and thyroid hormone receptors.  The aim of the present study was to examine the effects of endogenous and exogenous PPAR-α ligand on the development of exptl. colitis.  To address this question, we used an exptl. model of colitis, induced by dinitrobenzene sulfonic acid (DNBS).  When compared to DNBS-treated PPAR-α wild-type (WT) mice, DNBS-treated PPAR-α knockout mice (PPAR-αKO) mice experienced a higher rate of the extent and severity of the histol. signs of colon injury.  After administration of DNBS PPAR-αWT mice experienced hemorrhagic diarrhea, wt. loss and large areas of necrosis in the mucosa of the colon were also obsd.  Neutrophil infiltration was assocd. with upregulation of ICAM-1.  Immunohistochem. for nitrotyrosine showed an intense staining in the inflamed colon.  Absence of a functional PPAR-α gene in PPAR-αKO mice resulted in a significant augmentation of all the above-described parameters.  On the contrary, the treatment of PPAR-αWT with Wy-14643 (1 mg/kg daily i.p) significantly reduced: (i) the degree of hemorrhagic diarrhea and wt. loss, (ii) the degree of colon injury, (iii) the rise in MPO activity (mucosa), (iv) the increase in staining (immunohistochem.) for nitrotyrosine, as well as (v) the upregulation of ICAM-1 caused by DNBS in the colon.  In order to elucidate whether the protective effects of Wy-14643 is related to activation of the PPAR-α receptor, we also investigated the effect the of Wy-14643 treatment on PPAR-α-deficient mice.  The absence of the PPAR-α receptor significantly abolished the protective effect of the PPAR-α agonist against DNBS-induced colitis.  Thus, endogenous and exogenous PPAR-α ligands reduce the degree of colitis caused by DNBS.  We propose that PPAR-α ligand may be useful in the treatment of inflammatory bowel disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph2TYuskT6PrVg90H21EOLACvtfcHk0li__LKBwtIbDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFChtL3M&md5=f0eae11a30cd3d70dd95c47ae8042969</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Flabinvest.3700185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Flabinvest.3700185%26sid%3Dliteratum%253Aachs%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DDi%2BPaola%26aufirst%3DR.%26aulast%3DMazzon%26aufirst%3DE.%26aulast%3DGenovese%26aufirst%3DT.%26aulast%3DMui%25C3%25A0%26aufirst%3DC.%26aulast%3DCentorrino%26aufirst%3DT.%26aulast%3DCaputi%26aufirst%3DA.%2BP.%26atitle%3DRole%2520of%2520endogenous%2520and%2520exogenous%2520ligands%2520for%2520the%2520peroxisome%2520proliferators%2520activated%2520receptors%2520alpha%2520%2528PPAR-alpha%2529%2520in%2520the%2520development%2520of%2520inflammatory%2520bowel%2520disease%2520in%2520mice%26jtitle%3DLab.%2520Invest.%26date%3D2004%26volume%3D84%26spage%3D1643%26epage%3D1654%26doi%3D10.1038%2Flabinvest.3700185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calignano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Rana, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loubet-Lescoulié, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">A role for the endogenous cannabinoid system in the peripheral control of pain initiation</span>. <i>Prog. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">471</span>– <span class="NLM_lpage">482</span>, <span class="refDoi"> DOI: 10.1016/s0079-6123(00)29034-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fs0079-6123%2800%2929034-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=11098711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD3cXos1yjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2000&pages=471-482&author=A.+Calignanoauthor=G.+La+Ranaauthor=P.+Loubet-Lescouli%C3%A9author=D.+Piomelli&title=A+role+for+the+endogenous+cannabinoid+system+in+the+peripheral+control+of+pain+initiation&doi=10.1016%2Fs0079-6123%2800%2929034-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">A role for the endogenous cannabinoid system in the peripheral control of pain initiation</span></div><div class="casAuthors">Calignano, Antonio; La Rana, Giovanna; Loubet-Lescoulie, Patrick; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">Nervous System Plasticity and Chronic Pain</span>),
    <span class="NLM_cas:pages">471-482</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with 71 refs.  Topics discussed include endocannabinoid formation and inactivation; cannabinoid receptors; central modulation of pain signaling; peripheral modulation of pain signaling; palmitylethanolamide as a peripheral analgesic; and the synergistic inhibition of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNWalIvFXUebVg90H21EOLACvtfcHk0lhDEDelrso3sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXos1yjt7g%253D&md5=9029bc00f7e5847741ec3d86be40404a</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fs0079-6123%2800%2929034-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0079-6123%252800%252929034-1%26sid%3Dliteratum%253Aachs%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DLoubet-Lescouli%25C3%25A9%26aufirst%3DP.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DA%2520role%2520for%2520the%2520endogenous%2520cannabinoid%2520system%2520in%2520the%2520peripheral%2520control%2520of%2520pain%2520initiation%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D2000%26volume%3D129%26spage%3D471%26epage%3D482%26doi%3D10.1016%2Fs0079-6123%2800%2929034-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandevoorde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diependaele, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govaerts, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, A. R.</span></span> <span> </span><span class="NLM_article-title">Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice</span>. <i>Epilepsia</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">321</span>, <span class="refDoi"> DOI: 10.1046/j.1528-1157.2001.41499.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1046%2Fj.1528-1157.2001.41499.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=11442148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1Oqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=321&author=D.+M.+Lambertauthor=S.+Vandevoordeauthor=G.+Diependaeleauthor=S.+J.+Govaertsauthor=A.+R.+Robert&title=Anticonvulsant+activity+of+N-palmitoylethanolamide%2C+a+putative+endocannabinoid%2C+in+mice&doi=10.1046%2Fj.1528-1157.2001.41499.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice</span></div><div class="casAuthors">Lambert, Didier M.; Vandevoorde, Severine; Diependaele, Gerald; Govaerts, Sophie J.; Robert, Annie R.</div><div class="citationInfo"><span class="NLM_cas:title">Epilepsia</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">321-327</span>CODEN:
                <span class="NLM_cas:coden">EPILAK</span>;
        ISSN:<span class="NLM_cas:issn">0013-9580</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science, Inc.</span>)
        </div><div class="casAbstract">The purpose of this study was to evaluate in mice the anticonvulsant potential of N-palmitoylethanolamide, a putative endocannabinoid that accumulates in the body during inflammatory processes.  N-palmitoylethanolamide was injected i.p. in mice and evaluated for anticonvulsant activity [in maximal electroshock seizure (MES) and chem.-induced convulsions] and for neurol. impairment (rotorod).  It was compared with anandamide and with different palmitic acid analogs as well as with ref. anticonvulsants (AEDs) injected under the same conditions.  The MES test showed, after i.p. administration to mice, that N-palmitoylethanolamide had a median ED (ED50) value comparable to that of phenytoin (PHT; 8.9 and 9.2 mg/kg, resp.).  In the s.c. pentylenetetrazol test and in the 3-mercaptopropionic acid test, it was effective only against tonic convulsions.  N-palmitoylethanolamide was devoid of neurol. impairment ≤250 mg/kg, yielding a high protective index.  N-palmitoylethanolamide, an endogenous compd. with antiinflammatory and analgesic activities, is a potent AED in mice.  Its precise mechanism of action remains to be elucidated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9ijVptdycIbVg90H21EOLACvtfcHk0lhDEDelrso3sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1Oqt7s%253D&md5=5dc8d225903bb4782bed598532677017</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1046%2Fj.1528-1157.2001.41499.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1528-1157.2001.41499.x%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DVandevoorde%26aufirst%3DS.%26aulast%3DDiependaele%26aufirst%3DG.%26aulast%3DGovaerts%26aufirst%3DS.%2BJ.%26aulast%3DRobert%26aufirst%3DA.%2BR.%26atitle%3DAnticonvulsant%2520activity%2520of%2520N-palmitoylethanolamide%252C%2520a%2520putative%2520endocannabinoid%252C%2520in%2520mice%26jtitle%3DEpilepsia%26date%3D2001%26volume%3D42%26spage%3D321%26doi%3D10.1046%2Fj.1528-1157.2001.41499.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">West, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitten, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase</span>. <i>J. Proteome Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">972</span>– <span class="NLM_lpage">981</span>, <span class="refDoi"> DOI: 10.1021/pr200735a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr200735a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyhurnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=972-981&author=J.+M.+Westauthor=N.+Zvonokauthor=K.+M.+Whittenauthor=J.+T.+Woodauthor=A.+Makriyannis&title=Mass+spectrometric+characterization+of+human+N-acylethanolamine-hydrolyzing+acid+amidase&doi=10.1021%2Fpr200735a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Mass Spectrometric Characterization of Human N-Acylethanolamine-hydrolyzing Acid Amidase</span></div><div class="casAuthors">West, Jay M.; Zvonok, Nikolai; Whitten, Kyle M.; Wood, JodiAnne T.; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">972-981</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Acylethanolamine-hydrolyzing acid amidase (NAAA) is a lysosomal enzyme that primarily degrades palmitoylethanolamine (PEA), a lipid amide that inhibits inflammatory responses.  We developed a HEK293 cell line stably expressing the NAAA pro-enzyme (zymogen) and a single step chromatog. purifn. of the protein from the media.  Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry MALDI-TOF MS anal. of the zymogen (47.7 kDa) treated with peptide-N-glycosidase F (PNGase F) identified 4 glycosylation sites, and acid cleavage of the zymogen into α- and β-subunits (14.6 and 33.3 kDa) activated the enzyme.  Size exclusion chromatog. estd. the mass of the active enzyme as 45±3 kDa, suggesting formation of an α/β heterodimer.  MALDI-TOF MS fingerprinting covered more than 80% of the amino acid sequence, including the N-terminal peptides, and evidence for the lack of a disulfide bond between subunits.  The significance of the cysteine residues was established by their selective alkylation resulting in almost complete loss of activity.  The purified enzyme was kinetically characterized with PEA and a novel fluorogenic substrate, N-(4-Me coumarin) palmitamide (PAMCA).  The prodn. of sufficient quantities of NAAA and a high throughput assay could be useful in discovering novel inhibitors and detg. the structure and function of this enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsHb2ZNlA6QbVg90H21EOLACvtfcHk0lhDEDelrso3sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyhurnL&md5=b90eb948e0d859a08f4a777114820c94</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fpr200735a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr200735a%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DJ.%2BM.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DWhitten%26aufirst%3DK.%2BM.%26aulast%3DWood%26aufirst%3DJ.%2BT.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DMass%2520spectrometric%2520characterization%2520of%2520human%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2012%26volume%3D11%26spage%3D972%26epage%3D981%26doi%3D10.1021%2Fpr200735a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mileni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everdeen, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pabst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nugent, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamtekar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure-guided inhibitor design for human FAAH by interspecies active site conversion</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">12820</span>– <span class="NLM_lpage">12824</span>, <span class="refDoi"> DOI: 10.1073/pnas.0806121105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1073%2Fpnas.0806121105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=18753625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSmtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=12820-12824&author=M.+Mileniauthor=D.+S.+Johnsonauthor=Z.+Wangauthor=D.+S.+Everdeenauthor=M.+Liimattaauthor=B.+Pabstauthor=K.+Bhattacharyaauthor=R.+A.+Nugentauthor=S.+Kamtekarauthor=B.+F.+Cravattauthor=K.+Ahnauthor=R.+C.+Stevens&title=Structure-guided+inhibitor+design+for+human+FAAH+by+interspecies+active+site+conversion&doi=10.1073%2Fpnas.0806121105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided inhibitor design for human FAAH by interspecies active site conversion</span></div><div class="casAuthors">Mileni, Mauro; Johnson, Douglas S.; Wang, Zhigang; Everdeen, Daniel S.; Liimatta, Marya; Pabst, Brandon; Bhattacharya, Keshab; Nugent, Richard A.; Kamtekar, Satwik; Cravatt, Benjamin F.; Ahn, Kay; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">12820-12824</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The integral membrane enzyme fatty acid amide hydrolase (FAAH) hydrolyzes the endocannabinoid anandamide and related amidated signaling lipids.  Genetic or pharmacol. inactivation of FAAH produces analgesic, anxiolytic, and antiinflammatory phenotypes but not the undesirable side effects of direct cannabinoid receptor agonists, indicating that FAAH may be a promising therapeutic target.  Structure-based inhibitor design has, however, been hampered by difficulties in expressing the human FAAH enzyme.  Here, we address this problem by interconverting the active sites of rat and human FAAH using site-directed mutagenesis.  The resulting humanized rat (h/r) FAAH protein exhibits the inhibitor sensitivity profiles of human FAAH but maintains the high-expression yield of the rat enzyme.  We report a 2.75-Å crystal structure of h/rFAAH complexed with an inhibitor, N-phenyl-4- (quinolin-3-ylmethyl)piperidine-1-carboxamide (PF-750), that shows strong preference for human FAAH.  This structure offers compelling insights to explain the species selectivity of FAAH inhibitors, which should guide future drug design programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq16BzSUEI2DbVg90H21EOLACvtfcHk0lhDEDelrso3sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSmtrvP&md5=bebc9409a5e71734f651c5ab89303fad</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0806121105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0806121105%26sid%3Dliteratum%253Aachs%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DEverdeen%26aufirst%3DD.%2BS.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DPabst%26aufirst%3DB.%26aulast%3DBhattacharya%26aufirst%3DK.%26aulast%3DNugent%26aufirst%3DR.%2BA.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure-guided%2520inhibitor%2520design%2520for%2520human%2520FAAH%2520by%2520interspecies%2520active%2520site%2520conversion%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D12820%26epage%3D12824%26doi%3D10.1073%2Fpnas.0806121105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mileni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beidler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weerapana, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadagopan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazerwith, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiff, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamtekar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaney, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Becelaere, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">420</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2009.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.chembiol.2009.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=19389627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVCms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=411-420&author=K.+Ahnauthor=D.+S.+Johnsonauthor=M.+Mileniauthor=D.+Beidlerauthor=J.+Z.+Longauthor=M.+K.+McKinneyauthor=E.+Weerapanaauthor=N.+Sadagopanauthor=M.+Liimattaauthor=S.+E.+Smithauthor=S.+Lazerwithauthor=C.+Stiffauthor=S.+Kamtekarauthor=K.+Bhattacharyaauthor=Y.+Zhangauthor=S.+Swaneyauthor=K.+Van+Becelaereauthor=R.+C.+Stevensauthor=B.+F.+Cravatt&title=Discovery+and+characterization+of+a+highly+selective+FAAH+inhibitor+that+reduces+inflammatory+pain&doi=10.1016%2Fj.chembiol.2009.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain</span></div><div class="casAuthors">Ahn, Kay; Johnson, Douglas S.; Mileni, Mauro; Beidler, David; Long, Jonathan Z.; McKinney, Michele K.; Weerapana, Eranthie; Sadagopan, Nalini; Liimatta, Marya; Smith, Sarah E.; Lazerwith, Scott; Stiff, Cory; Kamtekar, Satwik; Bhattacharya, Keshab; Zhang, Yanhua; Swaney, Stephen; Van Becelaere, Keri; Stevens, Raymond C.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">411-420</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Endocannabinoids are lipid signaling mols. that regulate a wide range of mammalian behaviors, including pain, inflammation, and cognitive/emotional state.  The endocannabinoid anandamide is principally degraded by the integral membrane enzyme fatty acid amide hydrolase (FAAH), and there is currently much interest in developing FAAH inhibitors to augment endocannabinoid signaling in vivo.  Here, we report the discovery and detailed characterization of a highly efficacious and selective FAAH inhibitor, PF-3845.  Mechanistic and structural studies confirm that PF-3845 is a covalent inhibitor that carbamylates FAAH's serine nucleophile.  PF-3845 selectively inhibits FAAH in vivo, as detd. by activity-based protein profiling; raises brain anandamide levels for up to 24 h; and produces significant cannabinoid receptor-dependent redns. in inflammatory pain.  These data thus designate PF-3845 as a valuable pharmacol. tool for in vivo characterization of the endocannabinoid system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWANdntofbhbVg90H21EOLACvtfcHk0lg9ApJVRnQP1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVCms7w%253D&md5=c418dbdf626109415af7001db5a7cb93</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DMcKinney%26aufirst%3DM.%2BK.%26aulast%3DWeerapana%26aufirst%3DE.%26aulast%3DSadagopan%26aufirst%3DN.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DLazerwith%26aufirst%3DS.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DBhattacharya%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSwaney%26aufirst%3DS.%26aulast%3DVan%2BBecelaere%26aufirst%3DK.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520a%2520highly%2520selective%2520FAAH%2520inhibitor%2520that%2520reduces%2520inflammatory%2520pain%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D411%26epage%3D420%26doi%3D10.1016%2Fj.chembiol.2009.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falgueyret, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesolowski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydzewski, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasit, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riendeau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodan, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percival, M. D.</span></span> <span> </span><span class="NLM_article-title">Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1021/jm0003440</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0003440" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD3cXos1ajs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=94-104&author=J.-P.+Falgueyretauthor=R.+M.+Oballaauthor=O.+Okamotoauthor=G.+Wesolowskiauthor=Y.+Aubinauthor=R.+M.+Rydzewskiauthor=P.+Prasitauthor=D.+Riendeauauthor=S.+B.+Rodanauthor=M.+D.+Percival&title=Novel%2C+nonpeptidic+cyanamides+as+potent+and+reversible+inhibitors+of+human+cathepsins+K+and+L&doi=10.1021%2Fjm0003440"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Novel, Nonpeptidic Cyanamides as Potent and Reversible Inhibitors of Human Cathepsins K and L</span></div><div class="casAuthors">Falgueyret, Jean-Pierre; Oballa, Renata M.; Okamoto, Osamu; Wesolowski, Gregg; Aubin, Yves; Rydzewski, Robert M.; Prasit, Peppi; Riendeau, Denis; Rodan, Sevgi B.; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">94-104</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compds. contg. a 1-cyanopyrrolidinyl ring were identified as potent and reversible inhibitors of cathepsins K and L.  The original lead compd. I inhibits cathepsins K and L with IC50 values of 0.37 and 0.45 μM, resp.  Modification of compd. I by replacement of the quinoline moiety led to the synthesis of N-(1-cyano-3-pyrrolidinyl)benzenesulfonamide (2).  Compd. II was found to be a potent inhibitor of cathepsins K and L with a Ki value of 50 nM for cathepsin K.  Replacement of the 1-cyanopyrrolidine of compd. II by a 1-cyanoazetidine increased the potency of the inhibitor by 10-fold.  This increase in potency is probably due to an enhanced chem. reactivity of the compd. toward the thiolate of the active site of the enzyme.  This is demonstrated when the assay is performed in the presence of glutathione at pH 7.0 which favors the formation of a GSH thiolate anion.  Under these assay conditions, there is a loss of potency in the 1-cyanoazetidine series due to the formation of an inactive complex between the GSH thiolate and the 1-cyanoazetidine inhibitors. 1-Cyanopyrrolidinyl inhibitors exhibited time-dependent inhibition which allowed us to det. the assocn. and dissocn. rate consts. with human cathepsin K.  The kinetic data obtained showed that the increase of potency obsd. between different 1-cyanopyrrolidinyl inhibitors is due to an increase of kon values and that the assocn. of the compd. with the enzyme fits an apparent one-step mechanism. 13C NMR expts. performed with the enzyme papain showed that compd. 2 forms a covalent isothiourea ester adduct with the enzyme.  As predicted by the kinetic anal., the addn. of the irreversible inhibitor E64 to the enzyme-cyanopyrrolidinyl complex totally abolished the signal of the isothiourea bond as obsd. by 13C NMR, thereby demonstrating that the formation of the covalent bond with the active site cysteine residue is reversible. Finally, compd. II inhibits bone resorption in an in vitro assay involving rabbit osteoclasts and bovine bone with an IC50 value of 0.7 μM. 1-Cyanopyrrolidine represents a new class of nonpeptidic compds. that inhibit cathepsin K and L activity and proteolysis of bone collagen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWnsb8us0GkrVg90H21EOLACvtfcHk0lg9ApJVRnQP1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXos1ajs7g%253D&md5=aed27c1353797e413890ea02d900095b</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm0003440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0003440%26sid%3Dliteratum%253Aachs%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DOkamoto%26aufirst%3DO.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DAubin%26aufirst%3DY.%26aulast%3DRydzewski%26aufirst%3DR.%2BM.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DNovel%252C%2520nonpeptidic%2520cyanamides%2520as%2520potent%2520and%2520reversible%2520inhibitors%2520of%2520human%2520cathepsins%2520K%2520and%2520L%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D94%26epage%3D104%26doi%3D10.1021%2Fjm0003440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28K1%29+and+the+concentration+of+inhibitor+which+causes+50+per+cent+inhibition+%28I50%29+of+an+enzymatic+reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0litddSUbrxdkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528K1%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2520per%2520cent%2520inhibition%2520%2528I50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hale, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigelow, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormack, J. J.</span></span> <span> </span><span class="NLM_article-title">Analytical and pharmacokinetic studies with 5-chloro-2’-deoxycytidine</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">1493</span>– <span class="NLM_lpage">1502</span>, <span class="refDoi"> DOI: 10.1016/s0006-2952(02)01413-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fs0006-2952%2802%2901413-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=12417262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD38Xotl2mur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2002&pages=1493-1502&author=J.+T.+Haleauthor=J.+C.+Bigelowauthor=L.+A.+Mathewsauthor=J.+J.+McCormack&title=Analytical+and+pharmacokinetic+studies+with+5-chloro-2%E2%80%99-deoxycytidine&doi=10.1016%2Fs0006-2952%2802%2901413-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Analytical and pharmacokinetic studies with 5-chloro-2'-deoxycytidine</span></div><div class="casAuthors">Hale, JodiAnne T.; Bigelow, James C.; Mathews, Linda A.; McCormack, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1493-1502</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">5-Chloro-2'-deoxycytidine (NSC 371331, CDC) is in development as a possible radiosensitizing agent for cancer treatment.  This paper describes preclin. studies to det. the pharmacokinetic properties of CDC and the disposition of the drug, both alone and in the presence of the metabolic modulator tetrahydrouridine (THU), a cytidine deaminase inhibitor.  Detection of the drug in biol. fluids was performed by HPLC on a C-18 column, gradient elution with solvents composed of aq. F3CCO2H and MeCN, and UV absorbance at 290 nm.  Samples were processed by treatment with (NH4)2SO4 prior to injection into the HPLC system.  CDC was stable in aq. soln. and in mouse plasma.  High doses of CDC (100 mg/kg) were given i.v. or i.p. to mice for the detn. of plasma CDC half-life (10 min).  CDC was not detectable in plasma after oral administration.  It was converted rapidly to 5-chloro-2'-deoxyuridine (CDU) by cytidine deaminase, and CDU was readily discernable in plasma and urine collected after i.v. and i.p. administration of CDC.  When CDC in doses ranging 5-100 mg/kg was given with 100 mg THU/kg, increased plasma levels of CDC were seen.  CDC was eliminated through the kidneys, as well as by enzymic deamination, and did not bind to plasma proteins.  The initial steps of the CDC metabolic pathway were detd. in vitro with isolated enzymes.  Cytidine deaminase from mouse kidney converted CDC to CDU; thymidine phosphorylase converted CDU to 5-chlorouracil.  The conclusions of these studies are: CDC is a drug with a short half-life, and it is excreted through the kidneys, mainly in metabolite form.  Administration of THU substantially increased the concns. of CDC in mouse plasma, supporting proposals that the combination of THU with CDC should be evaluated in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC2_-xCofazLVg90H21EOLACvtfcHk0litddSUbrxdkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xotl2mur0%253D&md5=debac7fad27c8a8f9658ffecf212ce80</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fs0006-2952%2802%2901413-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0006-2952%252802%252901413-2%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DJ.%2BT.%26aulast%3DBigelow%26aufirst%3DJ.%2BC.%26aulast%3DMathews%26aufirst%3DL.%2BA.%26aulast%3DMcCormack%26aufirst%3DJ.%2BJ.%26atitle%3DAnalytical%2520and%2520pharmacokinetic%2520studies%2520with%25205-chloro-2%25E2%2580%2599-deoxycytidine%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2002%26volume%3D64%26spage%3D1493%26epage%3D1502%26doi%3D10.1016%2Fs0006-2952%2802%2901413-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janero, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Therapeutic modulation of cannabinoid lipid signaling: metabolic profiling of a novel antinociceptive cannabinoid-2 receptor agonist</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">482</span>– <span class="NLM_lpage">491</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2012.06.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1016%2Fj.lfs.2012.06.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=22749867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVyksb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2013&pages=482-491&author=J.+T.+Woodauthor=D.+M.+Smithauthor=D.+R.+Janeroauthor=A.+M.+Zvonokauthor=A.+Makriyannis&title=Therapeutic+modulation+of+cannabinoid+lipid+signaling%3A+metabolic+profiling+of+a+novel+antinociceptive+cannabinoid-2+receptor+agonist&doi=10.1016%2Fj.lfs.2012.06.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic modulation of cannabinoid lipid signaling: Metabolic profiling of a novel antinociceptive cannabinoid-2 receptor agonist</span></div><div class="casAuthors">Wood, JodiAnne T.; Smith, Dustin M.; Janero, David R.; Zvonok, Alexander M.; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">8-9</span>),
    <span class="NLM_cas:pages">482-491</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">AM-1241, a novel, racemic cannabinoid-2 receptor (CB2) ligand, is the primary exptl. agonist used to characterize the role of CB2-mediated lipid signaling in health and disease, including substance abuse disorders.  In vivo pharmacol. effects have been used as indirect proxies for AM-1241 biotransformation processes that could modulate CB2 activity.  We report the initial pre-clin. characterization of AM-1241 biotransformation and in vivo distribution.AM-1241 metab. was characterized in a variety of predictive in vitro systems (Caco-2 cells; mouse, rat and human microsomes) and in the mouse in vivo.  Liq. chromatog. and mass spectrometry techniques were used to quantify AM-1241 tissue distribution and metabolic conversion.AM-1241 bound extensively to plasma protein/albumin.  A pharmacol. AM-1241 dose (25 mg/kg, i.v.) was administered to mice for direct detn. of its plasma half-life (37 min), following which AM-1241 was quantified in brain, spleen, liver, and kidney.  After p.o. administration, AM-1241 was detected in plasma, spleen, and kidney; its oral bioavailability was ∼ 21%.  From Caco-2 permeability studies and microsomal-based hepatic clearance ests., in vivo AM-1241 absorption was moderate.  Hepatic microsomal metab. of AM-1241 in vitro generated hydroxylation and demethylation metabolites.  Species-dependent differences were discovered in AM-1241's predicted hepatic clearance.  Our data demonstrate that AM-1241 has the following characteristics: a) short plasma half-life; b) limited oral bioavailability; c) extensive plasma/albumin binding; d) metabolic substrate for hepatic hydroxylation and demethylation; e) moderate hepatic clearance.These results should help inform the design, optimization, and pre-clin. profiling of CB2 ligands as pharmacol. tools and medicines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq_9lYdOdaXLVg90H21EOLACvtfcHk0litddSUbrxdkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVyksb%252FI&md5=8b2e3023e1fd8eb9ebfdef3646b4935f</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2012.06.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2012.06.019%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BT.%26aulast%3DSmith%26aufirst%3DD.%2BM.%26aulast%3DJanero%26aufirst%3DD.%2BR.%26aulast%3DZvonok%26aufirst%3DA.%2BM.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DTherapeutic%2520modulation%2520of%2520cannabinoid%2520lipid%2520signaling%253A%2520metabolic%2520profiling%2520of%2520a%2520novel%2520antinociceptive%2520cannabinoid-2%2520receptor%2520agonist%26jtitle%3DLife%2520Sci.%26date%3D2013%26volume%3D92%26spage%3D482%26epage%3D491%26doi%3D10.1016%2Fj.lfs.2012.06.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mohutsky, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ring, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrighton, S. A.</span></span> <span> </span><span class="NLM_article-title">Predictions of the in vivo clearance of drugs from rate of loss using human liver microsomes for phase I and phase II biotransformations</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">654</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1007/s11095-006-9663-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10.1007%2Fs11095-006-9663-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=16550474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD28XktFWjsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2006&pages=654-662&author=M.+A.+Mohutskyauthor=J.+Y.+Chienauthor=B.+J.+Ringauthor=S.+A.+Wrighton&title=Predictions+of+the+in+vivo+clearance+of+drugs+from+rate+of+loss+using+human+liver+microsomes+for+phase+I+and+phase+II+biotransformations&doi=10.1007%2Fs11095-006-9663-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Predictions of the In Vivo Clearance of Drugs from Rate of Loss Using Human Liver Microsomes for Phase I and Phase II Biotransformations</span></div><div class="casAuthors">Mohutsky, Michael A.; Chien, Jenny Y.; Ring, Barbara J.; Wrighton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">654-662</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The utility of in vitro metab. to accurately predict the clearance of hepatically metabolized drugs was evaluated.  Three major goals were: (1) to optimize substrate concn. for the accurate prediction of clearance by comparing to Km value, (2) to prove that clearance of drugs by both oxidn. and glucuronidation may be predicted by this method, and (3) to det. the effects of nonspecific microsomal binding and plasma protein binding.  The apparent Km values for five compds. along with scaled intrinsic clearances and predicted hepatic clearances for eight compds. were detd. using a substrate loss method.  Nonspecific binding to both plasma and microsomal matrixes were also examd. in the clearance calcns.  The Km values were well within the 2-fold variability expected for between lab. comparisons.  Using both phase I and/or phase II glucuronidation incubation conditions, the predictions of in vivo clearance using the substrate loss method were shown to correlate with published human clearance values.  Of particular interest, for highly bound drugs (>95% plasma protein bound), the addn. of a plasma protein binding term increased the accuracy of the prediction of in vivo clearance.  The substrate loss method may be used to accurately predict hepatic clearance of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnnepLV-J41bVg90H21EOLACvtfcHk0lj7DlJ01DIAUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktFWjsL0%253D&md5=f620602ff7a48edfcac290891505c289</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1007%2Fs11095-006-9663-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-006-9663-4%26sid%3Dliteratum%253Aachs%26aulast%3DMohutsky%26aufirst%3DM.%2BA.%26aulast%3DChien%26aufirst%3DJ.%2BY.%26aulast%3DRing%26aufirst%3DB.%2BJ.%26aulast%3DWrighton%26aufirst%3DS.%2BA.%26atitle%3DPredictions%2520of%2520the%2520in%2520vivo%2520clearance%2520of%2520drugs%2520from%2520rate%2520of%2520loss%2520using%2520human%2520liver%2520microsomes%2520for%2520phase%2520I%2520and%2520phase%2520II%2520biotransformations%26jtitle%3DPharm.%2520Res.%26date%3D2006%26volume%3D23%26spage%3D654%26epage%3D662%26doi%3D10.1007%2Fs11095-006-9663-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1350</span>– <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=10534321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1350-1359&author=R.+S.+Obach&title=Prediction+of+human+clearance+of+twenty-nine+drugs+from+hepatic+microsomal+intrinsic+clearance+data%3A+An+examination+of+in+vitro+half-life+approach+and+nonspecific+binding+to+microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1350-1359</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Twenty-nine drugs of disparate structures and physicochem. properties were used in an examn. of the capability of human liver microsomal lability data ("in vitro T1/2" approach) to be useful in the prediction of human clearance.  Addnl., the potential importance of nonspecific binding to microsomes in the in vitro incubation milieu for the accurate prediction of human clearance was investigated.  The compds. examd. demonstrated a wide range of microsomal metabolic labilities with scaled intrinsic clearance values ranging from less than 0.5 mL/min/kg to 189 mL/min/kg.  Microsomal binding was detd. at microsomal protein concns. used in the lability incubations.  For the 29 compds. studied, unbound fractions in microsomes ranged from 0.11 to 1.0.  Generally, basic compds. demonstrated the greatest extent of binding and neutral and acidic compds. the least extent of binding.  In the projection of human clearance values, basic and neutral compds. were well predicted when all binding considerations (blood and microsome) were disregarded, however, including both binding considerations also yielded reasonable predictions.  Including only blood binding yielded very poor projections of human clearance for these two types of compds.  However, for acidic compds., disregarding all binding considerations yielded poor predictions of human clearance.  It was generally most difficult to accurately predict clearance for this class of compds.; however the accuracy was best when all binding considerations were included.  Overall, inclusion of both blood and microsome binding values gave the best agreement between in vivo clearance values and clearance values projected from in vitro intrinsic clearance data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWp2hUTOxyubVg90H21EOLACvtfcHk0lj7DlJ01DIAUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D&md5=7804cd4dfb131caac45aff9b7a1df901</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPrediction%2520of%2520human%2520clearance%2520of%2520twenty-nine%2520drugs%2520from%2520hepatic%2520microsomal%2520intrinsic%2520clearance%2520data%253A%2520An%2520examination%2520of%2520in%2520vitro%2520half-life%2520approach%2520and%2520nonspecific%2520binding%2520to%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1999%26volume%3D27%26spage%3D1350%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span> <i>LigPrep</i>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+LigPrep%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2017."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DLigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farid, R.</span></span> <span> </span><span class="NLM_article-title">Novel procedure for modeling ligand/receptor induced fit effects</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">534</span>– <span class="NLM_lpage">553</span>, <span class="refDoi"> DOI: 10.1021/jm050540c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050540c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCgsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=534-553&author=W.+Shermanauthor=T.+Dayauthor=M.+P.+Jacobsonauthor=R.+A.+Friesnerauthor=R.+Farid&title=Novel+procedure+for+modeling+ligand%2Freceptor+induced+fit+effects&doi=10.1021%2Fjm050540c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Procedure for Modeling Ligand/Receptor Induced Fit Effects</span></div><div class="casAuthors">Sherman, Woody; Day, Tyler; Jacobson, Matthew P.; Friesner, Richard A.; Farid, Ramy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">534-553</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present a novel protein-ligand docking method that accurately accounts for both ligand and receptor flexibility by iteratively combining rigid receptor docking (Glide) with protein structure prediction (Prime) techniques.  While traditional rigid-receptor docking methods are useful when the receptor structure does not change substantially upon ligand binding, success is limited when the protein must be "induced" into the correct binding conformation for a given ligand.  We provide an in-depth description of our novel methodol. and present results for 21 pharmaceutically relevant examples.  Traditional rigid-receptor docking for these 21 cases yields an av. RMSD of 5.5 Å.  The av. ligand RMSD for docking to a flexible receptor for the 21 pairs is 1.4 Å; the RMSD is ≤1.8 Å for 18 of the cases.  For the three cases with RMSDs greater than 1.8 Å, the core of the ligand is properly docked and all key protein/ligand interactions are captured.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm3E6ctnPGSrVg90H21EOLACvtfcHk0lj7DlJ01DIAUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCgsr7I&md5=388811ead5cee1fd460951263de486cb</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjm050540c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050540c%26sid%3Dliteratum%253Aachs%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DFarid%26aufirst%3DR.%26atitle%3DNovel%2520procedure%2520for%2520modeling%2520ligand%252Freceptor%2520induced%2520fit%2520effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D534%26epage%3D553%26doi%3D10.1021%2Fjm050540c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maple, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reboul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupyan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaus, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerutti, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krilov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.5b00864</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=281-296&author=E.+Harderauthor=W.+Dammauthor=J.+Mapleauthor=C.+Wuauthor=M.+Reboulauthor=J.+Y.+Xiangauthor=L.+Wangauthor=D.+Lupyanauthor=M.+K.+Dahlgrenauthor=J.+L.+Knightauthor=J.+W.+Kausauthor=D.+S.+Ceruttiauthor=G.+Krilovauthor=W.+L.+Jorgensenauthor=R.+Abelauthor=R.+A.+Friesner&title=OPLS3%3A+A+Force+Field+Providing+Broad+Coverage+of+Drug-like+Small+Molecules+and+Proteins&doi=10.1021%2Facs.jctc.5b00864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span></div><div class="casAuthors">Harder, Edward; Damm, Wolfgang; Maple, Jon; Wu, Chuanjie; Reboul, Mark; Xiang, Jin Yu; Wang, Lingle; Lupyan, Dmitry; Dahlgren, Markus K.; Knight, Jennifer L.; Kaus, Joseph W.; Cerutti, David S.; Krilov, Goran; Jorgensen, William L.; Abel, Robert; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-296</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and validation of the OPLS3 force field for small mols. and proteins are reported.  Enhancements with respect to the previous version (OPLS2.1) include the addn. of off-atom charge sites to represent halogen bonding and aryl nitrogen lone pairs as well as a complete refit of peptide dihedral parameters to better model the native structure of proteins.  To adequately cover medicinal chem. space, OPLS3 employs over an order of magnitude more ref. data and assocd. parameter types relative to other commonly used small mol. force fields (e.g., MMFF and OPLS_2005).  As a consequence, OPLS3 achieves a high level of accuracy across performance benchmarks that assess small mol. conformational propensities and solvation.  The newly fitted peptide dihedrals lead to significant improvements in the representation of secondary structure elements in simulated peptides and native structure stability over a no. of proteins.  Together, the improvements made to both the small mol. and protein force field lead to a high level of accuracy in predicting protein-ligand binding measured over a wide range of targets and ligands (less than 1 kcal/mol RMS error) representing a 30% improvement over earlier variants of the OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_jrOhcBRgrVg90H21EOLACvtfcHk0lhUeSFinmiLqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE&md5=42663f8cfa84b80a67132bbb13b9b7ce</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00864%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DMaple%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DReboul%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DKaus%26aufirst%3DJ.%2BW.%26aulast%3DCerutti%26aufirst%3DD.%2BS.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DOPLS3%253A%2520A%2520Force%2520Field%2520Providing%2520Broad%2520Coverage%2520of%2520Drug-like%2520Small%2520Molecules%2520and%2520Proteins%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2016%26volume%3D12%26spage%3D281%26epage%3D296%26doi%3D10.1021%2Facs.jctc.5b00864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanschagrin, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span> <span> </span><span class="NLM_article-title">Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6177</span>– <span class="NLM_lpage">6196</span>, <span class="refDoi"> DOI: 10.1021/jm051256o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051256o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6177-6196&author=R.+A.+Friesnerauthor=R.+B.+Murphyauthor=M.+P.+Repaskyauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=T.+A.+Halgrenauthor=P.+C.+Sanschagrinauthor=D.+T.+Mainz&title=Extra+precision+glide%3A+docking+and+scoring+incorporating+a+model+of+hydrophobic+enclosure+for+protein-ligand+complexes&doi=10.1021%2Fjm051256o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span></div><div class="casAuthors">Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P.; Frye, Leah L.; Greenwood, Jeremy R.; Halgren, Thomas A.; Sanschagrin, Paul C.; Mainz, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6177-6196</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel scoring function to est. protein-ligand binding affinities has been developed and implemented as the Glide 4.0 XP scoring function and docking protocol.  In addn. to unique water desolvation energy terms, protein-ligand structural motifs leading to enhanced binding affinity are included:(1) hydrophobic enclosure where groups of lipophilic ligand atoms are enclosed on opposite faces by lipophilic protein atoms, (2) neutral-neutral single or correlated hydrogen bonds in a hydrophobically enclosed environment, and (3) five categories of charged-charged hydrogen bonds.  The XP scoring function and docking protocol have been developed to reproduce exptl. binding affinities for a set of 198 complexes (RMSDs of 2.26 and 1.73 kcal/mol over all and well-docked ligands, resp.) and to yield quality enrichments for a set of fifteen screens of pharmaceutical importance.  Enrichment results demonstrate the importance of the novel XP mol. recognition and water scoring in sepg. active and inactive ligands and avoiding false positives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZiwN12vaY7Vg90H21EOLACvtfcHk0lhUeSFinmiLqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D&md5=ea428c82ead0d8c27f8c1a7b694a1edf</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm051256o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051256o%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DSanschagrin%26aufirst%3DP.%2BC.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26atitle%3DExtra%2520precision%2520glide%253A%2520docking%2520and%2520scoring%2520incorporating%2520a%2520model%2520of%2520hydrophobic%2520enclosure%2520for%2520protein-ligand%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6177%26epage%3D6196%26doi%3D10.1021%2Fjm051256o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DXX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DXX','PDB','6DXX'); return false;">PDB: 6DXX</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i79"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00076">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_10264"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00076?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00076</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Full experimental details of the preparation of the disclosed compounds, methods for testing the compounds, and methods used in the molecular modeling studies (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00076/suppl_file/jm1c00076_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00076/suppl_file/jm1c00076_si_002.csv">CSV</a>)</p></li><li><p class="inline">Induced Fit Docking of inhibitor 36 (<a class="ref showTableEvent internalNav" href="#tbl1">Table <a class="ref showTableEvent internalNav" href="#tbl1">1</a></a>) with a hNAAA structure 6DXX  (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00076/suppl_file/jm1c00076_si_003.pdb">PDB</a>)</p></li><li><p class="inline">Covalent Docking of inhibitor 36 (<a class="ref showTableEvent internalNav" href="#tbl1">Table <a class="ref showTableEvent internalNav" href="#tbl1">1</a></a>) with a hNAAA structure 6DXX (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00076/suppl_file/jm1c00076_si_004.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00076/suppl_file/jm1c00076_si_001.pdf">jm1c00076_si_001.pdf (5.07 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00076/suppl_file/jm1c00076_si_002.csv">jm1c00076_si_002.csv (3.93 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00076/suppl_file/jm1c00076_si_003.pdb">jm1c00076_si_003.pdb (413.89 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00076/suppl_file/jm1c00076_si_004.pdb">jm1c00076_si_004.pdb (421.01 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00076&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-9%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00076" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00076" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67994010db7b24eb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
